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Abstract 
 
Multi electrode array (MEA) systems have evolved from custom-made experimental tools, exploited 
for neural research, into commercially available systems that are used throughout non-invasive 
electrophysiological study. MEA systems are used in conjunction with cells and tissues from a 
number of differing organisms (e.g. mice, monkeys, chickens, plants). The development of MEA 
systems has been incremental over the past 30 years due to constantly changing specific bioscientific 
requirements in research. As the application of MEA systems continues to diversify contemporary 
commercial systems are requiring increased levels of sophistication and greater throughput 
capabilities. 
 
This research has identified current requirements of MEA systems. Generic system requirements, 
and application specific requirements, have been identified and prioritised. Product design 
specifications were drafted and a novel MEA biochip concept was designed. Manufacturing 
approach experimentation occurred until a suitable prototype of the biochip concept was produced. 
This first generation of prototype was tested by MEA system users at the University of Nottingham. 
User feedback and testing outcomes resulted in development of a second design concept that was 
also manufactured and tested.   
 
The research presented in this thesis identifies areas within the field of MEA technology application 
where design changes can bring significant benefits to MEA system users, especially to stem cell-
derived cardiomyocyte MEA system users. This thesis presents novel MEA biochip design concepts 
designed to address specific needs of MEA system users. The prototypes that were manufactured 
and tested have demonstrated promise within this application domain. Further work is required to 
achieve robust signal acquisition from the designs presented. The results of prototype testing have 
also been shared internationally at conference and through journal publications. 
  
Keywords: Multi electrode array, Stem cell-derived cardiomyocyte, Biosensor fabrication. 
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This ThesisChapter 1
Introduction
 
Chapter One 
1Introduction 
 
 
 
 
 
 
This thesis presents research that was conducted to understand contemporary Multi Electrode Array 
(MEA) system application and to define requirements that would lead to a novel system design. This 
research also presents the work conducted in the design, manufacture and testing of resulting novel 
prototype devices.   
 
1.1 Motivation 
This research is focused on the development of a novel Multi Electrode Array (MEA) System. MEA 
systems are tools that allow bioscientists to study electrogenic tissues in vitro by detecting and 
capturing electrical activity. Understanding this activity aids characterisation of cells and 
understanding of the functioning of that particular tissue.  
Technical development of the MEA system could: (1) enhance usability, (2) improve signal 
acquisition, (3) increase the volume of meaningful data that is extracted per test, and (4) reduce 
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time spent setting-up, using and maintaining systems. This thesis presents research undertaken 
during the definition of design-and-build objectives that were used to specify and prototype an MEA 
system-based solution that holds potential to be superior in functionality to current commercially 
available alternatives.   
 
1.2 Current MEA system employment 
Early research focused on protocols documented in literature that described employment of MEA 
systems. Author MEA system users were from institutions all over the world allowing identification 
of the following generic global similarities. Each culture used in conjunction with an MEA is 
prepared, maintained, used and disposed of manually by hand. The cell source(s) of interest must be 
set-up in an MEA biochip in such a manner that is amenable to MEA systems. The user must 
maintain the cells, set-up the MEA system, run the experiments (often timely), dispose of the cells, 
clean the system, and perform an appropriate analysis of the data.  
Currently trends across MEA system-based research utilise high data sampling rates (>10 kHz), 
resulting in generation of vast amounts of data, very little of which is used in analysis. Current 
methods of MEA system employment, and the consequent post experiment analysis, is highly skilled 
and user intensive.  
 
1.3 The research 
The fundamental concern of this research was to investigate the feasibility of an MEA system that 
was less intensive to use. It was intended that a reduction in the overall system and experiment 
complexity could be brought about through this work, resulting in a more intuitive and user-friendly 
MEA system. 
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1.4 This thesis 
This compilation of research demonstrates derivation of specific contemporary user requirements 
that have resulted in the development of product design specifications that have led to novel MEA 
biochip designs. Logical, previously validated research approaches have been used to create 
opportunities to gather information pertaining specifically to this research domain that is relevant 
and correct.  
The hypothesis (theory) driving forward this research is laid out in the initial research proposal 
(Appendix A). The author of this thesis then derived information (questioned) relating to current 
MEA systems and areas of research in which the systems are employed (Chapter 2). Once a basic 
understanding of the domain and its current needs were ascertained (Chapters 3 and 4) work was 
conducted to design and manufacture solution devices (Chapter 5) that better address the identified 
needs. Observations of users before and during testing were made (Chapters 4 and 6). Relevant 
data were generated and appropriate analyses performed (Chapter 6). The outcome of this process 
has resulted in the proposal of further work that needs to be pursued in this research and design 
domain (Chapter 7). This research cycle is depicted in Figure ‎1.1. 
Theory
Question
Observe
Collect 
data
Propose
Analyse
The Research 
Cycle
 
Figure ‎1.1: The Research Cycle. 
 [Adapted from How to Research by Blaxter et al, 2000.] 
 
Information relating to the manufacturing approaches that were implemented during prototype 
development is reported into this thesis. Initial testing of the prototypes manufactured is presented. 
Suggestions of future avenues for this research to pursue that are of high relevance are included in 
the conclusions of this thesis.  
The method of research presentation used in this thesis is presented in Figure ‎1.2 and the content of 
each chapter is summarised in Figure ‎1.3. 
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Introduction 
Research Statement. 
Multi Electrode Array 
technology holds potential for 
improvement
(Chapter 1)
Research Outline.
Proposal (Appendix A), 
Context and Literature Review 
(Chapter 2)
Research Design.
(Chapter 3)
Conduct Research and 
Record Data.
(Chapters 4 and 5)
Analyse Findings.
(Chapter 6)
Compile, Report and 
Suggest Further Work.
(Chapter 7)
 
Figure ‎1.2: Structure of the research presented in this thesis 
 
 
This ThesisChapter 1
Chapter 2
Chapter 3
Chapter 4
Chapter 5
Chapter 6
Chapter 7
Introduction
Electrophysiology
MEA systems
System Components
MEA biochips
MEA system Application
MEA system development
MEA Signals
MEA Signal Analysis
Future of MEA Systems
Product Design 
Product Assessment Research Design 
and Methodology
Context Research 
and Literature 
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MEA Application 
Case Studies
Design and 
Manufacturing at 
Loughborough 
University
Testing and 
Evaluation
Discussion and 
Conclusions
Problem Evaluation
Effective Design 
Quantitative Data
Qualitative Data
Modelling
Impacts of Context Specific Application Differences
Human Stem Cell Derived Beating 
Cardiomyocyte Clusters
Dissociated Neurons
Brain Region (Hippocampal) Slices
Specification
Concept Design
Fabrication Approach Design
Fabrication Approach Implementation
Prototype One
Design Iteration
Prototype Two – A & B
Fabrication Process Assessment
Live Trial Testing
Research Review
Research Achievements
Continuation of Research
 
Figure ‎1.3: A summary of the chapter content of this thesis. 
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1.5 Research Question Answers 
This research has considered the following questions: 
1. What is the research problem? 
Multi electrode array systems have developed into a confusing array of different configurations and 
system types, each matched to the subtly differing requirements of varying electrogenic tissue and 
cell preparations. Commercially available systems require further development before truly catering 
for the diverse plethora of contemporary user needs.  
 
2. What is the motivation for completing this research? 
New knowledge continues to be derived using these MEA systems that relates to cellular functioning 
and genetic variation. However, MEA system employment is both slow and costly. Systems better 
suited to contemporary research needs that are scalable would contribute significantly to 
accelerating bioscientific understanding and discovery. 
 
3. What is the current situation in this research domain? 
MEA system development has increased in pace over the past fifteen years. A global industry exists 
that is presently led by seven leading companies. In addition to this industry much technical 
advancement is being made by universities and academic institutions using MEA systems for various 
research purposes around the world.  
Facets that limit MEA system application that can be improved upon to better suit the increasingly 
specific requirements of MEA-based research are: 1) MEA systems are still not suited to humidified, 
incubated environments, 2) MEA systems still take up a relatively large amount of space, and 3) 
throughputs are low and so the amount of valuable data extracted collected is limited following 
significant time and labour outlays. 
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4. How does this thesis address identified research objectives? 
The content of this thesis identifies and addresses objectives by including:  
1) a thorough review of the subject area (Chapter 2),  
2) a description and justification of the processes employed in eliciting user requirements (Chapter 
3),  
3) an investigation of MEA systems in use (Chapter 4),  
4) the generation of solution concepts and investigations into manufacturing possibilities for those 
concepts (Chapter 5), and,  
5) the testing and evaluation of resultant prototypes (Chapter 6).  The testing outcomes are also 
discussed, conclusions draw and further work is suggested (Chapter 7). 
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This Thesis
Chapter 2
Electrophysiology
MEA systems
System Components
MEA biochips
MEA system Application
MEA system development
MEA Signals
MEA Signal Analysis
Future of MEA Systems
Product Design 
Product Assessment
Context Research 
and Literature 
Review
 
 
Chapter 2 
2 Context Research  
 
 
This chapter contains relevant research relating to MEA systems and their applications. Key topics 
are: 
 
 the physiology of a cell,  
 an introduction to electrophysiology,  
 multi electrode array systems and their components, 
 how MEA systems are used across bioscientific disciplines, 
 a brief summary of MEA system history, and of how systems have and are likely to continue 
to develop, 
 the different signal types detected from neural and cardiac cell types and features of 
interest within those signals, 
 how recordings made using an MEA are analysed and used by the bioscientist, 
 a prediction of the direction of future MEA system development. 
 
Product design and innovation management techniques are also included as this research has been 
of a design-and-build nature.  
 
The integration of engineering and biology is more profoundly needed and in vitro Micro or Multi 
Electrode Array (MEA) systems are just one example of a technological tool combining living 
biological samples with sophisticated engineering (Wang et al, 2009a). Further development of MEA 
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systems is required to optimise this tool for its numerous applications. The structure of this chapter 
is demonstrated in Figure ‎2.1. 
Electrophysiology
Activity in electrogenic tissue
Action 
Potential
Field 
Potential
Patch Clamp: Invasive MEA system: Non-invasive
MEA Systems Core components
Biochip
Headstage
Data Acquisition 
Unit
Software/GUI
Connects to
Key players
Commercial System Configurations
Leading  User Groups
Essential Peripherals
BIOCHIP in 
further detail
Variants
Electrodes
Workspace
Stem-cells
For cell-therapy (MEA 
system-based cell 
characterisation)
Drug Discovery 
and Safety 
Pharmacology
Tool for Neurotoxicity
Tool for Cardiotoxicity
High Throughputs  
Required
Validation of in vitro MEA is supporting in vivo: Brain-Machine Interfaces
What to do?
How to design?
How to assess what we design?
Product Design and innovation 
Management
Designing for success in the 
biotechnology industry
Connects to
Connects to
Essential Foundation: Basic physiology of a cell
Future of MEA 
Systems: 
Recent 
Influences 
Shaping MEA 
system 
development
Originally Applied to record naturally occurring activity in neural tissue. 
(Then to record activity using different cell types and preparations = applications diversified). 
System 
Development
Progressive 
evolution
Motivated by 
changes in...
 How MEA 
systems are 
applied
 An increase 
in suitable 
material 
availability
Contemporary Application
Cardiac
Neural
Other
Largest 
applications
Generic Analysis
Application Specific Analysis
Engineers provide tools to record potentials
Electrophysiology, and the purpose of MEA systems within electrophysiological research
How MEA systems have been and are used
Existing MEA systems
Commercial 
Systems
Requirements of future MEA systems Designing effectively
(sections 2.1 - 2.5) 
(section 2.6) 
(section 2.7) 
(sections 2.8 - 2.9) 
(sections 2.10 - 2.11) 
(section 2.12) (section 2.13) 
 
Figure ‎2.1: Chapter 2 Schematic 
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An MEA system is used in bioscientific settings as a sensor to detect, record and quantify 
electrochemical fluctuations as they occur through either a single electrogenic cell (grown over a 
microscopic electrode) or through samples of electrogenic tissue (grown or placed over several 
microscopic electrodes). An understanding of the fundamentals of cell physiology and the 
electrophysiological activity of single and multiple cells is demonstrated in this chapter (sections ‎2.1 
– ‎2.4). 
 
Two avenues exist for bioscientists wishing to assess electrophysiological activity of cells: clamping 
techniques (in the contemporary form, patch clamp) or MEA system techniques. Clamping 
techniques are described as invasive because they damage and ultimately kill the cell of interest. 
Non-invasive alternatives use an MEA system that does not require destruction of the cells during 
use. The fundamental difference between the two techniques is that clamping records the actual 
action potential (AP) as it occurs through an individual cell, and an MEA system records the field 
potentials, which are ion current fluctuations through the matter around the cells and close to the 
detecting electrode. 
 
A brief history relating to the evolution of MEA systems and how they have been developed over the 
last decade is included to support identification of current trends in, and possible future avenues of, 
component and system development (section ‎2.5 - ‎2.6). Latest developments are described in terms 
of what motivated the development (e.g. the user), how the development was realised (e.g. how it is 
manufactured), and what materials were used (e.g. for the microelectrode tip, tracking, insulation).  
 
Understanding of the activity that occurs on an MEA biochip at the complex cell-electrode interface 
has been pursued (section ‎2.6.6). A number of theoretical models of the interactions that occur at 
this interface have been collated for comparison and reference. This aspect was investigated to 
consider how a signal is physically detected and transmitted through existing MEA systems. 
 
The differing ways in which MEA systems are presently used has been presented and generic 
features of MEA analysis routines are described. Neural and cardiac applications are summarised 
and the future of MEA system application for higher throughputs via semi-automated or automated 
systems in these domains, as speculated by leading academic and industrial authorities, is 
considered (sections  ‎2.7 - ‎2.8).  
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MEA systems are made up of a chain of components that are integrated to provide appropriate 
sensitivity to detect microvolt signals that occur in electrogenic tissues. Manufacturers of 
commercial MEA systems maintain close relationships with academic development to keep up-to-
date with the various ways in which systems are being applied.  
 
The research outlined in this thesis has been focused on designing and manufacturing a novel MEA 
biochip. Therefore, current state-of-the-art MEA biochip variants have been identified and are 
presented (section ‎2.10). The microelectrodes and workspace layouts (key distinguishers for this 
component) show large degrees of variation across collated MEA biochip models. 
 
Understanding ascertained by completing this review has been integrated during the requirements 
definition and design of prototypes. Methods were considered from a product design point of view 
when assessing the success of prototypes. Innovation management and design for the biotechnology 
domain have been explored to support effective design and future product compliance within this 
field (section ‎2.12). 
 
Answers to the following research questions have been pursued and relevant information is 
contained in this chapter: 
1. In what context(s) are multi electrode array systems used, what are the core components 
and how do they differ between systems? What is the current state-of-the-art? 
 
1. How are MEA systems applied in research, how has that application changed since their 
introduction and are there any trends identifiable in development? 
 
2. What are the key factors that will influence and limit design possibilities and where are 
the biggest challenges associated with this work? 
 
3. How do applications using different cellular preparations differ and how are the signals 
that are recorded used? 
 
4. What is expected of future MEA systems? 
 
5. How can product innovation be managed throughout this research and how can 
developers design and assess prototypes appropriately?  
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2.1 The Cell 
Every living organism is comprised of either a cell or a collection of cells. A cell can be referred to as 
the “basic unit of life” (Allen and Cowling, 2011). Each cell is a separate entity enclosed by a surface 
membrane. Cells interact with the environment around them to extract nutrients and energy for 
growth and maintenance, and most cells are capable of replicating themselves. It has been 
suggested that a human is composed of about 100 trillion cells (Allen and Cowling, 2011).  
 
2.1.1 Fundamental Cell Physiology 
There are numerous types of cells within multi-cellular organisms, each of which has its own 
“blueprint”. A generic representation of the microscopic internal functional entities inside a cell that 
are responsible for metabolism (organelles) is demonstrated below (Figure ‎2.2). Organelles are built 
from proteins and each one has a particular function or functions. Collectively organelles (i.e. 
ribosomes, mitochondria, Golgi apparatus, endoplasmic reticulum, centriole), in collaboration with 
the surrounding cytoplasm, are responsible for the cell’s metabolism (Starr et al, 2010).  
 
Figure ‎2.2: Structure of a mammalian cell. 
 [Adapted from Pocock and Richards, 1999.] 
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Organelles (see Appendix B) exist suspended in a jelly-like fluid called cytoplasm that provides water, 
sugars, ions and proteins (Figure ‎2.2). The cytoplasm and organelles are all contained within a 
phospholipid membrane. All cells are enclosed by this membrane that consists of two layers of 
phospholipids (fat molecules). Membranes in animal cells have proteins embedded that facilitate the 
movement of molecules from the cell’s surrounding environment into the cell. Exchanges between a 
cell and its surroundings, the extracellular matrix, are selectively controlled by these proteins. It is 
the ion fluctuations into and out of cells through the cell membrane that are detected by MEA 
systems in the form of field potentials (see section ‎2.4.2.2).  
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2.2 The Neuron 
The nervous system in humans is a complex structure consisting of billions of interconnecting nerve 
cells, neurons. Numerous variants of neuron make up the nervous system and they can be classified 
according to their structure (e.g. number of dendrites, size, and degree of myelination) and function 
(e.g. direction of signal, effect on other neurons firing rates, discharge patterns, neurotransmitters 
produced). MEA systems were originally developed for neural research applications. 
 
Figure ‎2.3: Neuron Structure. 
(A) A typical sensory neuron. (B) A typical motor neuron.  
[Adapted from Scanlon and Sander, 1997.] 
 
The primary function of a neuron (Figure ‎2.3) is information transfer. Two descriptions are used to 
describe the types of signalling used for this information transfer; intracellular signalling, that is from 
one part of a neuron to another part, and intercellular, from one neuron to another neuron (Levitan 
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and Kaczmarek, 2002). The signal (electrical impulse) that is transmitted through and between 
neurons is called an Action Potential, AP (see section ‎2.4.1). Neurons consist of a soma (cell body), 
an axon, several dendrites and synapses.  
 
The soma contains the nucleus and therefore the DNA, and typically a high concentration of the 
other organelles necessary for metabolism (e.g. mitochondria, endomembrane system organelles). 
The axon is identifiable as the longest and thinnest projection coming from the soma. The 
movement of charged ions through membrane channels along the length of the axon generates an 
electrical impulse, the AP. Axons in the human brain can be less than 1mm in length, whereas others 
extending from the spinal cord to muscles in limbs can measure over 1m in length (Roberts, 2010).  
The axons of most neurons, especially those found in the peripheral nervous system (PNS) are 
wrapped in an insulating layer called a myelin sheath. Schwann cells make up this sheath 
encapsulating the axon in short sections, serving to insulate the signal and also resulting in an 
increased speed of transmission of that impulse. Small gaps between the Schwann cells, called 
Nodes of Ranvier, are responsible for the increased conduction velocities along neurons.  The nodes 
form specialised areas where ion channels and specific proteins are concentrated (Pavelka and Roth, 
2005). 
 
Dendrites are small protrusions most commonly originating from the soma, but in some cases from 
elsewhere on the cell, that are typically thicker and shorter than the axon. Dendrites are often 
branched resulting in what is called the dendritic tree.  The purpose of dendrites is to receive and 
integrate information from other nerve cells. The distal (away from the body) ends of dendrites are 
called receptors. Where neurons transmit impulses on to other neurons, no physical contact actually 
occurs. Synapses are minute spaces present between one neuron and another. Chemicals that are 
collectively classified as neurotransmitters, of which there are currently >100 identified, are released 
from a site referred to as the synaptic knob, present at the axon terminal, that diffuse rapidly across 
the minute gap to receptor sites on the dendrites of another neuron (Clark, Boutros and Mendez, 
2010). Stimulation of the receptor site by the neurotransmitter generates the electrical impulse that 
travels along the length of the neuron via the axon. 
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The brain has ~1011 neural cells. Each cell can have 10000 connections. Neurons communicate 
information around an organism’s body via APs through a network of nerves. Some basic nervous 
system dimensions and numbers are incorporated in Table ‎2.1. 
Table ‎2.1: Typical values for neurons in the human nervous system. 
Node of Ranvier 4µm 
Axon diameter 1-20µm 
Soma diameter 5-20µm 
Nerve diameter  Several mm 
Brain neural cells 1011 
Connections per brain cell  104 
Membrane resting potentials: 
    Resting potential of Na+ 
    Resting potential of K+ 
    Resting potential of Cl- 
 
+55mV 
-102mV 
-76mV 
 [Adapted from Rutten, 2002.] 
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2.3 The Cardiomyocyte 
The mammalian heart beats automatically at regular intervals. This rhythmic contractile activity is 
due to the electrical activity of the myocardium driven by the generation of action potentials in 
individual cardiomyocytes which propagates activity through the myocardium (Niwa and Nerbonne, 
2010). Cardiomyocytes are specialised muscle cells that connect forming myocardial tissue via 
intercalated disks (Figure ‎2.4). MEA systems are suited to recording from cardiac cell types (Reppel 
et al, 2004). The specific cell of interest within the cardiac tissue is the cardiomyocyte. 
Cardiomyocytes are the sole generators of contractile force within a mammalian heart’s 
myocardium (Lee and Terracciano, 2010). They have the unique ability to contract spontaneously 
without the need for nervous excitation.This research focuses on this cell type from Chapter 5 
onwards. 
 
Figure ‎2.4: A diagram of the light microscope appearance of cardiomyocytes as myocardial tissue. 
 [Adapted from Stapleton, 1983.] 
 
2.3.1 Cardiomyocyte contraction 
The contraction of cardiomyocytes is also associated with an action potential. These action 
potentials reflect the coordinated functioning of voltage-gated ion channels carrying depolarising 
(Na+ and Ca+) and repolarising (K+) ions.  Numbered phases (0-4) are used to characterise a 
cardiomyocyte AP when recorded via a patch clamp (Figure ‎2.5). 
Phase 4 is the resting state of the cell. When the cell membrane is electrically stimulated, 
permeability of the membrane alters. At Phase 0 Na+ channels open and sodium ions flow into the 
cardiomyocyte. The transverse potential of the cell membrane reduces. Membrane potential rapidly 
reaches 0mV and transiently becomes positive. This phase is depolarisation. 
Phase 1 is start of repolarisation. Na+ channels have been inactivated and a transient current moves 
the membrane potential back towards 0mV.  
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Phase 2 is mediated by slow Ca2+ channels that first began to open when the potential was 
approximately -40mV, but that remain open much longer than the Na+ channels. With low 
permeability to K+ the potential is maintained at around 0mV. This period is known as the plateau. 
Ca2+ channels begin to deactivate gradually and K+ channels open, beginning phase 3. 
Phase 3 occurs towards approximately -10mV when the K+ permeability increases. At about -60mV 
the K+ channels are most activated, accelerating a return to the resting potential of approximately -
90mV. 
 
Figure ‎2.5: An action potential (patch clamp) and the relative ion fluctuations for Na
+
, Ca
2+
 and K
+
. The 
resting potential of the cell is represented by phase 4 of the action potential.  
 [Adapted from Lilly, 1993.] 
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The action potential characteristics are also related to the position of the cell in the heart 
(Figure ‎2.6). 
 
Figure ‎2.6: The characteristics of action potentials through cardiomyocytes and the corresponding region of 
the heart.  
[Adapted from Pocock and Richards, 1999.] 
 
2.3.2 Stem-cells into cardiomyocytes 
Differentiation of stem cells into cardiac cell types has attracted significant attention in recent years 
and is an especially strong area of interest in the regenerative medicine domain (Braam et al, 2009). 
A major design challenge that accompanies interest in using stem cell-derived cardiomyocytes in 
MEA culture for drug candidate testing is largely associated with the immaturity of stem cell 
differentiation techniques. Generally, differentiation of pluripotent stem cells into beating embryoid 
body’s results in mixtures of ventricular-like, atrial-like and pacemaker-like cardiomyocyte cells 
(Gupta et al, 2010). This variation in cardiomyocyte phenotype has been identified and characterised 
in patch clamp studies of APs (He et al, 2003; Mummery et al, 2003). Specific differentiation 
protocols affect the ratios of cell phenotypes found in EB cultures (Braam et al, 2009). MEA and 
patch clamp tools are currently being applied in parallel, to understand and characterise the cells 
produced.  
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2.4 Electrophysiology 
“Electrophysiology is the branch of physiology that deals with the electrical phenomena associated 
with physiological processes, especially in nerve and muscle; also the electrophysiological 
characteristics of a process, tissue, or disorder” (“Electrophysiology,” Oxford English Dictionary). The 
study of electrophysiology involves functional and physiological responses of electrogenic 
(electrically active) cells, tissues and organs across an assortment of organisms from molluscs (i.e. 
snails (Merz and Fromherz, 2002)) to mammals (i.e. rats (Suzuki et al, 2004a) and humans (Shibasaki, 
2008)). MEA systems exist specifically as a tool to support electrophysiological investigation. 
ELECTROPHYSIOLOGY
Electrocardiology
Electromyography Electrooculography
Disciplines Techniques
I.e. sub-discipline: Electroretinography
Multi Electrode Array
Multi-cell cultures and 
tissue preparations
Acute or Chronic Study
Voltage Clamp
Patch Clamp
Single cell 
Single cell ion 
channel 
Acute Study Only
Electroencephalography
I.e. sub-discipline: Electrocorticography
 
Figure ‎2.7: Disciplines of electrophysiology and techniques that can be used to detect and record 
electrogenic activity. 
 
Mammalian electrophysiology has been divided into a number of disciplines (Figure ‎2.7) that are 
most commonly studied as research domains in themselves. Electrocardiography is 
electrophysiological study of the heart, electroencephalography is electrophysiological study of the 
brain, electromyography is electrophysiological study of muscles and electrooculography is the 
electrophysiological study of the eye(s).  
As a large proportion of electrophysiology interacts with the brain these separated disciplines 
overlap greatly sharing a vast number of commonalities (e.g. such as action potentials that have 
originated from neurons of the central nervous system).  To distinguish further regions of 
electrophysiological study these disciplines have in some cases been further defined into sub-
disciplines. For example electrocorticography is the specific study of the cerebral cortex (Ray et al, 
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2008), and electroretinography is the specific study of the retina within the eye. These sub-
disciplines fall into electroencephalography and electrooculography respectively. The underlying 
electrical occurrence fundamental to all of these disciplines and sub-disciplines is the Action 
Potential (AP) (Kaplan and Nguyen, 2011).  
 
2.4.1 Action Potentials 
Electrical potentials exist across many different biological cells due to different distributions in ionic 
concentrations between intracellular and extracellular spaces (Horsman, Conway and Yeager, 1985). 
Excitable cells are those that “are capable of generating rapidly changing electrochemical impulses 
at their membranes. In most instances, these impulses can be used to transmit signals along nerve 
or muscle membranes” (Guyton and Hall, 2000). The instance of one of these impulses is referred to 
as the occurrence of an Action Potential (AP) (Figure ‎2.8). Action potentials are defined as long-
distance electrical signals (e.g. up to 1m), that are a brief (~1-500ms depending on the cell), rapid 0.1 
to 100m/sec (Matthews, 2001), and large (100mV) change in membrane potential, during which the 
potential actually reverses so that the inside of the cell transiently becomes more positive than the 
outside (Sherwood, 2001). APs propagate along the length of a cell in a non-diminishing manner 
(Martinsen and Grimnes, 2008) meaning that the signal will not weaken as it passes through the 
cell’s membrane.  
To initiate an AP the cell membrane potential must alter (depolarise) from a resting potential of 
about -70mV beyond a threshold of about -55mV. Depolarisation from the resting potential towards 
the threshold potential occurs comparatively slowly. When the potential reaches the threshold 
explosive depolarisation occurs. Membrane potential increases rapidly towards about 30-40mV and 
then rapidly reverses, allowing the potential to drop again (repolarise) towards the resting potential. 
Hyperpolarisation, which is a brief fluctuation below the resting potential (~-10-20mV), often occurs 
as the ion changes responsible for repolarisation overshoot briefly (Figure ‎2.8). The entire period 
(~1-400ms (Matthews, 2001)) during which the potential changes from resting level, to its peak and 
returns back to resting is defined as the action potential. If the initial threshold (-55mV) is not 
reached during depolarisation no AP will take place. Thus, this threshold is in some texts also 
referred to as the critical all-or-none point (Plowman and Smith, 2008). 
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Figure ‎2.8: An action potential (neuron). 
 
Neurons exhibit the fastest APs, lasting 1 to 100ms. In muscular tissues the APs are slower (e.g. 
cardiomyocytes ~400ms). APs are often referred to in electrophysiology as spikes (Dai et al, 2010). 
Collections of APs occurring at about the same time or in very close succession (within a few ms) are 
referred to as bursts (Figure ‎2.39). 
Potassium ions (K+) are most responsible for the resting potential of excitable cells. This is due to the 
cell membrane at rest demonstrating increased permeability to K+ than to sodium ions (Na+). When 
an AP occurs the permeability of the membrane to K+ and Na+ ions changes rapidly, resulting in ion 
currents that are detectable as overall potentials. In brief, an action potential begins with a stimulus 
that prompts the Na+ channels to open, allowing an influx of sodium ions into the cell. The result of 
this influx is that the membrane of the cell becomes positive. As the positivity of the membrane 
increases, K+ channels open, allowing K+ ions to flow out of the cell. The Na+ channels close, ceasing 
the inflow of positive charge. As the K+ channels remain open the outflow of positive charge 
continues, resulting in a rapid drop in membrane potential. When the cell’s membrane potential 
reaches its original resting potential the K+ channels close. 
The occurrence of action potentials can be detected and quantitatively measured using 
electrophysiological techniques developed over the past 60 years. These techniques are either 
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termed invasive, using voltage or patch clamp technology (Levitan et al, 2000), or non-invasive using 
MEA systems (Raoux et al, 2011).  
 
2.4.2 Capturing action potentials 
The following is a brief introduction to the electrophysiology techniques developed for action 
potential detection, recording and analysis (Figure  2.9). 
Electrogenic Cells
I.e. cardiomyocytes, neurons
Fluctuations in ion 
concentrations.
Action 
Potential
(AP)
Field Potential
(FP)
Voltage clamp 
and patch clamp
MEA
Electrogenic Tissue
I.e. ventricle, brain region 
“Invasive”‎Approaches
“Non-invasive”‎Approach
Intracellularly 
Extracellularly
 
Figure ‎2.9: Electrophysiology techniques. 
 
 
2.4.2.1 Invasive Voltage and Patch Clamp Techniques – 
intracellular recording. 
 
Patch clamp techniques (Figure  2.10) are a progression of previous voltage clamp techniques used 
through the 1950’s for the measurement of ion currents through individual neuron membranes 
(Boulton et al, 1990). The patch clamp technique was developed at around the end of the 1970’s 
(Pine, 1980), introducing a greater level of sophistication to single cell characterisation by facilitating 
the assessment of ion movement through individual ion channels in cell membranes.  
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Glass micro-pipette containing 
electrolyte and an electrode is pressed 
against a cell membrane.
A piece of the cell membrane (the 
„patch‟) is positioned within the micro-
pipette orifice.
A tight seal of gigaohm electrical 
resistance (a‎„gigaseal‟) is formed 
between the micro-pipette rim and the 
contacting cell membrane.
(If the patch contains an ion channel(s)) 
Movement of ions through channels in 
the membrane is measured as tiny 
currents (picoamperes). 
Patch clamping of HEK293 
cell. The micro-pipette is 
touching the cell surface.
Glass micro-pipette
Cell
 
Figure ‎2.10: The patch clamp technique.  
HEK = human embryonic kidney 
 [Constructed with reference to www.sophion.com and Molnar and Hickman, 2007]. 
 
Voltage and patch clamp techniques are the most mature techniques used for analysing the 
electrophysiology of cells. They were fundamental in defining single ion channel communication 
between and within cells. The electrodes used are typically glass micropipettes with open tips. The 
tip opening is usually less than 1µm. These micropipettes are filled with a solution that is conductive 
and connected to a voltmeter. The AP (described in some texts as the “transmembrane voltage”) of 
the cell can then be recorded (Purves et al, 2000). For original voltage clamp recording techniques 
two electrodes were required, one micropipette tip records the membrane voltage, the other passes 
a current to maintain the membrane at a constant “command” voltage (Matthews, 2003). For patch 
clamp measurements only one electrode is required, the tip of which is placed against the cell 
membrane and suction is applied creating a high resistance “gigaseal” (typically >1GΩ) (Mathes et al, 
2009)) around a very small area (~>1µm2), or “patch”, of the cell membrane. Both of these 
techniques are described as invasive as they firstly require the cells to be dissociated out of the 
tissue of origin. Then secondly, the individual cell of interest is placed into a specific conductive 
solution (that is not the same as in vivo conditions) and is attached to, or punctured by, the glass 
micropipette electrode for recording. Due to these conditions of pinching or puncturing, patch clamp 
recordings must be taken within a few hours as the cells utilised are damaged and will die (Osorio 
and Delmas, 2011).  
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The action potentials through the cell membrane also result in ion current fluctuations in the 
extracellular fluid and matrix that surrounds the cell. This fluctuation, called an extracellular Field 
Potential (FP), can be detected using microelectrodes embedded at the centre of an MEA biochip. 
 
2.4.2.2 Non-invasive Multi Electrode Array Technique – 
extracellular. 
The detection of electrical activity occurring in a living sample using MEA systems is based upon the 
presence of membrane voltage gradients, or potentials, not only through cells but also through the 
surrounding extracellular matter and media. These potentials, referred to as field potentials (FPs), 
are a direct consequence of a flow of ions into or out of the fluid media as the result of cellular 
activity (Ray et al, 2008). When measured using an MEA system, ion current changes occurring over 
the microelectrodes (FPs) can be visualised in terms of both space and time, and recorded. This is 
due to the distributed nature of the micro electrodes underneath the sample of cells.  
The use of MEA systems for recording electrogenic activity in in-vitro preparations is now well 
established and validated (Heuschkel et al, 2002; Wagenaar, DeMarse and Potter, 2005). MEA 
system alternatives do not presently exist and so this in-vitro technique is unique in its ability to 
capture (non-invasively) electrical signals from living matter (Stett et al, 2003). In vitro MEA systems 
serve as an intermediary technology between acute patch clamp measurement and the concurrently 
evolving field of chronic in-vivo MEA recording (Caspi et al, 2009).  
In-vitro MEA systems also offer the facility to detect, measure and analyse particular parameters 
thought to be significantly influenced by, or the result of, particular genetic combinations (Valor et 
al, 2007; Chong et al, 2011). Genetic mutation investigations utilise tissues dissected out of 
specifically bred animals. The breeding of animals for laboratory testing is labour intensive and 
expensive (Jurga, Forraz and McGuckin, 2010). It has been described that complementary in-vitro 
MEA recording and analysis techniques help to overcome the limited availability of “significant 
collections of genetically interesting in vivo subjects” by making better use of the tissue and cells 
that are available (Kobel and Lutolf, 2010). For example, a brain region from one mutant mouse can 
be cut into very fine slices and studied on multiple in-vitro MEA biochips.  
Another advantage brought about by MEA systems has been the facility to take repeated 
measurements from the same culture of cells or tissue over prolonged periods of time (Gross and 
Pancrazio, 2006). Some cases have reported results taken from one culture over periods of up to 3.5 
months (Dubois-Dauphin et al, 2010). MEA systems serve too as powerful tools for evaluating the 
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dynamics and differences both in spontaneous activity and in activity evoked by exposure to external 
stimuli (e.g. drugs or electrical stimulation) (Johnstone et al, 2010). This combination of advantages 
described thus far has resulted in the suggestion that to further exploit MEA systems, adaptations 
that will allow an increase in throughput for chemical screening are now required to support the 
fields of safety pharmacology and drug discovery (Denning and Anderson, 2008; Braam et al, 2009; 
Yla-Outinen et al, 2010). 
MEA recorded data, particularly from dissociated cell cultures and stem cell derived cell cultures, 
show significant amounts of variation in terms of SNR, signal size and waveform shapes from culture 
to culture (Shahid et al, 2009; Cohen et al, 2011). These variations can be attributed to innate 
differences in the cultures themselves (e.g. cell size) and to the differing cell types under 
investigation. Cell orientations, spatial distribution of occurring activity, and the timing of that 
activity is also unique to each culture (Lappalainen et al, 2010). Various other user group specific 
factors such as MEA biochip pre-processing procedures (e.g. the use of coatings such as laminin or 
Matrigel) also affect signal detection (Graham et al, 2009). 
 
2.4.3 Cardiac Electrophysiology 
Ion current flows responsible for cardiomyocyte contractions are detectable as action potentials (AP) 
and field potentials (FP) using electrophysiological recording techniques. Cardiomyocyte studies 
conducted on an MEA system detect the extracellular FPs that can be correlated to both patch clamp 
AP recordings and whole heart electrocardiogram (ECG) contraction signals (see Figure ‎2.11).  
 
Across medicine and the pharmaceutical industry a significant emphasis has been placed on 
understanding the action of chemical substances used as prescription drugs on the natural 
contracting rhythm of the human heart (Braam et al, 2010). This follows unforeseen interactions of 
some commercially available drugs that have been recalled due to risks posed to human life, such as 
Vioxx (Martinez et al, 2004; Goenka et al, 2010). MEA systems are currently receiving much 
attention as a tool in helping to screen substances at pre-clinical stages of development. The 
parameter of most interest is called the QT-interval. It has been demonstrated that the correlation 
of this parameter in vitro (detectable on MEAs) with in vivo signals can be exploited to understand 
further this parameter that if altered in vivo can result in death of the animal or human.  
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range: -/+1.5 mV
 
Figure ‎2.11: The correlation between AP, FP and ECG signals. 
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2.4.3.1 Characterisation and Identification of Normal Cardiac 
Activity 
The normal electrophysiological behaviour of the heart is determined by ordered propagation of 
excitatory stimuli that results in rapid depolarisation and slow repolarisation of various excitable cell 
types across the heart (Sadek et al, 2008). The resulting contraction ejects blood from the heart 
forming the basis of the mammalian circulatory system (Sherwood, 2006).  
The excitable cells that make up the myocardium (heart muscle) receive stimuli originating from a 
region of the heart referred to as the sinoatrial (SA) node.  The SA generates a wave of excitation 
that spreads rapidly through both atria reaching the atrioventricular (AV) node. The AV node is 
positioned between the atria and the two ventricles of the heart.  The AV stimulates a bundle of 
conducting fibres, the Bundle of His, that spreads excitation down into the muscle of each ventricle 
through a further network of fibres, the Purkinje fibres (Starr and McMillan, 2007). This set route of 
stimulation is essential for normal cardiac function and can be detected and monitored through the 
use of an electrocardiogram (ECG) (Houghton and Gray, 1997).  
The ECG is used for identification of disorders of cardiac rhythm (e.g. torsade’s de pointes), diagnosis 
of heart abnormalities (e.g. myocardial infarction) and to provide clues to the presence of other 
generalized disorders of the body (e.g. electrolyte disturbances) (Houghton and Gray, 1997).  
The muscle mass of different regions of the heart (atria and ventricles) differs so the electrical 
change that accompanies contraction correlates to those differences. The contraction of the atria 
produces a smaller wave (P wave) of electrical excitation when compared to that detected when the 
ventricles contract (QRS complex).  It is the presence of these waves that allows ECG signals to be 
described in terms of the wave of excitation as it spreads through the heart. Different parts of the 
detected signal are classified using an alphabetical description. The letters P, Q, R, S, T and 
occasionally U (see Figure ‎2.11) are used to describe all ECG signals (Hampton, 2008).    
Each wave represents either depolarisation or repolarisation of a certain region of the heart. 
Changes (e.g. presence, duration, amplitude) in waves can be used to detect and diagnose 
abnormalities. 
Prolongation of the QT interval is one abnormality that can cause cardiac arrhythmia and 
consequently death (Stett et al, 2003). Pharmaceutical companies must assess all new cardio-active 
substances for adverse effects on the QT interval. QT interval can be detected in whole heart and in 
stem-cell derived beating cluster recordings (Figure ‎2.11), which can be of use when screening a 
substance for unwanted cardiac interaction (Halbach et al, 2003).  
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2.5 Original MEA system Application 
The development of MEAs began more than 35 years ago (Gross et al, 1977; Wolpaw and Wolpaw, 
2012). MEA system use has increased rapidly over the past twenty years following successful system 
uptake across research applications during the 1990’s (Connolly et al, 1990; Jimbo and Kawana, 
1992: Owens et al, 1995). Planar MEA biochips were the first type to be introduced and have slowly 
but steadily gained the highest degree of popularity amongst neuroscientists (Morin et al, 2005) 
later to be adopted by bioscientists working with other electrogenic cell types. MEA biochips for the 
first time enabled chronic monitoring of excitable cells in-vitro. Early work using these devices was 
able to monitor neural cultures for periods of several months capturing the exhibition of slowly 
altering field potentials and rapidly occurring spikes. For the first time neuroscientists were able to 
view the “plasticity” of neural networks over much more meaningful durations. Plasticity is the 
capacity of the nervous system to change during development and when learning new skills, 
establishing new memories and responding to injury (Purves et al, 2001). By capturing plasticity 
using MEAs neuroscientists have been able to understand more about how the mammalian brain 
works (Frey et al, 2009). 
 
The microelectrodes in an MEA can detect signals from neurons up to ~100µm away in a culture or 
within a tissue slice. The work of Egert et al. (2002a) has also suggested that in monolayer cultures 
typically the majority of signal sources are within a radius of about 30µm from the microelectrode 
centre. The current 8x8 arrangement of 60 electrodes (where one electrode missing at each corner) 
is believed to offer “good spatial and temporal resolution” for most network based neurological 
investigations (Stett et al, 2003).   
 
2.5.1 Stimulating with an MEA system 
MEA biochips have been used to record from cells and also provide electrical stimulation. Stimuli can 
be input to a culture electrically by application of either current or voltage impulses through the 
microelectrodes (Merrill et al, 2005; Kopanitsa, Afinowi, and Grant, 2006; Herrmann and Stett, 
2010). It is generally well understood that across neuroscience MEA application observations have 
shown that neurons respond differently to altered stimulation protocols (Figure ‎2.12, Wagenaar et 
al, 2004).  
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Figure ‎2.12: Example stimulation waveforms. 
[Adpated from Wagenaar et al, 2004.]  
 
When stimuli protocols are employed through a specific electrode(s) to a target region of cells the 
membrane polarisation of those cells is affected by an external voltage gradient in the surrounding 
media. The efficacy of stimulation protocols depends upon effective spreading of the input pulse at 
the cell-electrode interface and through the local region of the culture (Fejti et al, 2006). 
Descriptions of stimulation experiments across academic publications usually describe protocols in 
terms of the charge injected through the electrode(s) per pulse (Erickson, 2010; Ide et al, 2010). 
When charge is injected with current pulses the amplitude and duration of the pulse will be 
important in defining the protocol, but where voltage pulses are injected the tissue resistance and 
the capacity of the cell-electrode interface is also important. Most manufacturers of MEA biochips 
have investigated the “charge-injection capacity”. This is a value given in technical data sheets 
specifying the limit to which the biochip’s electrodes can be charged before irreversible damage may 
occur at the electrode surface.  
 
Important factors both users and developers alike must be aware of relating to stimulation include: 
1. Recording during the period of the stimulation is not possible as the electrodes saturate. 
2. Injection of stimuli creates artefacts across most channels during and immediately after 
stimulation due to saturation of the electrodes. This has been addressed across the MEA 
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domain and is typically overcome by specific signal processing or specialist hardware design 
(Morin et al, 2005). 
3. Care must be taken when selecting the input limit (i.e. 4V). If selection is too large harm may 
be inflicted upon cells or to the microelectrodes (Morin et al, 2005). The voltage at the 
microelectrodes should always be controlled to be as low as possible to prevent unnecessary 
electrochemical damage at the electrode surface. Inappropriately designed stimulation 
protocols may cause damage to the tissues under investigation or to the electrode in-use 
(Merrill, Bikson and Jefferys, 2005). 
 
2.5.1.1 Artefact suppression 
A recognised limitation of recording signals while using stimulation protocols is that when 
stimulation is applied it takes time (t = 50-100ms) for the electrodes to recover (Brown et al, 2008). 
The presence of a stimulation artefact results in a problem specifically associated with stimulation 
delivery and the microelectrode’s ability to retain appropriate recording capability during and 
straight after a pulse is input. Blanking circuits have been introduced for users of MEA systems who 
wish to stimulate their cultures or slices and record straight after (Zrenner et al, 2010; Biodo et al 
2010). These circuits are integrated into the headstage and work by decoupling all of the 
microelectrodes during the stimulation. The microelectrodes are then returned to their normal 
recording states prior to the resumption of spike activity in the culture, approximately 40-160msec 
after stimulation (Wagenaar, Pine and Potter, 2004). 
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2.6 MEA System Development 
 
Improvements in both electronics and electrogenic cell culture methods have brought about 
increased uptake of MEA systems for electrophysiological-based study in both academia and 
industrial settings (Johnstone et al, 2010). Original development was centred on simply recording 
signals from collections of neurons. Natural incremental advances from these early experiments to 
meet ever evolving user needs has resulted in improved systems and differing methods of 
employment.  
Objectives that have driven the developments of the first twenty-five years following the MEA 
biochip’s introduction, with more recent requirements that have been made in the last five to ten 
years are listed in Figure  2.13. 
2006 - Present:
 To keep increasing channel number 
(now from 100's to 1000's) for larger 
data sets and superior resolution. 
Systems to develop from cell-cell level 
recordings to synapse level recording. 
 To facilitate testing of thousands of 
chemicals currently used across global 
commerce that have not yet been fully 
characterised.
 To facilitate an increase in the number 
of chemicals characterised for 
potential neuro- or cardio- toxicity 
according to evolving regulatory 
requirements for drugs.
 To re-configure systems for improved 
usability. I.e. The relatively recent 
introduction of multi-well MEA 
biochips to allow increased 
comparability and faster results.
 To exploit appropriately applicable 
advances in micro- and nano- 
manufacturing techniques to increase 
sophistication at the workspace level. 
I.e. workspace patterning and 
microchambers creation.
 To produce more data sets that are 
comparable via the introduction of 
standards.
1975 - 2005:
 Visualise and capture recordings of 
the activity in brain tissue.
 Collect signals after cell activity had 
been evoked by stimuli.
 Reduce investigation time compared 
with clamp-based tests.
 Record from multiple sites in the 
same culture simultaneously. 
 Facilitate more data collection to 
obtain deeper knowledge of cell-to-
cell interactions. 
 Increase the number of channels 
available to facilitate the above 
points.
 Facilitate monitoring of activity over 
periods of time  greater than a few 
hours.
(Stett et al, 2003; Johnstone et al, 2010; Braam et al 2010)  
Figure ‎2.13: Past and present MEA development objectives. 
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This research presented in this thesis has been focused on design-and-build efforts addressing two 
distinct priorities: (A) the MEA biochip, and (B) the supporting system and required software 
(Figure  2.14). This thesis is centred on priority A. Generation of concepts and production of 
prototypes for testing are documented in this thesis (Chapter 5).  
Design details were identified pertaining to each priority and research was conducted relating to 
each design detail prior to design of the concepts for manufacture and prototype testing. For the 
MEA biochip material suitability, overall chip and workspace configuration, required throughputs 
and overall usability were considered. The cell-electrode interface is a topic still under investigation 
that has been addressed in this research (section  2.6.6). For the underlying system and software, the 
requirements, usability and throughput were considered with the intention to re-configure the MEA 
system to facilitate a reduction in the time required for analysis.  
v Acquisition Software 
Userability
v Analysis time reduction
v Throughput
Supporting System and Software
v Materials
v Configuration
v Throughput
v Usability
v Cell-electrode interface
MEA Biochip
Development focus for the initial stages of this research:
Design Priority 
A
Design Priority 
B
 
Figure ‎2.14: Priorities of development used in this research.  
 
 
 
 
 
54 
 
__________________________________________________________________________________
Context Research 
2.6.1 Industrial Case Study 
As the identified innovation leaders in this field, Multi Channels Systems (MCS) have progressed the 
development of their systems as documented into the following series of diagrams. This section 
presents an industrial case study. 
Study of MCS’s MEA systems development shows system iterations launched over the past three 
years since this research began. The standard MEA-60 system configuration, available in October 
2008 and those that have been developed since are depicted. The frequency range across all MCS 
systems is 2 – 50kHz. 
Biochip 
(60 electrodes)
Headstage 
1060
Custom Filter 
Amplifier 
(commonly FA60)
    1. MEA 60 (original MEA system configuration still available to purchase, February 2012).
Temperature 
control
High specification PC
Data acquistion card
(up to 128 channels)
GUI
Spring loaded 
pin connections
68 pin SCSI 
Cable
68 pin SCSI 
Cable
Analogue Analogue Analogue Digitised
 
Figure ‎2.15: The MEA 60. Multi Channels System’s original standard system. With a specialist PC housing the 
128 channel data acquisition card, running a Windows operating system. 
 
The MEA 60 system (Figure  2.15) consists of an MEA60 biochip connected via an MCS headstage 
1060 (section  2.9.1.2) to a personal computer (PC). The headstage unit connects via a standard 68-
pin SCSI cable to an FA60 Filter Amplifier (FA). The FA60 is sold and configured as part of the 
headstage configuration but exists as a separate unit that sits between the headstage and the 
MC_Card. The MC_Card is a PCB housed inside a PC that serves as the data acquisition unit for the 
system, converting the analogue signals to digital streams for visualisation and analysis. 
 
The MEA 120 system (Figure  2.16) can also be described as the MEA 60 system in a twofold 
configuration. The only alteration is the addition of an MEA_Switch unit. The MEA_Switch is a 
separate unit that connects between the FA60 of each headstage into the MC_Card. 
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Biochip 
(60 electrodes)
Headstage 1060
Custom Filter 
Amplifier 
2. MEA 120 (or MEA 60 Twofold)
Biochip 
(60 electrodes)
Headstage 1060
Custom Filter 
Amplifier 
MEA Switch
Temperature 
control
High specification PC
Data acquistion card
(up to 128 channels)
GUI
 
Figure ‎2.16: MEA 120. A representation of how the original MEA-60 can be scaled up using a device called 
the MCS MEA switch to accommodate two MEA biochips at one time. This allowed the data that could be 
captured per trial to be doubled from 60 to 120 channels. 
 
The MEA_Switch can also accommodate input from two further headstage units allowing the MEA 
120 system to also be scaled up into a twofold configuration (Figure  2.17). The number of channels 
that the MEA_Switch can process remains the same, so using the accompanying MEA_Switch 
software to turn on and off microelectrodes, the user must select up to 120 of the available 240 
microelectrode channels to monitor. 
3. MEA 120 Twofold
MEA Switch
Biochip 
(60 electrodes)
Headstage 1060
Custom Filter 
Amplifier 
Biochip 
(60 electrodes)
Headstage 1060
Custom Filter 
Amplifier 
Biochip 
(60 electrodes)
Headstage 1060
Custom Filter 
Amplifier 
Biochip 
(60 electrodes)
Headstage 1060
Custom Filter 
Amplifier 
Temperature 
control
Temperature 
control
High specification PC
Data acquistion card
(up to 128 channels)
GUI
 
Figure ‎2.17: MEA 120 Twofold. How the same MEA switch device can scale the system to accommodate four 
MEA biochips. The number of recordable channels remains 120. It’s intended to allow groups to capture 
more useful data using the equivalent number of channels (if their application resolution requirements 
permit). A reduction in the number of recordable channels per MEA biochip is required so either smaller 
areas at high resolution or larger areas at lower resolutions across the workspace must be defined. 
 
Developments up to this point allowed scientists to capture more data in one set-up, while 
concurrently allowing opportunity for increased throughput if an appropriate channel compromise is 
accommodated by the testing protocol. USB 2.0 connections (480Mb/s) have been employed in a 
new data acquisition unit that integrates with existing MCS system components (Figure  2.18 & 
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Figure  2.19) allowing increased flexibility in terms of data acquisition volume and the physical 
location of where the MEA system is set-up and on which PC the data is acquired and stored.  
Biochip 
(60 electrodes)
Headstage 
1060
Custom Filter 
Amplifier 
(commonly FA60)
    4. USB MEA 60
Temperature 
control
Interface Unit
(up to 256 channels)Spring loaded 
pin connections
68 pin SCSI 
Cable
68 pin SCSI 
Cable
Analogue Analogue Analogue Digitised
USB 2.0
Any PC with 
MC_Rack installed
 
Figure ‎2.18: USB MEA60. A visualisation of the first MEA-60 USB system. 
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Headstage 1060
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Amplifier 
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Biochip 
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Biochip 
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Custom Filter 
Amplifier 
Temperature 
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Temperature 
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Any PC with 
MC_Rack installed
5. USB MEA 240
 
Figure ‎2.19: USB MEA 240. The USB interface unit integrated with four MEA biochips. In this instance the 
recordable channel and resolution compromises of previous systems is eliminated. 
 
In the second quarter of 2010 a new generation of MEA system was launched by MCS. The model of 
the system was called USB MEA2100-60-HS (Figure  2.20). The headstage unit was redesigned to 
house more of the core technology compactly into one unit, i.e. the custom filter amplifiers (FA) and 
stimulation units were integrated together into one unit. The new headstages, called Headstage 
2100-60-HS, also offer the facility to house up to two MEA biochips side-by-side (Appendix B). 
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Biochip 
(60 electrodes)
Headstage 
(2100-60-HS)
     6. USB MEA2100-60
Temperature 
control
Interface Unit
(up to 256 channels)Spring loaded 
pin connections
68 pin SCSI 
Cable
Analogue Analogue Digitised
USB 2.0
Any PC with 
MC_Rack installed
NEW Feature: 
Built-in stimulation
 
Figure ‎2.20: USB MEA 2100-60. The MEA 2100 system in a 60 electrode MEA format. Two 60 electrode MEAs 
can also be used in this one unit positioned side-by-side is desired. 
 
Biochip 
(120 electrodes)
Headstage 
(2100-120-HS)
    7. USB MEA2100-120
Temperature 
control
Interface Unit
(up to 256 channels)Spring loaded 
pin connections
68 pin SCSI 
Cable
Analogue Analogue Digitised
USB 2.0
Any PC with 
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Figure ‎2.21: USB MEA 2100-120. The MEA 2100 system headstage connectors can also be adjusted to allow 
contact to biochips with >60 electrodes, in this configuration 120. 
 
The alternative configurations of the MEA2100 systems available are documented in figures 
Figure  2.20, Figure  2.21 and Figure  2.22. 
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(2100-120-HS)
    8. USB MEA2100-120-2
Temperature 
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(up to 256 channels)
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Headstage 
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68 pin SCSI 
Cable
Analogue Analogue 
Or 4x 
2100-60-HS
 
Figure ‎2.22: USB MEA 2100-120-2. Two 120 electrode chips can also be accommodated in one experiment 
via the use of two 2100 headstage units. 
 
The most recent models released to the market by MCS have been called “integrated MEA systems”. 
These configurations integrate the headstage and interface unit into one box that plugs in to an 
acquisition PC via USB 2.0.  
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9. USB MEA256
Integrated Headstage and  
Interface Unit
(up to 256 channels)
Biochip 
(256 electrodes)
Temperature 
control
Any PC with MC_Rack 
installed
Digitised
USB 2.0
 
Figure ‎2.23: USB MEA 256. The current state-of-the-art for neuron applications. This configuration allow 
MEA biochips that arrange 256 electrodes (16x16) into one biochip to be recorded from in a simple three 
piece system; the headstage, acquisition unit and PC. The headstage in this unit is not the 2100 but again has 
been redesigned into one compact unit. 
 
This unit (Figure  2.23) also accommodates a single biochip with up to 252 contact pads. This system 
can record 252 channels at sampling rates of up to 40kHz. The other 4 channels are additional 
analogue for units such as oscilloscopes or signal splitters. These units are regarded as the current 
state-of-the-art in MEA systems with other major competitors developing equivalents. 
 
 
Figure ‎2.24: The most recent configuration of USB MEA256 systems available from Multi Channels Systems.  
A) The USB-MEA256 System. B) The USB-MEA32-STIM4 System. 
 
The integrated unit (as of July 2011) is available in two distinctly different forms. The first unit 
(Figure  2.24A) would be classified as the new standard unit that accommodates one MEA biochip of 
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up to 256 electrodes depending upon user preference. The second (Figure  2.24B) has been adapted 
to accommodate the perforated, perfusion specific MEA biochips (Figure  2.25) developed specifically 
for longer term slice studies. 
 
Figure ‎2.25: A perforated MEA biochip manufactured by Multi Channels System for use in the USB-MEA32-
STIM4 system. 
 
 
2.6.2 System Design Limitations  
To address the complexity of developing a complete MEA system three naturally occurring design 
domains were defined:  (i) the biochip, (ii) the supporting network of electronics and (iii) the 
software(s) used to drive the system. It is also essential to communicate design influencing factors to 
support overall system success. These additional influences are those that dictate how a system is 
applied and have consequently motivated much of MEA system development in the past 
(Figure ‎2.26). 
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Figure ‎2.26: Factors influencing MEA system design. The areas highlighted in red show the three distinct 
areas of MEA design where incremental development occurs. 
 
The cell type under investigation affects the type of MEA biochip that a user will select as certain 
types of biochip make it easier to detect appropriate signals (e.g. 3D electrodes used in slice 
applications). The type of biochip coupled with the cell type affects the settings of the required 
underlying electronics as the signal detected will also vary (e.g. slice applications demonstrate higher 
amplitudes than cultured cells). The software must then provide appropriate support for the cell 
type selected (i.e. in terms of required sampling frequency), the biochip of choice (i.e. in terms of 
accommodating the layout and number of channels), the settings of the underlying electronics and 
the analysis requirements of the user.  
 
Continually evolving MEA systems on the market today are the result of development that has been 
motivated and driven by the desire to acquire as much information as possible from the cells of 
interest (increased useful data). This results in increased complexity during signal acquisition and 
analysis, the outcome is that there is an increased understanding of the subject. Consequently new 
questions arise based on this new knowledge (new research questions) and further assessment is 
required, often involving an increased level of sophistication to acquire the data (Figure ‎2.27). 
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Figure ‎2.27: The MEA motivation-development cycle. 
 
 
2.6.3 MEA system local environment 
The incubated cell culture environment in which living cells are contained is critical to their survival 
and currently MEA systems are a long way from being optimised for this facet of their use. Heated 
headstages and set-ups with microscope integration have been introduced (Morin et al, 2005) but 
these initial MEA systems developed have not been suited to long-term humidified, incubated 
environments.  
Control over the temperature (~37°C) and humidity (e.g. slow evaporation rates) of the environment 
local to a cell in culture is more critical for culture users than slice users. This is because slices are 
exploited in short studies and not required for the periods of days to months (Egert et al, 2002a). 
Successful survival of living samples in-vitro is dependent upon provision of an environment that 
mimics in-vivo as closely as possible. Temperatures at which cultures are maintained is matched to 
that of the in-vivo region of the body from which that cell type originates, and culture medium 
content is precisely controlled over defined durations by control of evaporation and gas exchange by 
incubators (Mather and Roberts, 1998). A consequence of this need to provide a controllable 
environment is that MEA systems in their current state are sub-optimal in design. Since the early 
2000’s some research groups have experimented with methods and specialised tooling specifically 
with the intention of allowing MEAs containing living contents to be left in MEA headstages for 
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longer under conditions that are better suited to cell survival. Examples of this include the use of dry 
incubators to reduce disturbances to set-ups and support long-term investigations in which the cells 
are monitored continuously and left untouched throughout the trial. The first research group to use 
dry incubators also needed to provide a way to reduce evaporation of the culture media. They 
developed a specialist lid for MEAs allowing them to subsist better in a non-humidified environment 
(Potter and DeMarse, 2001).  
In 2005 Morin et al stated that “establishment of an experimental set-up suitable for very long-term 
monitoring of neuronal networks cultured on planar MEAs is becoming an absolute requirement in 
order to design truly significant experiments”. This statement suggests that MEA systems were still 
not optimised and supports the on-going development of MEA systems that can be left in 
environments more suited to cell culture minimising human interventions after seeding. There is 
however, yet to be a suitable commercially available solution. 
 
2.6.4 Evolution of the motivations driving system 
development 
Since Jerome Pine first reported MEA employment in 1980 (Pine, 1980) numerous research groups 
have designed their own MEA biochips, headstages, amplifiers and even complete systems to match 
more closely their own needs (Jimbo et al, 2003; Chen et al, 2008; Clark et al, 2009; Hwang et al, 
2009; Shimada et al, 2011). The motivations that have driven MEA system development have varied 
from group to group but were roughly summarised by Stett et al (2003) as having been: 
 
i. to gain more information about the interactions that occur between cells, 
ii. to reduce the time required to run an experiment by simultaneously recording from multiple 
sites of the same culture, 
iii. to allow monitoring of the changes of electrical activity that occur over time (e.g. changes in 
burst durations, changes in waveform amplitudes). 
 
To acquire significant data from MEA systems an appropriate throughput capability is required, as is 
the ability to analyse the data in an efficient manner.   
An area that would benefit user applications the most is the increase of throughput via a parallel 
improvement of available signal analysis techniques (Johnstone et al, 2010; Braam et al, 2010; 
Natarajan et al, 2011) as well as rapidly and efficient identification of toxicity (Tanaka et al, 2009).  
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In addition, MEA systems that are simpler to use (e.g. require shorter set-ups, allow more instances 
to collect data per test) are also required (Robinette et al, 2011). Cheaper fabrication of biochips and 
system components will be essential to provide affordable MEA systems for the demanded higher 
throughputs of the future (Rolston et al, 2009). There are also expectations that systems need to 
provide continuous or integrated imaging capability in addition to the core electrophysiological 
monitoring (Shew et al, 2010). In 2010 Johnstone et al described the needs that are now motivating 
developers as:   
 
i. need for better understanding of the tens of thousands of chemicals currently used in 
commerce,  
ii. need to increase number of chemicals characterised for potential toxicity, 
iii. need to reduce the time, 
iv. need to reduce cost, 
v. need to reduce the number of animals used in contemporary tests. 
 
Early MEA system development focused upon elements demonstrated in Figure ‎2.28. The upshot of 
this focus and the consequent development has been that the elements that are depicted as 
secondary and tertiary design priorities (see Figure ‎2.28) have become more significant to the overall 
success of the whole system in application. 
 
 
64 
 
__________________________________________________________________________________
Context Research 
     TERTIARY
SECONDARY
                                                  PRIMARY
System 
Development
Throughput
Analysis
Reduce Cost
Simplify 
Complexities
Environment
Integration of 
optics
Current: Systems facilitate 1-4 
cultures per test.
Future: Systems will facilitate 10's - 
1000's per test. 
Current: Complex parameters and 
correlation studies offline file by file.
Future: Complex parameters and 
correlations with previously 
recorded data in real-time utilising 
all relevant files. 
Current: 
 High-skilled bioscientists prepare cells over 
microelectrodes and run timely experiments. 
 Numerous files of data are recorded to gather 
evidence. 
 Specialist analysis approaches to extract required 
details from numerous files.
Future: 
 Supplier provides prepared biochips with cell type 
in situ. 
 Experiments are run according to internationally 
standardised protocols.
 Analysis is automated and real-time. 
Current: 
 MEA System - £15 000 – 110 000
 MEA Biochips - £180+
Future: 
 MEA System - £100's - 1000's
 MEA Biochips - £1 - 10
Current: 
 MEA systems must be 
exploited in a dry 
environment. 
 Heating elements are 
necessary inside 
headstages as are not 
incubator safe.
Future: 
 MEA systems will be fully 
integrated with optic 
system and heated 
(37°C), humidified 
(>95%), CO2 (5%) 
incubator environments 
(Stein et al, 2011). 
Current: Can be used in conjuction 
with microscopes if system 
purchased is complementary model.
Future: MEA systems will be fully 
integrated with optic system and 
heated (37°C), humidified (>95%), 
CO2 (5%) incubator environments. 
 
Figure ‎2.28: MEA system development focuses and their prioritisation. 
 
With regard to the increased emphasis upon environment and integration of optics, presently, the 
ability to record from cells and to ensure their viability throughout prolonged testing depends upon 
1) maintaining an environment that ensures cell viability, and 2) providing optics that allow visual 
inspection of the cells (Li et al, 2008). These are important influences on MEA system design that do 
not necessarily appear as essential design parameters as they do not directly influence the data that 
is collected. Nonetheless, without adequate design for these requirements novel MEA solutions will 
fail to find support amongst scientist users and applications.  
 
The points highlighted describe motivations of developers, as well as cost and timing concerns 
associated with employment of this technology on the larger scales currently being demanded. The 
cell source is also a significant area for designers as new cell sources thought to be more suited to 
specific applications are being successfully derived and validated that may require different biochip 
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parameters or system settings. For example MEA biochips specifically for slices (perforated MEA, 
Figure ‎2.25) are being developed that connect to headstages that have different gains (x550) as 
when compared to a gain setting used in a headstage that is for cultured neurons (x1100) (Kopanitsa 
et al, 2006). 
 
2.6.5 Manufacturing Approach and Materials 
Advancement 
Microfabrication is a general term used for describing the construction of microstructures ranging in 
size from a few to hundreds of micrometres (Kobel and Lutolf, 2010).  MEA biochip developers have 
experimented with microfabrication approaches in line with their emergence as valid manufacturing 
capabilities over the past few decades (He et al, 2000), and the use of microfabrication techniques to 
construct specialised tools for stem cell biology is now becoming common place (Lutolf, Gilbert and 
Blau, 2009). This uptake of micrometre scale tooling has been motivated by a combination of lower 
reagent consumption, high throughput capacities and shorter analysis times (Maerkl, 2009). 
 
2.6.5.1 Microfabrication 
There are three clear schools of thought amongst those who exploit microfabrication approaches for 
MEA biochip advancements:  
1. To make more electrodes, smaller and positioned closer together (Aziz et al, 2007; Charvet 
et al, 2009) for greater detail of activity in recorded data. 
2. To incorporate growth pathways or patterning into biochip workspaces using specific 
biocompatible materials (Wonhee et al, 2010; Kunze et al, 2010). 
3. To design MEA biochips and electrode configurations to fit specifically to physiological 
tissues or regions of interest (i.e. in-vitro MEAs for stimulation of murine hippocampal slices 
(Gholmieh et al, 2006), or ex-vivo Langendorff heart recordings via flexible MEAs (Stett et al, 
2003)).  
 
Arrays with hundreds of microelectrodes at a high spatial density (i.e. 256 - 4096 microelectrodes) 
are being encouraged as results obtained to-date indicate that improved spatial precision will allow 
the simultaneous recordings from numerous dissociated cells without need for skilful control of 
positioning cells. The possibility to measure potentials at a synaptic level would also be more likely 
and that would be highly exploitable by neuroscientists working to understand the functioning of the 
brain (Berdondini et al, 2009). 
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2.6.5.2 Rapid Prototyping 
Modern technologies such as rapid prototyping techniques are also being explored within this 
domain for their suitability to produce customised arrays (Claverol-Tinture et al, 2005). The work of 
Morin et al (2005) is an example of a new method of fabrication for microelectrode arrays based on 
rapid prototyping concepts (Figure ‎2.29). The outcomes of this work have shown promise as cells 
were generally found to grow readily in the specific microchannels formed (in PDMS).  
 
Figure ‎2.29: New method of fabrication for microelectrode arrays based on rapid prototyping concepts using 
photolithographic masks printed on OHP sheets and WL5370 (a photo-patternable silicon from Dow Corning, 
Michigan, USA). (a) Commercial pMEA (Panasonic Medprobe) fitted with patterns with 50μm
2
 chambers and 
25 μm-wide channels. Electrodes are 50μm
2
 and give the scale of the picture. (b) Custom pMEA fitted with 
larger patterns: chambers are 600μm in diameter and channels are 30μm wide. Wiring tracks are 50 μm 
wide and give the scale of the image. 
[Adapted from Morin et al, 2005.] 
 
2.6.5.3 Substrates for manufacture. 
Flexible MEAs that can be curved around tissue and organ structures have also been fabricated 
(Myllymaa et al, 2008; Lacour et al, 2010). These devices are most suited to in vivo applications but 
material and manufacturing techniques have also been applied to produce devices for ex vivo 
applications such as brain slice study (Boppart et al, 1992). The recent emergence of MEAs made on 
thin glass substrates, allowing superior optical monitoring (Multi Channels Systems, 2011) has also 
supported the aforementioned need to incorporate adequate optical characteristics into the biochip 
and headstage design.  
 
2.6.5.4 Biomaterials  
Discussion across design of items for cell culture seeks to investigate the sensitivity of different cell 
types to biophysical factors (e.g. stiffness and density of the growth substrate) in culture (Vickerman 
et al, 2008; Chou et al, 2009; Gilbert et al, 2010). This questioning has come about concurrently with 
the development of, and increased application of, soft biomaterials (such as soft hydrogels), 
intended to mimic the elastic properties of the living tissue in which the cells in culture would have 
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originated (such as that of the brain when investigating the mechanisms of neuron differentiation), 
as cell culture substrates in micro-fabricated platforms (Flaim et al, 2005; Cordey et al, 2008). 
 
 
2.6.6 The Cell-Electrode Interface 
The interpretation of MEA recordings has been challenged by a lack of a definitive detailed electrical 
understanding of the cell-electrode interface (Jenker et al, 2001). Numerous theoretical models have 
been considered similar to the one demonstrated in Figure ‎2.30 (Stett and Kindervater, 2008).  
 
Figure ‎2.30: Stimulation and recording of electrical activity in tissue slices with a planar MEA biochip. 
Substrate-integrated microelectrodes can be used for both stimulation and recording.  
[Stett and Kindervater, 2008.] 
 
This interface is particularly important to understand if applications require electrical stimuli to be 
delivered to the cells in culture because the conditions for extracellular stimulation are affected by a 
delicate balance of interface geometry and ion channel dynamics in the target cell’s membrane 
(Kopanitsa et al, 2006). The region of depolarisation is known to depend upon the cell-electrode 
interface in terms of orientation and extracellular matrix (ECM) meaning that the signal shapes 
recorded from a cell sample may have been different if the same sample where placed on a different 
MEA biochip in a slightly different position (Buitenweg et al, 2002). 
 
There is still no single complete theoretical description of the interface that occurs between a cell (or 
tissue) and a planar metallic microelectrode that has been universally accepted. It has been 
suggested that the work of Buitenweg et al (2003) is the best so far as it is the first example of a 
model that attempts to incorporate the ion channel influences on local membrane properties. Finite 
Element Analysis (FEA) models studying both the electrical properties of the contact between a 
passive cell membrane (Buitenweg et al, 2002) and of a membrane containing voltage-gated ion 
channels (Buitenweg et al, 2003) over a planar electrode has been constructed allowing theoretical 
consideration of different influences on parameters that are not presently possible to physically 
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measure. The results of this work offered theoretical spatial and temporal information about the 
combined electrical behaviour of the extracellular space, the electrode-electrolyte interface and the 
cell membrane but additional considerations and reformulations where suggested as further work. 
 
A collection of the state-of-the-art cell-electrode models are provided in Table ‎2.2 addressing 
neurons and cardiomyocytes. The coupling between the cell and electrode is a critical parameter in 
determining the quality of the acquired signal, in terms of both the signal shape and amplitude 
(Grattarola and Martionoia, 1993). All cell-electrode interface models consist fundamentally of a cell, 
an electrode and the seal between the two, commonly refered to as the seal resistance. The seal 
resistance, the electrode parameters and the shunt capacitance of the interface are all documented 
as having a combined influence over the overall signal acquisition (Nisch et al, 1994; Buitenweg et al, 
1998; Yeung et al, 2008). Note: the discriptions accompanying each diagram are as stated in the 
referenced article. 
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Table ‎2.2: Examples of proposed models of cell-electrode interfaces in MEA biochips. 
Authors and 
Year  
Paper and model diagram Supporting notes 
Nisch et al, 1994 A thin film microelectrode array for neuronal 
activity in vitro. 
 
Where: 
en – isopotential line of neuron 
Rs - resistance of saline between 
metallic interface and ground 
electrode 
Re and Ce - resistance and 
capacitance of the double layer 
Rm - Resistance of the metallic 
portion of the electrode 
Cs - shunt capacitance to the 
ground 
Ra and Ca - input resistance and 
capacitance of the amplifier 
Ingebrandt et al, 
2001 
Cardiomyocyte-transistor-hybrids for sensor 
application. 
 
 
Where: 
gJ – cleft of electrolyte between the 
membrane and the gate (seal 
conductance), 
CJG the specific capacitance of the 
gate, 
CM - specific membrane 
capacitance,  
VJ extracellular voltage, 
iJM - current through the 
membrane, 
VM - intracellular voltage 
 
   
Buitenweg et al, 
1998, 2002, 2003 
Measurement of the sealing resistance of cell-
electrode interfaces in neuronal cultures using 
impedance spectroscopy (1998). 
Extracellular Stimulation Window Explained by a 
Geometry-Based Model of Neuron-Electrode 
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Contact (2002). 
Geometry-based Finite Element Modelling of the 
Electrical Contact Between a Cultured Neuron and 
a Microelectrode (2003). 
 
(1998) 
 
(2002) 
 
 
(2003a) 
 
(2003b) 
 
 
 
 
1998: Geometry of the neuron-
electrode interface. 
 
 
 
 
 
2002 & 2003b: 
Rseal- the current path through the 
gap between the bottom of the cell 
and the surface of the substrate. 
rc- circular soma radius. 
re- electrode radius. 
dg- sealing gap thickness. 
 
2003a: The neuron-electrode 
interface in extracellular 
stimulation and recording. Due to 
current densities, arising from the 
neuronal membrane of the 
electrode, a potential distribution 
exists in the sealing gap which 
modifies the membrane potential 
(stimulation) or can be probed by 
the electrode (recording). 
 
2003b:Electrical equivalent lumped 
circuit which is commonly used as a 
model of the neuron-electrode 
contact. 
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Morin et al, 2005 Investigating Neuronal Activity with Planar 
Microelectrode Arrays: Achievements and New 
Perspectives. 
 
 
 
For planar electrode, where: 
C, Ionic layer capacitance;  
Rs, spreading resistance;  
Rt, charge transfer resistance;  
Zw, Warburg impedance; 
 Zp, impedance associated with 
porosity; 
Rc, resistance of interconnects; 
Cp, capacitance to electrolyte; 
Cc, coupling capacitance between 
interconnects; 
Cs, capacitance to substrate; 
Vintra, Intracellular potential; 
Vextra, extracellular potential; 
Rseal, sealing resistance (a measure 
of the quality of the contact 
between cell membrane and 
electrode surface); 
Relec and Celec, resistance and 
capacitance of the recording 
electrode, respectively; 
Zinp, input impedance of the 
amplifier; 
Rref and Cref, resistance and 
capacitance of the reference 
electrode, respectively; 
Rcell and Ccell, resistance and 
capacitance of the cell membrane, 
respectively. 
Sommerhage et 
al, 2006 
Simulation of extracellular recorded cardiac action 
potentials. 
"The standard Point-Contact-Model 
for cardiac myocytes". This model 
can distinguish inputs for different 
ion currents. 
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Cho and 
Thielecke, 2008 
Electrical characterisation of human mesenchymal 
stem cell growth on microelectrode. 
 
 
 
 
 
 
 
 
 
 
 
 
(a) Schematic model of cell 
monolayer on electrode for FEM 
simulation (not scaled), σ and εr: 
conductivity and dielectric 
constant. 
 
(b) Equivalent circuit. 
CPEel – constant phase element for 
electrode impedance. 
Re – extra cellular resistance. 
CPEm – constant phase element for 
impedance of cell membrane. 
Rs – spreading resistance. 
 
Yeung et al, 2008 The Use of Microelectrode Array (MEA) to Study 
Rat Peritoneal Mast Cell Activation. 
 
 
Where: 
Rj - seal resistance typical distance 
values for the membrane from 
surface lie in range of 10s of nm to 
100nm (ref171) resulting in values 
of 1-10MΩ. 
 Vj - contact point. 
 
This model is for mast cells that 
have slower signals than neurons 
and cardiomyocytes so capacitive 
components have been excluded. 
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Joye et al, 2008 
and 2009 
An electrical model of the Cell-Electrode Interface 
for high-density Microelectrode Arrays (2008).                                                                                                                                                                                                                                   
A Cell-Electrode Interface Noise Model for High-
density Microelectrode Arrays (2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Point-contact model of the cell-
electrode interface (not to scale).
 
ZCPA – constant phase angle 
impedance (represents the 
interface capacitance in parallel 
with a charge transfer resistance). 
Rct – charge transfer resistance. 
Rspread – spreading resistance. 
Rseal – sealing resistance. 
Zload – load impedance of the cell-
electrode interface system.                                                                                                                                         
Chd - cell membrane-electrolyte 
capacitance                                                                                                                                                                   
Rm and Cm - membrane resistance 
and capacitance. 
 
Equivalent cell-electrode interface 
noise model for (a) no cell and (b) 
one cell lying on top of the 
electrode.                                                                                                                                                                              
Zel – the electrode impedance. 
Vel,noise – electrode noise voltage. 
Vinput,ampli – the input referred noise 
of the amplification stage of a 
CMOS-based MEA. 
Vrseal,noise – seal resistance noise 
voltage. 
 
Krinke et al, 2009 A microelectrode-based sensor for label-free in 
vitro detection of ischemic effects on 
cardiomyocytes. 
 
Where:  
Ze – impedance of the MEA system, 
comprising of an RC circuit in 
parallel (Re, Ce)  and an additional 
constant phase element (CPE, A, n) 
in series. 
Rsl – resistance of the support layer 
for cell adhesion. 
Zcl – impedance of the cell layer 
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constituting of an RC circuit in 
parallel (Rc,Ccl). 
Rbulk – resistance between the cell 
layer and the large counter 
electrode. 
 
 
 
 
2.6.6.1 Cellular sealing and signal-to-noise ratio. 
A number of different attempts to clarify and understand the influences of the “sealing” that occurs 
between a cell and its underlying electrode have been published, aiming to help interpretations of 
amplitudes and waveform shapes recorded by MEA systems. This literature also suggests that the 
signal-to-noise ratio of recordings increases if a cell completely “seals” an electrode, thus enhancing 
signal quality (Hofmann et al, 2011). The stimulation pulse required to evoke particular responses 
also decreases when the stimulating electrode is completely covered by the cell (Bove et al, 1995). 
By decreasing the sealing gap using adhesion promotors significant improvements can also be made 
to the quality of the signals acquired. Matrigel™ in an example of such an adhesion promotor shown 
previously to favourably support human embryonic stem cells (hESCs) (Braam et al, 2008).  
 
2.6.6.2 Simplified interface circuitry 
The following models (Figure ‎2.31 and Figure ‎2.32) offer a simplified summary of the theoretical 
models collated in Table ‎2.2.  
 
Figure ‎2.31: Cell-electrode model and calculated values of components of the interface model. CEDL – 
capacitance of Electrical Double Layer, RCT – charge transfer resistance, Zw – Warberg impedance, Zp – 
impedance of the porous surface, Rs – spreading resistance, Cx – parasitic capacitance. 
[Adapted from Al-Gayam et al, 2010.]  
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Figure ‎2.32: Equivalent circuit for a planar microelectrode array element. Where C - Ionic layer capacitance, 
Rs - spreading resistance, Rt - charge transfer resistance, Zw - Warburg impedance, Zp - impedance 
associated with porosity, Rc - resistance of interconnects, Cp - capacitance to electrolyte, Cc - coupling 
capacitance between interconnects, and Cs - capacitance to substrate. 
[Adapted from Kovacs (1994) by Morin et al (2005).]  
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2.7 Contemporary Application 
MEA technology is most commonly applied in cardiac and neural applications (Proceedings of MEA 
Meeting 2008). Other tissue types are discussed in this document as niche applications due to a 
lesser volume of published work validating protocols and findings (section ‎2.7.3). 
It is possible to use MEA technology with cells that have been dissociated from animal tissues or 
differentiated from various stem cell sources (Charlesworth et al, 2006). Cells can either be in the 
form of cultures or thin tissue slices dissected directly from animal subjects. The data yielded can be 
analysed to provide information for a number of differing research problems that may be considered 
to be within the fundamental research domain, for example “what happens electrically when this 
cell contracts?” or, within an applied research domain, such as “will this drug applied at high 
concentrations induce heart rhythm abnormalities?”   
The cell source used will result in differing application strategies in terms of how the cells are 
positioned and cultured to ensure a recordable signal. For example, when seeding beating 
cardiomyocyte clusters that have been differentiated from stem cells the challenges in terms of 
positioning those cells over the electrodes differs from that of positioning a heart slice dissected 
from a chicken embryo. Where in both cases a close cell-electrode interface is required, but in 
practical terms the achievement of this is pursued differently (see Chapter 4). 
2.7.1 Cardiac MEA Application and This Research. 
MEA systems are used to characterise cardiomyocyte preparations for both fundamental (e.g. 
understanding cell-cell communication) and applied (e.g. chemical entity effects on a cell type) 
research purposes. For this research, focus has been placed upon the stem-cell derived 
cardiomyocyte preparations used by the collaborating institute, the University of Nottingham (UoN), 
in applied cardio-active substance research.  The main topic of interest at the UoN is in the 
investigation and measurement of QT-interval changes following addition of chemical substances 
(e.g. drugs and drug candidates) and combinations of chemical substances.   
The cell sources used were human embryonic and human skin cell-induced pluripotent stem cells. 
From these stem cell lines cardiomyocytes were differentiated in vitro that could be used to monitor 
substance effects via correlations that have been identified (Denning and Anderson, 2008) between 
field potentials from these cells and ECG signals recorded from human hearts.   
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Signal features identification,
Signal features 
characterisation,
Drug candidate analysis,
Cell therapy,
Genetics,
Disease specific
Cell functioning,
Cell-cell communication,
Tissue functions,
Proliferation,
Embryonic to adult 
development
Slice
(I.e. Chicken 
embryo)
In vitro culture
(I.e murine tissue 
dissociation or stem 
cell differentiation)
Cardiomyocyte Electrophysiological 
Characterisation Using MEA Systems
Fundamental 
Research Domain
Applied Research 
Domain
Embryoid body 
derived beating 
clusters
Drug candidates
QT-interval identification
Unique FP signal 
every time
Randomly composed of:
Fibroblasts ( ~80-95%)
Cardiomyocytes (~5-20%)
Random ratio of 
cardiomyocyte phenotypes:
Pacemaker-like
Atrial-like
Ventricular-like
Unique according to 
recording electrode:
Beating segment size, 
orientation and location in 
terms of recording 
electrode.
Example 1
Example 4
Example 2
Example 3
Cell source associated 
DESIGN CHALLENGES
QT-interval prolongation 
detection
University of Nottingham Cardiomyocyte Application
 
Figure ‎2.33: Contemporary application of MEA systems for cardiac and specifically stem cell-derived 
cardiomyocyte based research. 
 
The research conducted at UoN has been limited by the variability that exists in stem cell derived 
cardiomyocyte clusters. The beating cardiomyocyte clusters that are dissected out and used for 
recording are typically composed of <20% cardiomyocytes.  The inherent variability of these clusters 
results in a different MEA recording for each cluster as no two clusters are the same.  Examples of 
four signals captured from four different beating cardiomyocyte clusters seeded over an MEA 
workspace are demonstrated in Figure  2.33. 
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2.7.1.2 International guidelines 
Over the last 10-15 years the QT-interval has been under investigation by the pharmaceutical 
industry and global regulatory bodies (Braam et al, 2010). Major losses in the region of hundreds of 
millions dollars have been incurred on drugs developed and marketed that have later had to be 
withdrawn due to unforeseen interference with the human QT interval (Frantz, 2007).  
 
At around the start of the millennium, in attempts to prevent QT interval altering drugs from making 
it to the market, the International Conference on Harmonisation’s Global Cooperation Group, 
comprised of representatives from Europe, Japan and the USA, produced two guidelines to be used 
by all parties involved in drug development. The document S7B (Appendix B) endorses nonclinical 
methodologies of QT interval assessment and the document E14 contains the clinical equivalents. It 
is intended that together these two documents will contribute to a better understanding of the link 
between results derived in a laboratory setting and QT prolongations as they actually occur in 
humans. In terms of MEA system application the document S7B is of greatest relevance as it 
emphasises the need to assess all new chemical entities, intended as cardiac therapies or otherwise, 
for any alteration to cardiac ventricular repolarisation.  
 
2.7.1.3 Using stem cell-derived cardiomyocytes 
Each time a new beating cardiomyocyte cluster signal is detected and visualised using MEA 
technology a unique contraction waveform is identifiable. This is due to the novel composition of the 
beating cluster. The resting potentials (signal baseline) of the cells also alters throughout 
development towards maturity. In early embryos it is typically at around -40 to -50mV. This changes 
progressively as the cells develop toward adulthood to approximately -75 to -85mV. The maximum 
rate of rise of an AP upstroke velocity also increases during this growth period from about 20V/sec 
to about 200V/sec. Consequently, the same beating cluster will show differing signal waveform 
characteristics as it matures (Banach et al, 2003; Marin-Garcia, 2011). Comparisons have shown 
hESC-derived cardiomyocytes are morphologically relatively immature but that they do contain the 
appropriate ion channels and signalling pathways previously been shown to be modified by specific 
cardiac drugs (Kohl et al, 2005; Harding et al, 2007). 
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Design Challenges Due to every beating cluster being different.
  Unique in:
  
 Shape
 Size
 Contraction profiles:
o duration of contraction
o maximum amplitude
o minimum amplitude
o duration between contractions 
GEOMETRY OF 
BIOCHIP FEATURES
(Hardware)
AUTOMATION OF 
SIGNAL ANALYSIS
(Software)
Contributes to unique signal: these parameters may also 
vary according to inherent genetic variability.
o Therefore – position of signal source relative to recording 
electrode.
o Therefore – matter (i.e. other cells) between signal source 
and recording electrode. 
Influences
Influences
 
Figure ‎2.34: Current design challenges in the cardiac domain. 
 
The design challenges that are introduced due to unique nature of each beating cardiomyocyte 
cluster were collated in Figure  2.34 for this research. 
 
 
2.7.1.4 Cell therapy 
In-depth understanding of under lying cellular mechanisms of cells could provide the most promising 
route toward their optimisation for cell therapy. To obtain such information by trial and error would 
take significant time and resources and expose patients to substantial risk. A methodical 
characterisation is required that also accommodates overall therapy safety. MEA systems will 
support safe methodical electrogenic cell characterisation.  
 
2.7.1.5 Commercial QT measuring MEA systems 
The first commercial system and enterprise to address the needs of MEA QT-interval assessment 
were QT-Screen by MCS, Germany and the QTempo service conceived and offered by ReproCELL, 
Japan.  
In the QT-Screen system (Appendix B) a ninety-six well plate specifically adapted to record from 
beating cardiomyocyte clusters has been the focus of design efforts. The format aims to seed 
beating clusters of single cardiomyocyte cells to each well for standardised QT interval analysis. 
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Note:  employment of a 96-well plate could be very labour intensive depending upon the preferred 
laboratory protocols of the user. No independent publications that have employed this system have 
yet been identified. 
The QTempo offers a service whereby functional assays are used to detect functional waveform 
responses. Standard MEA systems (MCS MEA60) are used and analysis is performed as part of the 
service, resulting in results provided to the relevant stakeholders in the form of portable document 
format (.pdf) reports. ReproCELL’s QTempo business model is included in Figure ‎2.35. 
 
Figure ‎2.35: Business system QTempo. 
[Adapted from Sengoku et al, 2010.] 
2.7.2 Neural  
Originally developed for neural applications MEA systems have been developed to suit specifically 
the needs of a plethora of neurological investigation domains. A brief summary of slice and culture 
applications in shown below (Figure  2.36). 
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Cell functioning,
Cell-cell communication,
Tissue functions,
Synapse junctions,
Ion channels,
Proliferation,
Embryonic to adult development,
Etc.
Spike and burst detection,
Network characterisation,
Drug candidate analysis,
Cell therapy,
Genetics,
Disease specific,
Etc
Slice
(I.e. murine brain 
region)
In vitro culture
(I.e. murine tissue 
dissociation or stem 
cell differentiation)
Neuron and Brain Region Characterisation Using MEA 
Systems
Fundamental 
Research Domain
Applied Research 
Domain
Different classes and phenotypes of neuron
Mixtures of neurons and glial cells
Unique‎“spike‎signature”‎for‎
each neuron
Capture and analyse network activity using numberous signals captured 
from a known segment of the culture/tissue.
Network activity characterised according to identification of spatio-temporal 
activity patterns
Spike sorting distinguish 
activity of each neuron in a 
signal
Brain regions: identify 
specific‎“pathways”‎or‎
patterns of activity. I.e. in 
the hippocampus
Dissociated neurons: 
form networks 
overtime. Neuron 
axons extend towards 
one another in vitro.
Unique network 
activity
Spacing of electrodes and electrode diameter
Biochip 
geometry
Resolution of recording:
Cell-cell, Individual synaptic junctions.
Bursts:
Multiple neurons 
firing in synchrony
Spikes:
Single neurons 
firing
Three-dimensional pointed 
electrodes for slice penetration
Evoke activity 
(spikes and 
bursts)
Observe pattern of 
response and 
Plasiticy
Plasticity: learning of 
neurons and networks 
overtime following input 
stimuli
Stimulation
Planar electrode tips
NEW! Perforated MEA biochips
(Complete new system required)
 
Figure ‎2.36: Contemporary application of MEA systems for neurology based research. 
The patterns of electrical activity that occur in the brain are complex and rapid (Hill et al, 2010). 
There is still much that is unknown about the mechanisms that underpin the functioning of the 
mammalian and specifically the human brain (Hinton, 2002).  
MEA systems were conceived and initially built by neuroscientists (Thomas et al, 1972). Neural tissue 
can be studied on MEA biochips in one of two forms of preparation (Potter, 2001). Preparations are 
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either dissociated cells cultured over the MEA biochip’s surface or are thin slices precisely anchored 
in place over the microelectrode array.  The cell preparation will influence which type of MEA 
biochip is best suited to use. 
Planar, 3D, perforated planar and CMOS biochips have been introduced, resulting in improved signal 
quality, longer testing times (e.g. minutes to hours) and ever greater degrees of resolution (e.g. from 
cell-cell towards synapse-synapse). Work of neuroscientists is moving deeper into how neural cells 
communicate, by shifting from the study of individual cells towards individual synapses (Berdondini 
et al, 2009).  
 
2.7.2.1 Stimulation studies 
 MEAs have been used in experiments aiming to decipher and comprehend the cellular mechanisms 
of learning and memory. Electrical stimuli have been used to induce activity and monitor plasticity. 
Stimuli and the tissue responses have been recorded and observed using MEA systems (Ide et al, 
2010; Li et al, 2010), with particular brain regions showing reproducible results on comparable set-
ups (Boehler et al, 2012).   
 
2.7.2.2 Cell preparations 
Dissociated neurons can be sourced from brains or brain regions that have been dissected out of 
animals or that have been differentiated from a stem cell source. Dissociated neurons can then be 
dispensed over a treated MEA workspace where a unique neural network will develop in vitro. These 
cultures can be maintained for periods of months (Dubois-Dauphin et al, 2010). Slices can be used if 
anchored securely over an MEA workspace. These preparations are usually maintained for periods of 
hours. In slice preparations, pathways of activity that already exist in tissue can be observed and 
interacted with via targeted stimuli input. In dissociated cultures the part of the neuron that 
successfully survives the dissociation process is the soma (neuron’s main cell body). Axons and 
dendrites are damaged and break off during centrifuge stages. The somas are suspended in media. A 
small sample of the suspension is examined and the number of cells counted so that an 
approximately controlled quantity of cells can be seeded per MEA. This process allows culture 
monolayers if desired. Axons and dendrites re-grow towards one another creating unique networks 
that start to spontaneously interact.  
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2.7.2.3 Tissue composition, spike signatures and spike sorting 
Both slice and dissociated cultures will be made up of a mixture of cell types. Glial cells will be 
present in all cases as they are essential for neuron survival. The activity that occurs through the 
neural samples is referred to as spikes and bursts. A key feature of the spikes, that collectively also 
make up bursts, is that each spike recorded on an MEA will be unique. Therefore each neuron is 
described as exhibiting its own spike signature. The signature is due to physical differences between 
the neurons and its unique position in relation to the recording electrode (Quian Quiroga, 2012).   
Specialist algorithms have been developed (Quian Quiroga et al, 2004; Pereda et al, 2005) that can 
separate out spike signatures thus allowing individual neurons to be identified and monitored.  This 
process is called “spike sorting” and is regarded a fundamental first step in the majority of analysis 
routines for MEA system recorded neural data. Deeper degrees of understanding require on-going 
monitoring of network activity to identify patterns and determine the significance of those patterns. 
 
2.7.3 Other/niche  
Other tissue application domains where MEA technology has been previously demonstrated with 
some success include duodenum tissue (Lammers et al, 1993), stomach tissue (Nakayama et al, 
2006), peritonea cells (Yeung et al, 2008), olfactory epithelium cells (nasal tissue) (Liu et al, 2010) 
and pancreas cells (Raoux et al, 2011) investigations (Figure ‎2.37).  
Potentials exist in “non-electrogenic” tissues that alter slowly. Slow field potentials that occur across 
muscle tissues of the gastrointestinal tract of small mammals have been successfully detected using 
MEA technology (Lammers et al, 1993; Nakayama et al, 2006). Note: Should MEA technology be 
adopted by gastrointestinal research on larger scales, these types of studies will require systems that 
can record for prolonged durations without disturbance. 
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Example Niché Applications Demonstrating MEA System Versitility
Gastrointestinal
(Lammers et al, 
1993)
Duodenum
(rabbit)
Smooth muscle 
cell preparation
 Possible to record slow wave propagation across muscle tissue.
 Maps produced can compare waves.
 Observed patterns of propagation with respect to stimuli.
 Waveform peak-to-peak amplitudes ~10µV.
Gastrointestinal
(Nakayama et al 
2006)
Stomach
(guinea pig)
Smooth muscle 
cell preparation
 Field potentials recorded with MEA and AP recorded with patch-clamp.
 Drug responses recorded and analysed.
 Waveform peak-to-peak amplitudes ~100µV.
Immune 
Response
(Yeung et al,  
2008)
Peritonea
(rat)
Isolated mast cells
 First study of non-excitable tissue
 Compounds added and changes in field potential detected and analysed.
 Waveform peak-to-peak amplitudes 4-6mV.
Plant – root apex
(Masi et al, 2009)
Root
(Maize Plant)
Root apex cells
 Chemically-elicited electrical activity
 Spatiotemporal characteristics of electrical network of a root or interest.
 ~10-20µV peak-to-peak.
Research Domain
Tissue Type
(source)
Preparation Type Observations
Nasal passage
(Liu et al, 2010)
Olfactory 
epithelium
(rat)
Olfactory receptor 
neurons
 Extracellular recordings taken from dissected tissue layer.
 Odour stimulants examine.
 Time and frequency domain analysis for provision of information of olfactory 
system for artificial olfaction biomimetic design (bioelectric nose)
Endocrine System 
and Diabetes
(Raoux et al, 
2011)
Pancreas
(mice)
Islet cells
 Extracellular recordings taken from clonal β-cells cultured for 2-7days.
 Electrical signals were conditioned, recognised and sampled. Offline 
analysis in MC_Rack. 
 Waveform peak-to-peak amplitudes -30 - +20µV.
 Subsequently developed Application Specific Integrated Circuits (ASICs) on 
Field Programmable Gate Array (FPGA) and implemented wavelet algorithm 
in real-time during online treatment.
 
Figure ‎2.37: Domains where MEA technology has been successfully applied to record field potential 
fluctuations over time. 
 
The electrical response of mammalian mast cells has been demonstrated (Yeung et al, 2008). Resting 
potential changes were observed in these cells showing successful application of an MEA system to 
collect data from cell samples that do not spike or burst.  
With regard to tissues of the nervous system, it is not just the study of neurons that have been 
demonstrated on MEA systems. Receptor cells also produce detectable signals and have been 
studied using MEA technology to demonstrate and derive knowledge concerning activity so as to aid 
the development of a biomimetic device that hopes to recreate the functionality of real organs (Liu 
et al, 2010). 
Non-mammalian cells have also been used on MEA systems (Masi et al, 2009). The electrical activity 
that occurs at the apex of a maize plant has also been detected and recorded for investigation.  
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2.8 Generic Analysis 
The analysis of MEA signals is a broad and diverse field of expertise however in all cases the generic 
processes involve signal detection, recording and knowledge extraction (see Figure ‎2.38).  
Detect Record
Replay
(extract data)
Convert file type Import
Manipulate
(extract data) 
Compile findings
Comparable between all users Application and user group specific
 
Figure ‎2.38: The elements of detection and analysis that are comparable between users and that are specific 
according to application and research group. 
 
Addressing the area of MEA signal analysis involves determining, what is output as a signal and what 
are the features identifiable within those signals. All signals captured contain a roughly consistent 
flat line referred to as the baseline. This baseline typically carries high frequency noise components 
and stays roughly consistent at the resting potential of the cells/tissue (Prentice et al, 2011). The 
high frequency noise, present in varying degrees in all MEA recordings, can be attributed to noise 
generated by items in the surrounding environment (such as lights, nearby PCs or electrical 
monitoring devices, e.g. microscopes). The field potentials occurring across the living sample are 
identifiable when the signal line diverts from the baseline and beyond the noise. This typically occurs 
rapidly, resulting in what is called a spike or a series of spikes called a burst (Figure ‎2.39), or 
depending on the application, can be identified more gradually as either a positive or negative 
fluctuation of the baseline from initial value and back towards it (Figure ‎2.39).     
 
Figure ‎2.39: Two channels of neural data. Each corresponds to a single microelectrode. Spike and burst 
features are distinguishable and baseline noise identifiable. 
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MEA systems present potentials to human users as a voltage value to an accuracy of a few 
microvolts (µV). Spikes that occur above the noise level are identifiable visually on the graphical user 
interfaces that are provided with MEA system acquisition software. These interfaces are essential for 
users who must ensure that their preparations are active, and that the contacts between the cells 
and the microelectrodes permits recordings of a quality that is reliable and valid as a source of data.  
 In some cases the user may focus their attention on specific channels of data within the array, or 
alternatively they may be interested in the spatiotemporal activity over the entire array. In all cases 
the data acquisition software must accommodate the user’s needs.  
View channels are all 
detecting
Observe a signal is 
present
Identify spikes, bursts, 
waveforms
Extract meaningful 
information
Record
 
Figure ‎2.40: Basic fundamentals of MEA system use. 
 
 
In Figure ‎2.40 basic user interaction with MCSs MC_Rack software is depicted with the purpose of 
demonstrating core functionalities required of all acquisition and analysis software. It is important to 
highlight that experimental outcomes vary from application to application according to the research 
questions of the scientist user groups. 
All users will prepare their MEA biochip with a living biological sample of interest. A designed 
protocol will be used for testing. A reliable signal is required before executing an experiment. All 
users will insert the biochip into the system’s headstage and wait for a few minutes to observe 
signals on an interface with a grid that corresponds to the microelectrode layout (Figure ‎2.41). 
Different experiments will quantify and assess different features within the signal shapes so users 
will initially observe signals prior to recording to ensure the feature(s) of interest is (are) identifiable. 
Once satisfied with signal presence and quality the user will conduct the experiment recording data 
as appropriate. The user will then analyse the recorded data in a fashion that best identifies and 
quantifies that feature(s) of interest. 
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Opportunity for 
specialisation more 
complex
Opportunity for simple 
specialisation
Activity occurs over microelectrodes
   
   Acquisition software (MC_Rack) displays all (60) channels available:
User can view each channel in 
greater detail if desired. 
Double click over channel to view 
one channel of interest (COI)
Single channel 
required for trail
Cardiomyocyte 
waveform feature 
extraction
MC-Rack 
software
For: Acquisition 
and analysis
 Visualise activity,
 Record activity to file and save,
 Manipulate data using virtual 
tools configured into a virtual 
rack.
.mcd file type
MC_Rack Replayer
For: Further analysis in 
MC_Rack.
MC-Datatool
For: File type 
conversion:
 binary, text or 
axon binary
Offline analysis
  Alternative softwares for useful data extraction:
- Matlab, Mathworks, Cambridge, UK
- Neuroexplorer, Nex Technologies, MA, USA
- pClamp, Molecular devices, CA, USA
- custom written software/scripts, i.e. R scripts
If >1 channel 
required
Neural 
applications,
Cardiac/GI wave 
propagations, etc
View channels and observe signal
Identify spikes, bursts, waveforms 
Record
Extract meaning
 
Figure ‎2.41: Analysis routine commonalities. The details of outputs will vary according to the preference of 
the user(s). 
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2.9 MEA Systems 
The core components of an MEA system are demonstrated in series in Figure ‎2.42 comprising of a 
cell generating an AP that is detected by a nearby voltage probe that is embedded into a circuit on a 
biochip that connects to an amplifier, filter and computer. The computer stores and displays the 
detected signals for the human user to view and analyse.  
Cell or tissue
Signal
(APs à FPs)
Microelectrode MEA Biochip Amplifier
PC
(Data 
Acquisition)
CORE MEA SYSTEM:
Filter
Cells of Interest:
 
Figure ‎2.42: Core components of an MEA system. 
 
 
Figure ‎2.43: A Multi Channels Systems MEA60 System in a bioscientific laboratory. 
 
A typical MEA system set-up in a bioscientific research laboratory at the University of Nottingham is 
illustrated in Figure ‎2.43. Specialist housing or units like that seen in Figure ‎2.43 are custom-made to 
serve as enclosures for the headstage to improve atmospheric conditions (e.g. temperature (37ºC), 
humidity (>95%), CO2 concentration (5%)) around the cells while in the headstage (Figure ‎2.47 and 
Figure ‎2.48). The unit also aims to reduce the possibility of contamination occurring as this particular 
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research group does not use MEA biochip lids. The need for an enclosing unit is also something that 
must also be factored into decision making prior to installation as space for the system within a 
laboratory environment may be limited.  
 
Not all research groups use their MEA system continuously and at times a system can remain unused 
for periods of weeks to months. This occurs due to the varying demands of the overall research 
question being addressed. The issue of portability of MEA systems has yet to be debated on a broad 
scale but recent discussion of “lab-in-a-box MEA systems” suggested that portability is one aspect 
that could be drastically improved upon (Fejti et al, 2006). This has been acknowledged in recently 
launched commercial systems as reconfigurations of the MEA60 set-ups into new plug-and-go units 
using USB connections have emerged (section ‎2.9.2.1).  
 
2.9.1 System components 
A brief description of the main units and critical components making up MEA system set-ups are 
shown in Figure ‎2.44. It is essential that developers looking to build a complete MEA system 
understand and can manufacture parts that integrate seamlessly. Microelectrodes must be 
manufactured to a high quality on a base substrate that can be insulated by specifically 
biocompatible materials. The insulation material must also accommodate a water-tight seal 
(between the glass or polymer ring that will form the media well) with an adhesive or sealant that is 
non-toxic and that will withstand periods of up to months in humid environments. A headstage must 
also be constructed that will reliably connect to the contact points on the MEA biochip. Amplifiers 
must be sufficiently close to that point of contact to ensure the signals reach the analogue-to-digital 
converters (ADCs) and required filters without too much noise interference from background 50Hz 
and radio frequency sources. A means of temperature control with sufficient accuracy (+/- 0.5ºC) 
must also be incorporated into the headstage to control the temperature local to where the cells 
and cell media will be positioned. This is especially important for longer recordings (e.g. for periods 
of months). Appropriate connections must be made between the headstage and PC. A PC must be 
programmed to run the MEA system and interface to software constructed for signal acquisition and 
manipulation. 
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MEA System
MEA biochip
Headstage
PC
GUI
 Microelectrodes
 Insulation
 Base Substrate
 Media well/reservoir
 Data Acquisition Card or Unit
 Memory
 Software
 Recording Software
 Analysis software
Cell-to-electrode 
interface
Human 
interface
Biochip to hardware 
interface
Optical 
monitoring
Headstage to data 
acquisition and PC 
interface
 Integrated Temperature Control Device 
 Contact Pins
 Pre-amplifiers
 Amplifiers
 Filters
 
Figure ‎2.44: An MEA system set-up, important interfaces and sub-components applying to each main 
component. 
 
The key interfaces that must be understood are cell-electrode, biochip to headstage hardware 
(electronics), headstage hardware to PC and PC to user.  
 
2.9.1.1 The MEA Biochip  
Typically the shape of an MEA biochip is square (i.e. Multi Channels Systems and Ayanda Biosystems 
are 49mm x 49mm), with the electrode array embedded at its centre (Figure ‎2.45). Each electrode is 
connected to a contact pad by a thin strip of conductive tracking. Contact pads fan-out around the 
periphery of the biochip in line with the layout of spring-loaded contact pins held in the MEA 
headstage unit. The local area of the biochip surface where the electrode tips are located is referred 
to as the workspace as it is only cells or tissue over this area that electrical activity can be recorded 
from.  
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Figure ‎2.45: A typical 60 electrode MEA biochip. This model is manufactured by Multi Channels Systems.  
Electrode diameter is 30µm with inter-electrode distances of 100µm. 
 
The standard MEA biochip containing 60 electrodes is arranged in an 8 x 8 grid array. The corners of 
the grid array are not filled with an electrode (see Figure ‎2.46). Above and around the workspace is a 
volume of space contained by an adhered ring. The ring is made from glass or plastic, forming the 
media well. A known volume of cell media will be added to this well to provide the living cells with 
both the nutrients that they require for in-vitro survival and to provide a means of removing waste 
products excreted. 
 
Figure ‎2.46: A schematic of the electrode arrangement in a typical 60electrode MEA biochip workspace. 
Inter-electrode distances vary between models (see Figure  2.65). 
 
2.9.1.2 The Headstage 
The headstage is the unit that supports the biochip and houses the initial interconnect pins and pre-
amplifiers. A range of headstage specifications (section ‎2.9.2.1) are available according to the MEA 
biochip configuration required and the cellular signal source of interest (e.g. brain slices, stem cell 
derived cardiomyocytes). Multi Channels Systems typical 60-channel headstage amplifier consists of 
a circuit board that integrates initial preamplifiers and filter amplifiers in one single unit. The 
dimensions of this unit are 165 x 165 x 19mm. The manufacturing approach used to create the 
circuit within is surface mounted device (SMD) technology (MCS MEA Amplifier for Inverse 
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Microscopes Manual, 2010). MEA headstages require amplification as close to the signal source as 
possible (Chu et al, 2006). This is due to the FPs being in the range of micro-volts thus the best 
signal-to-noise ratio (SNR) attainable is required.  
 
Figure ‎2.47: A Multi Channels Systems (MCS) Headstage Model, “MEA1060-Inv-BC-Standard”. 
Views are from the top. A) The top plate houses the contact pins and headstage circuitry. 1. Digital 
Input/Output (I/O), 2. Serial I/O (used for the MEA_Select tool where two headstages are used in parallel), 
3. 64-pin Connector to pre-amp and filter unit (FA60), 4. Opening to where the MEA biochip well is enclosed.  
B) The bottom plate. 1. One of four female connection alignment recessions. 2. Contains a brass plate that is 
heated by an external temperature control unit. The brass plate in this instance has a hole at its centre to 
accommodate and inverted microscope set-up. 3. Turning clasps used to hold the two parts of the device 
closed. 
 
 
 
Figure ‎2.48: The corresponding undersides of the MCS MEA1060-Inv-BC-Standard headstage (fig. 2.47). 
A) The underside of the top plate. 1. One of four male connection alignment pins. 2. Spring loaded gold pin 
interconnections. B) The underside of the bottom plate demonstrating a recession in which the induction 
board is situated for heating the brass plate surface above. 
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A number of headstages are now available with blanking circuits built-in to enhance recording 
properties during stimulation experiments (see section ‎2.5.1.1). Specialist adapters (i.e. physical 
connectors to the headstage of biochip) are also available that connect directly onto the headstage 
contact pins that are designed for certain stimulating protocols. Users can also have an adapter 
custom made (by MCS) to meet more individual requirements (e.g. most common for specialist 
stimulation experiments).  
In some instances up to four headstages can also be linked to one PC for simultaneous investigation 
of four independent MEA biochips. This is done with MCS systems through the addition of a 
hardware device called an MEA switch.  
 
Figure ‎2.49: The 68-pin small computer standard interface (SCSI) cable type used for connecting MEA 
components in MCS in-vitro MEA systems. 
 
In original MCS MEA-60 systems a small computer standard interface (SCSI) cable type (Figure ‎2.49) 
is used to connect the headstage to further filters, an MEA switch and the data acquisition card. The 
data acquisition card that is housed within a PC is based on PCI-bus technology allowing up to 128 
channels to be sampled at a frequency between 2kHz up to 50kHz. Therefore, if four headstages are 
connected to one PC via an MEA switch system, only 120/240 (50%) of the electrodes in the four 
MEA biochips will be recordable.  
Each headstage also has three analogue channels and a digital port for connection to other 
peripheral devices , such as additional oscilloscopes (MCS MEA Manual, 2010). 
 
2.9.1.3 Data acquisition card or unit  
Original MEA-60 systems connect from the headstage and filters, or MEA switch, directly into a data 
acquisition card (Figure ‎2.50) that is housed in a specially built PC operating an XP or Windows 7 
operating system.  
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Figure ‎2.50: An MCS MC_Card removed from PC 
 
In more recent years new compact acquisition systems have appeared on the market that connect to 
the PC using USB 2.0 cables. This has made MEA systems more portable in the sense that the 
acquisition unit no longer needs to be housed in a desktop computer and so any computer with 
MC_Rack software (the Multi Channels System acquisition software) installed. In some cases this can 
help user groups with many MEA system users to manage the data produced more effectively. 
Groups can divide up the memory load simply onto each individual user’s PC. Scientists are then also 
responsible for their own recording and analysis, and the adequate protection and back-up of their 
data. It is this feature that has brought MEA technology a step closer to being a tool that any user 
can plug in to and operate intuitively. However, conversely this potential division of memory, and 
thus data, may not be ideal for groups where users need to share centralised data. 
 
2.9.1.4 System software and GUI  
All commercially available MEA systems are provided with a specialist acquisition software allowing 
initial experiment set-up and data acquisition. 
The acquisition software used in conjunction with Multi Channels Systems system is called MC_Rack 
and it is used to record or replay corresponding multi channels data files (.mcd extension). Upon 
opening an instance of MC_Rack the user interface (Figure ‎2.51) presents a grey work bench area 
that is filled with an appropriate virtual rack of tools. The tools (Figure ‎2.52) used to record and 
extract information from an .mcd file varies according to the cell preparation and the nature of the 
experiment being conducted.  
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Figure ‎2.51: The user interface upon opening a previously constructed recording rack in MC_Rack. 
 
 
Figure ‎2.52: The tools available in MC_Rack. 
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Figure ‎2.53: The user interface for the MCS 96-well QT-Screen systems acquisition software, called QT-
Screen. 
 
 
 
 
Figure ‎2.54: The user interface for the accompanying analysis software, called QT-Analyser. 
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The graphical interface of the MCS QT screen’s system software is shown in Figure ‎2.53 and 
Figure ‎2.54. The QT-screen is a specialist system for use with cardiomyocyte cells types in chemical 
entity screening. Separate software has been provided for recording (QT-Screen) and analysis (QT-
Analyser). The interfaces of the two software system components are complementary to one 
another. This differs from MC_Rack and other comparable generic MEA software (e.g. 
neuroexplorer) where one software tool acquires and analyses MEA data. 
2.9.1.4.1 Racks 
The virtual instruments used in signal acquisition and manipulation in MCS’s MC_Rack systems are 
built up into custom configured lists, called “racks”, consisting of logically ordered software tools. 
These racks, once constructed, can then be saved with the recorded data for both reference and for 
later re-use. Saving racks into folders with the recorded data also creates a working record of the 
settings and parameters used in both the acquisition and analysis (if MC_Rack is used for analysis). 
For example, in Figure ‎2.55 all of the data (.mcd files) for a particular test has been created in one 
appropriately labelled folder. The settings used to record those data are also recorded by saving the 
rack to the folder. In this example one rack was used to record the data, and another was used to 
extract information from those data. 
 
Figure ‎2.55: The storage of acquisition and analysis racks constructed in MC_Rack are clearly distinguishable 
when stored in amongst recorded multi channels data files (.mcd files). 
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An alternative analysis route, exploited by many MEA system users is to utilise other software for 
analysis stages. A software tool that has been widely exploited by MEA system users across 
applications is called NeuroEXplorer from Nex Technologies, Massachusetts, USA (Kapucu et al, 
2009; Tye et al, 2010; Robinette et al, 2011). The interface differs greatly to that of the MC_Rack 
program (Figure ‎2.56). 
 
Figure ‎2.56: The user interface upon opening Nex Technologies’ neurophysiological data analysis software 
NeuroEXplorer (Version 4.088). 
 
The analysis capabilities built into NeuroEXplorer software is limited (e.g. can only process one file at 
a time). As a result a number of specialist analysis software tools are also available for more detailed 
analysis of MEA data (e.g. that can analyse a common feature of multiple files at one time). This is 
also the analysis software provided with much of Plexon’s electrophysiology hardware. 
NeuroEXplorer is compatible with a diversity of MEA recorded data due to the built-in facility to 
import data files from all of the major MEA data acquisition software (e.g. Spike-2, Cortex, 
SciWorks). The following data acquisition data formats were supported by NeuroEXplorer at the 
time of writing: 
 Alpha Omega’s data acquisition software Alpha map which is used with Axion Biosystems 
MEA devices as well as Alpha Omega’s other data acquisition hardware (www.alphaomega-
eng.com). 
99 
 
__________________________________________________________________________________
Context Research 
 Cambridge Electronic Design’s Spike-2 software (www.ced.co.uk). Cambridge, UK. 
 The Cortex software available from the US National Institute of Mental Health Laboratory 
of Neurophysiology for data acquisition and experimental control (www.cortex.salk.edu). 
Bethesda, Maryland, USA. 
 Cyberkinetics data acquisition systems as demonstrated in and exploited for the highly 
publicised Brain Gate project (www.cyberkinetics.com). Cyberkinetics is a spinout from 
Brown University, Rhode Island, USA. 
 DataWave Technology’s SciWorks core software for data acquisition and analysis. 
(www.dwavetech.com). Colorado, USA. 
 HEKA Elektronik’s numerous data acquisition software (formerly Instrutech). 
(www.heka.com).  Germany, Canada and USA.  
 Multi Channel Systems acquisition and analysis software MC_Rack 
(www.multichannelsystems.com). Reutlingen, Germany.  
 Neuralynx’s Cheetah Data Acquisition Software (www.neuralynx.com). Montana, USA. 
 Plexon’s MEA Sort Client primary MEA software interface (www.plexon.com). Texas, USA. 
 R.C. Electronics data acquisition systems (www.rcelectronics.com). California, USA,  
NeuroEXplorers functionality is described in Figure ‎2.57. 
NeuroExplorer Functionality
Working with Other Applications: 
Designed as an open analysis environment. Can use other 
programs to extend the capabilities of NeuroExplorer:
 Copy data to Excel, edit the data in Excel and paste it back to 
NeuroExplorer
 Generate data in Matlab and transfer it to NeuroExplorer
 Copy numerical results to Excel or Matlab for additional 
analysis
 Execute Matlab scripts from NeuroExplorer for additional 
processing
 Create a lab book of your results in Power Point
Graphics:
Fully editable publication-quality figures:
 2D and 3D black-and-white and color graphs
 Unlimited number of graphs per figure
 Tables of graphs. Example: all pairwise correlations within a 
group of neurons
 Completely customizable figure elements: colors, fonts, tick sizes, 
etc.
 Single-page and multi-page printing
 Export of graphics to other applications via the clipboard, 
Windows metafiles and bitmaps
 Completely customizable figure elements: colors, fonts, tick sizes, 
etc.
 Create lab books of your results in Power Point.
Analysis:
Spike train
 Interspike interval histograms
 Rate histograms
 Perivent histograms
 Perievent rasters
 Autocorrelograms
 Crosscorrelograms with shift-predictors
 Joint peristimulus histograms
 Burst analysis
 Spectral densities and spectrograms
 Perievent histgorams versus time
 Place cell analysis
 Cumulative activity
 Instantaneous frequency
 Interspike intervals versus time
 Poincare maps of interspike intervals
 Epoch counts
 Coherence analysis
Continuously recorded signals:
 Correlations between spike trains and 
continuous signals
 Spike-triggered histograms and rasters
 Spectral analysis
 Perievent spectrograms
Populations of neurons:
 Principal component analysis
 Population PST histograms
 Spectral analysis
 3D network activity animation
Numerical Results:
Two numerical results tables (Results and 
Summary) are produced for every analysis. 
Results table contains
 Bin location
 Bin counts/frequencies/probabilities
 Shift-predictor values and confidence limits for 
crosscorrelogram analyses
 Joint PST matrix for Joint PSTH analysis
 Other analysis-specific results
Summary table contains:
 The number of spikes used in analysis
 Minimum, maximum, mean, standard 
deviation and standard error of mean of the 
histogram
 Expected values and the confidence limits for 
the PST and crosscorrelogram analyses
 Other analysis-specific statistics
 NeuroExplorer can transfer the data from 
results tables to Excel or Matlab.
Trial-Based Data Analysis:
Support for trial-based experiments:
 Trials of variable duration are supported
 Trials can be selected using the trial list
 Trials can be tagged according to various criteria. 
Example: tag the trials that contain the correct response.
 Analysis can be performed using all data or only the data 
from the specified trial set
 Several trial sets can be used in one analysis. Example: 
calculate crosscorrelograms for the correct-response 
trials and the incorrect-response trials and display them 
side-by-side or overlaid
Internal Scripting:
Built-in scripting language allows automation of 
many analysis tasks:
 Open and close data files
 Select data for analysis
 Specify analysis parameters
 Specify graphics options
 Apply analysis templates
 Save results as a text file
 Send data and results to Excel
 Send data and results to Matlab
 Execute Matlab scripts
 Modify existing spike trains and other data
 Create new events and spike trains
 Read and write text files
 
Figure ‎2.57: NeuroEXplorer Functionality. 
 [Source: Nex Technologies, 2011.] 
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A user can dictate how many channels to record from, at what frequency, for how long and, if 
desired, which features from the pre-processed raw signal they wish to keep as the resultant data 
files. For example, only the spike traces and their timestamps from a raw signal that cross a set 
threshold may be retained from a recording at 25kHz to reduce the overall file size. 
 
2.9.2 Commercially available systems 
A number of commercial enterprises have created an MEA industry where MEA systems are 
available for special order purchase. Due to the varying needs of scientist user groups around the 
world these systems cannot be described as being available “off-the-shelf”. User groups must 
approach manufacturers with their requirements so that they can be advised of the system 
configuration that is best matched to their needs. Once the required configuration has been agreed 
upon the purchasing user group can acquire anything from a full MEA system down to the bare 
minimum components of a system (e.g. a two-fold system with perfusion cannulas, stages, 
micromanipulators or a basic MEA-60 with just headstage amplifiers and custom-PC) depending on 
their budget. The most prominent industrial players and the global region in which they are based 
are listed in Figure  2.58. 
 
Figure ‎2.58: The key providers of commercial MEA systems worldwide. 
 
The number of commercially available MEA systems is increasing (currently ~7 manufacturers with 
1-2 systems) with the leading manufacturers providing both the hardware and software solutions. 
MEA development has been driven by the evolving needs of electrophysiological research, and as 
such a number of academic-industrial collaborations exist between the world-leading suppliers and 
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world-leading user groups. Industrial-industrial collaborations are also apparent between the smaller 
industrial players. 
 
Example Collaborations: 
 Potter Lab – Multi Channels Systems (Academic-Industrial). The Potter Lab at Georgia Tech 
(formerly CalTech) developed specialised lids for MEA biochips to prevent contamination 
and maintain local environment around cells (Potter and DeMarse, 2001).  These lids are 
now available commercially via MCS (http://www.multichannelsystems.com/products-
mea/product-details/products/189/ala-mea-mem.html). 
 Ayanda Biosystems - Multi Channels Systems (Industrial-Industrial). Ayanda Biosystems 
manufacture MEA biochips only. Previously held a strong collaboration with MCS so the 
design configurations of Ayanda Biosystems MEA biochips is complimentary to early MCS 
headstages.  
 Ayanda Biosystems – BioLogic (Industrial-Industrial). At the MEA Meeting 2010 a new 
collaboration was demonstrated with the bioMEA system manufactured by BioLogic of Claix, 
France (www.bio-logic.info) following previous collaboration with MCS.  
 Multi channels Systems - NMI Natural, Germany - Medical Sciences Institute at the 
University of Tubingen, Germany (Industrial-Academic-Academic). A large amount of MCS 
research and development activity stems from the work of these two academic institutes. 
 3-Brain – Plexon (Industrial-Industrial). The world’s first CMOS-based commercial MEA 
system was developed by a company called 3-Brain who announced a collaborative 
relationship with electrophysiology key players Plexon in 2010. 
 
2.9.2.1 System Configurations 
Multi Channels Systems provide several system configurations that centre on the number of 
channels and type of data acquisition unit. Competing enterprises have launched a number of 
equivalent systems but fail to exhibit a similar number of varying model configurations (Table ‎2.3). 
Inv = Design is suitable for use with an inverted microscope. BC = Headstage contains a blanking 
circuit (for use with stimulation protocols. Up = Design is not suitable for an inverted microscope set 
up. Where -2- occurs implies two MEA biochips can be used through the same acquisition hardware 
simultaneously. E = system is supplied with the enhanced perfusion equipment included.  
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Table ‎2.3: Commercially available configuration and their manufacturers. 
Channels Systems Manufacturer 
60 
MEA60-Basic Systems 
Multi Channels Systems 
MEA60-Inv-System 
MEA60-Inv-System-E 
MEA60-Inv-BC-System 
MEA60-Inv-BC-System-E 
MEA60-Up-System 
MEA60-Up-System-E 
MEA60-Up-BC-System 
MEA60-Up-BC-System-E  
(£34533 – February 2012) 
MEA60-2-Systems 
MEA60-Inv-2-System 
MEA60-Inv-2-System-E 
MEA60-Inv-2-BC-System 
MEA60-Inv-2-BC-System-E 
MEA60-Up-2-System 
MEA60-Up-2-System-E 
MEA60-Up-2-BC-System 
MEA60-Up-2-BC-System-E 
MEA2100-System 
MEA2100-60-System 
MEA2100-60-System-E 
(£42558 – February 2012) 
MEA2100-60-2-System 
MEA2100-60-2-System-E 
USB-Systems 
USB-ME64-System 
USB-MEA60-System 
USB-MEA60-Twofold System 
MED64 
Alpha Med Sciences 
MED64 4-sample system 
The Muse  
(€42000 –June 2010) Axion Biosystems 
MEA Workstation Plexon 
120 
MEA120-2-Systems 
Multi Channels Systems 
MEA120-Inv-2-System 
MEA120-Inv-2-System-E 
MEA120-Inv-2-BC-System 
MEA120-Inv-2-BC-System-E 
(£48671 –February 2012) 
MEA120-Up-2-System 
MEA120-Up-2-System-E 
MEA120-Up-2-BC-System 
MEA120-Up-2-BC-System-E 
MEA2100-System 
MEA2100-2x60-System 
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MEA2100-2x60-System-E 
MEA2100-120-System 
MEA2100-120-System-E 
MEA2100-2x60-2-System 
MEA2100-2x60-2-System-E 
MEA2100-120-2-System 
(£45919 – February 2012) 
MEA2100-120-2-System-E 
USB-ME128-System 
USB-MEA120-Twofold system 
96 MEA96-Well System Multi Channels Systems 
256 
USB-MEA240-Fourfold System 
(£73571 – February 2012) 
Multi Channels Systems 
USB-MEA256-System 
(£52642 – February 2012) 
768 The Maestro (€142000 – June 2010) Axion Biosystems 
4096 BioCAM-4096 3 Brain 
 
 [Correct 31st May 2011] 
 
The fundamental the differences between the systems can be described in terms of the number of 
electrodes through which recordings can be made simultaneously. Each electrode results in a 
channel of data, so the number of electrodes is the number of channels. By offering systems with an 
increased number of channels the flexibility of the MEA system is improved (in certain applications).  
For example, users can take recordings from larger cultures grow over larger surface areas to 
observe the activity of increased, and therefore more complex, neural networks, or, they may use a 
greater number electrodes positioned in a tighter grid array in attempts to identify the activity of 
individual synapses as opposed to entire cells, or, they may use biochips with multi-well layouts that 
have improved resolution (more electrodes) within each well to facilitate more cellular samples per 
test. 
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There are also systems and biochips used in some published literature that are not commercially 
available but that have been built by researchers to cater for specific needs or problems (e.g. need 
to position electrodes in specific geometries or desire to grow cells into or through certain 
structures) (Gholmieh et al, 2006; Oka et al, 1999; Dworak and Wheeler, 2008; Wang et al, 2009b; 
Zhang et al, 2009). Example devices are demonstrated in the following figures (Figure ‎2.59 to 
Figure ‎2.63). 
 
60 electrodes
Diameter 30µm
Spacing 50µm
Impedance 176kΩ
Used with MEA60 system
60 electrodes
Diameter 30µm
Spacing 50µm
Impedance 176kΩ
Used with MEA60 system
39 round, 49 square electrodes
Diameter 30µm, 20µm
Spacing 50µm, 50µm
Impedance 110kΩ
Used with MEA60 system
64 electrodes
Square 40µm
Spacing 60µm
Impedance 85kΩ
Used with MMEP system
 
Figure ‎2.59: An example of an MEA biochip for targeted brain slice stimulation and recording.  
ITO tracking, Au microelectrode tips.  
[Source: Gholmieh et al, 2006.] 
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Figure ‎2.60: An example of a novel MEA biochip and MEA system for use specifically in hippocampal slice 
studies. 
 [Source: Oka et al, 1999.] 
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Figure ‎2.61: An example of a biochip for highly selective recordings of axonal signals. 
 [Source: Dworak et al, 2008.] 
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Figure ‎2.62: An example of the manufacturing approach for a novel flexible MEA made by researchers at 
Philips Research, Netherlands. 
 [Source: Wang et al, 2009b.] 
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Architecture of the sensing 
biochip.
Schematics of the 
preamplifiers.
Biasing circuit for 
preamplifier buffers.
Preamplifier with resistive feedback, 
configured with 20dB gain.
“Signals‎to‎be‎detected‎are‎typically‎of‎order‎
100µV – 1mV peak-to-peak.”
OTA = Operational transconductance amplifier.
4 x 6 Microelectrode sensor 
array pixels = 24 analogue 
signal processing channels.
Electrical testing conducted 
using emulated neural 
signals.
OTA 
high-gain 
amplifier 
with on chip 
capacitors
On-chip Capacitors
Single 
analog 
signal 
channel
Planar 
microelectrode 
array sensor
Preamplifier 
buffer 
implemented 
with two-
stage 
amplifier
Reference 
electrode Circle
4 x 6 planar sensor array 
and 24 analog signal 
processing channels
One channel analog 
neural signal
 
Figure ‎2.63: A 24-channel mixed signal CMOS integrated biochip and buffers, amplifiers and 
control/interface unit schematics. 
 [Source: Zhang et al, 2009.] 
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2.9.2.1.1.1 International Research Interest 
Every two years the world’s only conference for MEA users and developers, MEA Meeting, occurs in 
Reutlingen, Germany. It is at this event that the most up-to-date technical advances are showcased 
alongside presentation of developments in MEA system application. The following table (Table ‎2.4) 
shows how the division of interrelating MEA-specific research has been done for the past 3 meetings 
and is planned for the next meeting. 
 
Table ‎2.4: Lists of MEA Meeting conference categories. These lists demonstrate how MEA related research is 
categorised, expanding and diverse  
MEA Meeting 2006 
 
MEA Meeting 2008 
 
MEA Meeting 2010 
 
MEA Meeting 2012 
(Planned) 
Neural Dynamics and 
Plasticity 
Neural Dynamics and 
Plasticity 
Neural Dynamics and 
Plasticity 
Analysis of neural 
dynamics and 
plasticity & 
Information coding in 
neural networks 
 
Retinal Signalling Retinal Signalling Retinal Signalling Applications in 
Systems 
Neuroscience (brain 
slices, retina, spinal 
cord, others) 
 
Signal Analysis and 
Statistics 
Signal Analysis and 
Data Mining 
Signal Analysis, 
Statistics and Software 
Signal analysis and 
statistics: 
(standardization and 
validation of multi-
electrode recordings) 
 
Heart Heart Heart Heart: 
Electrophysiology and 
pharmacology in 
primary and stem 
cell-derived cardiac 
myocyte cultures 
 
Pharmacology, 
Toxicology, Drug 
Screening 
Pharmacology, 
Toxicology, Drug 
Screening 
Pharmacology, 
Toxicology, Drug 
Screening 
Pharmacology, 
toxicology, drug 
screening (with MEA-
based assays) 
 
Advances in culture, 
recording and 
stimulation techniques 
CMOS-based array 
technology; Advances 
in culture, stimulation 
and recording 
Electrodes, Surfaces 
and Set-ups 
New materials and 
MEA design; 
Advances in MEA 
fabrication and 
instrumentation 
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techniques.  
Cellular Sensors Neuronal Engineering Stem Cell Derived 
Neuronal Networks 
Molecular 
engineering and 
analysis of cellular 
and sub-cellular 
neuron properties 
 Neurostimulation and 
Neuroprosthetics 
Electrical Stimulation, 
Implants and Robotics 
Electrical stimulation 
of single cells and of 
neural tissue 
 
  Culture Techniques Cell and tissue culture 
including 
microfluidics 
 
  Active Arrays and 
Electronics 
Multi-electrode 
probes for in - vivo 
applications 
 
  Plant Cells  
   
The amendment of categories through the years shows continuing interest in neural, retina, heart, 
and pharmacological developments. Signal analysis is also a consistent area of interest. In addition to 
that the trend towards development for cell culture and in vivo influences is emerging.  
 
2.9.2.2 Cutting edge MEA Biochip Re-design  
New generations of biochips are emerging (Braeken and Prodanov, 2010). For example, a recent 
advance in biochips specifically suited to slice applications has emerged that allows perfusion of 
media and chemical entities throughout prolonged testing (Motamedi et al, 2011). These biochips 
are called perforated MEAs (pMEA) (Figure ‎2.65). 
 
Three dimensional arrays are also under development in the USA as the next step forward in in vitro 
recreation of natural neural conditions for controlled studies (Musick et al, 2009). The concept 
behind such a biochip is production of electrode sites at locations within the three-dimensional 
volume of space over and above the base substrate (Musick et al, 2009). A prototype of one concept 
developed by established researchers in the field (Figure ‎2.64) consists of a stack of individually 
patterned layers. Chambers are formed through the stacked structure defining a 3D region of 
microtunnels through which neurons are grown. Along the walls of these microchambers and 
tunnels are exposed gold electrodes that allow both recording and stimulation. Silicon elastomer 
microfluidic layers serve as an “artificial vasculature for nutrient supply and aeration” and are 
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incorporated to provide media to the neurons in situ as well as to serve as insulation between 
microelectrodes (Musick et al, 2009).  
 
 
Figure ‎2.64: A fully assembled 3D array with a layered approach manufactured by the University of Florida’s 
Neuroengineering laboratory (Musick et al, 2009). 
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2.10 The MEA biochip  
 
MEA biochips are delicate consumables that due to their micrometre scale features can be easily 
damaged by micromanipulators or cleaning protocols. Nevertheless, biochips are intended to be 
multiple use products (~10-30 uses) if cared for appropriately (MCS MEA Manual, 2010). Gentle cell 
removal and cleaning (i.e. enzymatic rinses, plasma cleaning, UV sterilisation) can allow repeated use 
before electrode degradation occurs. Johnstone et al (2010) described the MEA biochip as “quite 
economical” at “$10-30 per use”. There are a number of different MEA biochip configurations 
available from industrial vendors (see Figure ‎2.65) and some facility to make custom biochips also 
exists if scientists require a particular workspace design configuration for their research needs.  
 
 
 
2.10.1 Microelectrodes 
The microelectrode quality is critical to the success of each MEA biochip manufactured. Knowledge 
of material options, electrode geometries, electrode spacing, signal-to-noise ratios and insulation 
types is required.  
 
Microelectrode Materials: Traditionally MEA biochips were made using gold (Au) for the 
microelectrodes, tracking and contact pad material (Wise et al, 1970). Gold is relatively chemically 
inert so serves well as a conductive, non-toxic electrode material. Due to the relatively high 
impedance of pure Au compared to Au alloys later techniques used platinised gold to improve the 
Signal-to-Noise ratio (SNR) (Breckenridge et al, 1995). Alternative material types were required for 
the electrode tips, tracks and contact pads as the platinised Au electrodes were shown to be more 
unstable over prolonged use due to a greater degree of degradation (Fejti et al, 2006).  
 
New fabrication approaches have become available to MEA biochip manufacture, resulting in 
changes to the standard material used at the microelectrode tip, tracking and contact pad. Titanium 
nitride (TiN) microelectrode tips and contact pads are now the most common variant (Figure ‎2.65) 
due to superior electrical properties (see Table ‎2.5), with titanium (Ti), or Indium tin oxide (ITO) used 
for tracking tracks. Au is used for cheaper MEA biochips that have larger electrodes at greater 
pitches (e.g. ecoMEA from MCS). Other leading manufacturers, namely Ayanda Biosystems and 
Axion Biosystems, provide gold (Au) and platinum (Pt). Plasma-enhanced chemical vapour deposition 
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(PECVD) is an example of a manufacturing technique exploited for the production of these 
microelectrodes (De Asis et al, 2009).  
 
Table ‎2.5: Electrical properties of microelectrodes (microelectrode surface area = 80µm
2
) 
Material 
Safe Charge Injection Limit 
(mC/cm2) 
Charge Capacity 
(mC/cm2) 
Zf=1kHz 
(kΩ) 
Au 3.7 5.7 2900 
TiN 23 42 150 
[Adapted from Janders et al, 1996.] 
 
Titanium nitride (TiN) was introduced to MEA biochip manufacture in the 1990’s (Janders et al, 
1996). MCS currently produce a range of configurations using TiN microelectrode tips because of the 
superior electrical properties.  TiN has been adopted in part due to its high nanoporosity, which 
results in electrodes with higher capacitances values when compared to previous Au tips. A high 
capacitance not only results in improved SNR but also reduces undesirable faradaic processes that if 
allowed to occur may harm the cells in situ (Janders et al, 1996). The biocompatibility of TiN is also 
now well documented (Huang et al, 2005). Interesting properties that make it suitable for 
microelectrode tips include reduced levels of bacteria on TiN surfaces (Scarano et al., 2003) and 
improved cell adhesion (Groessner-Schreiber et al., 2002; Cyster et al, 2004) when compared to Ti. 
TiN is also stable in aqueous solutions, and has high abrasion and corrosion resistances (Watari et al, 
2004).  
 
Indium tin oxide (ITO) is optically transparent and has been found to have good biocompatibility 
(Zhang and Oyama, 2005). ITO has been demonstrated as a viable material for creation of recording 
and stimulating biochip elements allowing systems that could monitor network activity without 
limiting optical observation of the network during culture (Gross et al, 1995).  
 
Carbon Nantotubes (CNT): As well as good chemical and thermal stability (Gambazzi et al, 2010) 
carbon nanotubes has exceptional biocompatibility (Harrison and Atala, 2007), are ultra-light weight, 
high mechanical strength, large surface area and excellent electrical properties (Keefer et al, 2008; 
Gabay et al, 2007) which are all ideal for the MEA application environment. 
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MEA Biochip Variants
Standard MEAs with 60 electrodes
 
Electrode arrangement: 8x8 or 6x 10
Inter-electrode distances: 100, 200, 500µm
Electrode material: TiN
Tracking material: Ti or ITO tracks
Electrode diameter: 10 or 30µm electrodes
Electrode impedances: 30µm diameter = 30-50 kΩ, 10µm diameter 
= 250-400 kΩ
Electrode shape: Planar
Reference electrode: Electrode 15
Insulation material: Si3N4 
Base substrate: Glass
Base substrate thickness: ~1mm.
Temperature compatibility: 0 - 125°C
“Thin” MEAs
Electrode arrangement: 8x8, 2x(5x6)
Inter-electrode distances: 30, 100, 200µm
Electrode material: TiN
Tracking material: ITO tracks
Electrode diameter: 10 or 30µm electrodes
Electrode impedances: 30µm diameter = 30-50 
kΩ, 10µm diameter = 250-400 kΩ
Electrode shape: Planar
Reference electrode: Electrode 15
Insulation material: Si3N4 
Base substrate: Thin glass supported on 
ceramic.
Base substrate thickness: Thin glass - 180µm, 
ceramic - ~800 µm
Temperature compatibility: 0 - 125°C
Reason for selection: superior optics.
Flexible MEAs 
Electrode arrangement: 9x8, 6x6, 10x2 +4
Inter-electrode distances: 300, 625, 750µm.
Electrode material: TiN or Au
Tracking material: Au
Electrode diameter: 30, 50, 80, 100µm electrodes
Electrode impedances: ~50 kΩ
Electrode shape: Planar
Insulation material: Si3N4 
Base substrate: Polyimide (2611 foil or Kapton)
Base substrate thickness: ~1mm.
Temperature compatibility: 10 - 40°C (2611 foil), 
0 - 125°C (Kapton).
Reason for selection: For in vivo and semi-intact preparations.
“Eco” MEAs
Electrode arrangement: 8x8, 2x(5x6)
Inter-electrode distances: 100,200,500 µm
Electrode material: TiN or Au
Tracking material: ITO or Au
Electrode diameter: 10, 30, 100µm electrodes
Electrode impedances: 30µm diameter = 30-50 kΩ, 
10µm diameter = 250-400 kΩ, 10010µm diameter = 
~30 kΩ
Electrode shape: Planar
Insulation material: Si3N4, Kapton, SU-8. 
Base substrate: Glass or Kapton
Base substrate thickness: ~1mm.
Temperature compatibility: 0 - 125°C.
High-density MEAs
Electrode arrangement: 16x16
Inter-electrode distances: 60, 100, 200µm
Electrode material: TiN 
Tracking material: ITO 
Electrode diameter: 10 , 30µm electrodes
Electrode impedances: 30µm diameter = 30-50 kΩ, 
10µm diameter = 250-400 kΩ. 
Electrode shape: Planar
Insulation material: Si3N4, Kapton, SU-8. 
Base substrate: Glass
Base substrate thickness: 1mm.
Temperature compatibility: 0 - 125°C.
Spatial resolution for conduction velocity calculation and 
synaptic delay measurability.
100µm spacing in centre, 200µm further out.
Workspace ~2.8 x2.8mm
Multi-well MEAs
Number of wells: 4, 6, 9
Electrode arrangement: 4x (3x5), 6x (3x3), 9x (6x5) recording with 9x (2x1) stimulating
Inter-electrode distances: 200, 300, 500, 1000µm
Electrode material: TiN 
Tracking material: Ti or ITO 
Electrode diameter: 30, 50µm electrodes
Electrode impedances: 30µm diameter = 30-50 kΩ
Electrode shape: Planar
Insulation material: Si3N4, 
Base substrate: Glass
Base substrate thickness: 1mm.
Temperature compatibility: 0 - 125°C.
Electrodes split into groups/patterns.
Groups separated by varying distances.
Where electrodes: Electrode 10µm with Spacing 30µm. Principle = allows the activity of 
single neuron to be picked up by a number of electrodes. Allows “multi-dimensional 
fingerprint-like patterns” for identification of single cells more precisely (Fejti et al, 2006)
Perforated MEAs
Electrode arrangement: 8x8, 6x10
Inter-electrode distances: 200µm (8x8), 100µm (6x10)
Electrode material: TiN 
Tracking material: Ti 
Electrode diameter: 30 (record), 50 (stimulate) µm electrodes
Electrode impedances: 30-50 kΩ
Electrode shape: Planar
Insulation material: Polyimide 
Base substrate: Ceramic or glass carrier with Polyimide film perforated centre
Base substrate thickness: 1mm.
Temperature compatibility: 10 - 50°C.
Different arrangements exist where specific stimulation 
electrodes are integrated.
For slice recording. Positioning and fixation.
Tight contact – for good SNR 
By application of negative pressure.
Additionally the same openings can be used to perfuse 
the slice from the underside.
Addresses concern - penetrating 3D electrodes could 
damage the tissues natural circuitry.
 
Figure ‎2.65: A summary of state-of-the-art commercially available MEA biochips. Microelectrode shapes, 
materials, diameters, impedances and temperature compatibility can all be compared quickly. 
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2.10.1.1 Electrode Profile 
Microelectrodes may have a planar profile (Figure ‎2.66) to allow a monolayer of cells (Figure ‎2.67B) 
to be grown on top of them (Nam et al, 2004) or may alternatively be shaped into three-dimensional 
cones (Figure ‎2.68) for slice preparations (Figure ‎2.67A). The “3D tips” are designed to penetrate 
through the outer layers of cells damaged during slicing process to the healthy cells deeper into the 
slice (geometry information can be viewed in Table ‎2.6). The outcome is larger signal amplitudes due 
to better cell-electrode coupling with the inner undamaged cells (Heuschkel et al, 2002). 
 
Figure ‎2.66: A planar MEA. Electrode tips 50 x 50µm. 
 [Source: Oka et al, 1999.] 
 
 
 
 
Figure ‎2.67: Neural cell MEA applications. A) Hippocampus slice positioned over 3D microelectrodes. B) 
Dissocaited neurons cultured over planar electrodes (~1000 cells per mm
2
). 
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Figure ‎2.68: A scanning electron microscope (SEM) image of a 3D MEA biochip manufactured by Ayanda 
Biosystems intended for use with tissue slice applications. Model MEA60 V5. A) A top view of 5 
microelectrodes diameter 30µm, magnification x1000. B) A closer look at one 3D electrode, magnification 
x2500. 
 
Table ‎2.6: Example of 3D microelectrode geometries in MEA biochips. 
Author 
Diameter 
(µm) 
Height 
(µm) 
Comment 
Held et al, 2010a 30 50 Cylindrical pillar, Gold 
Vazquez et al, 2010 ~30 ≥50 “Scalloped” cone and pillar 
Held et al, 2010b ≥2 ~5 For intracellular recording on MEA, Silver 
Chu et al, 2005 30 50-70 Cylindrical pillar 
 
2.10.1.2 Signal-to-noise ratio 
Large electrode surface areas result in an increase in capacitance (Janders et al, 1996). High 
capacitance is ideal where low noise is required (Adl and Paekerar, 2008). High capacitance is 
especially relevant in applications that inject electrical stimuli via the microelectrodes, allowing more 
reliable stimulation protocols to be employed (Meacham et al, 2008).  
 
Typically the standard microelectrode diameter is 30µm. Noise levels have been documented at 
around less than +/- 10µV of the baseline when sampled at 25kHz. It is important to be aware of the 
compromises that are interrelated in MEA biochip design. The size of the electrode, the resulting 
signal-to-noise ratio, and the probability of recording a signal all vary between research applications 
(Morin et al, 2005). In terms of design, larger electrodes results in bigger capacitances. This reduces 
impedance values of the electrodes (good for stimulation protocols) but has a detrimental effect on 
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the signal-to-noise ratio. For detection of cellular signalling the signal-to-noise ratio needs to be as 
high as possible to ensure that the field potential is distinguishable from the noise.  
2.10.1.3 Electrode layout and spacing for signal detection 
There is an increasing demand for specific electrode layouts based on specifications laid out by 
scientists in pursuit of particular biological questions (Fejti et al, 2006). Biochips have been 
successfully manufactured that deviate from the traditional 8 x 8 grid array design (e.g. Figure ‎2.65). 
Previously the size and spacing of the electrodes was considered to be of critical importance when 
seeking to guarantee signal detection (from neurons). Preparation techniques such as controlled 
application of surface treatment agents (such as Poly-D-lysine (Soussou et al, 2007)) prior to cell 
seeding (or plating) are used to enhance attachment and control positioning of the cells over the 
workspace region of the MEA’s surface. 
 
Some particularly representative examples of physical design changes (Figure ‎2.69) that have been 
made to biochips in attempts to improve controlled cell positioning for signal detection and quality 
include the micro-machining of silicon wafers with integrated electrodes to produce “cages designed 
to imprison neurons” (Maher et al, 1999; Erickson et al, 2008) and production of micro-chambers 
and micro-channels made from agarose material around and between electrodes to “trap neural 
cells” (Suzuki et al, 2004b). Awareness of these designs supported research that has delivered novel 
ideas and findings to this area. 
 
Figure ‎2.69: “Caged neuron” MEA biochips. A) Scanning electron micrograph (SEM) of a neurochip cleaved to 
reveal the cross section. The octagonal structure on the top surface is the silicon nitride canopy. The radial 
raised bars of the canopy are tunnels through which neural processes can grow. The walls are silicon. The 
floor of the well is a suspended film of silicon nitride. The square centred in the floor of the well is a gold 
electrode. Scale bar: 20 µm.  B) SEM of the “neurocage” design. A neuron is placed in the central chimney 
region, near the electrode. Axons and dendrites are free to grow though the tunnels to synapse with other 
neurons. The cage is made out of 4 µm parylene, a biocompatible polymer. Low-stress silicon nitride 
insulates the gold electrode and leads. Scale bar: 10 µm. 
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2.10.1.4 Insulation 
Insulation materials are applied over the upper surface of the MEA biochips everywhere except at 
the microelectrode tips and the contact pads to isolate the conductive material from the external 
environment and culture medium (Heuschkel et al, 2002). This insulation material effectively serves 
as the underlying cell culture substrate. Biocompatibility is therefore important for all materials 
selected for application as insulators as they are exposed to the cellular environment within the 
media well area. The insulator must also be suitable for use in conjunction with pre-treatments, such 
as poly-D-lysine or Matrigel™, and post-treatments, such as trypsin, industrial methylated spirit 
(IMS) and plasma cleaning protocols. Materials that have been successfully adopted for this purpose 
include silicon nitride (Si3N4), polyimide, silicon resin, polyacrylamide and SU-8.  
 
In many cases the insulation surface is pre-treated with specific biological molecules prior to cell 
seeding to promote cell adhesion (Berichevsky et al, 2009). Treatments (e.g. poly-lysine, laminin, 
polyethyleneimine, and Matrigel™) are applied in minute quantities (e.g. 4µl per 50 biochips) prior to 
cell seeding via dispersion in solutions. These treatments have also been experimented with for 
enhancing signal capture reliability through localised, controlled application to precise locations over 
and between electrodes where cell attachment and growth are most desired (Brewer, Boehler and 
Wheeler, 2006; Worz et al, 2008; Goto et al, 2010). 
 
2.10.1.5 Most Recent Areas of Microelectrode Development  
The recent areas of MEA biochip are listed in Table ‎2.7. 
Table ‎2.7: MEA biochip areas of development. 
Area of Development Development 
Publication and Research 
Institution(s) 
Surface engineering of biochip for 
controlled cell positioning and/or 
growth 
“3D Scaffold” geometry or 
microchannels 
 
 
Patterned surface treatments 
 
 
 
Musick et al, 2009 – University of 
Illinois and University of Florida. 
 
 
Kim et al, 2010 - Seoul National 
University, Seoul, Republic of 
Korea /Department of Bio and 
Brain Engineering, Korea Advanced 
Institute of Science and 
Technology, Daejeon, Republic of 
Korea. 
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PDMS microchannels and Wells 
 
 
 
Agarose and hydrogel 
microchannels and wells 
 
 
 
Laser 
 
 
Dworak et al, 2008 – University of 
Illinois. 
 
Nam et al, 2010 - Department of 
Bio and Brain Engineering, KAIST, 
Daejeon, Korea. 
 
 
Harbodt et al, 2010 - University of 
Tübingen, Reutlingen, Germany 
/Multi Channel System MCS 
GmbH, Reutlingen, Germany/ TILL 
Photonics GmbH, Gräfelfing, 
Germany. 
Electrode Surface Carbon nanotubes (CNT) 
 
 
 
 
 
 
 
 
 
 
 
 
Nano-structures 
Gambazzi et al, 2010 - Lab. of 
Neural Microcircuitry, Brain Mind 
Institute, EPFL, Lausanne, 
Switzerland /Dept. Pharmaceutical 
Sciences, Univ. Trieste, Italy 
/Naturwissenschaftliches und 
Medizinisches Institut (NMI), 
Reutlingen, Germany /Dept. 
Biomedical Sciences, Univ. 
Antwerp, Universiteitsplein 2, 
Wilrijk, Belgium. 
 
 
Koester et al, 2010a – University of 
Rostock, Germany. 
 
 
Koester et al, 2010b - University of 
Rostock, Germany / University of 
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Pores 
Freiburg. 
 
Electrode Geometry Pillars and 3D cones for 
stimulation 
 
 
 
 
Cavities 
 
 
 
Microneedles  
Held et al, 2010a – NMI 
Reutlingen, Germany. 
Vazquez et al, 2010 – Technical 
University of Denmark. 
 
 
Baaken et al, 2010 - University of 
Freiburg, Germany  
 
 
 
Saito et al, 2010 – University of 
Tokyo. 
 
Gunning et al, 2010 - University of 
Glasgow, Glasgow, UK /AGH 
University of Science and 
Technolgy, Krakow, Poland 
/University of Indiana, 
Bloomington, IN, USA /University 
of California Santa Cruz, Santa 
Cruz, CA, USA /SLAC National 
Accelerator Laboratory, Menlo 
Park, CA, USA 
Electrode Material CNT 
 
 
 
 
 
Gabriel et al, 2010; Bongard et al, 
2010 - Instituto de 
Microelectronica de Barcelona, 
Spain /Institute of Biomedical 
Research August Pi y Sunyer, 
Barcelona, Spain /Institut Catala de 
Recerca i Estudis Avancats, 
Barcelona, Spain. 
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Solid silver (Ag) Microneedles 
 
 
 
Iridium Oxide 
 
 
 
Boron-doped nanocrytalline 
diamond 
 
 
 
Polymer Coatings 
 
Fuchsberger et al, 2010; Stamm et 
al 2010 - University of Tuebingen, 
Reutlingen, Germany /University 
of Trieste, Trieste, Italy. 
 
 
Held et al, 2010b - NMI Reutlingen, 
Germany. 
 
 
Gobbels et al, 2010 - RWTH 
Aachen University, Germany 
 
 
 
Colombo et al, 2010;Gosso et al, 
2010 – Ulm University, Germany 
/NIS Centre Italy. 
 
 
Ryynanen et al, 2010 (polystyrene) 
– Tempere University of 
Technology, Finland 
Kang et al, 2010 – KAIST, Daejeon, 
Korea. 
 
Gautam and Narayan, 2010 - 
Jawaharlal Nehru Centre for 
Advanced Scientific Research, 
Jakkur P.O., Bangalore, India. 
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2.11 Future 
In vitro MEA systems currently allow a number of different cell types and sources to also be analysed 
in different ways, increasing not only convenience for user groups but also the diversity of 
applications to which these systems can be applied. Figure ‎2.70 illustrates factors that are 
influencing the design and manufacture of MEA systems.  
Evolution of technology: 
 Through increased throughput (Breier et al, 2010)
 Increased Sophistication – analysis (Brown et al, 
2004), system (Charvet et al 2009), experiment 
protocols (Vickerman et al, 2008)
 Increased automation (Vickerman et al, 2008)
 Reduced system size/footprint (Johnstone et al, 
2010)
Improve specialisation for cell types and preparations:
 Biochips for brain region research (Gholmieh et al, 2006)
 Biochips for general slice preparations (Boppart et al, 1992)
 Biochips for beating cardiomyocyte clusters (Flaherty et al, 2012)
 Biochips for controlled neural network propagation (Dworak et al, 
2008) 
Improve fabrication capabilities:
 Manufacture biochips that allow more recording channels 
(Berdondini et al, 2009)
 Manufacture smaller electrode geometries to facilitate improved 
resolution over equivalent contact area (Aziz et al, 2009).
Pursue novel sensor/electrode materials:
 Carbon nanotubes for better electrical connection with cells 
(Bongard et al, 2010)
 ITO for improved optical parameters (Jahnke et al, 2009)
Types: 
 Neurons (Hill et al, 2010)
 Cardiomyocytes (Denning and Anderson, 2006)
 Other – smooth muscle cell (Nakayama et al, 
2008), mast cell (Yeung et al, 2008), Islet cells 
(Raoux et al, 2001), Plant root apex (Masi et al, 
2009).
Sources: 
 Animal – monkey (Lehmann et al, 2010), 
invertebrate (Merz and Fromherz, 2002), 
chicken (Jones et al, 2011), mice (Biodo et al, 
2010), rat (Hill et al, 2010).
 Human – embryonic stem cell (Banach et al, 
2003), induced pluripotent stem cells (Gupta et 
al, 2010) 
Cells
Biochips
El
ec
tr
on
ic
s
Future MEA 
Technology & Application 
Influenced By...
 
Figure ‎2.70: Future MEA technology application will be directly influenced by a combination of 
developments across cells, biochips and electronics. 
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There is promise for MEA systems to support assessment of cells for cell therapies, and in new drug 
discovery and safety pharmacology.  A need to screen compounds in their native environments on 
larger scales, rapidly is required.  Increased sophistication of attention to new chemical entity 
treatments prior to in-vivo studies could potentially eliminate earlier those candidates that will fail 
at a later stage (Stett et al, 2003), therefore reducing revenue lost.  
 
The following schematic (Figure  2.71) demonstrates potential cell sources that have been 
successfully coupled to MEA technology and how application of cells types is changing. The 
combination of patch clamp and MEA technologies have been validated as valuable methods of 
assessing electrophysiological characteristics of the cell types described. Systems will continue to 
evolve with the needs of the differing cell sources and electrophysiological characterisation 
requirements of fundamental research, cell therapy development and pharmacology settings. 
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Animal Human
Dissection Stem cell Cadaver
Embryonic
Induced 
pluripotent
Available in very 
low numbers, 
highly laborious, 
use for few hours. 
High maintenance, 
ethical issues 
Correlation studies 
required between 
animal and human
Effects directly 
correlated to 
humans
2. For cell therapies 3. For drug discovery and 
safety pharmacology
FDA recommendations
Assessment of neuro, 
cardio and respiratory 
effects.
Preserve human life, prevent 
suffering and prevent wasted 
investment
For example:
1. Replace damaged areas of 
tissue (i.e. myocardium 
following heart attack)
2. Component of realisation 
of artificial organs
Novel solutions for challenging 
medical problems
Stem cell
Patch clamp MEA Systems
1. For fundamental 
research
Improve understanding of 
cellular and tissue processes
Cell Sources
Electrical characterisation
Potential for combined systems, or systems that shared analysis resources/
routines. Opportunity to test for unidentified correlations.
&
From animal tissue sources towards human stem cell-derived 
sources for superior comparability to human body.
Continue to optimise for:
 
Figure  2.71: How cell sources and electrical characterisation technologies will combine serve future 
research, medical and pharmaceutical industry needs. 
 
2.11.1 Cell types/sourcing 
Much of the work published that has used MEA technology has studied cells and tissues from animal 
sources such as mice (Biodo et al, 2010), monkeys (Lehmann et al, 2010) and chickens (Jones et al, 
2011). Animal cell sources can be genetically mutated (Bazelot et al, 2012) relatively simply and are 
available in greater quantities (Johnstone et al, 2010) than living samples directly from humans. 
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Safety pharmacology applications still require animal tissue based testing but future intentions aim 
to reduce or eradicate the need for animal testing by adjusting testing to cells sourced from human 
stem cells (Johnstone et al, 2010). This source is intended to show a closer correlation of responses 
observed in in vitro testing to human centred in vivo stages at clinical trials. At present work must be 
conducted following animal based trails to correlate findings to likely human tissue/system 
responses.  
 
2.11.1.1 Human Stem Cell Sources 
Human stem cells can be acquired by different means. Embryonic stem cell lines have been 
established using discarded In Vitro Fertilisation (IVF) embryos (Thomson et al, 1998). This source of 
stem cells is globally controversial due to a number of ethical debates centred on the destruction of 
human embryos. Alternatively induced pluripotent stem cells have recently emerged (Takahashi et 
al, 2007) which derive stem cells from human adult somatic cells (already differentiated cells taken 
from an adult donor). A somatic cell can be any cell that contributes to the formation of an 
organism, such as a skin, bone or blood cell.  
Stem cell extraction and passaging from human embryos is illustrated in Figure ‎2.72. Stem cells are 
transferred from a pre-implantation stage embryo into a culture dish containing an appropriate 
culture medium. The stem cells divide and spread over the surface of the culture dish. In some cases 
a feeder layer is used to support the stem cells in vitro. Mouse cells are used to create a sticky 
surface to which the stem cells can attach. These feeder cells also release nutrients into the culture 
medium.  
If the plated cells survive, divide and multiply enough to crowd the culture dish they are gently re-
plated into several culture dishes. The process of re-plating (known as sub-culturing) is repeated 
many times over several months. Each re-plating (sub-culturing) cycle is referred to as a passage. 
Once a the embryonic stem cells have proliferated in cell culture for a prolonged period of time 
without differentiating , they are confirmed to be pluripotent, and they have not developed genetic 
abnormalities they are referred to as a stem cell line.  
The process of establishing stem cell lines is inefficient so a new line is not established every time 
embryonic stem cells are needed. At any stage in the passaging process batches of cells can be 
frozen and shipped to other stem cell users (The National Institutes for Health Resource for Stem 
Cell Research, 2012).  
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Embryo
hESCs
hESCs
hESCs hESCs hESCs hESCs hESCs
hESCs
hESCs hESCs hESCs hESCs hESCs
Pre-implantation stage embryo
Human embryonic stem cells
hESCs divide and spread over surface
Culture medium
Mouse embryonic skin cells serving as a 
feeder and attachment layer.
(Not used in every case.)
If cells survive and divide
Gently removed and re-plated into 
several fresh culture dishes
hESCs hESCs hESCs hESCs hESCs
hESCs hESCs hESCs hESCs hESCs
hESCs hESCs hESCs hESCs hESCs
hESCs hESCs hESCs hESCs hESCs
hESCs hESCs hESCs hESCs hESCs
hESCs hESCs hESCs hESCs hESCs
hESCs hESCs hESCs hESCs hESCs
hESCs hESCs hESCs hESCs hESCs
The re-plating process is repeated 
many times over many months. Each 
cycle is referred to as a passage.
Once the cell line is established 
millions of embryonic stem cells can 
be yielded from the original cells.
Batches of hESCs can be frozen and 
shipped to other laboratories for use.
 
Figure ‎2.72: Stem cell passaging and line establishment. 
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2.11.1.1.1 Cells for cell-based therapies 
Cell therapies are amongst the most appealing applications for stem cells. Cardiomyocytes derived 
from stem cells are an example of a cell type currently under examination as potential cell for 
therapy (Xu et al, 2006).  
 
A common mechanism of development of heart failure is the loss of ventricular cardiomyocytes (Lee 
and Terracciano, 2010). It is hoped that they may in the future contribute to restoration of normal 
heart function by replacing damaged cardiomyocytes in damaged tissue (Braam et al, 2008). This is 
an on-going area of research that is believed to hold much promise and early experiments using 
skeletal myoblasts were transplanted with the intention of replacing damaged cells. Results showed 
modest improvements (Taylor et al, 1998) but later repetitions found that cells appear to remain 
mechanically and electrically isolated from the recipient myocardium (Rubart et al, 2004). Bone-
marrow derived cells have also been attempted (Orlic et al, 2001), showed encouraging results, but 
these results have not been replicated by others attempting to reproduce them (Murry et al, 2004). 
Interestingly all groups measured improvement in whole heart function.  
 
2.11.1.1.2 Drug discovery and safety pharmacology. 
Recent work has revealed pharmacological sensitivities that can be identified and characterised 
using MEA systems (Bettencourt et al, 2008; Ham et al, 2008). Any possibility to improve decision 
making and reduce timelines and attrition rates would provide enormous benefits to the process of 
drug discovery and development (Braam et al, 2008). The current work of several laboratories is 
testing the same set of compounds using a standard approach to demonstrate that chemical entities 
can be identified and categorised consistently based on observations of their toxicity pathways 
(Johnstone et al, 2010). A 5 year European Union (EU) funded project called ACuteTox took place 
between 2005-2010. This project involved working to integrate toxicity screening approaches so that 
standard assessments of toxicity can be conducted (Bal-Price et al, 2008). 
 
2.11.1.1.2.1 Neurotoxicity 
“MEAs are high content platforms that can provide detailed information regarding changes in 
function of networks of neurons exposed to test compounds” (Johnstone et al, 2010). At present 
regulatory authorities (e.g. Organisation of Economic Cooperation and Development, U.S. 
Environmental Protection Agency) use solely animal in vivo methods for both adult and 
developmental neurotoxicity testing. Until now “no in vitro approaches for evaluating the neurotoxic 
hazard of compounds have been formally validated.” The main problem in the development of a test 
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strategy with a predictive capacity for neurotoxicity is the complexity of action on the human 
nervous system. Mechanisms underlying the effects of compounds in the central nervous system 
(CNS) and the peripheral nervous system (PNS) are so diverse that it is currently impossible to cover 
all these mechanisms with one single model and using a small set of end points (Bal-Price et al, 
2010). 
 
Previous work has used spike rates or average spike rate for neurons in a network as one parameter 
to describe actions of drugs or chemicals even though even more sophisticated assessment is 
possible on MEAs. The possibility to determine concentration-response curves using neural activity 
as a neuronal specific endpoint has been suggested and early demonstrations presented (Lenk and 
Priwitzer, 2011). 
 
2.11.1.1.2.2 Cardiotoxicity 
Effects on the hERG channel present in the cell membranes of cardiomyocytes, which governs the IKr 
current, can be blocked by drugs resulting in cardiotoxic effects. The hERG channel has a major role 
in cardiac repolarisation. Interference at the hERG channels affects the length of action potentials 
and consequently the QT interval on an ECG. In humans a prolongation to anything greater than 
about 440-460ms may result in life threatening arrhythmias. Identification of QT interval changes 
and specifically its prolongation has led to the withdrawal of some drugs from the global market. 
 
The QT interval on an ECG corresponds to the total time of ventricular depolarisation. It’s now part 
of standard pre-clinical evaluation of all new drug candidates to assess risk of delayed repolarisation 
and prolonged QT interval (Braam et al, 2008). 
 
 
2.11.2 Medium to High Throughput Screening 
The need for higher throughputs throughout future MEA system applications is summarised in 
Figure ‎2.73. MEA technology application is presently time consuming and labour intensive. 
Increasing the throughput capability of systems will allow opportunities to speed up experiments 
and to improve experiment efficiencies. Development of new MEA technologies will improve 
reproducibility of results in fundamental research by providing larger more detailed data sets, 
applicable cell therapies development, and especially in drug discovery and safety pharmacology 
settings. This combined with automation may be key to convincing the pharmaceutical industry to 
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use planar MEA technologies for drug discovery and high-throughput drug screening (Morin et al, 
2005).  
Future MEA:
Fundamental Research
Cell Therapy
Drug discovery and Safety 
Pharmacology
All require testing on statistically 
significant numbers of targets
Requires high throughputs 
(has been the case in other 
bioscientific screening domains)
 
Figure ‎2.73: Future MEA technology will be required with high throughput capability across application 
domains. 
 
 
2.11.3 MEA for a Brain Machine Interface 
The emerging field of neuroprosthesis aims to restore some of the lost neural function by selective 
electrical stimulation of specific sensory or motor pathways. A key element in this research field is 
the interfacing of the electronics that will deliver the stimuli with the nervous tissue. Development 
of penetrating MEAs for in vivo applications is concurrently evolving drawing upon over lapping 
scientific principles and microfabrication techniques. The active tips in these penetrating MEAs 
provide selective access to small populations of neurons or nerve fibres.  These MEAs also provide 
scientists with an ability to study spatiotemporal activity and information processing in a living 
nervous system, findings which may form the basis of future therapies. This technology is still in its 
infancy but current proof of principle studies argue much potential (Normann, 2007). 
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2.12 Product Design and Assessment 
Each time a novel product or new iteration of an existing product is developed, appropriate 
assessments must be carried out on that product to ensure that it delivers performance according to 
initial specifications. A design process incorporating innovation management principles relevant to 
MEA technology development is illustrated in Figure ‎2.74.     
 
MEA System 
Design
Multi-disciplinary:
 Bioscience,
 Materials engineering
 Chemical engineering,
 Electrical engineering,
 Mechanical engineering,
 Manufacturing engineering,
 Software development,
 Packaging design.
Innovation
Target Principles:
 Beneficial
 Usable
 Economical
Management
Effective pre-validated innovation 
management factors:
 Communication
 Iterative design
 Process modelling (Enterprise)
RESULT = Product 
superior to competitors!
A product 
that meets 
specification
Combined expertise to bring 
about
Must be successfully managed
To bring about
 
Figure ‎2.74: Innovation management principles. 
[Adapted from Le Corre and Mischke, 2005.] 
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2.12.1 Product design 
A new product must be designed with features that distinguish it from other alternatives (Saffer, 
2010). The research and design process must identify and realise potential product differentiators 
that will motivate consumers to purchase this product over competing equivalents. Distinguishers 
must be decided upon during the concept design stages to ensure adequate inclusion into the final 
product. In the case of MEA technology an existing industry and assortment of products already exist 
so distinguishers will be particularly important for intended large scale system user uptake. Work to 
introduce a new device or system will depend upon marketable distinguishers that offer real value 
to current and future system users. Before realisation planning can take place, a final design must be 
conceived. The design must be original if a unique benefit is to be brought to system users. The 
process of manufacture must then also be designed to realise the final concept as physical devices.  
Figure ‎2.75 describes concept design stages common to all design problems that lead to a final 
design, and the corresponding inclusion of those stages relating to this thesis. 
Identify and understand the market 
(chapters 2, 3, 4)
Identify and understand competitors 
(chapter 2)
Identify potential distinguishers and 
conceive a final design
(chapter 5)  
Awareness of existing products to 
serve a basis for ‘improvement’.
Knowledge of competing products. 
What’s influenced development that 
is likely to influence contemporary 
designs.
Significant in in aiding the 
determination and prioritisation of 
development objectives, and 
allocation of resources and 
expertise.
Design new product with 
strength vs. competing 
equivalents due to 
distinguishers.
Understand key stakeholder 
interactions and design to satisfy 
needs of all stakeholders 
adequately.
Identify and understand consumers 
(chapters 2, 4)
Design 
Process
A Product Exists
Motivation: Developers believe 
improvement is possible.
 
Figure ‎2.75: Product design research principles. 
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2.12.2 Innovation management 
Strategic business approaches are employed across industries in order to identify: (1) customers and 
markets to be served, (2) competitors, and (3) potential competitive strengths of a new product or 
redesign (Saffer, 2010). A framework for evaluating products and potential opportunities can be 
constructed via appropriate product planning (see Chapter 3), influencing product success from a 
number of angles. For example, if considering a product’s positioning relative to competing 
products, appropriate identification of distinguishers and product differentiators must be 
incorporated into the product development.  Awareness of competing products in the sense of how 
they have been, and how they continue to be developed is another angle that aids the 
determination and prioritisation of development priorities for new products. Resource allocation for 
product development and product deployment should also be contemplated and distributed 
appropriately in planning stages. This can be done by utilising information derived from forward 
planning (Schattenberg et al, 2005).  
Management principles that can be applied to innovation include: (1) manage time from start to 
finish, (2) map out objectives and allocate resources appropriately, (3) pilot tests prior to full scale 
commencement, (4) identify and understand key figures and institutes, (5) embrace techniques and 
technologies that will be required to facilitate innovation and communicate output early on, and (6) 
share responsibility appropriately between innovators (Stark, 2011). 
Early identification of key stakeholders in a product’s lifecycle serves as a good way to assess major 
interactions that are likely to occur during all product development stages, as well as throughout the 
product’s life in service (Finkbeiner, 2011). The stakeholders in this field and their interactions with 
one another can be seen in Figure ‎2.76. Relevant interaction details that are part of the overall 
impacts that may affect stakeholder parties that must be considered if changes are made to this 
particular product are depicted in this diagram. 
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STAKEHOLDER INTERACTIONS 
End User Groups
System Suppliers
Components Suppliers
DemonstrationTeam,
Sales Team,
Installation Team,
Training Team,
Maintenance
Experience Users,
Witnesses
Use System
Failures
Weaknesses
Requirement
Specifications
Budget
System Recommendation
Laboratory Installation
Technical Specifications
Manuals
Useage Instructions (Application Notes)
Maintance Guide
Upgrade Documentation
Spare parts
Component Parts Component Data 
Sheets
= Information
= Human Resource
= Physical Resource
 
Figure ‎2.76: The major human involvements, physical parts and information flows that result from MEA 
technology in use. 
 
Research at Cambridge University’s Centre for Technology Management has outlined a five-step 
process for making a business case for new technologies (see Figure ‎2.77 (IfM Briefing, 2009)). These 
steps have been taken into account during this work so as to ensure a final product that brings 
significant value to the real end-users. The five steps are concisely defined in terms of this project as 
follows: 
1. Identify the technology/problem combination.
2. Select potential customers and sales strategies.
3. Understand the chosen customers’ needs.
4. Develop the business case with the customer.
5. Present the business case and negotiate next 
steps.
 
Figure ‎2.77: Five steps for making a business case for new technologies. 
[Source: IfM Briefing 2009]. 
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1. Identify the technology/problems combination: MEA systems exist in a relatively immature 
state and are presently expensive to purchase. In addition to this, systems are inherently 
complex in both design and user interaction. The scales of employment of MEA technology 
in scientific trials is limited by hardware capability constraints and a lack of appropriately 
sophisticated analytical tools. 
 
2. Select potential customers and sales strategies: MEA-systems are sold on a global scale. 
Early employment of this technology has been for addressing specific research questions; 
the needs of which are becoming ever more diverse. Application of MEA-systems within a 
range of research domains has highlighted potential for next generation exploitation of this 
technology on greater scales within the pharmacology industry (Meyer et al, 2004).  
 
3. Understand the chosen customer needs: Systems that meet the specific needs of three end 
user cases have been explored. Proper identification and understanding of the needs of each 
case is essential if systems are to be designed to meet true user needs (see Chapter 5). 
 
4. Develop the business case with the customer: A final system that can be exploited 
economically must not only be what a high number of end users will desire, but it must also 
be a viable purchase that is affordable, maintainable and fully exploitable by individuals with 
differing skill sets. Input from the current user groups assists in ascertaining what these 
“desires” will be and what level of financial output will be acceptable to differing groups 
around the world. 
 
5. Present the business case and negotiate next steps: This step is covered in Chapter 7.  
 
 
These steps have been utilised throughout this product development and the information derived 
from them is presented in this thesis.  
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2.12.3 Biomedical industry 
In the last decade the biomedical industry has been the fastest growing sector of the US economy. 
Annual spending on healthcare in the USA increased from $75 billion in 1970 to $2.2 trillion in 2007, 
and estimates are at $4.3 trillion for 2018 (Turchetti et al, 2010). A positive correlation exists 
between the adoption of new medical technologies and the increased overall healthcare costs. The 
current global economic climate is resulting in increasing pressure on technology developers to 
produce medical technologies that are more cost effective. The role of biomedical device testing and 
evaluation is thus concurrently evolving to ensure that in products delivered at a lower cost overall 
safety is maintained. These evaluation processes also influence adopters decision to acquire, 
implement and apply these new technologies. 
 
The modelling technique used in this research seeks to improve efficiencies by identifying 
weaknesses or bottlenecks that can be improved through technical solutions. The CIMOSA technique 
has previously been used in a clinical setting to model the protocols employed in providing care to 
patients in a hospital (Staccini et al, 2001). This work highlighted inefficiencies that could be tackled 
through the development of new management methods and technological devices. The CIMOSA 
modelling technique has not been reported as having been used to assess protocols used in a 
bioscientific cell culture setting before. In the case of this research this method of user requirement 
elicitation is novel.  
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2.13 Chapter Summary 
 
The following list is a summary (Figure ‎2.78) of the key points identified and understood from initial 
context research and literature reviewed. 
 MEA systems are tools developed for evaluating tissues and cells non-invasively. 
 
 Traditionally MEA technology has facilitated testing of cells for longer durations than 
invasive patch-based recording techniques. In addition to this whole samples of tissue can 
be studied improving upon previous single cell methods. 
 
 Numerous tissue types can be examined using MEA systems. In more recent years some 
cases using non-electrogenic tissues where a resting potential could be detected have been 
successfully demonstrated. 
 
 It is possible to detect and capture signals by careful and specific preparation that varies 
according to tissue type and source. 
 
 Signal traces captured using MEA systems differ vastly between cell types, the form of cell 
preparation and the testing protocols employed. 
 
 MEA systems offer opportunities to exploit tissues from genetically mutated animal 
candidates more thoroughly and on larger scales; helping to provide better value genetics 
research.  
 
 Different types of stimuli can be applied to the cells in controlled and repeatable ways.  
 
 Analysis of signals is often via a custom routine that has been developed by the bioscientist’s 
research group, institution or collaborators. 
 
 An MEA system consists of a number of interconnected complex components. 
 
 Each component must be designed to fulfil its own function as well as be complementary to 
all of the other interdependent components in the system. Where necessary some 
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components must be designed and manufactured to be specifically configurable to the 
particular cellular preparations and/or applications. 
 
 A number of software packages can be adopted to meet the ever evolving needs of analysis; 
usability of these software could be improved. 
 
 A number of system configurations are commercially available from a small number of 
vendors. Systems must be custom ordered and configured to a specification that specifically 
suits the intended application(s) of users. 
 
 MEA biochips exist in a number of configurations to suit the needs of the differing cellular 
preparations.  
 
 In addition to differing configurations biochips are manufactured in a range of materials to 
help to accommodate differing budgets and applications. 
 
 Microelectrodes have evolved over the past thirty years due to improved sophistication of 
microfabrication and manufacturing techniques. 
 
 A number of research groups around the world are working to improve and further optimise 
MEA biochip designs. Current trends in design support re-configuration of MEA biochips 
toward cell type and application specialisation and away from a standard biochip for all.  
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Figure ‎2.78: A summary of the findings of Chapter 2. 
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2.14 Research Question Answers 
The following address the research questions originally defined at the start of this chapter. 
 
1. In what context(s) are multi electrode array systems used, what are the core components 
and how do they differ between systems? What is the current state-of-the-art? 
Used to: 
Multi electrode array systems are employed to detect and capture the electrical signalling occurring 
in electrogenic tissues and cells. Research characterising various cell types and seeking to 
understand specific responses can be conducted using these systems to detect, monitor and record 
changes of specific ionic concentrations over time. These systems are predominantly applied to 
record activity occurring through neural and cardiac tissues, or more specifically through neuron and 
cardiomyocyte cells.  
Used in: 
MEA technology is a tool that is suitable for both fundamental and applied research. For example 
MEA-based studies can be used to investigate fundamental research questions such as “how do 
neurons grow in vitro?” or “at what stage in development do neurons start communicating 
spontaneously?”, and applied research questions such as “how does this chemical entity effect 
activity in this neural network?”. 
Used by: 
MEA systems are also employed in the most part by small teams of research scientists working with 
a specific cell type that is prepared or cultured for recording in a particular way. For example, some 
MEA user scientists will prepare slices of tissue that will be anchored tightly over the 
microelectrodes for recording, whereas others will culture neurons dissociated from tissue and 
cultured over the microelectrodes surface. These differences in preparation will result in differences 
in signal detection that results a need to allow for system configurability.  
MEA systems are comprised of a biochip, interconnecting into a unit referred to as a headstage, that 
usually houses specialist amplifiers and filters that interconnects to a data acquisition system and 
PC. An acquisition and basic analysis software is usually supplied with MEA systems by the 
manufacturers. A number of other peripheral tools support MEA system application. For example 
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appropriate optical tooling makes it possible for bioscientists to work with microscopic cell 
populations.    
Different system configurations exist to meet differing needs of users. In essence the configuration 
used will depend on the cell type and the intended preparation of that cell type that is to be 
investigated. The model of MEA biochip will also be selected according to the cell preparation and 
intended nature of the investigation being conducted. The amplifiers will provide appropriate 
degrees of gain to suit the anticipated signal and filters will be configured to removed noise 
components and enhance signal features of specific interest. The settings in the acquisition unit and 
software will be dependent on the requirements of the users with regard to how they intend to 
analyse and interpret the data collected. 
Current state-of-the-art in MEA systems is demonstrated by Multi Channels Systems as the USB 
MEA256 system (section ‎2.6.1) and their USB-MEA32-STIM4 system. The USB MEA256 system can 
be considered that most advanced generally applicable MEA system, suited to all cell types and 
preparations. The USB-MEA32-STIM4 system is the first of new range of systems optimised 
specifically for slice studies. This system has perforated MEA biochips and an option for automated 
perfusion through the biochip and system while in use.  
The competing MEA system vendor Axion Biosystems, USA, intends to offer the new state-of-the-art 
system in the form of the “Maestro” system. This system will incorporate 768 recording electrodes 
into varying multi-well biochip configurations but has yet to appear on the market or in published 
literature. 
The relatively immature vendor, 3 Brain, offers the world’s first commercially available CMOS based 
MEA. This tool holds particular promise for neurological studies as the fine resolution of the 4096 
sensors offers superior resolution. A limitation of this system however is the restricted optical 
inspection of cells once cultured on the array; for studies where optical inspection is essential and 
resolution is less important this system is unlikely to be adopted. 
 
2. How are MEA systems applied in research, how has that application changed since their 
introduction and are there any trends identifiable in development? 
Initially MEA systems were developed by neuroscientists to facilitate recordings of the electrical 
activity in neural tissue with the intention to bypass the necessity to physically damage the cellular 
sample as is the case for early clamp-based electrophysiological recording techniques. For the first 
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time MEA tools allowed scientists to record several areas of activity simultaneously from a culture of 
cells. More has been learnt about the functioning of the mammalian brain due to early MEA-based 
testing and as more has been understood new questions requiring greater and greater degrees of 
resolution have been required. 
As a consequence of the need for greater resolution the number of channels that can be recorded 
from has also increased resulting in larger data sets if desired or required.  
The facility to record responses to stimuli has been demonstrated across differing cell types and 
preparations. Both chemical and electrical stimuli have been successfully delivered at non-lethal 
doses to cells on MEA biochips.  
So as more application compatibility has been demonstrated and understood, new questions have 
been asked and development of system components to suit this increasingly specialised questioning 
has resulted. A dominant trend in MEA development has been to facilitate more channels to record 
from in each single MEA biochip. In addition to this, the configuration of the available electrodes has 
also been explored on numerous occasions.  
 
3. What are the key factors that will influence and limit design possibilities and where are 
the biggest challenges associated with this work? 
Influence: 
The cell types used influence design and introduce diverse requirements. Literature sources report a 
broad selection of cell sources with predictions of moves from animal sources towards stem cells. 
Global research and development is especially strong in areas that offer high value returns, such as, 
drug identification and development, and pursuit of understanding how mammalian and human 
brains function. This may influence how systems develop if requirements in these fields are 
particularly specialised and strong. 
To understand complex research questions with thousands of variants that must be explored 
experiment scales required are large.  
Greater system applicability has led to greater system uptake across a plethora of bioscience 
settings. This has and will continue to identify new design priorities. In addition to this, if MEA 
systems are employed in larger numbers, economies of scale will improve, possibly reducing the cost 
to research using such systems. 
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Most importantly developers must try to anticipate the future needs of users based on findings and 
observations of contemporary experiments.  
Limit: 
Certain applications, such as spatiotemporal neural network investigations require high sampling 
frequencies (~25kHz). Developments will be limited by computing technology capabilities. As 
appropriately priced hardware develops that is capable of managing hundreds to tens of thousands 
of channels sampling at these high rates in real time MEA developers will continue to merge these 
tools into systems. 
Manufacturing techniques and resolutions available will continue to limit and facilitate what 
features shapes and sizes in micrometre and nanometre ranges can be made to an appropriately 
high quality using the biocompatible materials suited to the applications. 
Development of MEA systems uses top of the range technologies and highly skilled expert 
knowledge resulting in high development costs. 
The humid, warm environments suited to in vitro cell culture environments is not suited to 
electronic devices. 
Analysis capabilities must evolve with the hardware technologies to ensure that the increased data 
acquisition is adequately supported to allow users to reliably and robustly extract meaning and 
therefore value from the system. 
Greatest challenges: 
The development of systems globally applicable to diverse applications is complex and requires 
exceptional organisation, communication and management. Opportunities for and actions towards 
standardisation where possible would support development of high tech products in the future that 
are delivered to markets in a timely manner.  
 
4. How do applications using different cellular preparations differ and how are the signals 
that are recorded used? 
Cultured: 
Cells that are cultured over MEA workspaces are typically dissociated from an animal or stem cell 
source into a separated cell suspension. The MEA biochips surface will have been treated with a 
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specific growth protein prior to seeding of the suspended cells to ensure that close attachment 
occurs over the microelectrode tips. Typically a less dense covering of cells is achieved in these 
samples as when compared to a slice placed on top. Monolayers (layers of cells that are one cell 
thick) are also possible by careful control of the volume of cells dispensed into the MEA biochips 
media well.  
Attachment is important for signal detection, especially from immature cells. Signal amplitudes are 
typically in the region of tens to a few hundred microvolts (µV). 
Slice: 
Slices are made of a dissected organ and placed over the microelectrode array. In some cases careful 
positioning of anatomical landmarks may be required to study specific network pathways. Slices are 
anchored using commercially available weights or custom built micromanipulators to ensure tight 
cell-electrode coupling. Microelectrode tips used for slices are typically 3D in profile to penetrate 
through the outer layer of cut-through damaged cell matter. Signals captured are typically larger 
than from cultures.  
Stimulation experiments are common where groups use slices to study existing naturally developed 
networks or tissue responses. 
Neurons: 
A neuron action potential is triggered by a sufficient chemical or stimuli at a synapse. The action 
potential travels along the length of neuron in a few milliseconds. The corresponding field potentials 
(FPs) that are detected by nearby microelectrode tips are seen as spikes in the resting baseline data. 
Where several spikes occur at the same time or within a few milliseconds of one another the 
occurrence is referred to as a burst (see Figure ‎2.39).   
Cardiomyocytes: 
Cardiomyocytes contract in a rhythmic, roughly simultaneous manner, producing FP waveforms that 
are detectable when coupled to an MEA. These waveforms are the combination of the APs from all 
of the contracting cells present (which can vary in phenotype). Signal spikes, or waveforms, are 
much longer in duration than those recorded from neurons typically lasting several hundred 
milliseconds. 
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5. What is expected of future MEA systems? 
Present applications are moving towards targeted testing of cellular characteristics or chemical 
entities that require repeated experiment repetitions to ensure reliable and valid findings. Therefore 
it can be predicted that the trend to increase the number of useful channels per experiment will 
continue from the now hundreds of channels available into systems offering thousands and tens of 
thousands channels. Further re-configuration of biochips and systems will be required to facilitate 
this trend that will depend on cutting edge micro and nano-fabrication technologies. 
System usability must also improve to facilitate methods in which user scientists can manage and 
maintain larger numbers of cell cultures in conjunction with needs of future MEA biochips and 
systems.  
 
6. Can product innovation be managed throughout this research, and how can developers 
design and assess prototypes appropriately? 
Innovation management is required to steer design efforts towards a product possessing 
distinguishers that offer the best value to target users. 
This research requires inclusion of expertise from a number of overlapping disciplines to bring about 
a product that is usable, realistic and beneficial. The multidisciplinary team required must 
communicate effectively to prevent confusion that may otherwise be detrimental to efficient new 
product development. Employment of pre-validated modelling techniques allow thorough 
understanding of target user populations as well as offering a clear and comprehensive 
communication medium that is suited to multidisciplinary research. 
Throughout concept design and design development appropriate methods of prototype assessment 
must be agreed upon to ensure a final product that meets specification and is superior to competing 
equivalents. 
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Research Design 
and Methodology
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Quantitative Data
Qualitative Data
Modelling
Impacts of Context Specific Application Differences
 
Chapter Three 
3 Requirement Capture Methodology 
 
 
 
 
 
 
 
 
To tackle a research and design problem a strategy must be employed that controls how designs 
evolve and that available resources are exploited (Blaxter et al, 2000). A structured approach was 
sought for the research contained in this thesis to ensure research objectives were managed 
effectively, to ensure the delivery of research outcomes. The following research questions are 
addressed in this chapter: 
 
1. What can be done to ensure that a thorough evaluation of the field of multi electrode 
array application and system production is performed, to support the identification of 
robust end-user requirements in this research area? 
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2. Can formalised product design approaches be implemented to support the conception of 
effective component and system designs? 
 
3. What kinds of information will be required to support effective design and manufacture of 
prototypes? 
 
4. What formalised approaches should be used to represent and communicate research 
inputs and outputs? 
 
The logical order taken by this research is demonstrated in Figure  3.1. Research conducted and 
documented in this thesis has been based upon the research methods described in the following 
sections.  
Information 
(Quantitative and 
Qualitative)
1. Problem 
Evaluation
2. Effective design
3. Evaluation of 
solution(s)
Users, industry, literature, media
Realistic, economical, safe, 
compatible, novel, practicle.
Must be: 
obtainable, 
accurate,  
reproducible, 
reliable,
meaningful, 
communicable.
In terms of manufacture
In terms of employment
Construction of Research
ESSENTIAL
Considers:
Considers:
Considers:
drives forward
tested by
In terms of appropriate 
regulators. I.e. ICH, FDA
 
Figure  3.1: Construction of this research.  
 
Problems encountered by current MEA system users are evaluated and the resulting solution 
designs driven forward by product design specifications constructed to provide effective solutions to 
current needs.  There are many ways of designing, executing and analysing research (Edwards and 
Talbot, 1999), hence a mix of previously validated research methods have been used to evaluate the 
outputs of this work prior to physical prototyping and testing. 
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3.1 Evaluation of the Problem 
 
This research contains and draws upon information gathered using group meetings, one-on-one 
interviews, literature reviews, e-mail communications and enterprise modelling of MEA application 
domains (Figure ‎3.2). Information concerning the context of the research problems identified (user 
requirements) has been collated and summarised, highlighting problems as identified by the system 
stakeholders. 
Problem Discovery and 
Problem Evaluation
E-mails
One-on-one
Group Meetings
Enterprise 
Modelling
Literature
(Academic and 
industrial)
Context Research  
 
Figure ‎3.2: Research approaches brought together by this project to thoroughly evaluate problems faced by 
MEA technology users across three different applications. 
 
Key points identified through literature review as critical to the success of this research are listed 
below (Figure ‎3.3). 
A) Strategy: To design a product that will be successful a strategic design approach should 
be used. 
 
B) Existing MEA Systems: MEA systems are complex and exist in a number of different 
configurations (section ‎2.9.2.1). Each commercially available system configuration has a 
number of potentially different settings that have to be adjusted upon system 
installation according to the intended application (i.e. amplification gain settings, 
number of channels required for recording). 
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C) Applications: MEA technology is mainly used in brain and cardiac research domains, 
resulting in generic but also application specific needs. Any new system must maintain a 
comparable level of flexibility as is present in commercial systems, to permit 
experimental application of the system with other tissue types.  
 
D) Data Outputs: Data output formats and the approaches used to analyse those data vary 
between applications. There are nonetheless some commonalities that can be roughly 
defined as “standards” to work with, in terms of basic output requirements of any new 
or replacement software analysing system.  
 
E) Data Analysis:  MEA system users analyse data post-recording according to the needs of 
their research. The level of sophistication of analysis that is possible offline (post-
recording) is not possible online (while recording). This has led to a lack of comparability 
across published results as MEA users do not disclose full details of analysis routines in 
published results. The outcome of this has been calls for steps towards standardisation 
to be made (Smith et al, 2007a).  
Design Challenges
(addressing identified needs)
Strategy
Existing Systems
Applications
Data Outputs
Data Analysis
Finances
Expertise
Facilities
Time
Selection of appropriate 
project actions according 
to:
Affected by available:
 
Figure ‎3.3: Design challenge influencers. 
 
In this research design targets are defined in terms of the technology component or sub-component 
being designed (system needs), and also in terms of the application domain (user needs), i.e. heart 
or brain, dissected slice or stem cell-derived. A number of complex design (e.g. high frequency real-
time systems) challenges are associated with the development of MEA systems and system 
components (Rolston et al, 2009) that have to be refined into design specifications. The goal is to 
select the most appropriate approaches to address these specifications depending on capabilities in 
terms of expertise, time, facilities available, and financial constraints. Strategies employed to 
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ascertain relevant user and systems requirement information pertaining to the major application 
domains drew upon three current MEA system applications (see Chapter 4).  
A well-structured and previously validated modelling approach was adopted to represent relevant 
information and functionality while observing and interviewing the collaborating MEA system users. 
The enterprise modelling (EM) techniques utilised enabled a deeper understanding of current MEA 
system employment protocols to be determined than if literature alone had been used.  
 
3.1.1 Drafting Product Design Specifications 
Regular interview, meeting and email conversations followed initial shadowing of the MEA user 
groups studied during the construction of enterprise models. Three product design specifications 
(PDS) have resulted from what was uncovered using the multi-method combination of research 
approaches. A generic MEA system PDS (Figure  3.5) that can be considered as an industry-wide PDS 
(PDS1), an intermediary PDS that focuses on the specific needs of the collaborating users in this 
project (PDS2), and a specific cardiomyocyte application PDS (PDS3) have all been defined (Appendix 
C). Within the specification documents, defined points can be classified as system-requirement-
centred or user-requirement-centred.  
 
Specific
Local
GlobalUser Needs:
PDS1
PDS2
PDS3
Global – the combined 
needs of all MEA users 
across application 
domains.
Local – the combined 
needs of users supporting 
this work.
Specific – the needs of 
local users that will be 
targeted in this project. 
 
Figure  3.4: Product Design Specification Formats. 
 
150 
 
__________________________________________________________________________________
Requirement Capture Methodology 
3.1.2 Design Objective Prioritisation 
The overall industry-wide needs of MEA systems from a global point of view were address in PDS1. 
PDS2 is an evolution of the industry-wide PDS1, following a review and specialisation process 
introducing needs identified by enterprise modelling as specific to project collaborators. Therefore, 
PDS2 defines the longer term targets of the project. Within PDS3, realistic design requirements were 
laid out that allowed targets to be set with respect to time, cost, facility and expertise available at 
the time. Solutions that are realistic and that would bring the best value to MEA system users in the 
time scale of this research were targeted.  
Note: This research has focused efforts primarily on PDS3. All PDS documents are contained in 
Appendix C. 
 
3.1.2.1 PDS 3 
This product design specification incorporates specific features required by the University of 
Nottingham end users (cardiomyocyte applications) with global and local points that are of high 
importance to system success. 
Nottingham University users have specified needs for the biochip to be re-designed in accordance 
with their specific application needs. They have also specified the direction in which software 
changes should be made in order to support their analysis requirements more effectively than 
current protocols. It is the needs of the Nottingham users that this project will primarily focus time 
and resource on: 
Biochip: 
 Modify well maintaining commercial interface configuration. 
Comments: that will interface with the current MCS MEA60 System in their lab. 
 Alter well dimensions to be close to those of a 35mm culture dish. 
Comments: internal dimensions 35mm diameter, 10mm height, culture area 8.8cm2, media 
volume 3ml. 
 Incorporate a light-transmissible lid. 
Comments: to prevent evaporation. 
 Interior of well must allow for potential etching or patterning. 
 Re-usable. 
Comments: therefore must withstand sterilisation using UV light and 70% ethanol. 
 16 micro-wells. 
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Comments: in any pattern. 
 Microwells as far apart as possible.  
Comments: at least 5mm in from the edge of the dish.  
 Microwells 500µm diameter,  
 with a maximal depth of 250µm,  
 and a slightly curved shape. 
Comments: cardiomyocyte clusters at time of seeding vary between 200-500µm in diameter. 
 Electrode in centre of well flush to the surface. 
 Microwells with as large a surface area as possible. 
 Made from biocompatible material(s). 
 
Software: 
 Intuitive, simple-to-use software. 
 Output results in real-time 
Comments: while maintaining the current feature of optional post-processing if desired. 
 Features to allow patch clamp files to be analysed in the same software. 
Comments: WinEDR software format suggested. 
 Facility to average all traces for a given treatment. 
 Facility to compare averaged traces. 
 Increased detail at individual waveform level. 
Comments: QT-period identification and comparison emphasised as most important feature 
for automated extraction. Other waveform elements of interest detailed in the MEA 
Specification document by the UoN. 
 Adjustable, automatic pre-processing. 
 Automatic thresholding at the time of recording. 
 
System: 
 Sample rates of at least 2-25kHz. 
 Grounded. 
 Parts that can be sterilised  
Comments: If the entire system is to go in an incubator the electronics must be sealed in 
a suitable casing for sterilisation as incubators are sterile environments. 
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 Input capabilities limited appropriately. 
Comments: to protect/prevent damage to cells or tissue. 
 Appropriate pre-processing and amplification. 
 Facilitate/support a constant cell environment. 
Comments: I.e. temperature, humidity. 
 Allow easy access 
Comments: for users to perform culture maintenance and run perfusions systems. 
(Perfusion systems are ideal MEA system components as they support long term 
experiments (especially those using slices) and the balanced distribution of nutrients 
and/or chemical entities throughout the culture media during system use. In certain 
experiments perfusion systems are essential for the execution of particular testing 
protocols.) 
 Support visual inspection of the cells. 
 Simple to learn. 
 User-friendly interfaces. 
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3.2 Effective Design 
 
A number of previously formalised design approaches or methodologies exist (e.g. design for failure 
(Hojnacki, 1992), or design for sustainability (Dimson, 1996)) that could be suitable for supporting 
conception and the creation of a successful product. 
3.2.1 Design methods 
Product design specifications used in conjunction with approaches incorporating principles of 
iterative design, user centric design, design for manufacture, design for failure, and cost effective 
design are valid product design approaches (Pugh, 1991). The key point is that for any product to be 
successful it must be designed with the users in mind.  
3.2.2 Communication 
Careful communication of user needs to interdisciplinary team members has been used throughout 
this project to support the design of a system that will:   
(1) address real user needs,  
(2) that can be manufactured,  
(3) at a reasonable cost, and,  
(4) in an appropriate period of time.  
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3.3 Derivation of Information 
 
A multi-method approach has been taken throughout this research (Figure ‎3.5) to derive the 
required design information (Blaxter et al, 2000). Management of information compiled from 
multiple research methods involves a process of sorting, labelling (or coding), reducing and 
summarising. It is important to reduce size and scope of the information that is collected so that 
meaning can be subtracted from it. The summarised information that remains then consists of the 
important and significant information that relates specifically to particular development objectives. 
In this research enterprise models and PDS documents have been used to collate and condense 
research information of differing types into useful summaries that have been used to draw out the 
design and manufacture objectives.  
Multi-method research involves the integration of several research methods (e.g. one-one 
interviews, group brainstorming, observations) to determine information about the research topic. 
Research can be desk-based, involving the use of literature and media such as brochures and 
websites, or field based, involving activities to physically identify and attain information by means of 
some sort of pursuit (i.e. observing a human interacting with the system under investigation).  Both 
desk- and field-based methods have been used throughout this research.  
The information gathered by multi-method approaches is a mixture of qualitative (i.e. learning about 
how a user feels about the device being researched (high-value qualitative information)) and 
quantitative (i.e. gathering numerical data relating to the frequency of use of the device (high-value 
quantitative information)) (Figure ‎3.5). 
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Is:
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Verbal,
Original (primary),
Secondary.
Quantitative Qualitative
Collects and analyses 
data in numeric form
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to its subject
Can be more 
precise and 
more rigid
Can be more 
detailed and 
less rigid.
Collection typically involves stages: 
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- Conduct (numerical outputs)
- Analyse (numerically)
- Interpret
Representative data sets
Collect and analyse information from 
many sources and
in as many forms as possible.
Smaller numbers of instances – specifically interesting or 
illuminating. To achieve DEPTH rather than breadth. 
Quantitative and Qualitative research approaches are NOT mutually exclusive
Information
“Neither‎form‎of‎data‎is‎intrinsically‎better, more accurate or actual – each has to be assessed, analysed and 
used on its own merits (Blaxter et al, 2000).”
Field based Research Desk based Research
MULTI-METHOD 
research
Literature Review, Emails, etcObserving, Interviews, etc
 
Figure ‎3.5: Research in pursuit of useful information. 
 
3.3.1 Flexible Planning 
Flexible planning strategies involve acting opportunistically as opposed to following a fixed pre-
planned schema (Wallace, 1991; Schattenberg et al, 2005). Flexible planning was incorporated into 
this research so that appropriate amendments to objectives could be made as new information was 
ascertained, and to enable essential compromises to be accommodated during production of 
prototypes as necessary. This approach was particularly relevant as the project involved several 
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variables (e.g. number of recording channels required, electrode geometry required) resulting in the 
need for design alteration to facilitate progress towards achieving objectives. 
 
3.3.2 Enterprise Modelling 
To understand the needs of target MEA user groups in detail, enterprise modelling (EM) was 
adopted and used as a tool to support the derivation of relevant, up-to-date information.  
 
3.3.2.1 Process Modelling of Workflows 
EM is a variant of process modelling (Huertas-Quintero, 2010). Process modelling (also referred to as 
process mapping) is described as a way to “represent graphically the transactions and stories that 
make up a business” and it helps to complete an analysis of a process or processes (Jacka and Keller, 
2002). EM is one of a number of methodologies that have evolved to support design, analysis and re-
design of workflows, which in its entirety is a procedure known as Business Process Reengineering 
(BPR).  A workflow is “the sequence of processes through which a piece of work passes from 
initiation to completion”.   
Institution
(Resources)
Scientist
Publish findings
(New Knowledge)
Disease Specific Cell Function Genetics
Background literature Trials Derive meaning
Protocol 2 Protocol 3 Protocol 3Protocol 1 Protocol 4 Protocol5
I 0
I
I
0
0
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P
U
T
S
O
U
T
P
U
T
S
Level 1
Level 4
Level 3
Level 2
 
Figure  3.6: The high-level “drill down” associated with bioscientific research. 
 
 
BPR is used by both large and small organisations alike (Childe et al, 1995), as a way of characterising 
processes that are carried out in particular areas (domains) of their business. A thorough 
understanding achieved using BPR can influence overall improvements in the enterprise’s efficiency. 
BPR is a top down technique (see Figure  3.6). In terms of this project the EM feature of BPR serves as 
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a pre-validated method of identifying and understanding potential or existing bottlenecks in 
processes that can be addressed with protocol amendment, product alteration or a combination of 
both. 
 
3.3.2.2 Static Enterprise Modelling (AS-IS) 
The starting point for conducting BPR is to view the system under scrutiny as it currently is (Kawalek, 
1995; McHugh et al, 1995). Static models are generated identifying the major processes (workflows) 
undertaken to achieve a particular enterprise goal. The main process or processes of interest are 
then modelled to a greater extent as sets of smaller, more detailed individual workflows that 
collectively represent the whole (Peppard and Rowland, 1995). This allows the modeller to capture 
and document each and every activity exactly as it is currently completed. Therefore, these static 
workflow models are also referred to as “AS-IS” models (Petersen et al, 2010).  
Of the four levels of “drilling down” shown in Figure  3.6, the EMs derived and documented in this 
project pertain specifically to levels 3 and 4 as levels above do not directly influence project outputs. 
Thus the greater details of these levels have been modelled in the case studies completed (Chapter 
4). The “AS-IS” EMs that were constructed represent the entire duration of, and approach to, using a 
standard MEA system for different types of bioscientific investigations. A variety of information 
types have been amalgamated into one clear visual format in these models.   
In many cases, static “AS-IS” models can be used as a basis for drafting “TO-BE” processes, allowing 
experimentation of potential alterations to a workflow prior to any real-life execution of that change 
taking place. Therefore, any failing or loss that would have otherwise occurred as the result of 
implementing a particular change is identified and rectified before ever being made in reality. The 
result is a vast reduction in the amount of physical reengineering that was previously relied upon in 
past “trial-and-error” workflow improvement approaches (McHugh et al, 1995). 
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3.4 Modelling to Understand Users and 
Represent Information 
 
Models are representations that allow complex processes or systems to be represented in a more 
manageable format (Johansson et al, 1993). Through the thought processes used in the construction 
of models, different types of knowledge can be generated, formalised and used to benefit the 
organisation (DTI, 2002; DTI , 2004). It is important to be aware of who is doing what, how they are 
doing it, where and when is it done, and what is achieved by doing it.  Knowledge of these elements 
allows identification and extraction of requisite details of a system. As a consequence a better 
understanding of the important complexities and interactions involved in critical workflows is 
achieved (Hunt, 1996). It is these complexities and interactions that ultimately impact upon overall 
process or system redesign. In this research MEA system user workflows (e.g. activities to prepare 
MEA biochips, activities to run tests, activities to clean MEA biochips) have been defined as the 
workflows that are most critical to successful novel MEA system and component design.   
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3.5 Modelling Architecture Selection 
 
A number of previously defined and applied reference architectures exist (e.g. IDEF - Integration 
Defintion for Function Modelling (Kim et al, 2003), GRAF - Graphs with Results and Activities 
Interrelated integrated methodology (Doumeingts et al, 2000), Petri nets (Peterson, 1977), CIMOSA - 
Computer Integrated Manufacturing Open System Architecture (Vernadat, 1998)). Specific modelling 
architectures are used to provide structured models that are comparable. By using a previously 
validated reference structure the EMs are constructed in a consistent manner allowing 
straightforward, reliable comparisons to be made (Monfared, 2000). The CIMOSA-based approach 
has been exploited in both academic and industrial fields (Zwegers and Gransier, 1995; Pierard, 
1995; Ong, 2004; Mullane et al, 2010) and is the reference architecture chosen for this thesis. 
CIMOSA was also selected due to its greater level of versatility when compared to alternative 
methods (see Figure ‎3.7). 
 
Figure ‎3.7: Comparison of available modelling techniques. 
 [Adapted from Augilar-Saven, 2004] 
 
CIMOSA offered greater scope for learning, design, and development execution, which are all of 
importance to this research (Figure ‎3.7). CIMOSA was applied so that systematically generated sets 
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of EMs could be used to collectively represent all of the available knowledge relating to MEA system 
employment protocols and manufacturing processes used in this research. Multiple EM sets across 
three different settings by each partner user group permitted a more detailed understanding of 
generic MEA system user needs.   
 
3.5.1 One Architecture for All 
Throughout this thesis representation of physical bioscientific protocols and human-MEA system 
interaction, and manufacturing approach documentation, has been presented using a single EM 
architecture (CIMOSA).   
Process representation is a sub-set of CIMOSA enterprise modelling (Monfared, 2000) that suited 
the requisites of the required workflow examination in this research.  
Careful construction of sets of EMs was chosen as a single method to depict and visually 
communicate physical protocols and the human-MEA system user interaction. The single 
architecture offered a structured means of allowing the overall use of an MEA System to be broken 
down in terms of: 
(i) information inputs (e.g. cell type under investigation, cell preparation type),  
(ii) information outputs (e.g. number of MEAs sterilised and pre-treated per batch, number 
of data files recorded per experiment),  
(iii) resources consumed (e.g. volumes of media/solutions required per MEA biochip per 
experiment, high-skilled human dependant tasks, additional essential tooling),  
(iv) time required (e.g. time taken to set-up experiment, time to run experiment, time in 
terms of human labour, time taken to analyse), and 
(v) the dependencies on the human users (e.g. by-hand positioning of cells over 
microelectrodes, visual observation of cell viability prior to experiments, visual 
assessment of cell-substrate attachment quality).  
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3.6 The CIMOSA-based Modelling Solution 
 
CIMOSA  supports system decomposition into:  
1. an enterprise (workflow) modelling framework,  
2. an integrating infrastructure, 
3. an (computer) integrated (manufacturing) system lifecycle. 
(Adapted from Vernadat, 1996.) 
 
A number of fundamental concerns are incorporated into the CIMOSA approach. The multi-
dimensional nature of the approach is highlighted in Figure ‎3.8.  
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Figure ‎3.8: The concerns of the CIMOSA framework. Additional concerns can be added as required. 
 (Adapted from Vernadat, 1996). 
 
 
3.6.1 CIMOSA Flexibility 
When generating enterprise models using CIMOSA four different views are integrated to facilitate 
full description of workflows within an overall system (Figure ‎3.8). The views are divided into the 
function, information, resource and organisation views:  
 
 Function – is an activity-centred view. Models demonstrate activities that make workflows 
happen to reach endpoints and produce outputs. 
 Information – information enters and exits functions. 
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 Resources – are required to make functions happen and can be either human or physical. 
 Organisation – functions are ordered to ensure inputs become outputs during workflows. 
 
The DERIVATION dimension covers the lifecycle aspect of the system, from requirements definition 
to design specification and implementation.  
 
The INSTANTIATION is concerned with the level of granularity of the respective views (i.e. from the 
generic to the particular aspects of a domain).   
 
 
3.6.2 Specific CIMOSA Architecture Adaptation 
Application of CIMOSA relies upon representing processes and activities using constructs (see 
Table ‎3.1). Constructs have been adapted to improve the communicability of models generated in 
this research.   
 
Table ‎3.1: Constructs applied in this research. 
Constructs: Constructs with regard to MEA system research:  
Events Extraction of electrophysiological signals 
Domains In research and pharmaceutical industry laboratories 
Domain Processes Laboratory standard operating procedures (SOPs) and good practice 
Business Processes Application and laboratory specific protocols 
Enterprise Activities  Activities involved in carrying out SOPs and relevant protocols 
Functional Operations.  Activity details. This is where activities may be made up of a further 
set of activities, requiring a further drill down to ascertain all relevant 
information. Relevant information is included as various function 
operations. 
 
These constructs have been applied in modelling overall system functionality and user group 
behaviour in this work. A collection of pre-defined diagrams need to be adopted to enable the 
details of the domain to be represented in terms of these constructs. 
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3.6.3 Diagram Structure Type 
The specific types of diagram used in this work are based on Monfared’s (CIMOSA-based) Modelling 
Approach (MMA). This approach has been applied because it has been well represented within 
academic literature as a technique that can be used effectively to represent real processes and 
activities (Ong, 2004; Dong, 2006; Mullane et al, 2010), and it has been previously validated by 
Loughborough University (Monfared et al, 2002; Aguiar, 1995).  
 
A set of four basic representational diagrams that focus on the function view are required 
(Figure ‎3.9) (Monfared, 2000). Representations are decomposition-based breaking down workflows 
into distinct units that enable information (e.g. timing, cost, resource utilisation) to be readily 
derived.  
 
The context-, interaction-, structure- and activity-centred diagrams have been constructed (see 
Chapters 4 and 5) to provide a set of “views” of real bioscientific laboratory protocols and 
manufacturing approaches at varying levels of abstraction. The MMA modelling notations used to 
represent the different processes are documented in Figure ‎3.9. The four diagram types allow visual 
representation of all workflow processes in a manner that ensures derivation of clear and 
comparative information. The details contained within these diagrams serve as integrated sources of 
information. The information has been derived and exploited for the definition of user and system 
requirements, and for prioritisation of actions to meet those requirements.  
 
Context diagrams are used to define the high level of the workflows of an enterprise that are under 
investigation. For example, a research institute is comprised of a number of different areas of 
expertise that combine to produce new knowledge. Within an area of expertise different aspects are 
interrelated that are in themselves different areas of investigation (Figure  3.6). Distinctions between 
areas of expertise and differing investigations can be readily visualised using context diagrams.  
 
Structure diagrams indicate activities that make up workflows.  
 
Interaction diagrams can be used to demonstrate complexities (e.g. elements where outputs of one 
activity may vary, therefore resulting in alternative ensuing activities) that might exist within or 
between workflows. 
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Example 4: Interaction Diagram
Example 3: Activity Diagram
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Figure ‎3.9: The diagram types used in this research. 
 [Adapted from Monfared, 2002.] 
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All diagrams are constructed from the notations shown (Figure ‎3.9) allowing clear visual 
representation of the various details of domains, domain processes, processes and/or activities 
modelled.  
 
 
3.6.4 Model Set Organisation and Comparability 
To represent a system in detail using CIMOSA requires a number of differing models to be 
constructed. Careful organisation of these models into sets helps to define distinct modules within 
certain settings and can reduce overall system complexity, thereby improving information 
manageability (Smith, 2007b). 
 
The CIMOSA constructs are used to model domains, domain processes, processes and activities. A 
domain is a region that the modeller will choose to focus upon at its highest level (e.g. MEA system 
application in neuroscience). Domains (D) are broken down into sets of Domain Processes (DP), 
which are broken further down into Processes (P), that are made up of series of Activities (A).  
 
D.1.
Retinal
D.2.
Neurological
D.4.
Other (niché)
D.3.
Cardiologiocal
Events & 
results
- CIMOSA Domain
- Non-CIMOSA Domain
 
Figure ‎3.10: A context diagram identifying the main research domains that are currently exploiting MEA 
systems. 
 
Decomposition serves a functional purpose. Domains interact with one another by the exchange of 
events and results. In bioscience, for example, researchers from different domains publish findings 
obtained using multi-electrode array systems, this information can be of use to other MEA user 
groups, potentially altering workflows across domains (Figure ‎3.10). For example, a group working in 
the pharmaceutical industry with brain slices on MEA systems exploits findings derived by 
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researchers that are studying disease in dissociated neurons on MEA systems. The result is a change 
the pharmaceutical group’s protocols or workflows. 
 
In Figure ‎3.10 the niche domain (D.4) has been incorporated to represent the application of MEA 
technology in low volume novel domains such as nasal tissues (Liu et al, 2010) and the 
gastrointestinal tract which are fields that may expand in the future depending on the outcomes of 
these early investigations. 
 
In this case domain processes are the processes involved in using an MEA system independent of the 
research question under investigation. Each domain process (DP) is an end-to-end process. 
Modelling of DPs provides overviews of the sequence of activities that are carried out by the 
collaborating laboratories. DPs have defined starting conditions and finishing points that together 
provide a measurable or quantifiable end-result that can then be used by the bio-scientist. The 
domain processes delineated for this work are demonstrated in Figure ‎3.11. Specific model sets 
incorporating details of each partner user group’s workflows have been constructed (Chapter 4).  
 
Activity diagrams are detailed descriptions of a domain process in terms of functionality. The 
CIMOSA architecture defines an enterprise activity (in this case adapted to an Activity) as a set of 
elementary actions requiring resources and time for execution. Activity models are sets of 
elementary processing steps executed by one functional entity, in this case the MEA-system user. 
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Figure ‎3.11: The flow through generic domain processes demarcated for this work. 
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3.6.5 Application of the Modelling Approach 
Research domains where MEA technology has been applied (Chapter 2) have been separated into 
domains (see Figure ‎3.12). Within each domain MEA-systems are employed using different protocols 
to best suit the varying needs of each application. Differing application domains (D) consist of 
domain process (DP) details. For example, approaches employed when conducting trials using acute 
neural slices differ significantly from when using chronically cultured neurons. For more detail see 
Chapter 4. 
Generic 
Domain Processes
DP.2.
Set-up tools
DP.1.
Obtain Cells 
Of Interest
(Signals)
DP.5.
Process Signals 
DP.3.
Run Experiments
DP.4.
Save data
DP.6.
Derive Meaning
 
Figure ‎3.12: Domain processes generic to MEA system application into a context diagram. Domain processes 
that have been identified for modelling as part of this work are highlighted in red. 
 
Unique domain specific models were constructed following the initial model’s structure to provide 
increased levels of detail for each individual case study application.  
 
Context diagrams have been used to demonstrate each domain process as a distinct flow of 
activities using the activity diagrams constructed using detailed knowledge derived from protocol 
analysis and interview.  
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A.9.
A.7.A.5. A.8.A.6.
P.3
P.4
D.3. 
Domain (D): 
CARDIOLOGICAL RESEARCH
Domain Process (DP):
OBTAIN SIGNAL
(Generic to all MEA applications)
Process (P):
CULTURE CELLS
(Application specific)
Activities (A):
A.1 DIVIDE MATRIGEL,
A.2 THAW MATRIGEL,
A.3 DILUTE INTO BASE,
A.4 DISPENSE ON MEA,
A.5 LEAVE AT RT FOR ~45 
MINUTES,
A.6 ASPIRATE MEDIUM,
A.7 ADD FRESH MEDIUM,
A.8 SEED CELLS, 
A.9 INCUBATE WELL.
(Application specific)
 
Figure ‎3.13: The decomposition of a Domain into its Domain Processes, then into individual Processes, and 
then into the Activities involved in carrying out one of those processes. 
 
Figure ‎3.13 is a representation of how domains, domain processes, processes and activities 
decompose deeper and deeper into these cases of MEA-system use. An activity is the elementary 
unit within the architecture. A process is usually comprised of more than one activity. Activities are 
carried out in flowing routines to bring about a result or output. For example the activities (A.1. to 
A.9.) could be, A.1. Divide up Matrigel upon delivery and store in freezer, A.2. Thaw Matrigel prior to 
use, A.3. Dilute Matrigel in base media, and so on, depending upon the user application. 
 
3.6.6 Successful Application 
The CIMOSA modelling approach was successfully applied in this research setting due to the 
flexibility of the modelling constructs. MEA-system workflows are almost certainly unique to every 
institution and research group that uses an MEA system at this time. In addition to the clear 
institutional/research group differences it was possible to observe how individual preferences within 
groups at the same institute, working to the same guidelines, resulted in subtle differences in 
protocols (workflows).   
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3.7 Identification of Influential Application 
Differences 
 
Multi-method approaches to gather data for case studies that are of a comparable nature, such as 
those documented in Chapter 4, highlighted key differences between model sets (Figure ‎3.14). 
Research methods were selected and applied that suitably addressed collection of appropriate 
information for each set.  
The number of workflow stages required varied between MEA system user groups and their 
applications (e.g. the number of activities in sterilisation, cell seeding, experiment execution).  
Flexibility of the applied modelling architecture allowed models that differed to large extents while 
remaining comparable. The cell type used and type of preparation of that cell type resulted in 
substantial differences in MEA-system workflows.  All three user groups modelled used different cell 
preparations that are used in conjunction with an MEA system in different ways (Figure ‎3.14). 
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One MEA System
(MEA60)
Cardiomyocyte Neurons
Same source (mutant mouse). 
Different preparation (brain 
slice/dissociated cell culture).
Different cell types/preparations require different MEA biochip 
preparation and seeding approaches to achieve appropriate cell-
electrode contact to facilitate signal detection.
Results in different bioscientific protocols (workflows) for comparable 
processes (e.g. MEA biochip sterilisation, cell seeding, experiment 
protocol).  
Results in different sets of comparable enterprise models.
(Dissected stem cell derived 
beating clusters from embryoid 
bodies.)
 
Figure ‎3.14: Derivation of different workflows using the same MEA system. 
 
The University of Nottingham user group apply MEA systems in the electrical characterisation of 
stem cell derived cardiomyocyte (SC-CM) cells derived from one of a number of maintained stem cell 
lines. The cardiomyocytes are differentiated from human-derived stem cells into microscopic 
clusters of beating cardiomyocyte cells. The beating cluster, referred to by users as “beaters”, are 
dissected out of the original culture by hand and seeded into an MEA biochip over the array of 
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microelectrodes. In contrast, the scientist users at the Sanger Institute use two distinctly different 
instances of the same cell type from the same source type (mutant mice); brain slice and dissociated 
neuron culture. The dissociated neuron culture user (modelled in section ‎4.3) applies MEA 
technology to cultures where a dissected section of tissue is initially obtained from specifically 
genetically mutated mice and the cells are the dissociated from one another using specific enzymatic 
agents resulting in a suspension of single cells. It is these suspended cells that are separated (by 
centrifuge) and seeded into MEA biochips. Cells prepared in this manner are then allowed a period 
of attachment and re-growth in incubation, during which time new networks of activity will 
propagate. The brain slice user also uses brains taken from specifically mutated mice but in this 
instance the slices are left intact in their natural networks. Slices are then simply placed on top of 
the electrode array and gently secured in place. The protocols (workflows) undergone by each 
instance described differ, the result of which is that the three sets of EMs are unique, possessing 
differing timing and resource consumption information. 
 
3.8 Evaluation of Solutions 
 
The findings of the research conducted for this project are presented through this thesis and in 
research publications. Discussions of the areas of this research that must be evaluated (Figure ‎3.15) 
are included in Chapters 6 and 7. The following points have been defined for evaluating the research 
presented and for discussion in the closing chapters of this thesis as they are considered essential 
areas of evaluation specific to this research context.    
1. The effectiveness of the data collection methods.  
2. The design approach and prototype manufacture.  
3. The likelihood of product acceptance - that the designed solution will be accepted and 
adopted by real MEA system users.  
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Evaluation of 
Solutions
Effectiveness 
of data 
collection
Design 
approach and 
prototype 
manufacture
Likelihood of 
product 
acceptance
Literature 
Review
Product 
Design 
Specification
Enterprise 
Modelling
User needs
Final Design 
Concept
Prototypes
Concept 
design
Development 
of 
Manufacturing 
Workflow
Product 
Quality
Time
Cost
Sophistication 
(expertise/
tooling 
demands)
Performance 
of product in 
use 
„Dry‟‎testing
(in-house 
quality 
assurance)
„Wet‟‎testing
(using live 
cells) 
End-user 
Feedback
Identification 
of new user 
needs
By assessment 
of the identified 
user and system 
requirements
By production of 
a functioning 
prototype
By use of the 
prototype outputs
 
Figure ‎3.15: Defined areas of research evaluation for this project. 
 
 
3.8.1 The effectiveness of data collection methods 
An assessment of the techniques that have been used for gathering, archiving, communicating and 
exploiting information and data collected throughout this project is required.  
Compilation of a literature review, product design specification drafting and enterprise modelling 
research techniques have been used in both user and system requirements (Chapter 5)  definition 
and during the concept design stages. Physical prototypes were constructed to meet the 
requirements identified that have been tested by end-users. Feedback from users relating to the “in-
use characteristics” of the solution devices was sought and is described in Chapter 6.  
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3.8.2 The design approach and prototype manufacture   
An assessment of how design concepts were conceived and produced, and of how physical 
prototypes manufactured of those concepts performed in both “dry” (without living content) and 
“wet” environment have been carried out and documented in Chapter 6.  
 Testing and evaluation of prototypes was conducted with regard to MEA biochip integrity and also 
in a system integrated MEA system fashion. 
Planned configurations were pre-defined for testing and evaluation of prototype devices prior to 
commencing manufacture: 
 Prototype biochip(s) in commercial hardware (e.g. hardware: headstage, amplifier, ADC) 
with commercial software. 
 Prototype biochip(s) in commercial hardware with novel software. 
 Prototype biochips(s) in novel hardware with novel software. 
 Novel software with commercial MEA biochip in commercial hardware. 
 Novel software with commercial MEA biochip in novel hardware. 
 Novel hardware connecting to commercial MEA biochip and commercial software. 
 
The likelihood of product acceptance was considered throughout this research. An assessment of 
how the user felt using the prototypes was pursued (Chapter 7) during this research.  
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3.9 Summary 
 
In research and development, set approaches are used to support identification of issues or areas to 
be targeted for improvement, and to provide focus to the consequential derivation of appropriate 
solutions. The major objective of this research has been to produce a novel state-of-the-art multi-
electrode array system. A summary diagram of the content of this chapter has been included 
(Figure ‎3.16). 
 Research was constructed around three distinct project stages: (1) Problem evaluation, 
where short- and mid-term targets were defined; (2) Effective design, where the defined 
targets were addressed, resulting in the output of prototypes (solutions), (3) Evaluation of 
solutions, where prototypes were tested and evaluated.  
 During problem evaluation, felicitous context research facilitated the identification of up-to-
date user and system requirements and product design specification documents were 
consequently constructed. Context research was conducted logically and strategically in 
order to attain a crucial understanding of the research domain, existing MEA system 
technologies and different types of MEA system application. Producers of cutting-edge 
technologies in the field of MEA system application were identified as both competitors and 
domain leaders. It was understood from conducting strategically focused early research that 
different application of the same technology leads to considerably different data outputs 
and new knowledge contributions. New knowledge is excogitated based on quantified 
measurements extracted from those differing data types. 
 Through effective design, solution devices (prototype MEA biochips and system) were 
sought that would match user expectations at the same time as being economically viable 
and industrially competitive. Qualitative and quantitative information was called upon 
throughout decision making as evidence to support design decisions. Information and data 
was gathered using a multi-method research approach that integrated both desk-based and 
field-based findings to provide a detailed view of the design challenges (user and system 
requirements). It was identified that communication of relevant information between 
researchers and project stakeholders was important. A process modelling methodology was 
selected and exploited as a tool for documenting and communicating MEA system 
applications and specific application differences. The same previously validated and 
internationally standardised modelling framework was also used to model manufacturing 
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workflows as they were conceived and developed allowing simple monitoring of critical 
manufacturing details (e.g. time, resource input) as manufacturing workflows evolved.   
 
 Evaluation of the outputs of this research was conducted in terms of the physical prototype 
solutions demonstrated. The evaluation was conducted to address how well the research 
approaches used identified user and system requirements (Chapter 5), as well as how this 
research can be of use to others (Chapter 7).  
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Figure ‎3.16: A summary of the findings of Chapter 3. 
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3.10 Research Questions Answered 
The following statements address the research questions originally defined at the start of this 
chapter. 
1. What can be done to ensure a thorough evaluation of the field of multi electrode array 
application and system production is performed so as to support the identification of real 
end-user requirements in this research area? 
It was intended as part of this research that real end-user requirements would be identified to 
support the composition of a design specification that would be used throughout design and 
manufacture of a new state-of-the-art MEA system. Identification of user requirements 
depended upon appropriate understanding of how users apply MEA systems and where they 
encounter problems or issues that could be tackled through component and/or system redesign. 
Up-to-date research was pursued so as to identify current requirements that would ensure the 
evolving solutions would be classed as novel and state-of-the art. 
Thorough understanding of the field of MEA system technology use was sought. In addition to 
this it was recognised that a number of MEA system components depend upon recently 
developed manufacturing techniques. To ascertain appropriate knowledge with regard to both 
MEA system use and system component manufacture a strategic multi-method approach to 
research was engaged. This involved using a number of well-established, previously validated 
research techniques (Figure ‎3.2) to gather a broad range of information and relevant data. 
 
2. Can formalised product design approaches be implemented to support conception of 
effective component and system designs? 
A number of design approaches are described and formalised in design and innovation 
literature. For example, design for manufacture, design for failure, user-centred design and 
sustainable design are all examples of terms used to describe design processes with particular 
emphasis on a particular aspect of design (Pugh, 1991). Design for manufacture and user-
centred design foci have been most significant in this research. 
Formalised modelling (via CIMOSA enterprise modelling) of existing MEA systems as they are 
currently used, as well as during prototype manufacture also supported communication of 
necessary component and system details (e.g. MEA biochips electrode geometries used with 
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which cell type and preparation, what gains are set in the detection hardware) used throughout 
design conception and iteration.  
 
3. What kinds of information will be required to support effective design and manufacture of 
prototypes? 
A combination of qualitative (i.e. user preference and opinion) and quantitative information (i.e. 
timing and resource data) have been used to support PDS drafting and the consequent design of 
prototype solutions. Varying information has been collected from different sources using both 
desk-based and field-based research to provide a balanced and broad collection of information.  
Effective concept generation and user-centred design was supported by well-informed 
identification of user and system requirements.  Derivation of design specifications relied upon 
literature sources, observations, meetings, documents, emails and one-to-one interviews.  
Effective design for manufacture was supported by identification of information relating to 
current manufacturing approaches for similar existing devices (e.g. how commercially available 
MEA biochips are made, what manufacturing approaches offer a means to produce feature 
desired using materials necessary), as well as communication of timing and cost information 
relating to the novel manufacturing approaches being developed.  
 
4. What formalised approaches should be used to represent and communicate research 
inputs and outputs? 
Enterprise models have been used extensively throughout this research to document and display 
a range of input types (i.e. material, human labour). Conference paper and journal papers have 
been produced and published to communicate research findings in the form of prototype design 
and manufacture, testing and validation. In addition to this, this thesis presents the research 
from start to finish in one document. 
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This Thesis
Chapter 4
MEA Application 
Case Studies
1. Cardiomyocyte Clusters
2. Dissociated Neurons
3. Brain Region (Hippocampal) Slices
 
Chapter Four 
4 Case Studies and Requirement 
Identification 
 
 
 
 
 
 
“A case study is an account or description of a situation, or sequence of events, which raises issues 
or problems for analysis and solution” (Heath, 2002). Case studies have been used in this research to 
support problem, and user and system requirements identification.  
To consider the differing domains in which MEA systems are applied (i.e. in the neural research 
domain or the cardiac research domain), and to understand the ways in which MEA systems are 
used within those domains (i.e. differences between use in slice-based experiments and dissociated 
cell culture-based experiments with the neural research domain), three research institute-based 
case studies have been pursued and are presented in this chapter. Note: the domains of MEA system 
application and the ways in which systems are used within those domains is continually evolving and 
diversifying (section ‎2.7).  
 
181 
 
__________________________________________________________________________________
Case Studies and Requirement Identification 
Case studies contained within this chapter have supported identification of user and system 
requirements across application domains.  The following research questions are addressed through 
the work presented in this chapter: 
1. How are MEA systems currently employed by users that are working with different cell 
sources and cell types? 
 
2. What are the major differences between the applications examined? 
 
3. Can any system or component changes that have been identified as requirements by this 
research offer value to users, and of those changes, which ones can be realised by this 
research? 
 
The overall population of MEA system users is diverse so samples of representative users are 
discussed in this thesis. The population of MEA users has been divided into population samples 
depending upon the cell of interest (e.g. neuron, cardiomyocyte). Two cases from the neural tissue-
based sample and one from the cardiac tissue-based sample are presented (Figure ‎4.1). 
 
Population Samples of population Case Studies
MEA Systems Users
A
p
p
lic
a
ti
o
n
s
Neural Tissues
Cardiac Tissues
Other
Slice
(Case Study 3)
Dissociated  Culture
(Case Study 2)
Slice
(Future Case Study)
Beating culture
(Case Study 1)
Alternative tissue/cell 
type
(Future Case Study)
 
Figure ‎4.1: MEA system applications and corresponding case studies. 
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The MEA system user groups that have partnered this work are: 
1. The Wolfson Centre for Stem Cells, Tissue Engineering and Modelling (STEM) at The 
University of Nottingham’s Centre for Biomolecular Sciences 
Group leader: Professor Chris Denning.  
Major project contacts: Dr David Anderson and Miss Divya Rajamohan. 
Website: 
http://www.nottingham.ac.uk/news/expertiseguide/experts/d/professorchrisdenning.aspx 
 
2. Genes to Cognition Research Group at the Wellcome Trust’s Sanger Institute (moved to 
University of Edinburgh November 2011).  
Group leader: Professor Seth Grant.  
Major project contacts: Dr Paul Charlesworth and Dr Maksym Kopanitsa.  
Website:  http://www.genes2cognition.org 
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4.1 Case Study Development 
 
The method used to develop the presented case studies is illustrated in Figure ‎4.2. Data collection 
took place through desk-based research methods resulting in Chapter 2. Field-based research was 
required to gather the requirement specific information that was structured as enterprise models. 
As understanding of the application and user requirements of each application increased additional 
supplementary information was gathered and integrated into the case studies. 
1. Data Collection
2. Data Restructuring
3. Case Enhancement
Need‎specific‎Vs‎„trawling‟
Decide structure, write and edit
Supplementary material – printed word, audio, video
 
Figure ‎4.2: The case study development process. 
[Adapted from: Heath, 2002.] 
 
The enterprise modelling (EM) architecture used is described in Chapter 3. EM was applied to create 
structured sources of information that supported problem understanding, as well as up-to-date user 
and system requirement identification, definition and prioritisation.  
 
4.1.1 Case Study Commonalities 
Across the MEA system user population commonalities exist: i) obtain and/or culture appropriate 
cells over MEA electrodes, ii) record signals that these cells produce, and iii) analyse the signals to 
derive understanding so as to contribute new knowledge. The remainder of this Chapter 
demonstrates user group specific information that was collected and constructed into enterprise 
models centred on identifying application specific differences and problems associated with MEA 
system’s use. 
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4.1.2 Information for Requirement Identification 
Information derived during observations of MEA system users has identified user requirements that 
are presented at the end of each case study.  The information that is combined in the construction 
of each EM was initially obtained via passive observation of user workflows (bioscientific protocols) 
in each context.  Further detail was captured though interaction between the modeller (thesis 
author) and the system users, and also with the physical workflows themselves (e.g. the modeller 
gained hands on experience of the protocols with the users). Meetings were also held prior to and 
post modelling to plan what to observe and to collect supplementary information as required after 
observation. Reference to laboratory standard operating procedure (SOP) documents written by the 
UoN and Sanger Institute users were also referred to for additional details. Examples of these 
documents are contained in Appendix D. 
 
4.1.2.1 Modelling Identifiers and Process Relevance 
Processes and activities of each case study are presented as overall workflows using the CIMOSA 
architecture and modelling constructs. This approach enables the identification and definition of 
MEA system use into elements. Alphanumeric identifiers are used to note individual actions and to 
group actions into processes (see Figure ‎3.13). For example, the abbreviation P.1 represents process 
one, the first process of the overall workflow, and the abbreviation A.1 is used to represent the first 
activity carried out in order to complete that process. 
So in the forthcoming figure, Figure ‎4.4, process one could be “Obtain stem cells” which in this case 
is out of the immediate scope of this project but is a vital process that all project stakeholders need 
to be aware of. Process two in the same model, “Derive cardiomyocytes”, is also out of the scope of 
this project but is a focal area of research for the UoN group and must be documented in the model. 
Process three, “Seed and culture cardiomyocytes” is the first process that has direct relevance to the 
focus of this research and is dependent upon successful completion of P.1 and P.2. Process three is 
the first to have been modelled in further detail as  drill down models and this is usually represented 
in the model by the presence of a shadow under the shape in which the words “P.3. Seed and 
culture cardiomyocytes” are contained. Processes four, five, six and seven are also relevant to this 
research so have been modelled in further sub-models too, again indicated by shadowing. Processes 
eight (P.8 –Derive meaning) and nine (P.9 – Share findings) are not directly relevant so have also not 
been modelled beyond this point. 
The identifiers are constant throughout all three of the ensuing case studies.  
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4.2 Case Study One: Stem cell-derived 
Cardiomyocyte Application 
 
There are areas of cardiological research where using MEA systems to record electrogenic activity as 
it occurs in cardiomyocyte cells or across cardiac tissues can serve as tools that are used to 
contribute new knowledge (Caspi et al, 2009). Examples of such areas include: investigations of the 
mechanisms of arrhythmia, which is irregularity of the heartbeat (Jacquir et al, 2008); investigation 
of specific membrane channels present in cells of the myocardium (heart muscle) (Law et al, 2010), 
and investigation of responses to pharmacological substance testing (Caspi et al, 2009). 
Jacquir et al (2008) studied monolayers of cardiomyocytes cultured over an MEA. Basal conditions 
were observed. Proarrhythmic conditions (the new or more frequent irregularity of cardiac 
contractions) were then induced by using the MEA electrodes to deliver high frequency electrical 
stimulations to the cardiomyocytes. The response of cells to anti-arrhythmic drugs was then 
observed and the implications discussed. 
Law et al (2010) studied the effect of potassium channel openers (a selection of cardio-active drugs 
that facilitate transport of ions through potassium channels) by using an MEA system to facilitate 
observation of metabolic inhibition of cardiomyocyte cells. Parameters of cardiac activity captured 
from the system were beat frequency and field potential amplitudes and durations. This work 
supports the use of MEA systems for long- and short- term monitoring of metabolic inhibition of 
cultured cardiomyocytes and suggested that models of the heart on MEA systems could serve as a 
reliable platform for discovery and study of cardioprotective drugs.  
Caspi et al (2009) examined the possibility of combining single cell electrophysiology (see 
section ‎2.4.2.1) with MEA recordings as a novel model for complete electrophysiological drug 
screening. Anti-arrhythmic substances were examined to observe known responses using the MEA 
system. Alterations in field potential durations, and consequently QT-intervals, were observed and 
discussed to support MEA systems use in cardio-active substance screening.   
The context diagram in Figure ‎4.3 is an example of the highest high level of CIMOSA model created 
in this research case study. Figure ‎4.3 shows domains that can be autonomous research fields in 
their own right but that are also interdependent as they are all associated with the use of stem cell-
derived cardiomyocytes (SC-CM) for research. It is of use to this research to be aware of advances in 
the other fields depicted as they each contribute to an increased understanding across cardiological 
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research. Developments in one area (e.g. culturing of a stem cell line to meet a demand) may 
potentially influence developments in another field too (e.g. use MEA tools to extract useful 
electrophysiological data from SC-CM sources). Figure ‎4.3 also places electrophysiological data into 
context with overall research and development in the SC-CM research domain. 
 
Establish Stem Cell Line
Culture Stem Cell Line to meet demand
Develop stem Cell Differentiation Techniques
Use MEA Tools To Extract Useful 
Electrophysiological Data From SC-derived 
Cells
Apply SC-derived Cells To Research Needs
D.3.
Cardiological
- CIMOSA Domain
- Non-CIMOSA Domain
 
Figure ‎4.3: A context diagram depicting the interdependent research fields that are implemented 
contributing to successful stem cell-derived cardiomyocyte research. 
 
 
4.2.1 Case Study Context 
This case study is focused on an application that uses MEA systems to extract useful 
electrophysiological data from stem cell derived cardiomyocytes as they are exposed to various 
chemical entities.  
Bioscientific protocols have been defined by University of Nottingham (UoN) MEA system users to 
facilitate this application.  
Enterprise models (EMs) in this section communicate information relating to how MEA systems are 
presently used by the UoN and what current biochip and system requirements have been identified. 
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4.2.2 Modelling of the University of Nottingham SC-CM 
Application 
The ensuing EMs document the protocols employed in a specialist cell culture laboratory 
environment at the UoN. Early construction of a high-level application summary model (Figure ‎4.4) 
outlined the overall workflow used in this cardiomyocyte-centred MEA application. The workflow is 
broken down into processes that are elements with clear start and end points. Further “drill down” 
models were constructed of processes that were relevant to MEA system interaction to ensure 
collection of detailed knowledge of all relevant processes.  
 
4.2.2.1 Overview 
The UoN workflow used to detect, record and analyse electrical field potential signals from stem cell-
derived cardiomyocytes has been summarised as (Figure ‎4.4):  
 Process One (P.1.) – Obtain stem cells   
 Process Two (P.2.) – Obtain cardiomyocytes from those stem cells 
 Process Three (P.3.) – Seed and culture the cardiomyocytes over the electrodes of an MEA 
biochip 
 Process Four (P.4.) – Select and obtain substance(s) to be investigated 
 Process Five (P.5.) – Set-up and run experiment 
 Process Six (P.6.) – Collect data output 
 Process Seven (P.7.) – Analyse output offline 
 Process Eight (P.8.) – Derive meaning from values ascertained through analysis 
 Process Nine (P.9.) – Share findings to contribute new knowledge to the research community 
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P.1
Obtain Stem Cell 
source for 
differentiation
P.2
Derive 
cardiomyocytes
P.3
Seed and culture 
cardiomyocytes on 
MEA
P.4
Select and obtain 
the drug of choice
P.5
Set-up and run 
trial
P.6
Collect initial 
output data
P.7
Post-process raw data 
and produce visual 
representations
P.8
Derive meaning
P.9
Share findings
New 
knowledge
hESC
Scientist
Culture Media
Equiped Laboratory
hESC-CM
Scientist
Coating Media
t=~20 days
 Overall t= 
~2-5 days
MEA Biochips
Reason for 
selection
Scientist
Scientist
MEA System Hardware
MC_Rack 
Parameters for 
recording
Scientist
MC_Rack 
MC_Rack 
Software
MC_Datatool
Other Softwares
Scientist
Scientist
Trial 
runs
Cell line under constant 
maintenance
72 minutes to 
seed each batch
Batch size: 
5-8 MEAs
Six output files per drug:
1 basal, 5 concentrations
Time investment in terms of 
time spent producing beating 
clusters of CMs from stem 
cells
Experiment set-up 
time required to reach: 
healthy, attached and 
contracting clusters 
over electrodes. 
Microscope
Optics essential 
to confirm all 
three.
Need to increase number 
of beating clusters per 
media well because if the 
beating cluster stops 
contracting all time spent 
on that biochip to that 
point is wasted. 
When beating cluster is 
healthy, well attached 
and contracting testing 
can be fast
t= 18 mins 
(3mins x 
6.mcd files)
t=1hr 45 mins 
(to process 6 
.mcd files = one 
substance)
t= 57 mins 
(per substance - 
1control, 5 
concentrations)
Lengthy analysis
- process
- document
- human resource
- physical resource
- event
- information
- finance
 
Figure ‎4.4: An activity diagram of the overall workflow of processes implemented by UoN MEA system users. 
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To complete an investigation from start to finish takes a total of approximately 22-25 days. 
The protocols of most interest to this research are those where the MEA system or a component of 
the system has been physically interacted with in some way. These processes are identified and 
modelled further to capture relevant detail. Shadows are used under modelling constructs (e.g. P.3, 
P.5, P.6 and P.7) to indicate where further models have been constructed to incorporate details 
relevant to this research.  
 
User and system requirements identified during the observation and the construction of the overall 
workflow used for this application are:  
1. To ensure as many beating clusters as possible make it from differentiation to the end of 
testing through facilitating appropriate handling and cell culture conditions. 
2. To increase the number of beating clusters per media well, thereby improving the volume of 
output per test and to improve efficiencies of the MEA biochip preparation process. 
3. To ensure outputs are of comparable or better quality than current. 
4. To ensure tests can be conducted with comparable or better ease and speed. 
  
4.2.2.1.1 University of Nottingham processes 
The following models document each process that is MEA system or component relevant. 
Process Three – Seed and culture cardiomyocytes on MEA Biochip 
Process three (Figure ‎4.5) is the preparation of each MEA biochip (workspace and media well) to a 
standard suitable for beating cluster attachment and survival in vitro. This requires sterilisation and, 
depending upon the user preference, treatment of the surface with an appropriate attachment 
matrix, which in this case is e.g. Matrigel. The beating clusters of cardiomyocytes are seeded into the 
MEA biochips, one at the centre of each workspace and therefore per media well. 
Once seeded, the MEA biochips are moved from the culture hood into the incubator where the 
environment is controlled at a steady 37°C with a CO2 concentration of 5% (which is required to 
control acidity levels within the culture media) and left undisturbed for a period of at least sixteen 
hours. The exact incubation period differs, depending upon the individual scientist and the duration 
of time that each individual beating cluster takes to attach adequately to the underlying attachment 
matrix or surface.  
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P.3.A.1
Matrigel is divided 
up into quantities 
of 500µl and 
stored at ~ -80°C
Matrigel Obtained in 10ml 
quantities and stored at 
temperatures between -20 to -80°C
P.3.A.2.1
When required Matrigel 
is removed from cold 
storage and allowed to 
partially defrost to a 
temperature <0°C
P.3.A.3
Matrigel is diluted 
into a base 
medium up to a 
total volume of 
50ml
P.3.A.4
Matrigel is immediately 
dispensed into MEA 
well. 
P.3.A.5
Well is left at Room 
Temperature until a film 
(invisible to the human 
eye) develops on the base 
surface.
P.3.A.6
The remaining 
medium is 
aspirated 
P.3.A.7
Culture medium is 
added to each well
Culture 
Medium
Base Medium
MEA
P.3.A.2.2
Wells are rinsed with 
ethanol and 
sterilised under UV 
light
UV lamp
User
User
User
User
User
User
User
P.3.A.8
Cell cluster is 
seeded to well by 
skilled scientist
P.3.A.9
Well is held in a controlled 
environment while 
attachments form between 
the cells and the biochip 
workspace
Matrigel
Aspirator
User
Optical Tooling
Micropipette
Custom 
Micromanipulators
Incubator
MEA biochip preparation
t= ~20 mins
t= 1 min
t= 45 mins
t= 30s
t= 30s
t= ~1-5mins
t= > 16 hours
Seed cells
Incubate
 
Figure ‎4.5: An activity diagram depicting the activities carried out to complete process three. 
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User and system requirements identified: 
1. Sterilisation of the biochip takes 20 minutes. Treatment of the workspace surface with 
Matrigel takes a further 1 hour and 45 minutes.  
2. Attachment of the contracting cell cluster requires at least 16 hours. UoN users have 
described occasions where, due to the contracting nature of the sample, the beating cluster 
has moved away from the microelectrodes prior to attachments forming with the surface. 
On these occasions no signal is detected, so the time spent preparing the biochip to this 
point has been wasted. In addition to this, if the beating cluster of cardiomyocytes is to be 
re-used, more time is lost dissecting it out of the MEA for re-seeding onto a newly prepared 
MEA biochip. A biochip that ensures attachment over electrodes every time is required.   
Note: ~10% of cardiomyocyte clusters seeded onto an MEA biochip complete the testing process 
from initial seeding to full data capture (Personal Communication, Dr David Anderson). 
 
Process Four – Select and obtain drug 
Process four, select and obtain the drug of choice, is user dependant and is out of the scope of this 
project in terms of delivering improvements to the MEA system.  
 
Process Five – Set-up and run trial 
Process five (Figure ‎4.6), set-up and run trial, is when the MEA system is physically put to into use. 
Signals are detected and recorded into files that contain data for all of the 60 microelectrodes. The 
files are called multi channels data (.mcd) files. The response of the cardiomyocytes to chemical 
treatments added during recording is of primary interest to UoN users in this case study.  
User and system requirements identified: 
1. Every stage of each test is carried out manually by the user. Automation of the process or of 
parts of this process (i.e. automatic perfusion of the culture media and substances that are 
under investigation) would increase convenience to users and reduce the likelihood of 
human error. 
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P.5.A.1
Aspirate medium from 
the MEA with a plastic 
Pasteur pipette,  and 
discard in to pot 
containing trigene
P.5.A.2
Add 900 ul pre-
equiliberated Diff Med
Differentitation 
Medium
P.5.A.5
Set-up MC_Rack 
software
P.5.A.6
Take basal 
reading
P.5.A.7
Add 100ul of 10x stock 
drug at lowest 
concentration and start 
recording immediately by 
clicking [record] and then 
[play] 
Drug
P.5.A.8
After recording. Aspirate 
medium from the MEA 
with a plastic Pasteur 
pipette and discard in to 
pot containing trigene
Pasteur pipette
P.5.A.9
Wash with ~1ml Diff Med 
using a second pipette
P.5.A.3
Allow cells to 
stabilise 
P.5.A.10
Allow cells to 
stabilise
Pasteur pipette
P.5.A.4
Insert MEA into 
headstage
P.5.A.11
Add next 
concentration and 
record again
P.5.A.12
Dispose of cells 
and sterilise MEA 
for storage or re-
use
If all required 
data for culture 
obtained
User
User
t= 5 mins
t= 15 secs
User
User
MC_Rack
PC User
t= 3 mins
User
Pasteur pipette Pasteur pipette
User
User
t= 5 mins
User
User
t= 3 min
P.5.A.13b
Obtain next MEA 
biochip culture
t= 30s
t= 10s
t= 7 mins
t= 3 mins
t= 30s
t= 1 min
x4
P.5.A.13a
End Trial
- process
- document
- human resource
- physical resource
- event
- information
- finance
Recording durations are 
short
 
Figure ‎4.6: An activity diagram depicting the activities carried to complete process five. 
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Process Six – Collect initial output data 
Process six, collect initial output data (Figure ‎4.7), uses the MC-Rack re-player function to re-run 
recorded raw data files through a previously configured rack that has been specified to output 
specific parameters of interest.  
Parameters of interest 
 For this case study those parameters were:  
 Beat rate –  number of contractions per minute  
 Average peak-to-peak amplitude (per minute) – µV 
 Average minimum amplitude (per minute) – µV  
 Average duration between beats (per minute) – ms  
 Average QT-interval (per minute) – ms (see process seven) 
From the configured 
rack display windows 
extract readings. Taken 
at the end of each 1 
minute bin.
Trial is 
running
PC with MC-Rack 
running
User
Notebook
Information extracted: 
Beats per minute(bin),
Amplitude (mean),
Minimum Amplitude (mean),
Maximum Amplitude (mean),
Durations (mean).
t= 3 mins 
per trial
 
Figure ‎4.7: An activity diagram depicting process six, the initial data extraction using the replayer function in 
MC_Rack. 
 
Process six captures the parameters identified in bold type above. Average QT- interval is extracted 
by process seven.  
Process six takes a little over three minutes per file to perform. Six files are recorded per cell cluster, 
per test (1 basal, 5 during treatment with different concentrations of a substance). The data used is 
from the final two minutes of each three minute recording and is from a single channel. Values for 
each parameter for the signal occurring on the channel selected are documented by hand into a 
spreadsheet. The channel used is the “channel of interest” throughout the analysis (P.6 and P.7). 
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This process can be carried out during testing (online) but is most often done after the recordings 
have been made (offline) so as to reduce the likelihood of human error during the live experiments. 
User and system requirements identified: 
1. Automated extraction of basic parameters including beat per minute, amplitude values and 
durations of and between waveform features (i.e. duration between beats, duration of QT-
interval). 
 
Process Seven – Post-process raw data and produce visual representations of data 
Process seven, post process the raw data and produce representations, is documented in Figure ‎4.8. 
P.7.A.1
OpenMC_Rack, 
find .mcd file to be 
re-recorded and 
check content
P.7.A.2
Manually add 
trigger and re-run 
file to confirm 
trigger works
P.7.A.3
Re-record 
triggered data as a 
new .mcd file
MC_Rack
P.7.A.4
Open 
MC_Datatool, 
import newly 
recorded file and 
select option to 
convert to .abf
P.7.A.5
Depress the COI 
button on the GUI 
and leave all other 
default settings
P.7.A.6
Select location for 
saving file, file 
name and click 
save
MC_Datatool
P.7.A.7
Open ClampFit 
and import .abf file
P.7.A.8
Perform statistical 
manipulations
P.7.A.9
Extract valuable 
information
ClampFit
P.7.A.12
Copy and paste 
plots into 
powerpoint and 
overlay into one 
image.
P.7.A.10
Insert values into 
excel spreadsheet 
for multiple files
P.7.A.11
Perform 
comparisons 
between files
MS PowerPointExcel
t= 7min per file 
(typically 6 files) 
t= 2min per file 
(typically 6 files) 
t= 1min per file 
(typically 6 files) 
t= 40min t= 5min 
 
Figure ‎4.8: An activity model of process seven as it is currently performed. 
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In this application analysis of the raw signals recorded is conducted offline, assessing the influence of 
a substance or substances on a known feature of the cardiac waveform that is called the QT-interval. 
Process 7 takes a significant amount of time to perform 
The shape of signals varies between cell clusters (see Figure ‎2.33). Consequently user perception of 
where the Q feature starts and T feature ends is currently a variable.    
The parameter of interest extracted by this process is: 
 Average QT-interval duration (per minute) – ms (process seven) 
This is a critical parameter of drug development and safety pharmacology that is considered as part 
of new substance development prior to any clinic-based testing (section ‎2.11.1.1.2). 
The following further drill down models demonstrate how QT interval is extracted in further detail in 
way that is repeatable by different users of the same research group. 
 
Further drill down modelling 
Activity models have been used to document further details of each protocol. In this section the drill 
down models generated for this case study are presented and additional requirements identified are 
noted. 
Process Five 
Activities pursued to complete action P.5.A.4 are shown in Figure ‎4.9, insert MEA into headstage, 
into defined in the higher-level model of process five (Figure ‎4.6).  
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P.5.A.4.1
Ensure pre-
equiliberation.
P.5.A.4.2
Start computer
P.5.A.4.3
Switch on heated 
headstage and allow 
to reach desired 
temperature 
P.5.A.4.4
Open MEA_select.
MEA _Select
User
P.5.A.4.5
Click CHANGE 
MEA
P.5.A.4.6
Unclip housing 
and lift top 
plate
P.5.A.4.7
Insert MEA 
P.5.A.4.8
Replace top plate 
and fasten clips
P.5.A.4.9
Unclick 
CHANGE MEA
User
t= ~5 mins
t= 10 mins
User
Temperature 
Controller
t=~5 mins
T= 32°C
User
t= 1 sec
User
t= 1 sec
User
t= 5 secs
User
t= 1 sec
t= 5 secs
User
User
t= 1 sec
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P.5.A.4.10
Allow settling 
period
t= ~5-10 mins
 
Figure ‎4.9: The low-level activities carried out to complete activity four or process five. 
 
P.5.A.4.3 to P.5.A.4.10 (Figure ‎4.9) are repeated where >1 seeded MEA biochip is tested. P.5.A.4, 
insert MEA into headstage, takes approximately 10-15 minutes per biochip due to the need to allow 
a settling period. In this example an experiment may be repeated on five cell clusters. Therefore 
P.5.A.4 repeated five times adds ~50 minutes to the overall test duration. This research has been 
able to highlight that if five cell clusters were seeded into one MEA biochip and independent 
contractions maintained, then at least 40 minutes could be saved per experiment.  
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User and system requirements identified:  
1. Support system electronics that can facilitate more seeded beating clusters of 
cardiomyocytes per execution of a test automatically.  
 
The activities involved in P.5.A.5 are demonstrated in Figure ‎4.10, the initial software set-up at the 
start of the experiment. When a new analysis routine is constructed a new rack may be constructed 
that can be saved and re-used for subsequent relevant tests (section ‎2.9.1.4.1). Within this model 
P.5.A.5.3 has been modelled further as this aspect may be adjusted by users between individual 
MEA biochips in a complete testing cycle using several MEA biochips. 
 
P.5.A.5.2a
Open predefined 
rack. 
P.5.A.5.4
Create subfolders in 
accordance with 
established system
P.5.A.5.5
Set any 
parameters, 
subfolders or 
associated tabs
P.5.A.5.6
Click PLAY to check 
all working OK.
(Quality Control)
P.5.A.5.1
Open MC-Rack
P.5.A.5.3
Check and adjust 
rack tabs
P.5.A.5.7
Adjust individual 
channel thresholds by 
hand
t= 30s
User
PC with MC_Rack 
Installed
t= 30s
t=~1-3mins
t= 4s
t= 1s
t= 2 mins
t= 1 min
P.5.A.5.2b
Set up a new rack
I.e. the channel on which the 
usable signal is present will alter 
between MEA biochips 
depending on where over the 60 
microelectrodes the beating 
cluster attaches.
 
Figure ‎4.10: The low-level activities carried out in order to complete activity five of process five. 
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The following models incorporate further details of how the software is used in a visual manner. The 
software was described by users as complicated and lacking intuitive ease of use. For a novel 
software solution to be implemented a thorough knowledge of how current software is interacted 
with was sought by the author of this thesis. Figure ‎4.11 shows the steps taken to set-up the analysis 
rack used.   
P.5.A.5.3.11
Click on 
MC_Card icon
P.5.A.5.3.19
Click Raw Data to 
display tabs
P.5.A.5.3.1
On the Recorder 
Icon in the Rack 
windom. 
P.5.A.5.3.6
Click Recorder  
P.5.A.5.3.8
Specify file name 
for each new 
recording
P.5.A.5.3.7
Set file 
size to 3 min and 
tick auto Stop
P.5.A.5.3.4
Click Channels 
P.5.A.5.3.5
Tick Electrode Raw 
Data. Ensure all 
other options 
unchecked
P.5.A.5.3.9
Click Window
P.5.A.5.3.10
Highlight 
Continuous
P.5.A.5.3.12
Click Rack 
P.5.A.5.3.13
Check Status. No 
other action
P.5.A.5.3.15
Set Input voltage 
range to -819 
to +819mV
P.5.A.5.3.16
Set sampling 
Frequency to 
10000Hz
P.5.A.5.3.14
Click Hardware
P.5.A.5.3.20
Click Rack 
P.5.A.5.3.21
Check Status. No 
other action
P.5.A.5.3.22
Click Layout 
P.5.A.5.3.23
Open inverted 8x8 
file
P.5.A.5.3.24
Click Data 
P.5.A.5.3.26
Set plot type to 
trace
P.5.A.5.3.25
Tick Electrode Raw 
Data. Ensure all 
other options 
unchecked
P.5.A.5.3.27
Click Window
P.5.A.5.3.28
Highlight 
Continuous
P.5.A.5.3.17
Click Info
P.5.A.5.3.18
Confirm details 
are correct
P.5.A.5.3.2
Click on the Rack 
tab
User
PC with MC_Rack 
Installed
P.5.A.5.3.3
Check‎status‎“No‎
other‎action”
P.5.A.5.3.29
Add further 
analysis features 
to rack if required.
 
Figure ‎4.11: The low level activities carried out to complete A.5.3 of process five. (This process also the same 
for activity 2b of process five.) 
 
Settings are adjusted in the rack tabs prior to testing, via a series of repetitive click tasks. It is this 
element of software interaction that UoN users have described as complex and lacking intuition. This 
aspect of set-up is entirely user dependant so it must be carried out correctly if the recordings taken 
are to be useful. Figure ‎4.12 shows what the rack and its tabs in this instance look like. 
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Open the previously 
created .rck file
Check status of the 
rack
200 
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Adjust channels to be 
recorded
Define the file that is 
to be created 
201 
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Adjust window setting 
to continuous
Set hardware (the 
MC_Card) settings
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Confirm details
Set the layout map for 
the ensuing tools
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Set data
Set window to 
continuous
 
Figure ‎4.12: Setting up the recording rack for the UoN cardiomyocyte MEA system application. 
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User and system requirements identified: 
1. Software that has a greater level of automation. Should be more intuitive and less complex.   
 
Process Seven – QT-interval data collection 
The process used to extract the QT-interval are documented in greater detail in the figures 
Figure ‎4.13 to Figure ‎4.21. 
MC_Rack 
The MC_Rack replay function is used to re-record the original raw data files that have been recorded 
and used to extract other basic parameters into “triggered files”. A triggered file breaks the 
continuous stream of raw data into individual windows of data that each contain a single contraction 
waveform (SC-CM cluster field potential).  
The process required to add a trigger is:  
 A.1.1 – A.1.3: Add Replayer > Replay file tab > Select file > Slow replay rate to ~1.0x. 
 A.1.4 – A.1.5: Add display > Press play to run file in fast mode to confirm signal present and 
COI. 
 A.1.6: Return to replayer> adjust replay speed further if required. 
 A.1.7 – A.1.9: Double click on display over COI> Right click> Turn on “display crosshairs”> Use 
cross hairs to decide where threshold should be set and approximately how long each beat 
is in duration. Note values on a piece of paper. 
 
 A.2.1 – A.2.5: Add Trigger Detector > Select Trigger tab> Set channel to COI> Set Level to 
appropriate position for threshold (decided using cross hairs on replayer display)> Set dead 
time to point beyond end of last wave feature and before start of next wave > choose for 
trigger to be on the positive or negative slope of the spike. 
 A.2.6 – A.2.9: Add Display to trigger detector > Layout> Select COI in Channel drop down 
menu> Data > Check “Electrode Raw Data” and “Trigger 1” > Window> Start on Trigger> 
Drop down Trigger to “trigger 1”. 
 A.2.10 – A.2.11: Return to configuring replayer 
o Set start time to begin 181 seconds from end (last three minutes of recording. 
o Replay file. Ensure the Trigger detector display is showing each window overlaying 
and not the raw data stream. 
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 A.3.1 – A.3.6: Configure recorder: 
o Channels > Select channels to export 
o Recorder>Set file name and saving location 
o Window> Check “Start on Trigger” > Set start time to before wave begins>Select 
appropriate window extent by measuring using cross-hairs feature of 
MC_Rack>Leave Trigger 1. 
 A.3.7: To start rerecording the triggered file>On the main display press down the red 
“recording” spot button> Press play. 
 
If the settings are not correct during the re-recording of the data with the trigger the file will fail to 
convert in the MC_Datatool software. 
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P.7.A.1.1
Open MC_Rack
P.7.A.1.2
Click to add the 
replayer
P.7.A.1.3
On the File tab 
slow the replay 
speed to about 
x1.0
P.7.A.1.4
Add a display to 
the recorder
P.7.A.1.5
Press play and 
watch to confirm 
presence of signal 
and select most 
appropriate COI
P.7.A.1.6
Return to replayer 
and further adjust 
replay speed if 
required.
P.7.A.1.7
On the display 
window double 
click over the COI. 
P.7.A.1.8
Right click and 
select‎“display‎
crosshairs”.
P.7.A.1.9
Use cross hairs to 
find level that 
threshold should 
be set at and 
approximate 
duration of each 
the events. Note 
values on a piece 
of paper.
P.7.A.2.1
Click on the 
replayer and add a 
Detector.
P.7.A.2.2
Choose the 
“Trigger”‎tab‎and‎
select the COI.
P.7.A.2.3
Set‎“Level”‎at‎
value chosen 
using crosshairs 
and set deadtime
P.7.A.2.5
Set dead time to 
be in excess of 
any peaks that 
may re-trigger the 
same event. 
P.7.A.2.4
Select either the 
positive of 
negative slope of 
the spike
P.7.A.2.6
Add a display to 
the trigger 
detector
P.7.A.2.7
Select the 
“Layout”‎tab. On 
the‎“Channel”‎drop‎
down list select 
the COI.
P.7.A.2.8
Select‎the‎“Data”‎
tab. Ensure 
“electrode‎Raw‎
Data”‎and‎Trigger‎
1" are both 
selected.
P.7.A.2.9
Select‎“Window”‎
tab. Select‎“start‎
on‎Trigger”‎and‎
check drop down 
menu displays 
“Trigger‎1”.
P.7.A.2.10
Return to 
configuring 
replayer. Set 
replay time to last 
181 seconds of 
data.
P.7.A.2.11
Replay file 
watching trigger 
display. Ensure 
window shows 
overlaying of 
signals and not 
raw data stream.
P.7.A.3.1
Configure 
recorder. Select 
the‎“Channels”‎tab‎
and choose the 
channel(s) to re-
record in the 
triggered file.
P.7.A.3.2
Select the 
“Recorder”‎tab. 
Click browse and 
choose location to 
save new file. Add 
new file name.
P.7.A.3.3
Select the 
“Window”. Choose 
“Start‎on‎Trigger”.
P.7.A.3.4
Choose a start 
time before start of 
event. Choose 
Window extent to 
include duration of 
entire event.
P.7.A.3.5
Ensure‎“Trigger‎1”‎
is the Trigger 
selection.
P.7.A.3.6
Start recording by 
pressing the Red 
recording icon 
followed by the 
play icon.
P.7.A.1
P.7.A.2
P.7.A.3
MC_Rack
 
Figure ‎4.13: The low level activities of activities 1 to 3 of process seven. 
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MC_Datatool 
The MC_Datatool is a specialist software tool that specifically converts .mcd files into alternative 
formats that can be imported into other software. The MC_Datatool supports conversion to binary 
(.bin), text (.txt) and axon binary (.abf) file types. In this case users convert the raw .mcd files into 
.abf files, which is required to import MEA system data into the Clampfit software (Molecular 
Devices, Sunnyvale, CA, USA) used in the ensuing stages of the analysis (Figure ‎4.14). 
P.7.A.4.1
Open 
MC_Datatool. 
Click on file.
P.7.A.4.2
Select‎“Open‎
.MCD”
P.7.A.4.3
Find and select file 
for conversion.
P.7.A.4.4
Review‎“Data‎File‎
Information”‎to‎
ensure correct 
content for 
conversion.
P.7.A.4.5
Select the 
conversion to .abf 
icon on the 
toolbar.
P.7.A.5
Click on the button 
representing the 
COI in the centre 
of the display.
P.7.A.6.1
Click browse and 
select location to 
save converted 
triggered file.
P.7.A.6.2
Click‎“Save”
P.7.A.6.3
Check new file is 
created in desired 
location
P.7.A.6.4
Close 
MC_Datatool.
P.7.A.4
P.7.A.5
P.7.A.6
MC_Datatool
 
Figure ‎4.14: The low level activities of activities 4 to 6 of process seven. 
 
The process required to convert from .mcd to .abf is:  
 A.4.1 – A.4.3: Open MC_Datatool>File>Open MCD>Select file for conversion from .mcd 
(multi channels data) to .abf (axon binary file). 
 A.4.4: Check Data File Information. 
 A.4.5: Select the button on the main toolbar that looks like this . 
 
 A.5: Click on the button in the middle of the display that shows the channel of interest.  
 
 A.6.1 – A.6.3: Click Save. 
 A.6.4: Close the MC_datatool. 
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Clamp Fit 
Clampfit (pCLAMP v10) is a specialist electrophysiology data acquisition and analysis software that 
regards itself as the “gold standard” software for this electrophysiology application. This software 
has been developed recording and analysis of patch clamp data. In this application all of the 
waveforms in one triggered file (lasting 181 seconds) are averaged and the QT-interval is extracted 
by hand using drag-and-drop cross-hairs (Figure ‎4.15).  
P.7.A.7.1
Open ClampFit 
10.2. Click File.
P.7,A.7.2
Click‎“Open‎data”‎
and select file of 
interest.
P.7.A.7.3
View default 
display of all 
events overlayed
P.7.A.8.1
Click on the 
Analyse option on 
the main toolbar. 
Select‎“Average‎
Traces”.
P.7.A.8.2
Leave default 
settings on 
diaglogue box and 
click ok.
P.7.A.8.3
View averaged 
trace. Move 
cursors 1 and 2 to 
duration of interval 
of interest.
P.7.A.9
Read values and 
note by hand 
P.7.A.7
P.7.A.8
P.7.A.9
ClampFit
 
Figure ‎4.15: the low level activities of activities 7 to 9 or process seven. 
 
The process required to average the waveforms and capture the QT-interval is: 
 A.7.1: Open Clamp Fit 10.2 
 A.7.2: File>Open Data> Double click .abf of interest. 
 A.7.3: View all windows captured overlayed (Figure ‎4.16). 
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Figure ‎4.16: The ClampFit graphical user interface with the analyse tab selected.  
 
 A.8.1: Analyse> Average traces 
 A.8.2: Average Traces Button> click > Following Dialogue box appears>click OK 
(Figure ‎4.18).  
 A.8.3: View averaged trace> Move cursors at top of display to read off timing information and 
amplitude values (Figure ‎4.18). 
 
 A.9: Note values by hand for insertion.  
 
 
Figure ‎4.17: The average traces panel in the ClampFit software. 
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Figure ‎4.18: The averaged trace with click-to-drag cross-hairs that are accompanied by a panel displaying the 
time (ms) and amplitude (µV) of the selected data point. 
 
Additional analysis facility: The facility to extract statistical information regarding the file is also 
available. This is not fully exploited by users in this specific application but the outputs of this feature 
are considered useful by the bioscientist user. 
The process of accessing this statistical information is: 
 Click Analyse>Statistics…>Select preferences from panel demonstrated in Figure ‎4.19. 
 Click OK 
 To view results minimize the display to see the results spreadsheet (Figure ‎4.20). 
 Extract required data by hand and input into excel. 
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Figure ‎4.19: Statistical tools available in ClampFit. 
 
 
Figure ‎4.20: The resulting spreadsheet from the panel shown in figure 4.20.  
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Excel and Powerpoint 
The remaining stages are Microsoft Office based (Figure ‎4.21). Values are collated, correlated and 
presented as combined images to compare the cellular response to different concentrations, 
different substances and different combinations of substances.  
P.7.A.10.1
Open a new Excel 
spreedsheet
P.7.A.10.2
Construct table for 
hand derived FPD/
QT values
P.7.A.10.3
Add values 
collected over a 
period of 10 trials 
to document
P.7.A.11.1
Use excel 
functions to 
calculate % of 
basals and the 
mean average of 
these values.
P.7.A.11.2
Use excel 
functions to 
calculate the 
standard 
deviations
P.7.A.11.3
Use excel 
functions to 
calculate the 
Standard Error 
Mean
P.7.A.11.4
Use excel 
functions to 
calculate T-tests.
P.7.A.11.5
Using excel 
charting functions 
plot data of 
choice.
P.7.A.12.1
Copy and paste 
elements of the 
ClampFit traces 
into powerpoint
P.7.A.10.4
Add copy and 
pastes of average 
traces created in 
ClampFit.
P.7.A.12.2
Align signal traces 
according to axes
P.7.A.12.3
Save slide as an 
image
P.7.A.10
P.7.A.11
P.7.A.12
Microsoft Excel
Microsoft Powerpoint
 
Figure ‎4.21: The low level activities completed to carry out activities of process seven. 
 
Examples of the outputs from this stage can be seen in Appendix D. 
User and system requirements identified from process seven drill down models: 
1. Introduce automatic triggering or remove need for triggering. 
2. Automatic QT-interval identification. 
3. Facility to compare QT-interval values between different data files (data mining).  
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4.2.2.2 UoN Requirements summary 
Through carrying out this case study the following requirements have been identified as required by 
this specific application. The identified needs that are addressed by this research (compliment PDS 3) 
are marked in bold. Other needs identified are to be addressed by further work.  
1. To ensure as many beating clusters as possible make it from differentiation to the end of 
testing through facilitating appropriate handling and cell culture conditions. 
2. To increase the number of beating clusters per media well thereby improving the volume 
of output per test and to improve efficiencies of the MEA biochip preparation process. 
3. To ensure outputs are of comparable or better quality than current. 
4. To ensure tests can be conducted with comparable or better ease and speed. 
5. Removal of the need to sterilise and treat attachment surfaces would significantly reduce 
preparation time. (Comment: This could be addressed through further consideration of 
production using low cost, disposable materials supporting production of MEA biochips that 
can be sold in a pre-treated, sterile package and thrown away after use. The facility to print 
suitably biocompatible, conductive material onto transparent polystyrene substrates will 
facilitate this in the future. Application of dehydrated artificial extracellular matrix materials 
could also be considered in line with current experimental applications of comparable 
substances across this research domain if required.) 
6. A biochip that ensures attachment over electrodes every time is required.   
7. Every stage of each test is carried out manually by the user. Automation of as many 
processes or of parts of processes (i.e. perfusion of culture media and investigated 
substances during testing or automated software configuration) would increase convenience 
to users and reduce the likelihood of human error. 
8. Automated extraction of basic parameters including as beat per minute, amplitude values 
and durations of and between waveform features (i.e. duration between beats, duration of 
QT-interval). 
9. System which automatically facilitates more beating samples per test.  
10. Software that has a greater level of automation which is intuitive and less complex.   
11. Introduce automatic triggering or remove need for triggering. 
12. Automatic QT-interval identification. 
13. Facility to compare QT-interval values between different data files (data mining).  
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4.3 Case Study Two: Neural Cell Culture 
Application 
Neurologists have spent centuries investigating the workings of the human brain (Finger, 1994). 
Several different types of neural cells have been identified (Hao and Young, 2009) within complex 
structures throughout the brain (Halloway, 1967). Neurons communicate by the propagation of 
action potentials (APs) (see section ‎2.4.1). Neural APs propagate from cell to cell across synapses, 
which are physical gaps (20-40nm) between the axon terminal of one cell and the dendrites of 
another (see section ‎2.2). Minute volumes of chemical substances, collectively known as 
neurotransmitters, are released across a synapse resulting in a shift in ionic charge all the way along 
the membrane of the neuron. This change in ionic charge is the AP, which is recorded by MEA 
systems in the form of field potentials. Observing spikes and bursts of APs (see section ‎2.4.2) using 
MEA systems is contributing to furthering understanding of the brain. 
 
4.3.1 Case Study Context 
MEA systems are used by neuroscientists at the Sanger Institute to study synaptic function via the 
monitoring of spatial and temporal aspects of the electrical activity in neural tissue simultaneously 
(Chiappalone et al, 2008; Teemu et al, 2008).  
The networks studied in this case study are grown over the MEA biochip microelectrodes from 
somas (cell bodies, see section ‎2.2) of neurons that have been dissociated (chemically separated into 
single cells) from dissected samples of brain tissue. While in culture new axons and synapses grow 
out from the somas forming new neural networks. Neural cells dissociated from samples of brain 
tissue (typically murine sourced) have been used in research investigating network development 
(Chippalone et al, 2006), learning and plasticity (Broccard et al, 2009), memory (Marom and Shahaf, 
2002) and degenerative diseases, such as Alziemer’s disease or dementia (Gortz et al, 2004).  
Chippalone et al (2006) cultured networks from dissociated neurons over MEA biochip workspaces. 
Spontaneous activity was monitored during development. Results of correlations between 
recordings taken at regular intervals demonstrated the development of rich patterns of activity over 
the electrode array. These patterns changed as the network matured. 
Broccard et al (2009) used cultures of dissociated neurons to investigate learning and plasticity.   
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Marom and Shahaf (2002) investigated the formation of neural activity groups that was defined as 
learning and the conservation of those activity groups as memory using dissociated neurons grown 
over an MEA. 
Gortz et al (2004) investigated neuropharmacological effects of homocysteine (a substance 
connected to the occurrence of dementia and Alzheimer’s) on neuronal networks developed from 
dissociated neurons. 
 
4.3.2 Modelling of the Chronic Neural Cell Culture 
Application 
Specifically bred mice are used to source genetically specific brain tissue in the application presented 
in this case study. Spontaneous network activity is recorded that is no way induced by any form of 
chemical or electrical stimuli. All of the activity observed is associated with the natural development 
of the neural network in vitro. The MEA system allows the neuroscientist to visualise and quantify 
the growth and formation of these functional networks over time.  
Neurons are dissociated from a genetically mutated mouse brain and seeded over the electrode 
array. They are then and left in incubation for ~6 days before recording. Spiking activity (the 
presence of APs) can be observed in a newly developing neural network after about 3 days in vitro 
(DIV). The neuroscientists in this case study have observed the development of hundreds of these 
unique neural networks over several years to create a bank of data files. Comparison of hundreds of 
data files is carried out using statistical analysis written as R scripts. Particular parameters are 
calculated and correlated automatically by the scripts, for example, spiking frequency and the 
duration of bursts.  
 
4.3.2.1 Overview 
The EMs in this case study document the bioscientific protocols employed by the Genes to Cognition 
research laboratory at the Wellcome Trust’s Sanger Institute (WTSI) when studying dissociated 
neurons in culture. An overview of the application (Figure ‎4.22) was constructed to separate the 
workflow used into distinct processes that encompassed all of the scientific protocols used from the 
start of an MEA system-based experiment to its completion.  
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The overall workflow used to in the MEA system application of this case study is: 
 Process One (P.1.) – Breed genetically mutated mice 
 Process Two (P.2.) – Kill mice, dissect brain region of interest, dissociated desired cells 
 Process Three (P.3.) – Prepare MEAs 
 Process Four (P.4.) – Seed and culture cells 
 Process Five (P.5.) – Set-up and run trials 
 Process Six (P.6.) – Condition data and analyse 
 Process Seven (P.7.) – Derive meaning 
 Process Eight (P.8.) – Share findings 
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Figure ‎4.22: An activity diagram of the overall workflow carried out by the chronic neural cell culture users 
at the Sanger Institute. 
 
The processes of interest to this research were those where the MEA system or its components are 
interacted with. These processes are identified in modelling using shadows: P.3, P.4, P.5, and P.6. 
The shadowing indicates that further modelling has taken place in order to extract all details 
relevant to understanding the system in use, and to support user and system need identification.  
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User and system requirements identified from construction of Figure ‎4.22: 
1. To guarantee recordings are obtained from cells due to the high cost of the source.  
2. To improve surface properties of MEA biochip to reduce or eliminate the need for special 
cell type specific workspace surface treatments.  
3. To provide a system that allows longer or continuous recording. 
4. To provide a system that correlates new data with previously recorded data automatically 
and quickly. 
 
4.3.2.1.1 Chronic Culture (Neurons) Sanger Institute Users Processes 
 
Process Three – Prepare MEAs 
In carrying out process three in this instance, the MEA biochips are removed from storage and 
treated in a plasma cleaner. The workspace is treated for improved cellular attachment by applying a 
small amount of Poly-D-lysine using a suspended solution. After a two minute settling period the 
contents of the well are aspirated out and reverse osmosis water is used as a rinse. The Neurobasal 
medium is then added to the well and a small amount (4µl) of Laminin is dropped exactly over the 
workspace. A specially made zero-evaporation lid is placed over the well. All of the biochips 
prepared in that batch are then placed into a Petri dish and inside an incubator at 32°C with 5%CO2  
and left for >45minutes (Figure ‎4.23). 
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Figure ‎4.23: An activity model depicting process three, Prepare MEAs. 
 
User and system requirements identified: 
1. Remove the need to apply specific treatment the MEA surface. 
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Process Four – Seed and culture cells 
Process four involves dispensing 21µl of the previously prepared neural cell suspension over the 
MEA workspace (Figure ‎4.24). The user must set-up the required items in a culture hood, refresh the 
culture media and dispense the cells into the centre of the media well. A lid is placed over the MEA 
to prevent media evaporation and contamination. Labels are added and the biochip use is logged 
manually by-hand in a notebook. Cells are visualised under an inverted light microscope to check for 
adequate dispersion over the workspace area. Seeded MEA biochips are carefully moved into 
incubation where they are left for >3 days.   
A.4.2
Remove surface 
coated MEAs from 
incubator
A.4.1
Prepare sample of 
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A.4.4
Add fresh culture 
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A.4.10
Transfer to 
incubator and 
allow cell 
attachment.
User
User
User
User
User
User
A.4.8
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Figure ‎4.24: An activity model of process four, seed and culture cells. 
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User and system requirements: 
1.  To provide an automatic or electronic based method of recording MEA biochip use. Possibly 
creating facility the to insert into data file metadata for future reference. 
Process Five – Set-up and run trial 
Process five is the stage at which the full MEA system is employed to record the field potential data 
that is of value to the user application (Figure ‎4.25).  
Previously seeded 
neurons in culture 
spontanoeusly 
propagate action 
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MEA
A.5.8
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A.5.1
Remove from 
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perform cell count
A.5.3
Insert into 
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 of cells in given space
 on screen. New 
methods of automated
 counts being tested.
Cells of interest
A.5.5
Open MC_Rack
A.5.6
Adjust required 
parameters
A.5.7
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individual 
detection 
thresholds as 
required.
25kHz
t= 15 mins
A.5.9
At end of trail 
promptly return 
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User
User
User
User
User
User
User
User
User
t= 30s
Pre-heated to 
32ºC
t= 3 mins
t= 1 min
t= 5 mins
Repeat x3
t= 30s
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t= ~20mins
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- process
- document
- human resource
- physical resource
- event
- information
- finance
 
Figure ‎4.25: an activity model of process five, set-up and run trials. 
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To record the cellular signalling that is analysed in this application the user removes the MEA biochip 
from incubation, visually assesses the cells under a microscope to ensure health and attachment to 
the workspace area, and places it into a pre-heated MEA system headstage (see section ‎2.9.1). The 
configuration of system used in this instance is the MEA 60 two-fold system. Two instances of this 
configuration are used at the same time by the user observed for this work, Dr Paul Charlesworth, so 
up to four MEA biochips are recorded from simultaneously. 
When all four headstages are set-up the user opens two instances of a previously configured and 
saved recording rack in the MC_Rack software. The user checks all 60 channels of each MEA to see 
where spiking activity is occurring using the graphical user interface (GUI). For every channel where 
bursts or spikes (see Figure ‎2.39) are present the threshold bar for that channel is adjusted by-hand 
to ensure the spike amplitude(s) exceeds the threshold required for detection. A recording of 15 
minutes is taken. The MEA biochips are then returned to the incubator where they will remain in 
culture until the next testing day.   
User and system requirements: 
1. A system where the MEA biochips do not need to be removed from the incubator. 
2. A system that can record continuously. 
 
Process Six - Condition data and analyse 
This process (Figure ‎4.26) involves the conversion of the data files generated, multi channels data 
(.mcd), into multi channels time (.mct) files using NeuroExplorer software (Nex Technologies, 
Massachusetts, USA).  The .mct file then contains only timing information pertaining to the spikes 
recorded in the original .mcd file. Noise and periods of inactivity are discarded, thereby reducing the 
file size. These .mct files are linked to the statistical scripting software, “R”, by inserting the file name 
into a condition table that exists in Microsoft Excel. Once the condition tables are complete a full 
automatic analysis is run using a custom written “R script”. The outputs generated by these scripts 
are compiled directly into a report format that contains the data tables and plots of correlations 
generated by the R script. These reports are created as portable document format (.pdf) files. The 
content of the reports is then manually manipulated for presentation by entering useful sections 
into the data analysis and graphing software OriginPro (OriginLab Corporation, Massachusetts, USA).   
 
 
223 
 
__________________________________________________________________________________
Case Studies and Requirement Identification 
User and system requirements:  
1. Remove the need to convert file types by facilitating The facility to produce statistical 
outputs through the recording software  
2. Statistical outputs in real-time. 
3. The facility to automatically produce plots. 
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Figure ‎4.26: An actvity model of process 6, condition data and analyse. 
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4.3.2.1.2 MEA biochip cleaning protocol 
Applications presented in case study two (chronic neural network culture) and in case study three 
(acute brain slice) clean the biochips following use in the same manner. The process used to clean 
MEA biochips after use, in preparation for storage before re-use, is shown in Figure ‎4.27. 
A.
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contents.
A.
Place MEA into 
Plasma Cleaner. 
Turn on.
A.
Remove from 
cleaner and re-fill 
with distilled 
water.
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A.
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A. 
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- information
- finance
t= 5s 
t= 5s 
t= 5s 
t= 10s 
t= 5s 
t= 10s 
t= 5s 
t= 15s 
 
Figure ‎4.27: The cleaning protocol employed by the Sanger Institute applications presented in case study 
two and three. 
 
User and system requirements identified:  
1. Remove need to clean MEA biochips or make process automated. 
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4.3.2.2 Chronic Culture (Neurons) Requirements summary 
Through carrying out this case study the following requirements have been identified that are 
specific to this application.  
1. To guarantee recordings are obtained from cells due to the high cost of the source.  
2. To improve surface properties of MEA biochip to reduce or eliminate the need for special 
cell type specific workspace surface treatments.  
3. To provide a system that allows longer or continuous recording. 
4. To provide a system that correlates new data with previously recorded data automatically 
and quickly. 
5. Remove the need to apply specific treatment to the MEA surface. 
6. To provide an automatic or electronic based method of recording MEA biochip use. Possibly 
creating facility to insert into data file metadata for future reference. 
7. A system where the MEA biochips do not need to be removed from the incubator. 
8. A system that can record continuously. 
9. Remove the need to convert file types by facilitating The facility to produce statistical 
outputs through the recording software  
10. Statistical outputs in real-time. 
11. The facility to automatically produce plots. 
12. Remove need to clean MEA biochips or make process automated. 
 
The requirements that have been identified through this case study are to be addressed by further 
work. 
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4.4 Case Study Three: Brain Slice Application 
 
This application differs from the applications presented in case studies 1 and 2 in the following ways: 
 it investigates responses of brain slices to electrical stimuli delivered via a microelectrode.  
 cell sources are not cultured inside an incubator. Slices are used for recording on the same 
day that they are dissected; they are then disposed of at the end of testing. 
 the MEA biochip used with the MEA-60 system the 3D 8x8 grid array, whereas for case study 
1 and 2 the planar 8 x 8 array is used. 
The Multi Channels MEA-system requires a specialist system called a Stimulus_II that injects 
electrical stimuli into slices though user designated microelectrodes.  
For this application the positioning of the brain slice over the electrode array is imperative as 
stimulus pulses must be delivered to precise anatomical locations in the brain slice. Controlled 
positioning of stimulus delivery is required to evoke the particular network pathway under 
investigation.  
 
4.4.1 Case Study Context 
The application observed for this case study electrically stimulates known signal pathways that are 
present in the hippocampus. The response of neurons at particular locations is recorded and 
analysed. Slices tested are genetically different. The user in this application is investigating the ability 
of the slices to learn responses to the same stimulation protocol, and then is correlating differences 
that are observed between the different genetic combinations assessed. 
4.4.2 Modelling of the Acute Brain Slice Application  
Modelling the processes employed in this application has resulted in the identification of application 
specific user requirements. 
4.4.2.1 Overview 
An overview of the workflow used in this application is documented in Figure ‎4.28.  
The overall workflow used to in the MEA system application of this case study is: 
 Process One (P.1.) – Breed genetically mutated mice 
 Process Two (P.2.) – Kill mice, dissect out brain region of interest, prepare slices 
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 Process Three (P.3.) – Prepare MEAs 
 Process Four (P.4.) – Position slices, set-up software and run trails 
 Process Five (P.5.) – Convert data and analyse 
 Process Six (P.6.) – Derive meaning 
 Process Seven (P.7.) – Share findings 
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Figure ‎4.28: An activity model of the overall workflow implemented by the acute brain slice Sanger Institute 
users. 
 
228 
 
__________________________________________________________________________________
Case Studies and Requirement Identification 
Genetically appropriate mice are bred and the brain region of interest, in this case the hippocampus, 
is dissected out. The hippocampus is cut into slices of a thickness ~300-350µm and stored in a 
special brain slice chamber (Warner Instruments, Connecticut, USA). Slices are placed into MEA 
biochips and stimulated. Recordings are taken of the stimuli delivery and the consequential 
responses that are analysed offline to examine the plasticity exhibited by that particular genetic 
combination. 
 
User and system requirements identified: 
1. Biochips that make hippocampal slice positioning easier and quicker. 
2. Automated data analysis. 
 
4.4.2.1.1 Acute Brain Slice Sanger Institute Users Processes 
 
Process Three – Prepare MEAs 
The activities carried out to complete process three are shown in Figure ‎4.29.  
P.3.A.1
Aspirate out 
contents.
P.3.A.2
Place MEA into 
Plasma Cleaner. 
Turn on.
P.3.A.3
Remove from 
cleaner ready for 
use.
User
t= ~60-100 s
Aspirating pipette
User
User
Plasma Cleaner
 
Figure ‎4.29: An activity diagram of MEA biochip preparation for brain slice application. 
 
While in storage the MEA biochip media well is filled with distilled water. This water is removed prior 
to placing the MEA biochip into the plasma cleaner. After ~60-100s inside the plasma cleaner the 
biochip is ready for use in this particular application.  
 Users are very satisfied with this process and did not highlight any problems or suggest any 
improvement. 
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Process Four – Position slices, set-up software and run trial  
Process four describes the steps executed from inserting the slice into the media well to recording 
the useful data (Figure ‎4.30).  
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User
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User
User
Generates 
.mcd files
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Figure ‎4.30: An activity model depicting activities carried out in order to complete process four.  
 
MEA biochips are inserted into the headstage and filled with artificial cerebrospinal fluid (ACSF) prior 
to addition of the hippocampus slice. Slices are carefully positioned by eye through a light 
microscope and gently clamped in position using a home-made mesh. The intended recording 
electrodes are observed according to the anatomy of the slice and assigned in the software. Base 
line readings are taken of the response of the slice to a 2V pulse. The full stimulation protocol 
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(Table ‎4.1) is executed generating .mcd files containing the useful data, and when complete the 
slices are disposed of.  
Table ‎4.1: The stimulation protocol delivered by this application user: 
Stimulation Type Frequency of delivery Voltage 
Biphasic stimulations 
(positive/negative, 
100µs/a phase) 
2 trains of 100 pulses at 100Hz 
 
– 2V up to a maximum of 4.2V 
 
 
The system configuration used in this application involves 8 MEA system headstages in two four-fold 
configurations. Two stimulus generators are used. The operator sets-up up all of the MEA biochips 
and the software, and the stimulation protocols are the delivered together using two separate 
computers. 
User and system requirements identified: 
1. MEA biochips that offer better slice positioning.  
2. One system that can facilitate ≥8 MEA biochips at one time. 
3. A stimulus generator that can deliver protocols to >4 MEA biochips at one time. 
 
Process Five –Convert data and analyse 
Process Five also explains analysis at the very highest level (Figure ‎4.31).  
A.5.1
Convert to .txt
files
A.5.3
OriginPro for 
manipulation and 
visualistion
A.5.2
Separate data in 
excel sreadsheet
MEA_Datatool
Excel
OriginPro
User
User
Usert= 3 min 
per file
t= ~1-2hrs
t= ~4-5hrs
 
Figure ‎4.31: An activity model of process five. 
 
One .mcd data file is generated per stimulus generator. Therefore two files are recorded per system 
per stimulus protocol repetition. So in this application 8 .mcd files (2 baseline, 6 stimulated) contain 
231 
 
__________________________________________________________________________________
Case Studies and Requirement Identification 
the data used to investigate the response of the hippocampus under investigation. Each file is 
converted into a text (.txt) file using the MEA_Datatool software. The text file is imported into 
Microsoft Excel and relevant data extracted by-hand and inserted into OriginPro for further 
manipulation and presentation. 
User and system requirements identified: 
1. Analysis features in the recording software. 
2. Analysis in real-time. 
 
Further drill down modelling 
Additional activity models have been generated for this case study to incorporate relevant 
information that provided better understanding. Additional needs collated by addressing/including 
deeper details are noted. 
Process Four 
The protocol undergone for checking the set-up and configuring the recording software is 
documented in Figure ‎4.32.  
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through 
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Refreshing 
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A.4.7.3.
Select electrode(s) 
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MC_Rack
MEA-Select
MC_Stimulus II
Light Microscope
Temperature Controller
Perfusion System
Headstage
Additional reference electrode
User
User
User
User
User
User
User
t= 10s
- process
- document
- human resource
- physical resource
- event
- information
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t= 10s
t= 10s
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t= 16mins
t= 10s
t= 8mins
 
Figure ‎4.32: A model of the activities carried out in order to complete process four, activity seven, check set-
up and configure recording software. 
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User and system requirements identified: 
1. Predefined stimulating electrodes facilitated by anatomically precise microelectrode 
positioning. 
2. Automated slice position checking. 
3. Integrated perfusion system.  
The protocol undergone for obtaining at baseline recording from each slice is documented in 
Figure ‎4.33.  
A.4.8.1
Ensure correct 
electrode(s) for 
stimulation 
selected on both 
computer 
systems.
A.4.8.2
Apply initial 
voltage through 
computer one
A.4.8.4
Recorded 
response
MEA-Select
A.4.8.3
Straight after 
apply same initial 
voltage through 
computer two
MC_Stimulus II
User
A.4.8.5
Review responses 
are as expected 
prior to starting 
trial. Adjust any 
settings.
User
User
User
User
MC_Rack
t= 8mins
- process
- document
- human resource
- physical resource
- event
- information
- finance
t= 1min
t= 1min
t= ~30mins
t= ~15min
 
Figure ‎4.33: A model of the activities carried out in order to complete process four, activity eight, obtain 
baseline for each slice. 
 
User and system requirements identified: 
1. Automatic baseline recording feature. 
The protocol undergone for delivering the stimulations is documented in Figure ‎4.34.  
The stimulation protocol delivered using the MC_Stimulus II software for this process is documented 
in the aforementioned Table ‎4.1. 
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A.4.9.1.1
Apply voltage 
steps to computer 
one.
A.4.9.1.2
Record responses
Amplitude, duration 
and frequency of 
stimulus controlled 
by MC_Stimulus II 
software
MC_Stimulus II
A.4.9.2.1
Apply voltage 
steps to computer 
two.
A.4.9.2.2
Record responses
MC_Stimulus II
 
Figure ‎4.34: A model of the activities carried out in order to complete process four, activity nine, run 
stimulation tests. 
 
User and system requirements identified: 
1.  System that can apply defined stimulation protocol to all >4 MEA biochips. 
2.   System with lists of stimulation protocols that the user can select without needing to adjust.  
 
4.4.2.2 Acute Brain Slice Requirements Summary 
Through carrying out this case study the following requirements have been identified that are 
specific to this application.  
1. Biochips that make hippocampal slice positioning easier and quicker. 
2. Automated data analysis. 
3. MEA biochips that offer better slice positioning.  
4. One system that can facilitate ≥8 MEA biochips at one time. 
5. A stimulus generator that can deliver protocols to >4 MEA biochips at one time. 
6. Analysis features in the recording software. 
7. Analysis in real-time. 
8. Predefined stimulating electrodes facilitated by anatomically precise microelectrode 
positioning. 
9. Automated slice position checking. 
10. Integrated perfusion system.  
11. Automatic baseline recording feature. 
12. System that can apply defined stimulation protocol to all >4 MEA biochips. 
13. System with lists of stimulation protocols that the user can select without needing to adjust.  
The requirements that have been identified through this case study are to be addressed by further 
work. 
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4.5 Summary 
 
Accounts of the sequences of activities that are required by three different MEA system applications 
were documented to support identification of user and system requirements for this research. 
The applications observed and presented in this chapter as case studies were:  
1. Stem-cell derived Cardiomyocyte Application 
2. Neural Cell Culture Application 
3. Brain slice Application 
The case studies were developed thoroughly and methodically using research approaches 
documented in Chapter 3.  
All MEA systems require the user to source cells. The MEA biochip must be made sterile and, 
depending upon the application, treated before the living cells can be added. The durations that 
cellular samples spend on an MEA biochip’s surface before testing can be from ~15 minutes to 
several months depending upon the preparation. The user will insert the MEA biochip into the full 
MEA system when appropriate for recordings of the electrical activity in the cells above to be made. 
These recordings are then analysed offline in all of the case applications. Following experimentation 
and recording the cells are discarded and the MEA biochips are cleaned in preparation for future re-
use. 
A summary of all of the requirements derived from these case studies is contained in Figure ‎4.35. 
The case studies differ from one another significantly. This research has chosen to address the 
requirements derived through case study one. Consideration and prioritisation of those needs is 
presented in Chapter 5. 
The requirements identified through case studies two and three are suggested as further work 
following achievements of the design targets defined in Chapter 5. 
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Case 1:
Stem-cell derived 
cardiomyocytes for 
cardio-active substance 
screening
Case 2:
Dissociated neural cell 
cultures for observation 
and assessment of 
network development 
and synaptic plasticity
Case 3: 
Hippocampal slices for 
known pathway 
plasticity following 
stimulation 
experiments.
Obs. 1.1  Facilitate appropriate handling for cell culture.
Obs. 1.2  Increase the number of contracting cell clusters per media well/per biochip. 
Obs. 1.3  Ensure output  at comparable or better quality than current.
Obs. 1.4  Ensure testing can be comparable, faster and simpler. 
Obs. 1.5  Remove need to sterilise and treat biochip before use.
Obs. 1.6  Provide a way to guarantee attachment of cell cluster over electrodes every 
time.  
Obs. 1.7  Automation of as many processes (or of parts of processes as possible).
Obs. 1.8  Automated extraction of basic parameters.  
Obs. 1.9  Automation of software to be more intuitive and less complex.  
-  Automatic triggering or remove need for triggering.
-  Automatic QT-interval identification and QT-interval value 
   comparisons between different data files (data mining). 
Obs. 2.1  Provide a way to guarantee recordings are obtained.
Obs. 2.2  Reduce or eliminate the need for cell type specific workspace surface 
treatments. 
Obs. 2.3  Facilitate longer or continuous recording.
Obs. 2.4  Correlates new data with previously recorded data automatically and quickly.
Obs. 2.5  Electronic based method of recording MEA biochip use. 
Obs. 2.6  An incubator compatible MEA system.
Obs. 2.7  Remove the need to convert file types.
Obs. 2.8  Statistical outputs in real-time.
Obs. 2.9  Automatic production of plots.
Obs. 2.10  Removal of need to clean MEA biochips or introduction of an automated 
cleaning process.
Obs. 3.1  Biochips for fast and easy hippocampal slice positioning.
Obs. 3.2  Automated data analysis.
Obs. 3.4  One system that can facilitate ≥8 MEA biochips at one time.
Obs. 3.5  A stimulus generator that can deliver protocols to >4 MEA biochips at one 
time.
Obs. 3.6  Analysis features in the recording software delivered in real-time.
Obs. 3.7  Predefined stimulating electrodes facilitated by anatomically precise 
microelectrode positioning.
Obs. 3.8  Automated slice position checking.
Obs. 3.10  Integrated perfusion system. 
Obs. 3.11  Automatic baseline recording feature.
Obs. 3.13  System with lists of stimulation protocols ready for use. 
 
Figure ‎4.35: Case study observed requirements 
[Format adapted from: Gerring, 2007.] 
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4.6 Research Questions Answered 
 
The following statements address the research questions originally defined at the start of 
this chapter. 
 
1. How are MEA systems currently employed by users that are working with different cell 
types and cell sources? 
The overall process stages are the same irrelevant of the application. This research has focused on 
the following common stages: 
1. Preparing the MEA biochip to the point of use,  
2. Insertion of the MEA biochip in the MEA system for recording of electrogenic activity of 
the cells within the MEA biochip, 
3. Extraction of meaning from those data.  
The details of the activities undertaken at each stage differ between applications resulting in 
significant differences between the case study model sets generated. 
 
 
2. What are the major differences between application domains and application types within 
those domains? 
Each application domain differs significantly due to the differing nature of the cells that are used, 
and the form in which those cells are used. For example, case study one and two differ most 
significantly due to case study one’s exploration of the cardiomyocyte cell type and case study two’s 
exploration of the neuron. Different cell types result in different requirements. Case studies two and 
three both seek to understand neural functions but use different formats of cells sources (individual 
cells grown in culture versus slices) which also have different requirements. 
The major differences identified through case study construction are: 
 The MEA biochip can be altered to suit the form in which the cells are to be observed. For 
example the planar style microelectrode grid array is well suited to cultured neurons, but for 
slices a 3D electrode profile is more suitable so as to enable closer detection of the field 
potentials generated from the live cells away from the sliced surface. For the cardiomyocyte 
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application this work has defined a requirement to alter the MEA biochip to better suit the 
beating clusters produced from the stem cells. 
 The signals that are recorded across each of the case study applications differ significantly. 
This is attributed back to the different cell types and the format in which those cells are 
presented to the microelectrodes. Consequently the signal features that are of interest in 
each case study differ. 
 The system settings (e.g. amplifier gain, sampling frequency) differ for each application. The 
cultured neurons sample at 25kHz, the brain slice application at 10kHz and the 
cardiomyocyte application at 2kHz. 
 
3. What system or component changes have been identified as required?  
This question is addressed by the summary section (section ‎4.5) and Figure ‎4.35. 
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This Thesis
Chapter 5
Design and 
Manufacturing at 
Loughborough 
University
Specifications
Concept Designs
Manufacturing Approaches 
Prototype One
Design Iteration
Prototype Two – A & B  
Chapter Five 
5 Requirements, Concept Design, and 
Manufacturing Approach  
 
 
 
 
 
In the preceding chapters research has: 
 Described current MEA system technology and its application (Chapters 2 and 4) ,  
 Demonstrated the research methods selected and implemented to identify and define 
contemporary user requirements and the needs of next generation systems (Chapters 2, 3 
and 4),  
 Presented three real end user case studies conducted to support the understanding of 
practical realities associated with MEA system application in differing settings. Case studies 
also demonstrated the diversity of applications and identified application specific user 
requirements that have been targeted by this work (Chapter 4). 
 Derived and described three product design specifications created by this research to drive 
the definition of objectives (Chapter 3). The product design specification that is specifically 
addressed by the remainder of this thesis is PDS 3.  
The work in this chapter has been carried out to address the following research questions: 
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1. What current and future user and system requirements have been derived from literature 
reviews, commercial system assessment and case studies that can be realistically addressed 
by this research? How does this research prioritise requirements? 
 
2. How can this research project meet the defined and targeted requirements? 
 
3. What manufacturing solutions are suitable for production of the proposed solution concept?  
 
4. What are the critical manufacturing outcomes with regard to the proposed solution? What is 
the benchmark or gold standard to which the novel biochip will be compared?  
 
Contemporary MEA biochip design modifications are (see section ‎2.9.2.2 and Figure ‎2.65): 
i) Reductions in microelectrode tip geometries; to facilitate more electrodes, with denser 
distributions, to assist closer coupling to cells and more detailed data collection. 
 
ii) Provision of specifically patterned surfaces using growth proteins or materials with 
hydrophobic characteristics, or growth pathways through polymers or hydrogels; used 
for the controlled and/or structured proliferation of cells in-vitro. 
 
iii) Provision of microelectrode layouts specifically suited to certain physiological 
geometries or experimental requirements; to improve ease of set-up and experiment 
result consistency and repeatability. 
 
These modifications have not occurred sequentially but concurrently through academic necessity 
(MEA Meeting 2010, Reutlingen, Germany). Each development has been made possible due to 
technical advances in microelectronics and microelectromechanical systems (MEMS) manufacturing 
(Khoshnoud and de Silva, 2012). This research has investigated how existing electronics fabrication 
techniques could be exploited to produce new generations of MEA biochip that are better suited 
specifically to the cardiomyocyte application documented in case study one.  
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5.1 Design Rationale 
 
The initial aims of this research presented a vision for a new MEA system that is compatible with 
continuous operation within a humidified incubator with integrated optics for neural applications 
(Appendix A). The areas that guided realistic prioritisation of early research objectives are 
(Figure  5.1): (1) existing systems, (2) MEA system application, (3) manufacturing possibilities, and (4) 
the pursuit of novelty, were of most significance to the production of successful prototype devices.   
MEA Systems are
This research has 
ascertained 
knowledge of...
Manufacturing 
Approach and 
Expertise 
Assessment 
Manufacture of larger 
electrode geometries.
Reduced number of 
electrodes per media well.
Scalability (future).
Feasibility of delivering a 
solution based on user 
requirements (within time 
frame of this research)
(Influence of other research 
revolving around system 
electronics (hardware) and 
software.)
MEA biochip with microwell features
Designed to specification written by 
users.
Complex
Used for many 
different applications
Electrophysiology and electrogenic cell types,
MEA systems and their components,
Bioscientific domains in with MEA systems are applied,
Historical development and suggested future of MEA systems,
Signal types,
Signal recording and analysis,
Needs of real-life applications.
1. Existing
2. Application
3. Manufacture
4. Novelty
Current MEA biochips are 
not suited to cardiomyocyte 
applications 
- throughput is low
- analysis is slow
Realistic
 
Figure  5.1: Design Rationale. 
 
PDS documents were generated to target the overall research objective to create a novel MEA 
system. These documents considered research targets from differing levels (section ‎3.3.1): general 
(e.g. needs of all MEA systems), partial (e.g. needs identified from all case study users) and specific 
(e.g. needs specific to cardiomyocyte beating cluster applications). The design targets focused upon 
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in this thesis were specific in nature to address the needs of the stem cell-derived cardiomyocyte 
(SC-CM) application domain.   
Prior to action on any design targets an assessment of manufacturing facilities and the expertise 
available was carried out (see section ‎5.4.1.1). Manufacturing facilities immediately available for 
prototyping were limited to producing circuitry resolutions >~100µm. Smaller feature sizes were not 
possible during early stages of concept prototyping. 
Chapters 5 and 6 of this thesis describe research conducted to develop a novel MEA biochip that is 
optimised specifically for stem-cell derived cardiomyocyte applications.  
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5.2 MEA Biochip Specification 
 
The research targets addressed in the following concepts are based on a specification document 
derived from University of Nottingham (UoN) MEA system users defining application specific 
requirements (Appendix C).  
The following specification points were set as design deliverables for this research incorporating user 
requirements from UoN with generic and partial PDS points identified as of high in importance to 
system success (see PDS 1 & PDS 2).  
Biochip: 
 Modify the media well while maintaining commercial interface configuration. 
Comments: that will interface with the current MCS MEA60 System in their lab. 
 Alter the media well dimensions to be close to those of a 35mm culture dish. 
Comments: internal dimensions 35mm diameter, 10mm height, culture area 8.8cm2, media 
volume 3ml. 
 Incorporate a light-transmissible lid. 
Comments: to prevent evaporation. 
 Interior of well must allow for potential etching or patterning. 
 Re-usable. 
Comments: therefore must withstand sterilisation using UV light and 70% ethanol.  
 16 micro-wells. 
Comments: in any pattern. 
 Microwells as far apart as possible.  
Comments: at least 5mm in from the edge of the dish.  
 Microwells 500µm diameter,  
o with a maximal depth of 250µm,  
o and a slightly curved shape. 
Comments: beating clusters at time of seeding vary in size and shape (Figure  5.1) between 
200-500µm in diameter. 
 Electrode in centre of well flush to the surface. 
Comments: To support early attachment of the beating cluster to the surface. 
 Microwells with as large a surface area as possible. 
Comments: To support early attachment of the beating cluster to the surface. 
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 Made from biocompatible material(s). 
Comments: Essential for cell culture. 
System: 
 Sample rates in the range of 2-25kHz. 
Comments: Current commercial systems 2-50kHz though few applications utilise 
>25kHz. 
 Electrically grounded. 
Comments: Essential for provision of reference channels and electrical safety. 
 Parts that can be sterilised  
Comments: If the entire system is to go in an incubator the electronics must be sealed in 
suitable casing for sterilisation as incubators are sterile environments. 
 Input capabilities limited appropriately. 
Comments: to protect/prevent damage to cells or tissue. 
 Appropriate pre-processing and amplification. 
Comments: Noise reduction or removal. Commercial gains: Slice ~x550, Culture ~x1100. 
 Facilitate/support a constant cell environment. 
Comments: I.e. temperature, humidity, etc 
 Allow easy access 
Comments: for users to perform culture maintenance and run perfusions systems. 
 Support visual inspection of the cells. 
 Simple to learn. 
 User-friendly interfaces. 
 
UoN users specified requirements for a biochip design that would complement their cellular 
preparation, stem cell-derived beating cardiomyocyte clusters (Figure  5.2), more appropriately than 
the most suitable commercial biochip currently used; which is a standard planar 60 electrode 8x8 
array (Figure ‎2.45). 
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Figure  5.2: Stem cell-derived cardiomyocyte cells. A) A single cardiomyocyte in culture. B) A monolayer of 
cultured cardiomyocytes. C) An example of freshly dissected ‘beating cluster’, consisting of fibroblast cells 
and cardiomyocytes. D) An example of the attachment that forms between a beating cluster and the 
substrate. Fibroblast cells are the predominant cell type present in a cluster and are responsible for the 
attachment of the cluster to the base substrate. E & F) Examples of beating clusters seeded over MEA 
biochip microelectrodes. (Scale: electrode tips are 30µm in diameter.) 
 
5.2.1 New Product Development and Quality Assurance 
To consider how the aforementioned requirements influence one another and affect design and 
manufacturing decisions a Quality Function Deployment (QFD) methodology was employed.  
QFD is a part of internationally standardised quality management system (QMS) guidance (ISO 
9000:2005; ISO 9001:2008). QMS guidance was produced to specifically support the achievement of 
customer satisfaction through the appropriate execution of planning, design and manufacture 
(Justham and West, 2008) making this guidance relevant to this research.  
QFD methods are applied during investigation and definition of user requirements, and also while 
translating those requirements (“user desires”) are translated into technical requirements. QFD has 
been successfully demonstrated in diverse application domains, such as hospitality and finance, as 
well as in engineering (Shahin and Chan, 2006; Justham and West, 2008), and as such was deemed 
suitable for the needs of this work.  
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5.2.1.1 The House of Quality Interrelationships Matrix 
An enterprise can improve its productivity, control costs and remain competitive through application 
of QFD (Madu, 2006). The primary planning tool available in QFD is the house of quality (HoQ) matrix 
(Besterfield et al, 2011). A HoQ matrix is completed to logically examine a number of factors that 
influence a product’s quality in terms of meeting customer or user expectations. User requirements, 
technical requirements, requirement interrelationships, planning for competitiveness and design 
and manufacture targets, are all incorporated into one structure (Figure  5.3).  
Within the matrix user requirements are identified and prioritised (see section ‎5.2.1.1.1). Existing 
products are compared and evaluated, identifying potential areas of greatest pay-off (see 
section ‎5.2.1.1.2). Technical characteristics required in order to respond to the user requirements 
are identified (see section ‎5.2.1.1.3), and relationships between the customer requirements and 
technical characteristics are considered (see section ‎5.2.1.1.4 and ‎5.2.1.1.5). Product development 
targets are defined using scores generated by all of these aspects together (Barkley and Saylor, 
2001).   
 
Figure  5.3: The QFD House of Quality Matrix. 
 
The complete HoQ used in this research can be viewed in Appendix E. The spread sheet template 
was sourced from QFD (Quality Function Deployment) Online (2010). 
246 
 
__________________________________________________________________________________
Requirements, Concept Design, and Manufacturing Approach 
5.2.1.1.1 User Requirements 
The requirements from PDS 3 were listed and given an importance weighting by a system user 
(Figure  5.4). This panel of the matrix represents the “voice of the customer” (Zhang and Wang, 
2011). Weightings were given assigning a number between zero and five to each requirement; five 
indicated most important/essential and zero indicated not important.  
 
Figure  5.4: HoQ User requirements 
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Requirements were also listed in groups, biochip-centred and system-centred (Figure  5.5), for clarity.  
 
Figure  5.5: HoQ Biochip- and system-centred user requirements. 
 
5.2.1.1.2 Product Planning 
The product planning panel (Figure  5.6) correlates the listed user requirements with user perception 
of how existing products perform in terms of those requirements.  
This panel of the matrix serves to demonstrate current user satisfaction and to highlight areas where 
improvements may provide the greatest pay-back when compared to existing products. Sales points 
have been used to add to weight requirements that could be heavily exploitable in marketing the 
product according to current user trends (Chapter 2).  
Combined scores relating to each user requirement have been calculated by multiplying 
previously defined user importance weighting by the improvement (0 = poor, 5= best) and 
sales point scores (0 = neutral, 1 = current sales point). 
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Figure  5.6: HoQ Product Planning and Competitive Analysis 
 
This panel identified that an MEA biochip that meets the biochip-centred user requirements 
defined at the start of this chapter will better meet the needs of users of SC-CMs and this 
will offer good competitive advantage. The system-focused requirements that were 
assessed did not offer as clear an advantage. 
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5.2.1.1.3 Technical Requirements 
It is in this panel (Figure  5.7) the engineering requirements (“voice of the company”) are described.  
Technical requirements that are perceived as important in meeting the specified user requirements 
were listed and analysed. An additional row at the top of the panel illustrates the direction of the 
intended change of each characteristic to achieve the desired improvement.  
 
Figure  5.7: HoQ Technical Requirements 
 
This panel highlighted: 
 Materials are required at the lowest possible prices, while facilitating processing techniques 
that are as low cost and fast as possible. 
 The selection of the materials for biochip construction should be such that the highest 
durability available for each sub-component (e.g. interconnection point, insulator, electrode 
surface).  
 The weight of the biochip should be low so as to ease both handling and transportation.  
 The overall size of the MEA biochip should be small to promote future biochip footprints 
that are as small as practically possible. Initial interconnect design had to be kept the same 
as commercial equivalents so as to meet the user specified requirement to connect with 
commercial systems.  
 A flexible design that facilitates a vertical interconnection layout should be aimed for so as 
to support system foot print and module size reduction.  
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5.2.1.1.4 Requirement Interrelationships 
This panel (Figure  5.8) forms the main body of the matrix and its purpose is to translate the user 
requirements into technical requirements. Combined consideration of user and technical 
requirements resulted in the definition of design and manufacturing targets used in this work.  
 
Figure  5.8: HoQ Interrelationships 
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In this grid (Figure  5.8) symbols were used to represent interrelationship significance in terms of 
product success. Correlations between each user-technical requirement were considered and rated 
using a four point scale (high significance, medium significance, low significance, no significance). 
These ratings then corresponded to a score that was agreed prior to completing the matrix (e.g. high 
– 9, medium – 3, low – 1, none – 0). This panel guided decision making when compromises where 
required. The strength of relationships could be visually referred to with ease. The scores generated 
in this panel also contributed to the final weighting calculation of the design and manufacture 
targets derived. 
  
5.2.1.1.5 Technical interrelationship impedance or support  
The “roof” of the matrix looked at how previously defined and scored technical requirements either 
supported or impeded one another (Figure  5.9). Consideration was made of whether improving one 
requirement would cause either an improvement or deterioration of the other requirement. 
 
Figure  5.9: HoQ Technical Requirement Interrelationships 
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Where deterioration was identified a “-” symbol is inserted and where improvement was identified a 
“+” symbol was inserted. The level of positive or negative interactions was indicated by adding 
strength to the indicators:  
 + = weak positive,  
 ++ = strong positive,  
 - = weak negative,  
  = strong negative).  
This panel was used during concept design to identify positive interrelationships (e.g. increasing the 
number of recording channels would support the ability of the biochip and system to record and 
analyse from more than one beater at a time. Negative interactions were also identified and given 
attention in attempts to seek an innovative solution that would not introduce new problems where 
compromises had to be made (i.e. in selection of material and manufacturing processes). 
 
 
5.2.1.1.6 Targets 
This was the final panel of the HoQ to be completed (Figure  5.10). The targets panel summarises the 
conclusions drawn from completing the matrix. Within this panel the relative importance of each 
technical requirement in meeting the specified user requirements was calculated from the 
weightings contained in the other panels. Design and manufacture targets were set and the difficulty 
of achieving those targets quantified and considered prior to action.  
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Figure  5.10: HoQ Targets 
 
 The outputs from this panel (Figure ‎5.52) are ordered in Figure  5.11.  
 
Figure  5.11: Priority of defined development targets according to HoQ matrix score.  
 
The highest importance score (416.0) was obtained by the requirement “ability to analyse all 
detecting channels”. Although this requirement is therefore prioritised as priority 1 this requirement 
could not be directly addressed in conjunction with the following biochip-centred requirements. 
Highly scoring biochip-centred requirements could be addressed in conjunction with one another so 
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were tackled in this research.  Table ‎5.1 shows prioritised targets in terms of the HoQ weightings. 
The combined biochip-centred requirements scored more highly than the system-centred targets 
justifying this research’s pursuit to design and manufacture a novel MEA biochip for this particular 
application domain. 
Table ‎5.1: Prioritised targets with discussion. Blue panels = biochip, orange panels = system. 
HoQ 
Priority 
Target Discussion 
1 The system must possess the ability 
to analyse data collected from all of 
the detecting channels.  
This is an essential system requirement. All existing and 
future MEA systems possess this feature. The biochip 
produced must also support this requirement. 
2 Biochip must be as small as possible 
(supporting scale up). 
Small biochips improve practicality for bioscientist users by 
allowing batch sterilisation, preparation, cleaning and 
storage. The area to work with inside culture hoods is 
limited. Small biochips facilitate scaling up by better suiting 
the limiting dimensions of incubators. (In this application 
cells must be cultured over the microelectrodes prior to 
recording.)  
3 Biochip to withstand greater than 
10-15 uses. 
Present day commercial biochips degrade with use and it is 
recommended by manufacturer’s that they are replaced 
after every 10-15 uses. To improve value and convenience 
(3-6 weeks delivery) to customers biochips that can be used 
>15 times are desired.   
4 Materials used to be the most 
durable possible (i.e. support 
production of a device that is suited 
to at least 10-15 uses). 
Current degradation of biochips is attributed to the delicate 
nature of the materials and feature size, as well as 
detrimental consequences of stimulation protocols. 
Materials that do not degrade with use are required. 
=5 Use of manufacturing processes that 
are of lowest possible cost while 
producing device at required quality.  
A number of manufacturing processes are combined to 
produce an MEA biochip. There are choices in which 
combination of processes are employed at each stage of 
device manufacture. Compromises are made between 
speed: cost: quality. Decisions are also influenced by 
expertise: tooling: funding. Low cost approaches are 
favoured.  
=5 Use of manufacturing processes that 
produce devices to required quality 
as quickly as possible 
MEA biochips are developing rapidly (chapter 2) so 
processes that can produce devices quickly and efficiently 
are favoured so as to realise a suitable device as soon as 
possible. In addition to that processes that take a long time 
to execute in this manufacturing domain may be high-skilled 
and high cost.  
6 Materials selected to be lowest 
priced available 
Materials used to manufacture current commercial MEA 
biochips (i.e. glass, gold, titanium nitride) are relatively high 
cost. Where the in use and manufacturing properties of two 
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 materials is comparable the price of the material must be a 
priority. Compromises between function: quality: cost: 
processing. 
7 Safety of the biochip (i.e. when in 
use, when in storage).  
Must be comparable to or better than standard commercial 
equivalents. The new device must not pose any additional 
risks. 
8 Safety of the system (i.e. when in 
use, when in storage). 
Must be comparable to or better than standard commercial 
equivalents. The new device must not pose any additional 
risks. 
9 System should be modular in design 
to accommodate easy upgrade of 
components.  
Due to the diversity of MEA application types a system that 
can be adapted to meet the needs of either different 
applications or of future needs of contemporary applications 
is desired. Chapter 2 demonstrates the diversification of 
systems into application specific units due the need for 
different hardware settings. Modular design to facilitate 
maximum component and sub-component cross over is 
desired which will also increase efficiency in terms of 
production. 
10 Successfully support >1 beating 
cluster 
 
For the novel biochip to be competitive with a commercial 
equivalent it must support the attachment and recording 
from 2 or more stem cell-derived beating cardiomyocyte 
clusters per media well.    
11 Light-weight 
 
Biochips must be light-weight to support ease of use and 
transportation but without any compromise to durability. 
12 Designed for scalability   In order to compete with state-of-the-art commercial 
systems the novel system is required to support hundreds of 
channels. 
13 Small as possible (system) Competitive advantage can be gained by producing a system 
that is a compact and small as possible. Current commercial 
systems are about the size of a shoe box. A system that is 
comfortably accessible while operating inside an incubator is 
desired. 
14 Interconnects and tracking that is as 
short and close together as 
functionally possible 
 
In order to facilitate production of a low noise, small MEA 
system components and sub-components should be design 
with close interconnects and short lengths of tracking. 
15 Best low noise components possible 
 
The components sourced to build system units should be 
specified with low noise characteristics as a high priority if 
affordable. 
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5.2.2 Section Summary 
This research has sought to identify and prioritise targets for design and manufacture of a novel 
device. The QFD methodology’s HoQ matrix resulted in a prioritised list of targets used in concept 
design, prototype manufacture and testing. 
The targets focused on by the work in this thesis were: 
 Produce a biochip to support >1 beating cluster of SC-CMs at one time, providing >1 
channel of usable data per test repetition.  
 Provide a biochip that safely interconnects with an existing MEA system that is small, 
lightweight and can withstand repeated use (at least 15 times).  
 Manufacture a biochip using the best quality possible, lowest priced materials that 
complement fast and low cost production.  
 Design a biochip flexibly to allow potential future scalability, whilst also featuring low 
noise design properties. 
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5.3 MEA Biochip Concept Design 
The specification provided by the UoN and targets identified through the HoQ matrix highlighted 
potential competitive advantage in biochip-centred user requirements over system-centred 
requirements (section ‎5.2.1.1). Biochip-centred requirements were used to generate a design 
concept suited specifically to stem-cell derived cardiomyocyte beating cluster cell preparations.  
A number of manufacturing approaches were conceived for manufacturing the novel design, and 
due to varying degrees of success, were progressively adapted until a prototype of a satisfactory 
quality meeting the specified requirements was achieved.  
5.3.1 Critical MEA Biochip Components  
An MEA biochip is comprised of two components: (1) a patterned base substrate and (2) a media 
well (Figure  5.12). The media well is usually a ring of material adhered to the base substrate so as to 
enclose the surface area of the biochip that supports the microelectrode tips, which is referred to as 
the workspace (see Figure ‎2.46). The volume of space within the media well is filled with a liquid cell 
culture media (e.g. Neurobasal, DMEM) when in use.  
Design of an MEA biochip requires appropriate consideration of the techniques applicable for the 
manufacture of: i) a base substrate, with integrated microelectrodes capable of detecting microvolt 
sized amplitudes and appropriate contacts for external interconnects; and ii) a media well that 
reliably adheres to ensure a water-tight product that can be used for periods of hours to months in 
incubated conditions. 
 
 
Figure  5.12: The two main components in MEA biochip design and manufacture. 
 
All commercially available MEA biochips have an insulating material applied over the upper, 
patterned surface of the base substrate. The insulation layer ensures only the tips of the 
microelectrodes are exposed to the cellular environment and media reducing noise and protecting 
the underlying circuitry. Insulation is described in section ‎2.10.1.4. 
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5.3.2 The Concept  
Throughout the process of designing a suitable manufacturing approach the fundamental design 
concept for the novel MEA biochip remained consistent. A recess of ~200-250µm, with a diameter of 
500µm at each electrode site, to accommodate a single beating cardiomyocyte cluster directly over 
an electrode (see Figure  5.13) was required.  
An inter-electrode distance (pitch) of ~5mm was maintained across designs to accommodate the 
user requirement to keep beating clusters far enough apart so as to keep contractions independent 
from one another while in the same culture media. It has been observed by UoN users that beating 
clusters of cardiomyocytes that are in close proximity will gradually exhibit synchronised 
contractions. 
 
Figure  5.13: A computer aided design of the original MEA concept for beating cluster cardiomyocyte 
applications at the University of Nottingham. 
 
The geometry of the peripheral interconnect design was kept consistent with commercial 
equivalents produced by Multi Channels Systems and Ayanda Biosystems (see Figure  5.14) so as to 
facilitate the connection with the commercial system headstage (e.g. in this case MCS MEA60) as 
specified by the UoN user group.  
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Figure  5.14: Interconnection geometry of Ayanda Biosystems and Multi Channels Systems standard 60 
electrode MEA biochips. Contact pads are represented by yellow squares. The numbering on each pad 
represents the channel that the pad corresponds to in the recording and analysis software. 
 
5.3.3 Section Summary 
A biochip specifically suited to SC-CM beating cluster cell source applications does not yet exist and 
is required. A microwell feature over each electrode is desired by users to increase the number of 
beating clusters accommodated per biochip. Underlying circuitry must be appropriately insulated 
using materials that are biocompatible and that can withstand wet and warm (~37°C) conditions for 
periods of days to months.  
Media wells are essential around the area of the electrodes as the SC-CMs require a constant supply 
of cell culture medium, which in this application is Dulbecco's Modified Eagle's medium (DMEM). 
The peripheral interconnect layout was to be kept consistent with commercial designs. 
The user specified microwell feature at each electrode is completely novel in its size, shape and 
suggested material. This novel feature brings new advantages to the user by facilitating easier cell 
positioning during the seeding process, improving signal quality as cells will attach directly over the 
larger surface area of the larger diameter electrode, and creating the facility to process more than 
one beating cluster per MEA biochip. 
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5.4 Manufacturing Approach Selection 
 
A design concept was conceived to meet the prioritised biochip-centred design and manufacture 
targets. Manufacturing approach and materials suited to production of the design concept were 
considered (Figure  5.15) with respect to possibilities the materials or techniques offer, limitations 
that might be of significance, costs, environmental factors and scalability for manufacture of the 
likely quantity of biochips required, both separately and in association.  
 
Possibilities 
(e.g. provides good optics, cells adhere well)
Limitations 
(e.g. requires several high skilled techniques to process, poor availability)
Cost 
(e.g, of materials, of facilities, of tooling maintenance)
Environmental 
(e.g. location and facility in which approach is carried out, chemicals used in processing are 
detrimental to the environment)
Scalability and quantity 
(e.g. will quantity required by market increase due to product introduction, if so is process scalable to 
meet predicted demand)
Design of the 
Manufacturing Approach
Possible Fabrication ApproachMaterials
Procedure
Tooling and facilities
Expertise
Suitability for 
manufacturing approach
Compatibility with  cell 
culture environment
Integrated Circuit (IC) 
and Micro Electrical 
Manufacturing 
Systems (MEMS) 
Techniques
Electroplating
Laser Processing
Inkjet Printing
Gold
Indium Tin Oxide
Titanium Nitride
Glass
FR4
Polyester
Hydrogel
 
Figure  5.15: Manufacturing approaches conceived were described in terms of what was possible, what 
materials were suitable and specific advantages and disadvantages posed by each approach. 
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Possibilities and limitations: Manufacturing technology was evaluated to determine what would be 
possible and where limitations of techniques might rule them out with regard to identified potential 
manufacturing techniques (section ‎5.4.1) in terms of: 
i) the physical procedures required to execute that technique;  
ii) the tooling and facilities those procedures required;  
iii) the feature sizes and geometries attainable using that technique; 
iv) the level of expertise available to ensure necessary procedures could be carried out 
effectively and safely.  
These considerations are described in Table ‎5.3. 
This research demands the use of materials that suit biosensor applications. Only materials that 
were biocompatible and suited to incubated conditions were considered. Materials selection priority 
was such that materials chosen would be compatible with:  
1. the needs of the cell culture environment; 
2. the manufacturing approach.  
 
Costs: Associated costs that would impact upon the manufacture and thus the final unit price of the 
MEA biochip and/or system were taken into account. The scale on which the novel MEA biochip 
could be manufactured was an influence as it is essential that manufacturers balance the scale of 
production and supply to the actual market need (Fisher et al, 1994).  
 
Environment: Environmental concerns are now a major consideration for all parties involved in 
manufacturing electrical or electronic products (Toyasaki et al, 2011). Disposable devices would be 
ideal for MEA system user groups as they could vastly reduce demands on users in terms of 
sterilisation and preparation. However, the ability to reclaim the high cost raw materials (such as 
gold or ITO) used in fabrication would be an environmental concern if large quantities were 
manufactured and sold.  
 
Quality and scalability: Current commercial manufacturing uses approaches that are carried out in 
batches. Scalable approaches are desired as the demand for devices in this application area will 
initially be low during research to validate the stem cell-derived cardiomyocyte as a reproducible 
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and reliable cell source. If substance screening is validated using these cells it is hypothesised that 
the pharmaceutical industry will require assays that process 100’s to 1000’s beating clusters per 
instance. 
 
5.4.1 Possible Fabrication Approaches 
A number of existing microelectronics manufacturing approaches were identified as potentially 
suitable for the manufacture of the novel MEA biochip concept: 
 Integrated Circuit and Micro Electrical Manufacturing Systems (MEMS) Techniques  
- Photolithography 
- Thin Film Deposition 
- Etching (wet) 
 Electroplating 
 Laser Machining 
 Additive Manufacturing (Inkjet Printing) 
[Source: Campbell, 1996.] 
 
The following sections describe each approach and the ways in which that approach is suited to the 
manufacture of the concept. 
 
5.4.1.1 Integrated Circuit and Microelectromechanical Systems 
(MEMS) Techniques 
Microelectromechanical systems (MEMS) are combinations of electrical and mechanical systems 
with manufactured parts that are less than 1mm in length (Meyer, Bischoff and Feltrin, 2009). The 
manufacture of MEMS devices draws upon many batch processing technologies that are used in the 
manufacture of various integrated circuit (IC) devices (Figure  5.16).  
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IC and MEMS Manufacture
Thin Film 
Deposition
Photolithography Etching
Sputtering
Physical Vapour 
Deposition (PVD) 
or
Evaporation
Chemical Vapour 
Deposition (CVD)
Ultraviolet (conventional 
photolithography)
Deep UV
Extreme UV
X-ray
Electron beam
Wet
Dry 
Sputter
Reactive Plasma
Physical-chemical
Cryogenic
= used in this research
 
Figure  5.16: Processes used for the manufacture of Integrated Circuits (IC) and Microelectromechanical 
Systems (MEMS) that are applicable to this research. 
 
This research utilised UV photolithography, e-beam PVD and wet etching throughout the described 
approaches. 
Technique suitability was considered in terms of possible feature size, process complexity, tooling 
sophistication, facility access and expertise availability (Table  5.2 and Table  5.3), contributing to 
decision making during manufacturing approach selection and implementation. 
Table ‎5.2: Suitability and accessibility states used in Table 5.3. 
Consideration Possible States 
Feature Size ≥100µm, <100µm, ≤30µm 
Process Complexity Low, Moderate, High 
Tooling Sophistication Low, Moderate, High 
Facility Access Available, Limited Access, No Access 
Expertise Access Available, Limited Access, No Access 
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Table ‎5.3: Technique suitability with regard to this research 
Technique Consideration State Comments 
IC and MEMS 
(Conventional 
photolithography and 
etching @ LU) 
Feature Size ≥100µm Facility and expertise is 
readily available at low cost 
to the research. Proof-of-
principle parts can be 
manufactured in a few days. 
Process Complexity Low 
Tooling Sophistication Low 
Facility Access Available 
Expertise Access Available 
IC and MEMS 
(Clean room based thin 
film deposition @ 
HWU) 
Feature Size ≤30µm Access can be booked 
month in advance. Process 
is time consuming. 
Additional expertise 
required to supervise. 
Process Complexity Low 
Tooling Sophistication Moderate 
Facility Access Limited Access 
Expertise Access Limited Access 
IC and MEMS 
(Clean room based 
photolithography and 
etching @ HWU) 
Feature Size <100µm Access can be booked 
month in advance. Variable 
results as done by hand. 
Time consuming.  
Process Complexity Moderate 
Tooling Sophistication Moderate 
Facility Access Limited Access 
Expertise Access Limited Access 
Electroplating Feature Size <100µm Low throughput. Time 
consuming. Facility to 
perform batches of ~4 
biochips. Electroplating 
parameters experimental.  
Process Complexity Moderate 
Tooling Sophistication Moderate 
Facility Access Available 
Expertise Access Limited Access 
Laser Machining Feature Size ≤30µm CO2 and Excimer laser 
facilities available. High 
cost.  Expertise available. Process Complexity High 
Tooling Sophistication High 
Facility Access Available 
Expertise Access Available 
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Additive Manufacture  
(Inkjet Printing) 
Feature Size ≤30µm Available through 
collaborative efforts with 
Printed Electronics Limited. 
Au inks on glass not 
optimised. 
Process Complexity Moderate 
Tooling Sophistication High 
Facility Access Limited 
Expertise Access Limited 
HWU= Heriot Watt University 
Conventional photolithography facilities were readily available to this research. Photolithography is 
used to produce commercial MEA biochips (Heuschkel et al, 2002). This technique has been 
exploited in this research in clean and non-clean environments. 
 
5.4.1.1.1 Photolithography. 
Photolithography has been used in all manufacturing approaches presented in this thesis for the 
production of the electrode patterns on the upper surface of the MEA biochip base substrates. The 
exact procedure executed and the materials used differ slightly between manufacturing approaches 
to suit the needs of concept iterations. However, the overall principles of manufacture via 
photolithography are consistent (Figure  5.17). The feature sizes possible using different types of 
lithography (Table ‎5.4) support the suitability of photolithography for MEA manufacture. The 
smallest feature sizes present in commercial MEA biochips (section ‎2.10) is 10µm. Therefore UV 
photolithography was confirmed as suitable for manufacture of all base substrate electrode patterns 
where material selection is complementary. 
Table ‎5.4: General characteristics of lithography techniques. 
Technique Wavelength (nm) Finest feature size (nm) 
Ultraviolet (photolithography) 365 350 
Deep UV 193 190 
Extreme UV 10-20 30-100 
X-ray 0.1-1 20-100 
Electron beam - 80 
[Source: Dupas et al, 2004.]  
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i) Design pattern 
ii) Produce electronic 
artwork of pattern
(I.e. AutoCAD file)
iii) Make a photomask
iv) Obtain suitable 
base substrate with 
appropriate conductive 
material layer
v) Coat conductive 
surface of the base 
substrate material to 
be patterned with a 
photoresist
vi) Align and expose to 
UV light with 
photomask in position
vii) Develop photoresist
viii) Etch away 
exposed conductive 
material
ix) Strip away 
remaining photoresist
x) Rinse patterned 
substrate clean of 
chemicals
 
Figure  5.17: Step-by-step photolithography procedure overview. The details at each stage may differ 
depending upon intended geometries and resolution of the pattern being transferred. 
 
As seen in Figure  5.17, the stages of photolithography are as follows: 
The photolithography process involves developing a design concept (i) and an electronic file, called 
an artwork (Figure  5.18), of that design constructed (ii). A number of CAD and electronic design 
software are suited to this purpose (e.g. AutoCAD, DipTrace, CadSoft EAGLE). From this file a 
photomask of the pattern is made (iii). A photomask can be made in either a positive or negative 
format to suit the photoresist that it is to be manufacture micro electrode array used in conjunction 
with. 
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Figure  5.18: Artworks produced for this research in a format to suit either positive or negative photoresists. 
 
A base substrate is selected (iv) that has been previously coated or laminated with a conductive 
material (e.g. copper, Figure  5.19) is processed to produce the desired conductive pattern on its 
surface using the photomask. Designers select the conductive material and the thickness of the film 
(laminated layer) of that material that is required to give appropriate resistivity to the conductive 
pattern being produced. The process of transferring the pattern from the photomask to the 
substrate is the photolithography stage of the MEA biochip manufacture. The most common form of 
lithography (Campbell, 2001), and the type used in this research is optical (photo) lithography. Other 
types of lithography used in the production of microelectronics include x-ray lithography, electron-
beam lithography and ion beam lithography (Kalpakjian and Schmid, 2008). 
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Figure  5.19: Copper laminated FR4 used as base substrate for manufacturing approaches 1, 2 and 3, and 
consequently Prototype 1. 
 
 
Figure  5.20: Photolithography Stages 
 
A photosensitive material called photoresist is thinly and evenly deposited (e.g. by lamination, spin 
coating, sputtering) over the conductive surface that is to be processed (v). Photoresists are 
available in various forms (i.e. liquid, film) that can be classified into positive or negative resists 
(Figure  5.20). The photoresist coated substrate is positioned with the photomask tightly over the top 
and given a controlled exposure to UV light (vi). The exposed areas of resist undergo a 
photochemical reaction resulting in some areas of photoresist being resistant to a developing 
solution and other areas being easily dissolved by the same solution. 
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Figure  5.21: Continued photolithography stages. 
 
The exposed samples are developed to remove areas of dissolvable photoresist (vii) resulting in 
patterned areas of developed photoresist and exposed conductive material. The exposed conductive 
material is etched away by submerging the sample in an appropriate acidic formulation (viii). When 
all of the exposed conductive material has been removed the semi-prepared substrates are removed 
from the acid and immediately rinsed clean under water.  
The desired conductive pattern has now been created (Figure  5.21, viii and Figure  5.22) on the 
substrate surface (viii). Remaining photoresist is removed using an appropriate alkali solution and 
samples are rinsed clean again (x) and dried. 
 
Figure  5.22: An example of a patterned substrate made during this research by photolithography. 
 
There are two kinds of photoresist used in photolithography: positive and negative (Figure  5.23). 
In the case of positive resists the area of the resist that is exposed to UV light under goes chemical 
changes that result in those areas becoming soluble to a particular developing solution. Therefore 
when the area that has been exposed to UV light is submerged in developer the photoresist covering 
that area is removed.  
In the case of negative resists the area of resist that is exposed to UV light polymerises to more 
resistant to being dissolved by the developing solution. Therefore it is the unexposed areas of the 
negative resist that are removed. 
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Positive 
resist
Negative 
resist
Photoresist
Material to be 
patterned (i.e. Cu)Base Substrate 
(i.e. FR4)
Photomask
UV Light
 
Figure  5.23: Positive and negative photoresists. 
 
Photoresists that have been used in this research are negative Alpha 940 and positive AZ 9260. 
5.4.1.1.2 Thin Film Deposition   
Films of various materials are thinly deposited over substrate materials for various microelectronics 
manufacturing requirements, such as patterning, protecting or insulating. The type of material 
depends upon the function required of the layer and the properties of the material. In the case of 
conductive films used for circuitry, materials such as titanium, copper and gold, (used in this 
research) are usually selected for their suitably low resistivity, current carrying ability and suitability 
for connection. 
Thin films may be deposited via a number of deposition techniques. Techniques vary in terms of 
pressure, temperature and vacuum systems required. The simplest and oldest method of thin film 
deposition is evaporation. Sputtering and chemical-vapour deposition techniques are also available 
for film deposition and have not been used in the research presented in this thesis but may be suited 
to future work. 
 
271 
 
__________________________________________________________________________________
Requirements, Concept Design, and Manufacturing Approach 
Physical Vapour Deposition (PVD)/ Evaporation 
Involves heating (via a hot filament or electron beam) metal in vacuum to the point of vaporisation 
(e.g. for Au temperature of vaporisation =~2800ºC). The vaporised (or evaporated) metal forms a 
thin layer on the surfaces of substrates contained within the deposition chamber.  
Electron beam deposition was used in this research. Detailed description of this approach is included 
in section 5.8.2.1). 
 
Sputtering 
Involves bombarding a target with high-energy ions (typically Ar+) in a vacuum. As the ions strike the 
target material atoms are knocked off and deposited on wafers mounted in the system. Sputtering 
gives a highly uniform coverage (Ueda et al, 2006). Advanced sputtering approaches have been 
developed using radio-frequency power sources (RF sputtering) and magnetic fields (magnetron 
sputtering). 
Sputtering was not used in this research but may be useful to future work. 
 
Chemical Vapour Deposition (CVD) 
In CVD the film of metal covering a substrate is deposited by way of the reaction and/or 
decomposition of gaseous compounds. There are two different set-ups: 
Low pressure chemical vapour deposition (LPCVD): operates at low pressures and is capable at 
higher production rates than atmospheric pressured CVD. The low pressure approach also provides 
superior uniformity with lower consumption of carrier gases. 
Plasma-enhanced chemical vapour deposition (PECVD): involves processing wafers in an RF plasma 
containing source gases. The advantage of this process is that it can operate at relatively low 
temperatures. 
These approaches may exploited in future work. 
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Thin film deposition and this research 
Thin film deposition stages for the materials used in this project were carried out commercially in 
the case of FR4 based prototypes. Cu laminated FR4 is readily available. For the glass based 
prototypes thin film deposition processes were carried out as part of this research. The specific 
process used in this work was e-beam deposition of Ti and Au at very low pressure. 
 
5.4.1.1.3 Etching  
Once a photoresist pattern has been created on the surface the next stage is to transfer that image 
into the relevant layer of material (e.g. Cu, Ti) underneath. Etching is used to remove the conductive 
material and is classified as either dry or wet (Campbell, 1996).  
Wet etching involves immersion of the photoresist patterned substrate into an etchant solution. The 
etchant reacts with the exposed areas removing the material from the substrate into the solution. 
Dry etching involves the acceleration of reactive ions towards the base substrate in a low pressure 
system. Dry etching usually provides improved directionality when compared to wet etching 
(Kalpakjian and Schmid, 2010) but is typically more expensive (Wilkinson and Rahman, 2004). There 
are four variants of dry etching: (i) sputter, (ii) reactive plasma, (iii) physical-chemical and (iv) 
cryogenic. Dry etching has not been used in this research. 
This research called upon wet etching of Cu (sections ‎0, ‎0, ‎0), Ti (section ‎0) and Au (section ‎0) 
through various manufacturing approaches designed. 
 
5.4.1.1.4 Clean rooms 
Clean room facilities are necessary for the production of IC and MEMS devices due to the scale 
features produced. Clean rooms serve to remove potentially damaging particles from the 
manufacturing atmosphere (e.g. dust, smoke, perfume, bacteria). There are varying levels of 
cleanliness of clean room defined into internationally standardised classes. The system of 
classification refers to the number of particles within a cubic foot of air that are greater than 0.5µm. 
Most clean rooms used for microelectronics manufacturing range from class 1 to 10. The size and 
number of particles are used to classify clean rooms, demonstrated in Figure  5.24. 
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Figure  5.24: Particle size and concentrations of particle per m
3
 for clean room classes. 
[Source: ISO 14644-1:1999] 
 
A class 1000 clean room was used by this research for the manufacturing approach described in 
section Error! Reference source not found.. 
 
5.4.1.2 Electroplating 
Electroplating is the process of coating an article with metal by means of electrolysis (Oxford English 
Dictionary, 2012). The article that is being plated is referred to as the cathode and the metal being 
used as the plating material is called the anode. This research has both implemented (section ‎0) and 
outsourced (section ‎0) electroplating. 
The electroplating process can be described as follows:  
1. Metal ions from the anode are discharged by means of a potential (usually from an external 
power source) or are delivered in the form of metal slats. 
2. The metal ions dissolve into solution. 
3. The metal ions move to the cathode where they are deposited on its surface. 
[Adapted from Kalpakjian and Schmid, 2010] 
 
Copper (Cu) is commonly the coated material where electroplating is used. Cu has been 
electroplated with gold (Au) in this research to meet biocompatibility requirements. A typical 
electroplating process involves the application of a DC voltage between the article that is to be 
plated (cathode), and a source of the material that is to be deposited (anode). Both the cathode and 
the anode are submerged in a conductive electrolyte solution. Application of voltage results in the 
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metal ions of the anode migrating to the cathode. Upon reaching the cathode’s surface the ions lose 
their charge and are consequently deposited on the surface. 
Plating can be controlled to produce high quality end results. Appropriate selection of a combination 
of variables is required for controlled plating. Those variables are:  
 the electrolyte and concentration of its various dissolved components, 
 the temperature of the electroplating bath, 
 the electrical voltage and current. 
Variables are interrelated increasing process complexity and making the process of control a more 
challenging problem (DeGermo, Black and Kohser, 1999). Investigation of appropriate control of the 
above variables has been a challenge encountered by this research. 
5.4.1.2.1 Surface preparation for electroplating 
Preparation of the surfaces prior to plating is especially important to quality of the final surface. 
Holes, scratches, and defects must be removed if a smooth end result is to be achieved. Degreasing, 
cleaning and pickling can be used to ensure a chemically clean surface prior to plating.  
5.4.1.2.2 Part geometry in electroplating 
The geometry of the part to be plated also influences the final surface shape and finish. Plated metal 
tends to be preferentially attracted to corners and protrusions and as such design recommendations 
exist for parts to be electroplated (Figure ‎5.25). 
 
Figure ‎5.25: Design Recommendations for Electroplating Operations. (Source: DeGarmo, Black and Kosher, 
1999) 
275 
 
__________________________________________________________________________________
Requirements, Concept Design, and Manufacturing Approach 
Electroplating has been used in this research to pursue a manufacturing approach based on via 
(through) hole filling approaches used in layered PCB construction (section ‎5.6.1). The geometry of 
the feature electroplated in section ‎5.6.1 is a blind hole.  
 
5.4.1.3 Laser-beam Machining  
Laser-beam machining (LBM) uses various sources of focused, high-density energy as tools that can 
melt and vaporise a target’s material in a controlled manner (Dubey and Yadava, 2008). LBM can be 
used to process metallic and non-metallic materials. In this research lasers are used in conjunction 
with non-metallic materials. Different lasers are advised for different purposes (Table ‎5.5). 
Table ‎5.5: General applications of lasers in manufacturing. 
Application Laser Type 
  
Cutting 
Metals 
Plastics 
Ceramics 
 
Pulsed CO2, Continuous Wave CO2, Nd:YAG, ruby 
Continuous Wave CO2 
Pulsed CO2 
Drilling 
Metals  
Plastics 
 
Pulsed CO2, Nd:YAG, Nd:glass, ruby 
Excimer 
Marking 
Metals 
Plastics 
Ceramics 
 
Pulsed CO2, Nd:YAG 
Excimer 
Excimer 
Surface Treatment Continuous Wave CO2 
Welding 
Metals 
Plastics 
 
Pulsed CO2, Continuous Wave CO2, Nd:YAG, Nd:glass, ruby, Diode 
Diode, Nd:YAG 
 CO2 = Carbon dioxide,  Nd:YAG  = neodymium: yttrium-aluminium-garnet, Nd:glass  = neodymium: glass. 
[Source: Kalpakjian and Schmid, 2010.] 
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The outcomes of LBM are affected by the physical parameters of the surface of the material that is 
to be processed. Reflectivity and thermal conductivity influence LBM outcome. The lower the 
reflectivity and thermal conductivity the more efficient the process (Kalpakjian and Schmid, 2008).  
 
Gas streams: Many lasers are used in conjunction with gas streams (e.g. oxygen, nitrogen, argon) to 
leave oxide free surfaces and edges. Gas streams also have the important function of blowing away 
molten and vaporised material from the surface of the workpiece. 
 
Carbon dioxide (CO2) laser: The CO2 laser is one of the most efficient and powerful lasers used 
industrially for cutting and welding. The laser consists of 10-20% carbon dioxide, 10-20% nitrogen, a 
few per cent hydrogen, and the remaining helium (Hummel, 2011). 
The smallest comparable features that can be manufactured using a CO2 laser have been 12.6µm 
(Longsine-Parker and Han, 2012) supporting the use in this application setting. 
 
Excimer lasers: Are used across materials processing, medical devices and research and 
development settings (Csele, 2004). The term Excimer laser does not describe a single device but a 
family of lasers (Table ‎5.6) that possess comparable output characteristics (Hecht, 1992). Excimer 
systems work by using pulses of short wavelengths such as ArF (193nm), KrF (248nm), XeCl (308nm) 
and XeF (351nm). The pulses are short in duration (3-10 ns) and high in energy. The pulses interact 
rapidly with the sample material resulting in material ablation at the surface (Lee and Wu, 2007). 
Excimer lasers have been reported in use for the fabrication of components with feature sizes 
between 0.05µm -1mm (Gower, 2001).  
Table ‎5.6: The excimer laser family gas mixtures. 
Excimer Species Halogen Inert gas Balance 
KrF 0.2% fluorine 5% krypton Helium 
0.1% fluorine 2% krypton Neon 
ArF 0.23% fluorine 14% argon Helium 
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0.1% fluorine 4% argon Neon 
XeF 0.39% fluorine 0.75% xenon Helium 
0.15% fluorine 0.35% xenon Neon 
XeCl 0.06% hydrogen chloride 1.5% xenon Helium 
0.06% hydrogen chloride 1.5% xenon Neon 
[Source: Csele, 2004.] 
The excimer laser type used in this research was KrF (section Error! Reference source not found.).  
 
5.4.1.4 Additive Manufacturing (Inkjet Printing) 
Inkjet printing is used in manufacturing because of its high speed and accuracy (Fahad, 2011). The 
material processed in inkjet printing presently exhibit poor mechanical properties. The functionality 
of printed products is therefore limited. 
Inkjet printing has however been applied across a diversity of applications including industrial, 
textile, bio-medical, and electronics manufacturing.  
Electronic applications of inkjet printing include (Fahad, 2011):  
i. Manufacture of printed circuit boards (PCB), 
ii. Manufacture of polymer light emitting diodes (PLED) 
iii. Manufacture of colour filters for liquid crystal displays (LCD) 
iv. Manufacture of organic thin film transistors (OTFT). 
Inkjet printing is classified into two categories: Continuous Inkjet Printing (CIJ) and Drop-on-Demand 
Inkjet Printing (DOD). 
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Inkjet Printing
Continuous Drop-On-Demand
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Multiple Deflection 
System
Thermal Electrostatic Piezoelectric Acoustic
Squeeze Bend Push Shear
 
Figure ‎5.26: Categories of Inkjet Jet Printing. 
 [Source: Le, 1998] 
CIJ is the provision of a steady stream of droplets onto the substrate at a controlled rate. These 
droplets are produced and controlled by the continuous vibration of a piezoelectric crystal inside the 
printer head. The vibration creates a pressure wave inside the chamber where the ink is held forcing 
a droplet out of the nozzle (Fahad, 2011). 
DOD sends a signal to the nozzle only when needed. DOD is categorised according to the actuation 
system used: electrostatic, acoustic, thermal and piezoelectric.   
A wide variety of materials have been printed using inkjet technology (e.g. polymers, organic 
solvents, ceramic suspensions, nanoparticle materials, molten metal, biological materials). 
Properties that will influence the final quality of the print include: 
 Surface tension 
 Viscosity 
 Molecular weight 
 Concentration of the polymer (in polymer based suspensions or solutions). 
Inkjet printing is promising in electronics manufacture due to the ability to pattern high-purity 
electrically functional materials without the need for a mask (Sekitani et al, 2008). It is the facility to 
print PCBs that was pursued as an avenue of interest to this research. The feasibility of using inkjet 
printing was considered in collaboration with PEL Printed Electronics Limited (Invotec Group, 
Tamworth, UK).  Further details are presented in section ‎5.9.  
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5.4.2 Selection of manufacturing Approaches for 
Implementation 
The major factors (Figure ‎5.27) influencing which manufacturing approaches should be implemented 
were materials suitability, fabrication technique suitability, resolutions and geometries limitations, 
suitability for sterilisation and cleaning, and robustness.   
MEA Biochip Manufacture
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(Chapter 5)
Design feature 
resolution
(Chapter 2)
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(Chapters 2 and 
4)
Cleaning and 
sterilisation
(Chapter 4)
 Water-tight
 Re-usable
 Transporatable
 Material Deposition
 Photolithography
 MEMS
 Laser Processing
 Ink jet Printing
 Millimeters
 Micrometers
 Nanometers
 Trypsin
 Ethanol (70%)
 UV Light
 Plasma Cleaner
 Laminate
 Plasma Enhanced Chemical Vapour Deposition 
(PECVD)
 Electron Beam
 Sputtering
 Mm
 µm
 nm
Conventional tooling and approach
High precision clean room facilities
 Ink formulation
 Droplet size
 Resolution
 High Temperature Curing
 Possible Base Substrates
 Laser source
 Feature geometry
 Ablation Rates
 Consistency
 Laser Alignment
 Material Properties
 Ablation Debris
Requirements of 
design concept
(Chapter 3, 4 
and 5)
 See PDS 3
Materials
(Chapters 2 and 
5)
 Base substrate
 Conductive Pattern
 Adhesive or sealant
 Insulator
 Media Well
 Interconnect contact pads
 Electrode Tip
 Tracking
Cell culture 
environment
(Chapter 4)
 Warm = ~37ºC
 Humidity = >95%
 Atmosphere = 5% CO2
 
Figure ‎5.27: Factors Influencing Manufacturing Approach Selection. 
 
Note: The MEA biochip must be made to be robust enough to withstand repeated use, exposure to 
prolonged periods in humidified incubation and the repeated cleaning and sterilisation procedures 
associated to that use without failure.  
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5.4.2.1 Materials Selection 
Appropriate material selection for MEA biochip sub-components was based upon the materials 
demonstrated in comparable applications, material properties, processing technique suitability, 
availability and costs. 
 
5.4.2.1.1 Conductive Pattern and Electrode Tips 
Copper, gold, platinum, titanium, ITO and TiN were considered as potential materials for the 
conductive pattern and electrode tips of the novel MEA biochips designed and manufactured during  
this research. 
 
Gold: Is used for areas of the electrode surface that are exposed to the cellular environment 
throughout derived design concepts as a wealth of literature reviewed had previously demonstrated 
its successful application in numerous similar biochip designs (Nam et al, 2004; Held et al, 2010a). Au 
is biocompatible (Chen, 2011) and was favoured over ITO and TiN because the processing of Au 
using photolithography methods is more mature with a vast amount of published information 
available to support experimentation. Suitable facilities and access to expertise (PMD Plating, 
Coventry) supported the use of Au during this project.  
Au was selected for use in all of the manufacturing approaches that were designed by this research 
as the cell-electrode surface interface material.  
 
Indium tin oxide (ITO or tin-doped indium oxide): Is a semiconductor made from a mixture of 
typically 90% indium oxide (In2O3) and 10% tin oxide (SnO2) and is  exploited in the manufacture of a 
number of contemporary electronic devices (e.g. flat panel displays, solar cells). ITO exhibits good 
transparency, low electrical resistance and excellent surface adhesion (Damiani and Mansano, 2007).  
ITO also demonstrates good physical and chemical stability (Eisgruber et al, 1999) making it a 
suitable candidate material for transparent tracking in MEA biochip manufacture. Thin films of ITO 
are required in MEA manufacture. A selection of techniques can be used to deposit films of ITO: (i) 
Thermal evaporation deposition, (ii) Direct current (dc) and radio frequency (rf) magnetron 
sputtering, (iii) Electron-beam evaporation, (iv) Spray Pyrolysis, (v) Chemical Vapour Deposition 
(CVD), (vi) Dip coating, or (vii) Pulsed Laser Deposition (Singh, 2006). Of these, sputtering is one of 
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the most versatile methods with the advantage of providing uniform thin films reproducibly (Singh, 
2006). 
The research presented in this thesis has not used ITO in designs but future design iterations may be 
suited to this material. 
 
Titanium Nitride (TiN): A surface is coated in TiN by reactive sputtering and CVD with titanium 
tetrachloride as the metal source and either nitrogen gas or ammonia gas as a source of nitrogen 
(Pierson, 1996). TiN is ideal for MEA biochip electrodes as it is biocompatible, stable in aqueous 
solutions, and has high abrasion and corrosion resistances (Watari et al, 2004) 
The research presented in this thesis has not used TiN in designs but future design iterations may be 
suited to this material. 
 
Electrode Material Combinations: Combinations of metals are use in manufacture to reduce costs 
and improve quality and performance. In this research the combinations Cu/Au and Ti/Au were used 
for the conductive patterns and electrodes of the prototype biochips produced.  
Cu/Au combinations were used to reduce costs in prototype one. Ti/Au was used in prototype two A 
and B as Au on glass required an initial seed layer of Ti to ensure high quality coating on the glass 
surface. 
Using thin film deposition, glass substrates were coated with titanium (Ti) as a seed layer and then 
gold (Au).  
 
5.4.2.1.2 Base Substrate and Media Well 
The polymer-based material FR4 was used in initial prototyping (sections ‎5.6.1, ‎5.6.2, and ‎5.6.3) as it 
was suitable for manufacturing approaches available and the FR4 and Cu layer were designed such 
that there would be no contact with the live matter. Glass was also used as a base substrate and 
media well material. Glass was selected due to its superior optical qualities as when compared to 
transparent and translucent plastics (Thibaud et al, 2005), as well as its suitability and durability for 
repeated processing and sterilisation. In addition to that glass is also bio-inert making it suitable for 
chronic cell culture.  
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5.4.2.2 Bioscience Influences 
Selection and implementation of the varying manufacturing approaches has also been influenced by 
the bioscientific application environment. General observations identified during case study 
construction influenced decision making.  
 
An example of an influence from observation of the bioscientific environment in which the device is 
to be applied that may have affected component geometry decisions or compromises is that the 
amount of space in a tissue culture hood. This space is limited and the specific tooling used during 
cell seeding is of particular dimensions. Awareness of these factors (that will influence how the user 
interacts with the biochip) helps to make appropriate design compromises when defining 
component geometries. 
 
Influences that were specific to using SC-CMs were also central to design decisions. An example of 
an observation that influenced material selection was awareness of UoN users’ observations that SC-
CMs attach differently to different materials. During material selection certain materials were 
favoured over others if they were suited to the manufacturing workflow under development (e.g. 
UoN users have observed that polyester can facilitate better cell attachment than glass which is also 
supported by the work of Jiao and Cui (2007) who demonstrated the importance of the surface 
interface on attachment using osteoblast cells).  
 
In the initial biochip design novelty was favoured over optical assessment capability. This 
compromise was made by UoN users; a high quality signal for analysis was considered more 
important than good optical assessment. 
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5.4.3 Section Summary 
A number manufacturing approaches can be used to produce the feature geometry specified in PDS 
3. Decisions relating to which approach to pursue in the following section of this chapter are based 
upon material suitability, facilities availability, expertise, time and reducing the cost of manufacture.  
This research called upon combinations of the listed manufacturing techniques while attempting to 
manufacture the concept designed to meet the needs of real users: 
 MEMs approaches – in the form of UV photolithography, physical vapour deposition and 
etching 
 electroplating 
 laser machining 
 inkjet printing 
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5.5 Manufacturing Approach 
Implementation 
 
A design concept was conceived (Figure  5.13) using PDS3 and attention was directed toward 
planning a method of manufacture. An overview of the manufacturing approaches planned and 
implemented during this research is described in Figure ‎5.29. The manufacturing approaches were 
designed and implemented as workflows (Table ‎5.7). A period of concurrent manufacturing 
development occurred until a suitable prototype was achieved (section ‎5.6.3).  
The prototypes were tested using live SC-CMs, and initial user feedback collected which led to a re-
evaluation of the MEA biochip design concept, resulting in a different second generation design 
concept.  
Clean room based manufacture was required to produce a finer conductive pattern in the second 
MEA biochip design concept. The new design, concept 2, was manufactured with two different 
electrode iterations, A and B (Figure ‎5.28, section 5.8). These prototypes were also tested using live 
SC-CMs (Chapter 6). 
The remainder of this chapter describes how each manufacturing approach was planned and 
implemented, and the general success of each approach in terms of critical manufacturing 
outcomes. Detailed results of each manufacturing approach are presented in Chapter 6. 
 
 
Figure ‎5.28: The electrode designs (A & B) used in the second generation of MEA biochip prototypes. 
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Figure ‎5.29: The design cycle used throughout this work. Three initial manufacturing approaches were 
designed and progressively adapted until a prototype of satisfactory quality was achieved for testing. 
Following feedback from that testing a new approach was adopted for the next generation of prototype. 
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5.6 Prototype One Manufacturing  
 
Four manufacturing approaches were implemented by this research with differing levels of success. 
Each manufacturing approach described in the following text was implemented successively, and for 
a time concurrently, building upon the successes and failures of the previous approach until a 
satisfactory prototype was achieved. Table ‎5.7 summarises each approach explored and visualises 
the planned outcome. 
Table ‎5.7: A brief summary of manufacturing approaches designed and implemented in pursuit of functioning 
prototypes. 
1. Via Hole Fill 2. Vertical Pins 3. Micro drilling
4. Clean room based 
Photolithography
Concept
Design
Progress
Approach
Failed at manufacture Failed at manufacture Generation One Prototype
Generation Two Prototypes A 
and B
Section in this 
thesis
5.6.1 5.6.2 5.6.3 5.8
 
Where an approach is investigated via a number of tangents the details of those tangents are also 
described. The success of the manufacturing approach in terms of production of a prototype is 
stated in Table ‎5.7. Manufacturing approach success was considered and compared in terms of the 
following critical component outcomes (Table ‎5.8).  
Table ‎5.8: Outcomes critical to successful manufacture of an MEA biochip. These critical outcomes were also 
prioritised with respect to interdependencies. 
Priority Critical Manufacturing Outcome 
1 Produce satisfactory base substrate 
2 Produce satisfactory media well 
3 Facilitate adequate attachment of the media well and base substrate components 
4 Produce a satisfactory electrode site for cell-electrode interfacing 
5 Produce an appropriate micro-well geometry around electrodes 
6 Produce enough sites so as to allow assignment of a reference 
7 Produce an MEA biochip that allows appropriate optical inspection of living samples 
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5.6.1 Manufacturing Approach One: Via hole filling 
(Electroplating). 
1) Create deep hole through Petri dish  to underlying 
electrode pattern below. 
2) Use through hole (via) fill electroplating techniques to 
plug the hole creating a microwell with Cu to a specified 
depth (~250µm).
3) Plate exposed Cu surface with Au for biocompatibility.
 
Figure ‎5.30: The intention of the via hole fill manufacturing approach. 
 
The first manufacturing approach exploited a well-defined and extensively demonstrated process 
used throughout printed circuit board (PCB) manufacturing.  An electroplating process is used to fill 
“vias” and “through holes” in layered printed circuit boards (PCBs). The same principle was utilised 
as a method of filling 500µm diameter holes drilled through a 35mm diameter Petri dish previously 
adhered over an underlying electrode pattern. Each hole was to be filled to a controlled depth, 
resulting in a recession ~250µm deep. Electroplating was used to fill the hole/ a filling tolerance of 
~10µm was aimed for. The intention was to create a microwell feature into which the beating cluster 
would be seeded and “held” during the physical attachment period. The intention of this 
manufacturing approach is seen in Figure ‎5.30 and Figure ‎5.31. 
500
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Figure ‎5.31:  A schematic of the intended cross-section though the electroplated microwell. 
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5.6.1.1 Manufacturing Approach One Description 
On overview of this manufacturing approach can be seen in Figure ‎5.32. The CIMOSA modelling 
technique described in Chapter 3 and demonstrated in Chapter 4 has been used to construct these 
manufacturing approach models. 
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Figure ‎5.32: A CIMOSA activity diagram representing the major processes attempted for the via hole filling 
manufacturing workflow design. 
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The processes physically implemented for this manufacturing approach are: 
 P.1. – production of base substrate,  
 P.2. – securing of media well (35mm culture dish),  
 P.3. – drilling of the microwell recessions, 
 P.4. – copper electroplating processes (via hole filling).   
 
Process One – Production of base substrate 
Base substrates were produced using photolithography (section ‎5.4.1.1.1). The precise approach 
implemented for this process is documented in the activity model below (Figure ‎5.35). 
 
Auto_cad
Inkjet printer
Draft paper
LU
Orange dry film
UV source
Pattern
UV source
Etch tank
Stripper Unit
PCB cutter
Deionised water
Developer
t= 240mins
t= 30mins
t= 10mins
t= 10mins
t= 10mins
t= 10mins
t= 10mins
t= 10mins
LU
LU
LU
LU
LU
Photoresist
LU
LU
LU- process
- document
- human resource
- physical resource
- event
- information
- finance
P1.A.1
Obtain substrate 
material 
P.1.A.2
Design pattern
P.1.A.3
Make mask
P.1.A.5
UV expose 
substrate with 
mask in place
P.1.A.6
Develop and rinse
P.1.A.7
Etch and rinse
P.1.A.8
Strip photoresist 
and rinse
P.1.A.9
Cut sheet into 
individual biochip 
substrates
P.1.A.10
Clean and store
P.1.A.4
Laminate FR4 with 
photoresist film
t= 20mins
Alpha 940 
Negative Dry Film 
Photoresist
Laminator
Cu laminated FR4
LU
 
Figure ‎5.33: A CIMOSA activity diagram of the photolithography process used to manufacture Cu patterned 
base substrates for the novel MEA biochip design. 
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For the activities A.1 - A.3 the materials required for this approach were purchased and a conductive 
pattern was designed using AutoCAD software (Autodesk, Inc., CA, USA). The pattern was printed 
onto to draft paper using a deskjet printer. The printed pattern was transferred to orange dry peel 
film by UV exposure resulting in a photomask to scale (Figure ‎5.34).   
 
Figure ‎5.34: An orange dry peel film photomask used in the manufacture of base substrates for the via fill 
approach. 
 
During activity A.4, an A4 sized sheet of Cu coated (35µm) FR4 (Figure  5.19) was laminated by hand 
with a negative dry film photoresist, Alpha 940 (Figure ‎5.35) on one side by passing through an 
Albyco PhotoPro33 laminator (Figure ‎5.36) set at 115°C. A roll through speed of 350mm/min was 
used to ensure a uniform covering.  
 
Figure ‎5.35: Aplha 940 negative dry film photoresist. 
 
During activity A.5, the photomask was then secured over the laminated substrate and the 
combined sheet exposed to UV light using a Parker Graphics UV exposure unit (Figure ‎5.37). 
Exposures were 9 seconds in duration at full power. 
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Figure ‎5.36: The Albyco laminator used to cover the FR4 substrates with the negative dry film photoresist. 
 
 
Figure ‎5.37: The Parker Graphics UV exposure unit used for UV exposure. 
 
During activity A.6, the exposed sheets were passed through a film developing tank (Figure ‎5.38). A 
Roller speed setting 6 (~0.2m/min) was used to pass the sheets through jets of the alkaline K2CO3 
developing solution (1% potassium carbonate). The temperature of the solution was 35°C. 
Developed sheets were rinsed under tap water and dried before etching. 
 
Figure ‎5.38: The dry film developing unit. 
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To etch the exposed areas of Cu, as occurs in A.7, the developed sheets were passed through a Mega 
Electronics etching machine (Figure ‎5.39) containing a ferric chloride solution. The substrate sheets 
were rinsed under tap water and dried.  
 
Figure ‎5.39: The Mega Electronics etching machine. 
 
Throughout activities A.8 – A.10 the developed photoresist was then stripped from each sheet using 
the stripping well portion of a Circuitape Circuit 4 Processor (Figure ‎5.40). Sheets were rinsed under 
jets of distilled water following stripping. The resulting patterned sheets were cut into individual 
biochip substrates by hand (Figure ‎5.41). 
 
Figure ‎5.40: The Circuitape Circuit 4 Processor used for photoresist stripping following Cu etching. 
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Figure ‎5.41: Individual patterned FR4 substrates manufactured for Via hole filling approach 
experimentation. Top: Larger resolutions used during initial process experimentation. Bottom: Ensuing finer 
resolutions.  
 
 
Process Two - Securing of media well 
An example of the commercially available Petri dishes utilised in experiments is seen in Figure ‎5.42.  
 
Figure ‎5.42: A 35mm diameter Petri dish made by Corning, USA. 
 
The process used to secure the commercially available 35mm diameter Petri dish is documented in 
Figure ‎5.43. This process was completed by-hand for speed and convenience as small batches were 
required to experiment with critical approach parameters (e.g. the electroplating parameters were 
more important to spend time on than precise positioning of the Petri dish at this point).  
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Figure ‎5.43:  The activities (carried out by-hand) to secure the Petri dish onto the base substrate. 
 
During activities A.1 – A.7, the materials required were gathered and the biochip components 
cleaned. The two part adhesive was mixed in a small disposable vessel and an approximate amount 
added to the centre of the biochip substrate. The Petri dish carefully positioned over the base 
substrate and a gentle, even force was applied to spread the adhesive between the dish and 
substrate. A circular 25g weight was placed into the Petri dish and the part was left for ~24hours to 
cure. 
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Figure ‎5.44: A biochip base substrate with Petri dish adhered prior to drilling. 
 
The adhesive used in the proof-of-principle tests described was transparent epoxy-based resin 
(Figure ‎5.44), Epoxicure™, manufactured by Buehler (Dusseldorf, Germany). The recommended cure 
time at room temperature, 6 – 8 hours, was exceeded in all devices to ensure the resin was 
completely cured prior to further processing. The ratio of resin to hardener was 5 parts resin to 1 
part hardener. 
 
Process Three - Drilling of microwell recessions 
The process used to create the holes that would subsequently be filled to a controlled depth to 
result in microwells was investigated using two different methods (Figure ‎5.45). Computer 
numerically controlled (CNC) drilling and CO2 laser beam machining (LBM) approaches are described.  
Drilling 500µm diameter hole, through polystyrene and 
epoxy, to a depth of 700-800µm
Computer numerically 
controlled (CNC) 
drilling
Carbon dioxide (CO2) 
laser ablation
 
Figure ‎5.45: Two approaches investigated for the creation of the microwell recessions. 
 
Drilling specification: 
 16x 500µm Ø holes through the polystyrene dish and adhesive to the underlying Cu surface,  
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 in a square arrangement, spaced 5mm apart (Figure  5.46). 
x
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5
To Scale.
Dimensions in mm.  
Figure ‎5.46: The drilling diagram for CNC processing. 
 
Process Three by Computer Numerically Controlled (CNC) Drilling: The CNC drilling procedure 
(Figure  5.48) exploited to produce holes through a polystyrene Petri dish and epoxy resin to an 
underlying Cu electrode pattern was carried out by high-skilled workshop technicians to 
aforementioned specification (Figure  5.46) using a Hurco VM1 3 axis milling machine (Figure  5.47). 
 
Figure ‎5.47: The Hurco VM1 CNC milling machine used in this research. 
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Figure ‎5.48: The CNC drilling process used to drill through the polystyrene culture dish and epoxy resin to 
the underlying Cu pattern. 
 
In activities CNC.A.1 – CNC.A.4, a biochip with Petri dish secured was positioned inside the drilling 
machine and held in place using a jig. The CNC drilling programme was configured and allowed to 
run. The biochip was removed and these steps repeated for each biochip in a batch of 20. 
During CNC.A.5 – CNC.A.8, large debris was shaken off the biochips. To remove smaller debris that 
may have been inside the 500µm diameter holes the biochips were submerged in deionised water in 
an ultrasonic bath for 5 minutes. Samples were dried and the holes were inspected using light 
microscopy.  
 
Process Three by CO2 Laser Ablation: The carbon dioxide laser-based process required precise 
positioning of the substrates in the system such that the co-ordinates of the pins measured and 
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entered into the lasers program were drilled in the precise location required to within a tolerance of 
5 - 10µm. Activities carried out are depicted in Figure ‎5.49. 
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Figure ‎5.49: The CO2 laser process used to drill through the polystyrene culture dish and epoxy resin to the 
underlying Cu pattern. 
 
Activities CO2.A.1 - CO2.A.2 were the start of drilling where the CO2 laser was set-up and the beam 
focused. The typical diameter of the focused beam throughout this process was 0.2 – 0.3mm. The 
pulse repetition rates used were varied across samples in pursuit of approach optimisation. The 
observations and outcomes of this drilling method is detailed in Chapter 6. 
During activities CO2.A.3 - CO2.A.7, a biochip was positioned onto the headstage inside the laser unit 
and secured in place with adhesive tape. The laser program was configured by zeroing the system 
and providing the appropriate drilling co-ordinates. The laser program was run. The MEA biochip 
substrate was removed from the laser system and cleaned. 
(Activities A.3 – A.6 were repeated for each biochip. MEA biochip substrates were processed in a 
batches of 10.) 
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The laser parameters for this approach were: 
 Wavelength: 10.6µm 
 Pulse energy: 10V 
 Focused beam diameter: 0.2-0.3mm 
The laser configurations were tested for this method (Table ‎5.9):  
Table ‎5.9: The CO2 laser repetition rates tested for manufacturing approach one. 
Pulse-repetition 
rate 
Number of 
passes 
Comments 
500/30 2 No hole 
500/35 2 Observed holes not through PS 
to Cu. Measured depths 
between 0.535 - 0.674 µm. 
500/40 2 Not through 
500/50 2, 3 Not through. For three passes 
hole depths between 0.756 – 
0.800µm. Sooty deposits. 
500/65 3 Not through. Sooty deposits. 
500/75 3 Not through Sooty deposits. 
500/85 3 Not through. Sooty deposits. 
500/95 3 Not through. Sooty deposits. 
 
This approach resulted in sooty deposits around the holes. The Petri dish was distorted around the 
holes which were irregular in shape. Debris material also coated the surrounding surface of the Petri 
dish so samples from the CO2 laser drilling method were not carried forward to the electroplating 
stage. 
 
Process Four – Copper electroplating 
The following CIMOSA model (Figure ‎5.50) represents the electroplating stage implemented for this 
research using only samples that had been drilled mechanically using the CNC process. 
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In activity A.1, two electrolyte solutions were tested. One was commercially available through-hole 
plating solution (Electroposit 1300) and the other was a recipe made in-house. 
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Figure ‎5.50: The electroplating process implemented by manufacturing approach one. 
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Home-made electroplating solution 
The electrolyte solution mixed by hand for initial electroplating experimentation failed to produce a 
filling suitable for this work (section ‎6.1.1). 
 
The formula of the electrolyte used was:  
22.4g Copper (II) sulphate hydrate (CuSO4) • 5H2O:  0.26 mol/dm
3  
42.61ml Sulphuric acid (H2SO4):  2.0 mol/dm
3 
357.4ml Deionised water 
This recipe is for 400ml of electrolyte which was the quantity mixed for each test.  
 
Operating conditions used:  
Temperature: Room temperature 18-20ºC 
Agitation: Regular agitation by ultrasonic vibration. 
Ventilation: Electroplating took place in a well-ventilated laboratory. 
 
Commercial Solution 
The Electroposit™ 1300 acid copper solution (The Dow Chemical Company, USA) is a single 
component additive that is specifically designed to improve reliability in via and through-hole plating 
in PCB manufacture.  
As the Electroposit solution is a commercial product the formula is unavailable. The mixture is 
however described as > 95% water and <5% inorganic salts. 
 
The advised operating conditions were adhered to while using this solution: 
Temperature: advised 20-25ºC, used 20 ºC.  
Agitation: advised moderate, used stirring and occasional ultrasonic bath. 
Ventilation: advised to work in a ventilated space, used a ventilated laboratory. 
 
The results of electroplating were improved by using this solution. The outcomes were however not 
up to the standard required of this application (see section ‎6.1.1). 
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Activities A.2 – A.3 of Figure ‎5.50 demonstrate the electroplating set up. The equipment used was 
set-up and a cathode and anode created using electrode probes and a copper sheet (Figure ‎5.51). 
The electrolyte solution was added to a glass vessel into which the biochip was submerged vertically. 
The areas of the biochip that were not to be plated (tracking and peripheral interconnect points not 
insulated by the Petri dish) were previously covered in protective insulating tape and the anode 
connection made using solder paste.  
A.4 – A.10: Place the glass vessel into an ultrasonic bath. Suspend the copper cathode in the 
electrolyte close to the Petri dish connect both the cathode and the anode to the DC Supply TTi PL 
330 unit. Begin electroplating by switching on the power supply. Turn on the ultrasonic bath every 
thirty minutes for five minutes to dislodge any air bubbles. After 7-8 hours switch off the power 
supply.  
 
Figure ‎5.51: The electroplating set-up used for the via hole filling manufacturing approach. 
 
A.11 – A.13: Remove biochip from the solution and rinse under deionised water. Prepare samples for 
quality inspection. 
 
Cross-sections of the holes filled using this approach are contained in section ‎6.1.1. 
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5.6.1.2 Manufacturing Approach One Summary 
A 35mm diameter Petri dish was adhered over a prepared Cu patterned base substrate using an 
epoxy resin. Drilling of 16, 500mm diameter holes, 5mm apart was computer-numerically controlled 
(CNC) allowing hole depth controlled to a tolerance of a few micrometres. The tolerance for this 
aspect is important to prevent detrimental removal of the underlying Cu pattern that was essential 
for successful electroplating. The drilled holes were ~800µm in depth. A conventional via hole filling 
(electroplating) procedure was adopted to fill the 500µm.  
 
Figure ‎5.52: An exploded view of the amended original concept according to the possibilities of the initial 
design of a manufacturing approach using via hole filling techniques. 
 
Copper (Cu) filling to a depth of ~600µm was aimed for with Gold (Au) to be plated on top to seal in 
the Cu, creating a cell-friendly surface. An exploded diagram depicts the intended Cu filling of the 
drilled holes (Figure ‎5.52). 
This approach initially plated too slowly using the home-made electrolyte. When the electrolyte was 
replaced for a commercial equivalent the quality of the outputs improved but the presence of air 
bubbles in all samples plated was a continuing problem.   
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5.6.1.3 Evaluation of Manufacturing Approach One 
The via hole filling approach produced the following outcomes. 
Table ‎5.10: The outcomes of the via hole filling approach. 
Priority Critical Manufacturing Outcome Approach achieved? 
1 Produce satisfactory base substrate Yes 
2 Produce satisfactory media well Yes 
3 Facilitate adequate attachment of the media well and base 
substrate components 
Yes 
4 Produce a satisfactory electrode site for cell-electrode 
interfacing 
No 
5 Produce an appropriate micro-well geometry around 
electrodes 
No 
6 Produce enough sites so as to allow assignment of a reference No 
7 Produce an MEA biochip that allows appropriate optical 
inspection of living samples 
No 
 
Further description of the results of this approach are contained in section ‎6.1.1. 
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5.6.2 Manufacturing Approach Two: Vertical Pins. 
An alternative manufacturing approach was developed in parallel with the on-going experimentation 
of the via hole fill approach. 
The vertical pin approach was considered as a potential avenue for developing an MEA biochip that 
has vertical as opposed to presently commercially available horizontal interconnections. A metallic 
pin was sought to serve as the electrode tip that could be mounted such that it would protrude 
through the culture dish into a drilled microwell recession to a controlled depth, thus filling the hole 
to result a ~200-250µm microwell feature with an electrode at the bottom (Figure ‎5.53). 
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Figure ‎5.53: A schematic of the intended cross-section at the microwell-electrode site for the Gold Pin 
manufacturing approach. 
 
Vertical interconnects are described in the original novel system vision. The intention of vertical 
connections is to support the pursuit to reduce the overall footprint of the MEA system. Moving the 
interconnect points away from the biochip periphery would be novel in in vitro MEA biochips and 
the use vertical pin interconnects would enhance the feasibility of creating a system where the 
electronics are contained in a compact package underneath the MEA biochip while in situ.   
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5.6.2.1 The Pins 
The pins used in early approach experimentation were sourced from pin grid arrays, PGA 
(Figure ‎5.54) as they are easy to obtain quickly and at low cost.  
 
Figure ‎5.54: A standard 68-pin gate array. 
 
The pins used were made of beryllium copper core, encased by a tin pin protrusion that is plated in 
100µm nickel. It was intended that once the overall approach was approved the pins used would be 
replaced with the more expensive Au equivalents so as to introduce biocompatibility. 
 
 
Figure ‎5.55: A visualisation of the PGA Gold Pin concept and the microwell-electrode site. 
 
The new design concept (Figure ‎5.55) connects the vertical interconnect points to a patterned FR4 
base substrate to accommodate proof-of-principle testing in an existing MEA system. 
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5.6.2.2 Manufacturing Approach Two Description 
Processes implemented for this manufacturing approach are (Figure ‎5.56): 
 P.1. – Make patterned MEA base substrate 
 P.2. – Drill Petri dish 
 P.3 – Produce electrode in microwell 
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Figure ‎5.56: A CIMOSA activity diagram representing the major processes attempted for the Gold Pins 
manufacturing workflow. 
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Process One  – Make patterned MEA base substrate 
For details of the UV photolithography method used to manufacture the base substrate see 
section ‎0. 
To connect the sections of pins (four pins per section) tin (Sn) paste was used to create a conductive 
interface between the vertical pins and the underlying Cu patterned FR4 substrate. In future designs 
the patterned base substrate is not intended to be a necessary feature of the design as vertical pins 
are intended to connect straight in the system electronics below.  
Process Two - Drill Petri dish. 
The Hurco VM1 3 axis milling machine was used to drill holes in the Petri dishes that would align 
with the spacing of the PGA pins. PGA pin alignment was measured using a Zygo 3D touch probe and 
co-ordinates calculated for the CNC program.  
Process Three - Produce electrode in microwell 
For this process attention was paid toward how to locate the pins in the correct position. 
Fundamentally two methods were considered (Figure ‎5.57).  Both methods considered for securing 
the pins were intended to hold the pins in position in a robust, water-tight manner at a controlled 
depth, allowing the pins to create electrode tips over which contracting SC-CM clusters could be 
seeded. 
Vertical Pin Design Concept 
Manufacturing Approaches
Method One Method Two
A B
Push pins through 
as far as possible 
and secure and 
fill.
Re-drill to produce 
microwell 
recession at 
electrode
Push to level that 
is flush with 
surface and 
secure and fill.
Cut back excess 
pin
Re-drill to produce 
microwell 
recession at 
electrode
Position pin so tip 
is at desired level 
and secure and fill
 
Figure ‎5.57: The different methods experimented with for the vertical pin approach.  
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1. Push pin through pre-drilled hole in Petri dish firmly to furthest point, fix in position using a 
filling and sealing material, cut-off the protruding part of the pin and drill the pin back down 
to a level that is ~200-250µm from the culture dishes surface. 
2. Position pin precisely in pre-drilled hole to a controlled depth, control adhesion and filling 
around the pin to hold in correct position.  The manufacturing approach did not progress 
past this point during this research as alternative approaches yielded prototypes for testing 
(see sections ‎5.6.3 and ‎5.9). 
Method 1 above requires a precise re-drilling procedure to ensure the first drilling of holes aligns 
exactly with the second. The drilling was to be carried out using the CNC procedure documented in 
section Error! Reference source not found.. 
Method 2 required a device to facilitate controlled pin positioning during the securing process, 
ensuring that the pin tip (serving as the electrode tip) is 200-250µm from the inner surface of the 
Petri dish. This approach contemplated whether to position pins level with culture dish surface and 
drill back slightly (method 2A, Figure ‎5.58) or, to position the pin tip at the correct depth, removing 
the  second drilling process (method 2B, Figure ‎5.59). 
Method Two A 
A circular, perfectly flat mild steel weight was placed into the Petri dish over the holes. The 
transparent adhesive, Araldite Instant Clear, was injected all around the pins and left for 24 hours to 
harden. A second drilling over each pin to a depth of 200-250µm was then to be carried out to 
create a concave pin tip and therefore microwell.   
 
Figure ‎5.58: Method 2A. A) Secure pin tips flush with the inner surface of the Petri dish. B) Drill back 200-
250µm to create a microwell.  
Method Two B 
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A custom-made block with precisely aligned nipples was to be used to hold pins to the desired depth 
during filling and sealing. This method was not practically implemented by this research as an 
alternative manufacturing method produced prototypes for testing prior to manufacture of the 
nippled block.  
 
Figure ‎5.59: Method 2B. A) Secure pin tips at desired depth using nippled block. B) Remove block leaving 
pins in place. 
 
 
5.6.2.3 Manufacturing Approach Two Summary  
A section of mounted pins were adhered to a previously made patterned base substrate. Holes were 
drilled into a commercially available 35mm diameter Petri dish. The intention was to mount the Petri 
dish over the pins in a controlled manner. Two methods were considered for ensuring the provision 
of a microwell that the specified meets user requirements. One method considered a second drilling 
of pins after mounting. Another considered precise positioning so as not to require a second drilling 
procedure. This approach failed to yield a prototype. The outcomes are summarised in following 
section and described in greater detail in Chapter 6.   
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5.6.2.4 Evaluation of Manufacturing Approach Two 
This approach was under investigation concurrently with manufacturing approaches one and three. 
The outcomes are summarised Table ‎5.11 and described in greater detail in Chapter 6.   
Table ‎5.11: The outcomes of the gold pins approach. 
Priority Critical Manufacturing Outcome Approach achieved? 
1 Produce satisfactory base substrate Yes 
2 Produce satisfactory media well No 
3 Facilitate adequate attachment of the media well and base 
substrate components 
No 
4 Produce a satisfactory electrode site for cell-electrode 
interfacing 
No 
5 Produce an appropriate micro-well geometry around 
electrodes 
No 
6 Produce enough sites so as to allow assignment of a reference No 
7 Produce an MEA biochip that allows appropriate optical 
inspection of living samples 
No 
 
Further results of this approach are contained in section ‎6.1.2. 
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5.6.3 Manufacturing Approach Three: Micro Drilling 
As the Via Fill and Gold Pin approaches were being optimised a third alternative approach was also 
conceived and concurrently investigated.  
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Figure ‎5.60: A schematic of an intended cross-section of the microwell-electrode site for the micro-drilling 
approach. 
 
This manufacturing approach was the first of the three approaches under development to yield a 
prototype suitable for presentation to and testing by our external collaborating user group at the 
UoN. A cross-section schematic of the microwell feature produced using this approach is 
represented in Figure ‎5.60. 
This approach aimed to create a microwell over each electrode site by carefully drilling a 500µm hole 
through a layer of insulating material (Figure ‎5.61). This process was implemented with glass and 
polyester coverslip materials. Outcomes of implementation are included in section ‎6.1.3. 
 
Figure ‎5.61: An exploded view of the micro drilling concept where the Melinex film is drilled through over 
the conductive pattern to form a microwell over each electrode. 
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5.6.3.1 Manufacturing Approach Three Description  
All of the processes of this manufacturing approach were implemented (Figure ‎5.62). 
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Figure ‎5.62: A CIMOSA activity diagram representing the major processes attempted for the micro drilling 
manufacturing workflow. 
 
 P.0. – Source consumables 
 P.1. – Make patterned MEA base substrate 
 P.2. – Gold plate copper base substrate 
 P.3 – Adhere coverslip material 
 P.4 – Drill holes 
 P.5 – Clean 
 P.6 – Secure media well 
 P.7 – Clean 
 P.8 – Package and distribute for testing 
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Process One – Make MEA base substrate 
The process used to make the base substrate pattern is described in section ‎0. 
Process Two – Gold plate base substrates 
Base substrates were outsourced to PMD Group, Coventry, UK for Au plating. The Au coating was 
approximately 3-5µm thick. 
Process Three – Add coverslip material 
Coverslip material was employed as a growth surface and insulator due to depth problems 
encountered when using the 35mm diameter Petri dish. The Petri dish was base was also relatively 
thick (~800µm) in comparison to coverslips. Therefore the hole in the Petri dish (plus adhesive) was 
too deep to meet user specified microwell depth. Filling wasn’t producing satisfactory results so an 
alternative approach was to alter the insulating material and media well. Coverslip coverglass 
material is available in thicknesses from 150 to 220µm. These thicknesses plus adhesive held the 
potential to create a well simply by drilling through them. Glass and polyester coverslips were 
tested. A specialist film, Melinex, was also commercially available as a specifically treated cell culture 
substrate material in sheets of thicknesses 125 - 350µm. Being available in sheet form offered 
advantages over coverslips that are available in standard geometries, or alternatively if custom made 
are high cost.  
Process Four – Drill holes  
CNC drilling and Excimer laser ablation were considered for precision drilling of holes through the 
insulating material to the underlying electrode pattern (Figure ‎5.63). These methods were both 
implemented with polyester and glass coverslips and Melinex film. The results for each material 
investigated are discussed in section ‎6.1.3. 
 
Au plated conductive pattern insulated by 
sheet material (e.g. glass, polyester)
CNC Drilling
Excimer laser 
ablation
 
Figure ‎5.63: The two methods of drilling the 500µm diameter holes required to produce the microwell 
features. 
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The CNC drilling approach detailed in section Error! Reference source not found. using the Hurco 
VM1 3 axis milling machine was used to create 500µm diameter holes over each electrode. 
This approach damaged the surface of electrodes resulting in exposed copper and was therefore not 
appropriate for further investigation. 
An Excitech Lambda Physik LPX 100i Excimer laser, consisting of a short-pulse laser source (KrF, 
wavelength 248nm) and an Aerotech positioning system was used to ablate 500µm diameter holes 
at each electrode site (Figure ‎5.64). 
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Figure ‎5.64: An activity diagram of the Excimer laser process implemented by this research. 
 
During activities A.1 – A.3, a mask was made by drilling a 5mm diameter hole into a brass plate. The 
brass plate was inserted into the laser system during set-up. A program was written and configured 
to control the laser source and positioning system. 
During A.4 – A.5, biochip substrates were positioned on the positioning system’s headstage one at a 
time and the laser program run. These two activities were repeated until a batch consisting of 
between 4 to 10 samples (depending on success of previous sample) had been machined. Where the 
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processed showed to be repetitively breaking or causing damage to the sample, testing was ceased. 
The program was adjusted to testing different degrees of exposure. Figure ‎5.65 demonstrates the 
system and the system while carrying out this process. The results of this activity using three 
different test materials are included in this thesis in section ‎6.1.3.2.  
 
 
Figure ‎5.65: The Excimer laser system used in this research with example of a base substrate being 
processed. 
 
For activities A.6 –A.7, each hole of each biochip was inspected optically. If samples demonstrated 8 
good holes they were cleaned and progressed to the next process. 
Process Five - Clean 
Samples were placed into glass vessel containing deionised water. The glass vessel then was placed 
into an ultrasonic bath for 50 minutes to remove any debris from the ablated holes.  
Process Six - Secure media well 
Two adhesives were used to secure a PE and glass ring to the surface of the insulating Melinex™ film. 
The results of adhesive testing for this prototype are contained in section ‎6.1.3.  
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Process Seven – Clean 
The cleaning process was completed by submerging the completed biochips in 70% ethanol in an 
ultrasonic bath for 2 minutes, removing and leave to dry.  
Process Eight – Package and distribute for testing 
Packaging for storage and transportation exploited 90mm diameter Petri dishes. Biochips were 
secured to the surface using adhesive tape and the lid placed over the top. Lids were seal with 
adhesive tape to prevent dust contamination and prototypes were delivered to the UoN for testing. 
 
5.6.3.2 Manufacturing Approach Three Summary 
This approach created a microwell in the insulating material over each electrode (see Figure ‎5.66). 
An FR4 base substrate that had been patterned in Cu and outsourced for a thin layer of Au to be 
electroplated on top was insulated using a layer of cell friendly material (e.g. polyester, polystyrene, 
glass) with a thickness comparable to the specified microwell depth. An excimer laser process 
successfully removed selective areas of insulator over the underlying gold electrodes. 
 
Figure ‎5.66: A CAD model of the concept and microwell site for the micro drilling manufacturing approach. 
 
The approach exploiting an excimer laser produced results of a satisfactory quality for testing with 
live SC-CM cells. Live testing is incorporated into this thesis in Chapter 6. 
 
318 
 
__________________________________________________________________________________
Requirements, Concept Design, and Manufacturing Approach 
5.6.3.3 Evaluation of Manufacturing Approach Three 
The micro drilling approach produced the following outcomes. 
Table ‎5.12: The outcomes of the micro drilling (Excimer laser) approach. 
Priority Critical Manufacturing Outcome Approach achieved? 
1 Produce satisfactory base substrate Yes 
2 Produce satisfactory media well Yes 
3 Facilitate adequate attachment of the media well and base 
substrate components 
Yes 
4 Produce a satisfactory electrode site for cell-electrode 
interfacing 
Yes 
5 Produce an appropriate micro-well geometry around 
electrodes 
Yes 
6 Produce enough sites so as to allow assignment of a reference Yes 
7 Produce an MEA biochip that allows appropriate optical 
inspection of living samples 
No 
 
This manufacturing approach resulted in the first prototype (Figure ‎5.67) available for testing.  
Further description of the results of this approach are contained in section ‎6.1.3. 
 
 
Figure ‎5.67: Prototype One. A) Made using 33mm diameter opaque polyester media well ring, adhered using 
epoxy resin. B) Made using 22mm diameter glass ring, adhered using silicon sealant.  
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5.7 Prototype One Design Iteration 
Prototype one underwent a period of testing that was conducted by MEA users in a cell culture 
laboratory at the University of Nottingham, UK. Testing was conducted in small batches. Feedback 
was collected through observation of the prototype in use, and through interviews following testing. 
Early feedback led to sub-component alteration of the prototype.  
Further testing that ensued following sub-component amendment resulted in total MEA biochip re-
design. Testing is described fully in section ‎6.2.1. 
5.7.1 Early testing of prototype one. 
Problem 1: The media well geometry specified by the user was excessive. The media well was too 
deep so in retrospect the end users specification was incorrect. 
Problem 2:  The initial feedback (received during testing of the first batch of prototypes, Figure ‎5.68) 
was that the optics where too restricted when compared to using to the commercial standard.  
Problem 3: The beating cluster was difficult to position into the microwells. It was suggested that 
this was due to the combination of the reduced lighting of the culture media, the large media well 
wall height, and the geometry of the microwell or size of the beating culture used in this particular 
instance. 
Problem 4: No beating clusters attached inside a microwell. Contractions could not be observed. No 
signals were recorded. 
Action: The opaque polyester ring used as the media well (Figure ‎5.67,A) was replaced with a glass 
alternative of smaller dimensions (diameter 22mm, height 6mm) to improve lighting for optical 
enhancement and to improve access to the microwells. Further testing using the amended 
prototype (Figure ‎5.67,B) was conducted. 
Problem 4: The adhesive used to secure the Melinex™ film (insulating and microwell material) to the 
base substrate and the media well to the Melinex™ film showed signs of having absorbed some 
culture medium after use. A pink residue was present in each microwell and around the inner seal of 
the media well to Melinex film joint. 
Action: Replace adhesive with a non-absorbent alternative. 
 
320 
 
__________________________________________________________________________________
Requirements, Concept Design, and Manufacturing Approach 
 
Figure ‎5.68: Seeding of a beating cluster of stem cell-derived cardiomyocytes into prototype one. 
 
5.7.2 Ensuing testing of prototype one. 
An example of the alterations made to the first prototype design following the first batch of tests 
can be seen in Figure ‎5.67. This amended version of prototype underwent further testing and the 
following problems were identified and actions taken as solutions. 
5.7.2.1 Problems and solutions 
Each problem identified through the wet testing conducted at the UoN is documented in Table ‎5.13. 
The implications of the problem are briefly presented from the users’ point of view and the actions 
decided upon to address each problem is described. 
Problem 1: Scientists could still not confirm whether clusters were contracting or were adequately 
attached due to the limited optics. 
Action: Replace the translucent base substrate with a transparent alternative. 
Problem 2: Although seeding of cells into microwells was more successful a number of seeded 
beating clusters did not attach inside the microwell. 
Action: Alter microwell geometry. 
Problem 3: No signals were recorded from any of the MEA biochip prototypes where beating 
clusters were growing inside a microwell. 
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Action: Investigate cell-electrode interface. Amend electrode design to improve likelihood of good 
cell-electrode interface formation. Investigate if detection system parameters are appropriately 
complimentary for detection of the microvolt signals. Adjust detection system parameters if 
appropriate. 
Problem 4: The media well joint between the glass ring and the Melinex™ film failed during second 
use. 
Action: Investigate suitable alternative and replace the adhesive.  
 
5.7.3 MEA Biochip Re-design 
A number of problems were identified with the first concept that impact upon the success of the 
design concept and the manufacturing approach used to construct the prototype. The MEA biochip 
design was revised.  Actions that were considered necessary by this research to produce a final 
device that would meet the user needs are collated and Table ‎5.13.  
Table ‎5.13: Problems associated with prototype, the implications each problem has for the user and actions 
to solve each problem. 
Problem Implication for user Action to solve 
Difficulty getting beaters 
to attach inside the 
microwells 
Cells must attach very close to, or 
on, the electrode surface for a 
signal to be detected. 
Improve ease of cell positioning 
by increasing the size of the 
microwell. Cloning rings (viable 
in Figure ‎5.68) are used to aid 
cell positioning. The new 
microwell geometry 
specification was diameter 
800µm to 4mm, height 200 - 
250µm.  
The level of optical 
inspection was not 
suitable for confirming 
the degree of attachment 
of the beating cluster to 
the surface or if the 
The clusters of cells that are 
derived from stem cell in this way 
contract spontaneously. Clusters 
may stop contracting at any time 
for currently unknown reasons. A 
signal will only be detected from a 
Change the base substrate to 
glass to suit the inverted 
microscope facilities at the 
testing laboratory. 
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cluster is contracting. beating cluster. The routine prior 
to setting up an MEA based test 
using cardiomyocytes involves 
visually confirming that cells to be 
recorded from are both attached 
to the MEA surface and are 
contracting. Cells are also checked 
visually during testing. 
Where a beating cluster 
is seen to be inside the 
microwell no signals have 
been recorded from any 
of the devices tested. 
The signals recorded contain the 
information of use to the scientist. 
Without signals this device fails. 
Investigate possibility of short 
circuits in the prototype device. 
Investigate alternative 
electrode geometries that offer 
greater likelihood of beating 
cluster attachment. 
 
 
5.7.4 Section Summary 
The prototype devices manufactured using manufacturing approach three – micro drilling – were 
tested in wet trails using live stem cell-derived cardiomyocyte beating clusters. Problems were 
identified with:  
 adhesive 
 well size 
 well material 
 micro-well geometry 
 base substrate transparency 
 signal capture 
Actions to address the identified problems (Table ‎5.13) were incorporated together into an 
improved design concept. Design concept 2 and the required manufacturing approach to produce 
prototypes for testing are presented in the following section. 
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5.8 Prototype Two Manufacturing 
 
An improved concept design was conceived to address the following actions defined as required of 
this research: 
1. Improve ease of cell positioning by increasing the size of the microwell. Cloning rings (viable 
in Figure ‎5.68) are used to aid cell positioning. The new microwell geometry specification 
was diameter 800µm to 4mm, height 200 - 250µm. 
2. Change the base substrate to glass to suit the inverted microscope facilities at the testing 
laboratory. 
3. Investigate why no signals were detected. Consider the possibility of short circuits in the 
prototype device. Investigate alternative electrode geometries that offer greater likelihood 
of beating cluster attachment. Consider if detection system was appropriately matched.  
5.8.1 Generation Two Concept Design 
The actions are present in the concept design alteration in the following ways. 
1. Improve ease of positioning – The purpose of the microwell feature is to provide a perimeter 
around the area of MEA biochip’s surface where the electrodes are located. This perimeter is 
intended to ensure that the beating clusters containing cardiomyocyte cells, which move 
due their contracting nature, attach over an electrode every time. There can also be 
additional movement of the beating cluster from the original position on which it has been 
positioned due the fact that the MEA biochip must be moved by hand from the culture hood 
where seeding takes place, into an incubator. A larger perimeter has been specified to 
ensure the beating cluster of cells can settle and attach within it. Consequently the electrode 
geometry was increased. 
2. Change the base substrate – The area of micro electrode array workspace for all 
commercially available MEA biochips is made from glass. The use of glass for this part of the 
device allows good quality visual inspection of the cellular sample. This work has used glass 
to allow visual confirmation that cell samples seeded are contracting before testing and to 
allow verification that the beating cluster is attached to the base substrate. The electrode 
geometry has been amended to facilitate optics. 
3.  Investigate why no signals were detected – The conductivity of the surrounding culture 
media (DMEM) was assessed and impedance of the electrodes compared to a previously 
demonstrated commercial equivalent. The electrode geometry was altered in two variants 
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to ensure that an increased number of beating clusters seeded would attach to the 
electrode surface. 
5.8.1.1 MEA biochip Concept 2 
The re-designed MEA biochip is demonstrated in Figure ‎5.69. Two different electrode geometries 
were considered to address the question – will altering the electrode geometry influence signal 
detection? Both variants of electrode were manufactured in exactly the same way at the same time 
using a clean room based UV photolithography process. The patterned MEA biochip substrates were 
outsourced to Fondazione Filarete, Milan, Italy, for microwell creation using a novel process 
currently under development. 
 
Figure ‎5.69: An exploded view of MEA biochip design concept 2. 
 
The results for both A and B versions of this chip in live testing were the same. User feedback 
showed slight variation as the user commented that the radiator (B) pattern was easier to use as the 
cloning ring appeared to catch on the spiral design, making movement more awkward. Details of 
testing and results are contained in Chapter 6. 
5.8.1.1.1 A – Spiral electrode 
The spiral shaped electrode was designed to the following specification: 
 Spiral diameter: 3.5mm 
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 Width of track from contact pad to spiral: 150µm 
 Width of spiral tracking: 80µm 
 Spacing between spiral tracking: 150µm 
 Contact pad: 2mm x 2mm 
 Largest gap between tracking (at spiral centre): <300µm 
The position of the contact pads matches commercial equivalents so that the biochip can be tested 
in the headstage of a commercial MEA system (MCS MEA-60). The artwork generated for this 
electrode pattern is below (Figure ‎5.70).  
 
Figure ‎5.70: Artwork generated for the spiral electrode design. 
5.8.1.1.2 B – Radiator Electrode 
The radiator shaped electrode was designed to the following specification: 
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 Radiator dimensions: 2.5mm x 2.75mm 
 Width of track from contact pad to radiator: 150µm 
 Width of radiator tracking: 100µm 
 Spacing between tracking: 100µm 
 Contact pad: 2mm x 2mm   
 Largest gap between tracking (at spiral centre): <300µm 
The position of the contact pads matches commercial equivalents so that the biochip can be tested 
in the headstage of a commercial MEA system (MCS MEA-60). The electrode pattern can be seen 
Figure ‎5.71.  
 
Figure ‎5.71: The radiator shaped electrode. 
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5.8.1.1.3 Microwell 
The material that was selected for insulation and microwell formation in this design was 
polydimethylsiloxane (PDMS). PDMS is a lower cost material than traditional micro-fabrication 
materials such as silicon and glass (Jo et al, 2000). PDMS is also chemically inert, thermally stable, 
and simple to handle (Mata et al, 2005) and has been successfully demonstrated in biomedical 
microdevices (Fujii, 2002; Yabuta et al, 2003).  The application of the PDMS onto the glass substrates 
was carried out by a collaborating research group at Fondazione Filarete, Milan, Italy using a plasma 
surface activation technique to adhere hand stamped PDMS discs over the biochip surface 
(Figure ‎5.72). 
 
 
Figure ‎5.72: A CAD representation of the intended design concept 2 with PDMS microwells. 
 
The results of this approach are presented in section ‎6.2.2. 
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5.8.2 Manufacturing Approach Four: Clean Room Based 
Photolithography 
All of the processes of this manufacturing approach were implemented (Figure ‎5.73). 
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Figure ‎5.73: An activity diagram depicting the major processes used in clean room based MEA biochip 
manufacture. 
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All of the processes were successfully implemented resulting in the production of prototype 
biochips. 
P.1. – Use electron beam deposition to coat glass slides with titanium and then gold. 
P.2. – Spin coat the Ti/Au coated glass substrates with photoresist 
P.3. – Expose the photoresist coated samples to UV light with patterned photomask in place. 
P.4. – Develop the exposed photoresist 
P.5. – Etch the exposed areas of the Au and Ti layers  
P.6. – Strip the remaining photoresist to expose Au pattern 
P.7. – Adhere PDMS microwells 
P.8. - Add a media well to each biochip 
P.9. – Package for transportation 
P.10. – Distribute for testing 
 
 Process One – Electron beam deposition 
An electron beam deposition system was used for this process (Figure ‎5.74). The process used to 
make the base substrate pattern is described in Figure ‎5.73. Additional drill down models of each 
activity can be viewed in Appendix E. Coating was done using batches of five base substrates. 
Substrates were coated in Ti then Au while inside the system. 
 
Figure ‎5.74: Electron beam deposition system. 
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Figure ‎5.75: The process used to make the base substrate pattern for the clean room based manufacturing 
approach. 
 
In activities A.1 – A.3 (Figure ‎5.74) the deposition was set-up by switching on the electron beam (e-
beam) deposition system and venting the chamber up to atmospheric pressure. The chamber was 
opened and the glass wafers that have the glass base substrates secured (Figure ‎5.76) were placed 
inside on to the turn table (Figure ‎5.77). 
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Figure ‎5.76: Glass base substrate secured to glass wafer for mounting in the e-beam deposition system 
chamber. 
 
 
Figure ‎5.77: The turn table inside the chamber that allows sample to be rotated directly over the metallic 
source as it is heated by the electron beam. 
 
For activities A.4 – A.6, the chamber was closed and pumped down to low pressure. Ti deposition 
was performed first. Then the source crucible was rotated to the Au and Au was deposited over each 
substrate. When completed the system was allowed to cool and vented back to atmospheric 
pressure. The chamber was opened and the coated glass substrates removed (Figure ‎5.78).  
 
Figure ‎5.78: A Ti/Au coated substrate. 
 
For system shut down, A.7, the chamber was closed, pumped down and switched off.  
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Process Two – Spin coat 
The negative photoresist AZ 9260 was applied to each substrate by hand using a spin coating 
machine. Figure ‎5.79 shows the processes used. 
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Figure ‎5.79: The activities carried out for spin coating of the glass base substrates. 
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For A.1 the SPS spin processor 150 (Figure ‎5.80) was switched on and allowed to initialise up to the 
programming options.  
 
Figure ‎5.80: The SPS spin processor 150 used in this manufacturing approach. 
 
Table ‎5.14: The Spin coating program used to apply AZ 9260 photoresist. 
Step One Step Two 
Time 60 Time 40 
RPM 400 RPM 2400 
 
During activities A.2 – A.4 the substrate to be coated was positioned as centrally as possible onto the 
chuck. The vacuum was switched on to hold substrate in position. Using a disposable pipette 2.5ml 
of the AZ 9260 photoresist was dispersed onto the substrate in the centre (Figure ‎5.81) while taking 
care not create any air bubbles in the resist.  
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Figure ‎5.81: Application of AZ 9260 onto a Ti/Au coated base substrate. 
 
For activities A.5 – A.8 the coating program was allowed to run. When the program was complete 
the lid was opened, the vacuum switched off and the coated substrate removed. Substrate where 
then left for 15 minutes before baking on a hot plate (Figure ‎5.82) at 100ºC for 3 – 4 minutes. 
 
Figure ‎5.82: The hot plate and temperature control unit used in this manufacturing approach. 
 
Process two was repeated for each individual base substrate. 
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Process Three – UV expose 
Each photoresist coated substrate was exposed one-by-one in a UV exposure machine (Figure ‎5.83).  
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Figure ‎5.83: An activity model of clean room based UV exposure.  
 
For activities A.1 – A.2 of process three the UV exposure unit (Figure ‎5.84) was switched on, allowed 
to initialise and programmed to exposure for a given period (30s) at a set energy (800mJ/cm2).  
 
Figure ‎5.84: The UV exposure system. 
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For activities A.3 – A.6 the AZ 9260 coated substrates were positioned on the system’s stage. The 
acetate photomask (printed by JD Photo-Tools Ltd, Oldham, UK) was carefully lined up over the 
substrate by hand and a vacuum switched on to secure. The exposure program was run. When 
complete the substrate was removed from the system. This process was repeated for each base 
substrate.  
 
Figure ‎5.85: A coated substrate being positioned in the UV exposure system with the acetate photomask in 
place. 
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Process Four – Develop 
The following model (Figure ‎5.86) described the activities carried out to develop the exposed 
substrates. 
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Figure ‎5.86: Developing the UV exposed base substrates. 
 
For activities A.1 – A.4, a glass Petri dish was filled with 200ml of AZ developer, 1 part AZ® 400K with 
3 parts purified water. The substrate was placed into the Petri dish and gently agitated to move the 
solution over the surface. The substrate was left in the developer (Figure ‎5.87) for 8-10 minutes until 
all of the exposed resist had been removed. The substrate was removed from the solution and 
rinsed under purified water. To dry the sample a pressurised stream of nitrogen gas was moved over 
the surface.  
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Figure ‎5.87: A base substrate in AZ developer. The pattern can be seen as the exposed areas of photoresist 
are dissolved. 
 
 
Process Five – Etch 
Etching was a two part process (Figure ‎5.88). The gold material was etched using a solution of nitric 
acid mixed with hydrochloric acid (1: 3 parts respectively). The titanium layer was then etched using 
a solution of hydrofluoric acid (HF) with hydrogen peroxide in deionised water (1: 1:20 parts 
respectively).  
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Figure ‎5.88: An activity diagram of the etching activities carried out for the clean room manufacturing 
approach. 
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To complete activities A.1 – A.8 200ml of the gold etchant solution was poured into a glass Petri dish 
and 200ml of the titanium etchant was poured into a polystyrene petri dish. The base substrate was 
placed into the etchant and gently agitated until the exposed metal was removed. The substrate was 
rinsed under purified water and dried under the nitrogen gas stream between etches, and again 
after etching. See Figure ‎5.89 for images of the process etching conducted. 
 
Figure ‎5.89: The etching of design concept 2 base substrates. 
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Process Six – Strip 
The process used to strip the remaining photoresist from the patterned substrate is documented in 
Figure ‎5.90. Substrates were clean using acetone manually in a one-by-one fashion. Each one was 
them rinsed and dried using nitrogen gas. 
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Figure ‎5.90: The photoresist stripping process for the clean room-based manufacturing approach. 
 
Process Seven – Adhere PDMS microwells 
The PDMS microwell and insulating material was applied to the prepared base substrate 
(Figure ‎5.91) by researchers at Fondazione Filarete, Milan. 
 
Figure ‎5.91: A base substrate with the PDMS microwells adhered. 
 
Process Eight - Add media well 
The media well attachment was conducted using the same process described in section ‎0. 
Processes 9 and 10 – package and distribute are the same as those described in section ‎0. 
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5.8.3 Manufacturing Approach Four Summary 
This manufacturing approach was completed inside a class 1000 clean room at Heriot Watt 
University, Edinburgh, UK. UV photolithography tooling was used to produce patterns in Ti/Au of 
resolutions down to 80µm. Two pattern variants were manufactured as one batch. A total of 24 base 
substrates were patterned. After a quality inspection the base substrates suitable for testing were 
constructed into MEA biochips for wet testing at the University of Nottingham.  
 
5.8.4 Evaluation of Manufacturing Approach Four 
The clean room based photolithography approach produced the following outcomes. 
Table ‎5.15: The outcomes of the micro drilling (Excimer laser) approach. 
Priority Critical Manufacturing Outcome Approach achieved? 
1 Produce satisfactory base substrate Yes 
2 Produce satisfactory media well Yes 
3 Facilitate adequate attachment of the media well and base 
substrate components 
Yes 
4 Produce a satisfactory electrode site for cell-electrode 
interfacing 
Yes 
5 Produce an appropriate micro-well geometry around 
electrodes 
Yes 
6 Produce enough sites so as to allow assignment of a reference Yes 
7 Produce an MEA biochip that allows appropriate optical 
inspection of living samples 
Yes 
 
This manufacturing approach resulted in the second generation of prototype available for testing 
(Figure ‎5.92).  Further description of the results relating to this manufacturing approach and the 
prototypes tested are contained in section ‎6.2.2. 
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Figure ‎5.92: The second generation prototype, with spiral shaped electrodes.  
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5.9 Inkjet Printing Investigation 
In addition to the manufacturing approaches, described the feasibility of using inkjet printing 
manufacturing techniques to make the base substrate component was investigated. The 
investigation of this approach was conducted by Printed Electronic Limited of the Invotech Group 
(Tamworth, UK).  Attempts were made to print the design concept 2 pattern directly on to glass 
using an Au ink. The results of this investigation are demonstrated here in Figure ‎5.93 and 
Figure ‎5.94.  
 
Figure ‎5.93: The design concept 2 pattern printed using a gold ink. 
 
 
Figure ‎5.94: Examples of the failed adhesion (highlighted within yellow circles) of the Au ink to the surface of 
the glass. 
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The findings of this work imply that inkjet printing might be a viable manufacturing technique for 
devices such as MEA biochips in the future if ink formulations can be suited to the necessary base 
substrate materials. The key benefit that inkjet printing offers is fast (e.g. patterns as illustrated in 
Figure ‎5.94 can be produced in <15 minutes) and flexible production of conductive parts. A 
potentially limiting factor that would require appropriate consideration if this technique were to be 
implemented in the future would be that printed inks show poor mechanical properties so may not 
be suited to the cleaning protocols required by the bioscience environment and re-use facility 
demanded by consumers purchasing these high cost consumables.  
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5.10 Summary 
 
The rationale used to guide design and manufacture target definition considered both the original 
aim of the research, to produce a novel MEA system (described in Appendix A), and also existing 
systems in terms of what would be novel and realistic. Existing systems were considered in terms of 
capabilities they offer users, how components of existing systems are manufactured, and how 
systems are used.  
An application specific design specification was created during this research and used to generate 
targets that were prioritised into design and manufacture deliverables. 
The prioritisation of targets intending to produce a solution device that would meet the defined user 
requirements was made using a house of quality matrix that assessed interrelationships and 
influences present between user requirements and the technical requirements brought about by the 
solution concept designed. 
Two novel concepts were designed and manufactured to meet the prioritised targets. 
In the pursuit of prototype manufacture a number of possible manufacturing techniques were 
considered and implemented to differing extents. The results of prototypes manufactured during 
this research are presented and discussed in the following chapters.  
The requirements, rationale, concept design, manufacturing and prototype success that have been 
presented through this Chapter are detailed in Figure ‎5.95. 
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MEA Biochip Concept and Manufacturing 
Approach Design
1. Applications have been identified and 
user needs defined. Manufacturing solutions 
for needs defined in PDS 3 are focused upon 
in this chapter.
2. Contemporary in the field of MEA biochip design:
- increased numbers of electrodes, at smaller geometries, more 
densely packed,
- specifically enhanced surfaces and growth corridors or 
structures in an range of materials such as hydrogels, etc,
- electrode layouts in geometries suited to study of particular 
anatomical sites (e.g. in hippocampal slice investigations.)
3. Rational – cardiomyocytes application centred on as 
PDS3 offers most achievable design objectives 
4. Rationale – manufacturing facilities suited 
to resolution >100µm
5. Rational – lesser number of recording 
electrodes required per biochip 
 6. Rationale – the selected microprocessor (ARM Cortex 
M3) supports a limited number of channels.
7. Rationale – PDS was provided by real users well 
qualified to identify contemporary needs.
8. Critical components in all current MEA biochip 
manufacture: (1) base substrate incorporating 
microelectrodes, (2) a media well.
9. Solution concepts have been 
designed and modelled in CAD. 
Design is in line with PDS and 
therefore target application group 
needs. Methods of how to 
manufacture the concept have 
been investigated.
10. Manufacturing workflows were constructed considering:
- what was possible,
-what materials were compatible,
- what were the advantages or disadvantages of considered 
techniques and workflows.
So as to attempt to identify the best manufacturing approach 
in terms of quality, scalability, time and costs.
12. Technique selection was influenced by material, 
tooling of technique, resolution and geometries 
achievable, suitability of produced parts for cleaning 
and sterilisation required in cell culture settings, and 
final robustness of produced component or device.
11. Existing manufacturing techniques were 
investigated in the course of this aspect of the research 
presented in this thesis:
 -photolithography
- electroplating
-laser processing
-Inkjet printing
-MEMS techniques
13. Gold selected as electrode material as previously 
successfully applied in equivalent devices, at start of 
research was less expensive than common alternatives 
ITO and TiN, and expertise of processing gold was 
available.
14. Three manufacturing workflows were 
concurrently developed until an initial prototype 
of a quality suitable for testing was produced. Via 
hole filling (electroplating), gold pin and micro 
drilling approaches are detailed in this chapter.
15. The Excimer laser dependent micro drilling workflow 
produced the first suitable prototype. This design was 
tested and initial feedback prompted a radical redesign. 
Clean room based photolithography was suited to 
manufacture of the new design concept with features 
<100µm in resolution.
16. A PDMS surface treatment was considered as a possible 
method of creating the desired microwell on the second 
generation of prototype. Limitations in the procedure used 
to position hand cut wells resulted in limited testing taking 
place before the project time elapsed. 
Requirements
Design rationale
Concept design
Manufacture
Prototypes
 
Figure ‎5.95: A summary of the contents of chapter 5. 
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5.11 Research Questions Answered 
 
1. What current and future user and system requirements have been derived from literature 
reviews, commercial system assessment and case studies that can be realistically addressed 
by this research? How does this research prioritise requirements? 
User requirements identified and documented throughout Chapters 2, 3 and 4 have been prioritised 
using the quality function deployment house of quality (HoQ) method. The HoQ considered 
interrelationships and influences present between both user and technical requirements. The 
following targets were prioritised and addressed by this research: 
 Biochip must be as small in size as possible 
 Biochip must be re-useable at least 10 – 15 times 
 Materials used in manufacture must be durable 
 Manufacture of the device must be through techniques that are as low cost as possible 
 Manufacturing techniques must be as fast as possible 
 Materials utilised must be as low cost as possible 
 Prototype devices must be safe 
 Solution biochips must support >1 beating cluster per media well 
 The biochip must be lightweight 
 
2. How can this research project meet the defined and targeted requirements? 
This research constructed product design specification documents to collate the numerous needs 
identified through this research (section ‎5.2). User requirements were assessed and prioritised 
targets used to specify and create solution design concepts (section ‎5.3). Investigation took place of 
how to manufacture the design concepts into prototypes for testing (section ‎5.4 – ‎5.9). Prototypes 
manufactured were tested and the results in terms of successfully meeting targets are discussed in 
Chapters 6 and 7. 
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3. What manufacturing solutions are suitable for production of the proposed solution concept?  
A number of existing microelectronics manufacturing approaches were identified as suitable for the 
manufacture of the novel MEA biochip concept: 
 Integrated Circuit and Micro Electrical Manufacturing Systems (MEMS) Techniques  
- Photolithography 
- Thin Film Deposition 
- Etching 
 Electroplating 
 Laser Machining 
 Additive Manufacturing (Inkjet Printing) 
 
The ways in which each method has been implemented in pursuit of prototype manufacture are 
described in this chapter.  
 
The success of the above approaches implemented in this work are listed in Table ‎5.16.  
Table ‎5.16: A summary of successes of the manufacturing approaches implemented. 
Approach Successful / Unsuccessful 
IC and MEMS Techniques 
- Photolithography 
- Thin Film Deposition 
- Etching 
Successful  
     Successful (sections Error! Reference source 
not found.) 
     Successful (section 5.8) 
     Successful (section 5.6 and 5.8) 
Electroplating Unsuccessful (section ‎5.6.1) 
Laser Machining Successful (section ‎5.6.3) – Excimer laser 
Unsuccessful (section 5.6) – CO2 laser 
Additive Manufacturing (Inkjet Printing) Unsuccessful (section ‎5.9) 
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4. What are the critical manufacturing outcomes with regard to the proposed solution? What is 
the benchmark or gold standard to which the novel biochip will be compared?  
Manufacturing approaches were assessed during implementation through achievement of the 
following critical manufacturing outcomes: 
 Produce satisfactory base substrate 
 Produce satisfactory media well 
 Facilitate adequate attachment of the media well and base substrate components 
 Produce a satisfactory electrode site for cell-electrode interfacing 
 Produce an appropriate micro-well geometry around electrodes 
 Produce enough sites so as to allow assignment of a reference 
 Produce an MEA biochip that allows appropriate optical inspection of living samples 
The benchmark and gold standard device for the target application type, stem cell-derived 
cardiomyocyte beating clusters, is the same. A typical planar microelectrode array, arranged in an 
8x8 grid array with ~200µm spacing is available for all MEA manufacturers  and is presently the most 
suited MEA biochip for this particular cell source. Novel prototypes are compared to this device.  
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This Thesis
Chapter 6
Testing and 
Evaluation
Manufacturing Approach Results
Prototype Testing Results  
Chapter Six 
6 Manufacturing and Prototype Testing 
Results 
 
 
 
 
 
 
This chapter presents the findings of this research in terms of the manufacturing approaches 
implemented, and the subsequent testing of the resulting prototype MEA biochips. 
The work in this chapter answers the following research questions: 
1. What has this research done to produce a solution device to meet the requirements 
identified? 
 
2. How were the manufactured prototypes tested, and what were the outcomes of those 
tests? 
 
3. Has a suitable alternative to current the standard commercial biochips used in 
cardiomyocyte cluster application been realised? 
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6.1 Results of Manufacturing Approaches 
Each manufacturing approach presented in Chapter 5 is described in the following sections.  
6.1.1 Via Hole Filling Approach 
The via hole filling manufacturing approach produced the following MEA biochip outcomes 
(Table ‎6.1). 
Table ‎6.1: The outcomes of the via hole filling approach. 
Priority Critical Manufacturing Outcome Approach achieved? 
1 Produce satisfactory base substrate Yes 
2 Produce satisfactory media well Yes 
3 Facilitate adequate attachment of the media well and base 
substrate components 
Yes 
4 Produce a satisfactory electrode site for cell-electrode 
interfacing 
No 
5 Produce an appropriate micro-well geometry around 
electrodes 
No 
6 Produce enough sites so as to allow assignment of a reference No 
7 Produce an MEA biochip that allows appropriate optical 
inspection of living samples 
No 
Prototype produced for testing: No 
6.1.1.1 Base substrate 
The base substrates were manufactured using a UV photolithography approach. The lowest feature 
resolution produced in manufacturing was ~ 100µm. Figure ‎6.1 shows the first batch of MEA base 
substrates manufactured at Loughborough University using standard FR4 board with a 35µm Cu foil 
cladding.  
A B C
 
Figure ‎6.1: An example of three base substrates patterned by hand for experimentation during the 
development of manufacturing approach one. 
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The initial interconnect contact pads and electrode sites patterned were 2mm x 2mm. Tracking was 
500µm wide. Large electrode sites reduced the precision required of early drilling process 
experimentation while providing samples for electroplating testing. Samples A, B, and C (Figure ‎6.1) 
demonstrate the variation in patterning quality where substrates were processed in the same way. 
Sample B particularly demonstrates occurrences where areas of speckled Cu remained on the 
substrates. The consequence of this speckling of conductive material over the substrate is significant 
if it results in short circuits.  
 
The quality of base substrates patterned was variable throughout manufacture. Factors that 
influenced the variability of samples were: the manual positioning of the photomask and UV 
exposure system set up; the presence of dust contamination in the atmosphere during UV exposure; 
and the concentrations of the etchants used, varying between processing of different batches due to 
numerous facility users. Improved control over these variables resulted in achievement of an 
optimum manufacturing process for base substrates (Figure ‎6.2) that was used by manufacturing 
approaches one to three (Chapter 5).  
 
Figure ‎6.2: A suitably patterned base substrate containing 16 electrode sites and 1 reference electrode site 
at the centre. 
 
In the demonstrated samples (Figure ‎6.1 and Figure ‎6.2) the outer geometries of the boards are 
random. Samples were cut by-hand for speed and convenience as these base substrates were for 
experimental use only. As the patterning process was optimised smaller electrode and track 
dimensions ensued for base substrates and biochip dimensions were more tightly controlled. 
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6.1.1.2 Media well selection and attachment to the base 
substrate  
To accommodate the specified 35mm diameter media well dimensions commercially available Petri 
dishes were selected. The Petri dishes required a small amount of pre-processing to make them 
suitable for application. The bottom surface of the dish has a small lip to aid stacking. This lip was 
polished down using a very fine grade of wet and dry paper producing a flat surface. A flush contact 
between the Petri dish surface and the Cu patterned base substrate was achieved.  
 
Figure ‎6.3: A base substrate with a 35mm Petri dish adhered. Scale: Electrode tip diameter is 500µm. 
 
A transparent epoxy resin suitably affixed the Petri dish over the Cu pattern as demonstrated in 
Figure ‎6.3. A cylindrical 25g weight was placed into the Petri dish during curing to ensure good 
contact. 
 
6.1.1.3 Satisfactory electrode sites and microwell geometry  
Each prepared substrate required individual positioning inside a CNC drilling machine (Figure ‎5.47) 
due to biochip-biochip variation.  
Cu Foil
FR4
PS Petri dish
AdhesiveA
B
C
Drilling Machine 
Headstage and Clamp
 
Figure ‎6.4: The zeroing positions considered for this process.  
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A problem encountered during the CNC drilling process related to the by-hand, relatively imprecise 
positioning of the Petri dish on the base substrates and base substrates on the drilling stage. Base 
substrates placed on the level stage did not sit level due to warping of the FR4. Figure ‎6.4 shows 
three positions (A, B and C) considered as zeroing points for the CNC drilling program. 
The most significant issue encountered during drilling was in controlling the tolerance of the drilling 
depth in the z-axis.  The base substrates had each been cut by-hand and were of differing 
dimensions. A standard jig was also not able to guarantee that the substrates were positioned in 
exactly the same position each time. The Petri dishes had also been adhered to the base substrate 
by-hand resulting in differing thicknesses of adhesive between the two surfaces on differing 
prototype samples. The consequence of this was that the drilling in the z-orientation could be either 
too deep, resulting in detrimental removal of the underlying Cu, or not deep enough, therefore not 
reaching the Cu. 
Zeroing position A –This was not used as substrates were different shapes and were positioned by-
hand each time.  
Zeroing position B – This position was considered to provide greater z-axis control due the variations 
in adhesive thickness. By drilling from the surface through to the plane on which the Cu was located 
would improve drilling success.  In this case, where base substrates sat level on the drilling stage 
surface adequately, controlled depth of drilling was achieved. However, a number of the substrates 
did not lay flat resulting in holes that were of differing depths. A number of holes were either too 
deep, resulting in detrimental removal of the underlying Cu pattern, or not deep enough to reach 
the Cu.   
Zeroing position C – This position was considered as a method of preventing imprecise drilling on the 
z-axis but was not implemented due to time constraints. 
Substrates failed to progress beyond the drilling stage due to the following drilling process defects: 
 Holes too deep  
 Holes not deep enough 
 Holes were not completely over an electrode. 
For the substrates where drilling was successful, to minimise costs of material consumption, initial 
electroplating was Cu. A final thin layer of Au was plated on top to seal in the Cu from the living cells 
and culture media. The depth of holes through the Petri dish and adhesive to the under lying Cu 
were approximately 780-850µm. The Cu layer was intended to be ~550-600µm deep to create a 
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recess over each electrode that would serve as the microwell into which a single beating cluster of 
cardiomyocytes would be placed. Unfortunately, this approach failed to fill adequately due to air 
bubbles lodged in the drilled holes during electroplating (Figure ‎6.5 and Figure ‎6.6).  
 
Figure ‎6.5: Images of the electrode sites and attempted microwell filling. Petri dishes and adhesive were 
carefully removed to reveal the extent of filling. 
 
Initial drilling and electroplating was performed using the pattern design demonstrated in Figure ‎6.2. 
Different electroplating solutions were tested (section ‎0). The commercial solution, 
Electroposit™1300 (Figure ‎6.6), produced better results than the home-made alternative 
(Figure ‎6.5). To tackle the problem of air bubbles in the drilled holes the electroplating process was 
conducted in an ultrasonic bath. Improvements were made but bubbles inside the holes persisted 
(Figure ‎6.6). 
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Figure ‎6.6: Cross-sectional micrograph images of the microwells filled during manufacturing approach 
implementation. 
 
Control over the depth of the filling was variable. The surface of the holes that did fill was also not 
level or smooth which was not suitable for the intended application where consistent microwells are 
required that can be thoroughly cleaned. 
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6.1.2 Gold Pins Approach  
The gold pins manufacturing approach produced the following outcomes (Table ‎6.2). 
Table ‎6.2: The outcomes of the gold pins approach. 
Priority Critical Manufacturing Outcome Approach achieved? 
1 Produce satisfactory base substrate Yes 
2 Produce satisfactory media well No 
3 Facilitate adequate attachment of the media well and base 
substrate components 
No 
4 Produce a satisfactory electrode site for cell-electrode 
interfacing 
No 
5 Produce an appropriate micro-well geometry around 
electrodes 
No 
6 Produce enough sites so as to allow assignment of a reference No 
7 Produce an MEA biochip that allows appropriate optical 
inspection of living samples 
No 
Prototype produced for testing: No 
6.1.2.1 Base substrate 
The base substrates were manufactured using the photolithography process previously described. 
The only difference was that the artwork was adjusted to produce a pattern of contact points that 
matched the alignment of the pins held in sections of PGA (Figure ‎6.7). The sections of pins were cut 
by-hand and successfully connected to the base pattern using a conductive tin solder paste.  
 
Figure ‎6.7: The adjusted pattern of contact points used for the gold pin manufacturing approach to ensure 
prototypes could connect to a commercial MEA system for testing. 
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6.1.2.2 Media well drilling and attachment of the media well to 
the conductive pins 
Base substrates were paired with Petri dishes that had been drilled with hole configurations 
matching the PGA vertical pin geometry. Petri dishes were secured in position using clear epoxy 
resin (Figure ‎6.8). Two methods were explored for securing the Petri dishes in position (section ‎0). 
For methods where a second drilling process was intended, imprecise positioning of the Petri dish 
resulted in difficulty repeating the drilling process. Method 2B was not implemented so no results 
are presented. 
 
Figure ‎6.8: Securing the previously drilled Petri dish to the base substrate that has PGA pins connected to 
each electrode site. 
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Problems with this approach were: 
 For method 2B a precision manufactured nippled blocker was required. 
 Ensuring a water-tight seal every time without encapsulating the electrode tip or protruding 
out of the hole was difficult to control.  
 Where the PGA attachment was not at exactly 90° there were differences in pin location that 
were significant when drilling for the second time.  (The re-drilling process was difficult to 
align due to the imprecise construction of the biochips, described in ‎5.6.2.2). 
While this approach was being explored manufacturing approach 3 (micro drilling) was also being 
developed. Manufacturing approach 3 provided a prototype for testing before this approach was 
developed any further. 
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6.1.3 Micro Drilling Approach  
The micro drilling manufacturing approach produced the following outcomes (Table ‎6.3). 
Table ‎6.3: The outcomes of the micro drilling approach 
Priority Critical Manufacturing Outcome Approach achieved? 
1 Produce satisfactory base substrate Yes 
2 Produce satisfactory media well Yes 
3 Facilitate adequate attachment of the media well and base 
substrate components 
Yes 
4 Produce a satisfactory electrode site for cell-electrode 
interfacing 
Yes 
5 Produce an appropriate micro-well geometry around 
electrodes 
Yes 
6 Produce enough sites so as to allow assignment of a reference Yes 
7 Produce an MEA biochip that allows appropriate optical 
inspection of living samples 
No 
Prototype produced for testing: Yes 
 
6.1.3.1 Base Substrate 
Base substrates were manufactured in Cu and outsourced to PMD Group, Coventry, UK for Au 
plating. Eight electrode sites were incorporated per biochip, of which one (not seeded with cells) 
required assignment as a reference electrode in the detection and recording software. 
 
Figure ‎6.9: The Cu pattern produced for manufacturing approach three. Design compliments connections for 
Au plating. 
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6.1.3.2 Production of microwell features  
Three materials were tested during this manufacturing approach development as insulator and 
consequent microwell material: glass coverslips, PE coverslips and Melinex PET film. Two methods 
were investigated for drilling microwells into these materials: a mechanical CNC drilling technique 
and an Excimer laser ablation technique. 
CNC Drilling: Glass and PE cover slips were drilled using the Hurco VM1 CNC milling machine 
described in section Error! Reference source not found.. The glass cover slips shattered for all 
attempts at drilling. The PE coverslips were successfully processed using this approach but 
difficulties arose relating to the control of the exact depth of the hole (as described in 
section ‎6.1.1.3). This process damaged the underlying metallic surface on test samples due to 
warping of the FR4 base material and the variation of the thickness of the epoxy adhesive. The holes 
produced were also distorted in shape. 
Excimer laser ablastion: Glass and PE coverslips were initially investigated. The PE samples were 
ablated at much lower energies than the glass equivalents. All of the glass coverslips used in testing 
broke with handling so glass was eliminated from testing. To overcome the dimensional limitation of 
standard coverslips an alternative film, Melinex™, was tested. Melinex is a polyethylene 
terephthalate (PET) film available as A4 sized sheets of varying thicknesses (12-350µm) that had 
been used previously in cell culture as a growth substrate (Laskarakis, Georgiou and Logothetidis, 
2010). Melinex™ is treated on both sides producing a surface that is well-suited to cell culture. The 
Melinex™ film was ablated successfully to produce microwells meeting the specification. 
 
Figure ‎6.10: A cross sectional micrograph of the microwell ablated over an electrode through Melinex™ to 
form a microwell that meets the specification. 
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6.1.3.3 Media Well 
Media wells were made by cutting standard PE tubing into rings (height 10mm) and adhered to the 
Melinex surface to complete construction (Figure ‎5.67). During trials the user testing the devices 
recommended that this sub-component was changed to a transparent material and was reduced in 
height. The PE tubing material was replaced with transparent tubing cut to heights of 6mm. 
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6.1.4 Clean Room Based Photolithography  
The clean room based photolithography manufacturing approach produced the following outcomes 
(Table ‎6.4). 
Table ‎6.4: The outcomes of the clean room based photolithography approach. 
Priority Critical Manufacturing Outcome Approach achieved? 
1 Produce satisfactory base substrate Yes 
2 Produce satisfactory media well Yes 
3 Facilitate adequate attachment of the media well and base 
substrate components 
Yes 
4 Produce a satisfactory electrode site for cell-electrode 
interfacing 
Yes 
5 Produce an appropriate micro-well geometry around 
electrodes 
Yes 
6 Produce enough sites so as to allow assignment of a reference Yes 
7 Produce an MEA biochip that allows appropriate optical 
inspection of living samples 
Yes 
Prototype produced for testing: Yes 
6.1.4.1 Base Substrate 
The base substrates were successfully manufactured using the processes described in section Error! 
Reference source not found..  
 
Figure ‎6.11: A patterned glass substrate made using clean room based photolithography. 
 
6.1.4.2 Microwell  
Microwells were created on five sample substrates by researchers at Fondazione Filarete, Milan, 
Italy, for testing of a PDMS alternative microwell and insulating material. The microwell geometry 
was re-specified in this design to a diameter of 4mm and depth between 150-250µm. The 4mm 
diameter was specified to compliment the dimensions of the cloning rings that are used to control 
beating cluster position during seeding. The electrode geometries are also intended to cover the 
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surface area within these large microwells with the intention of achieving 100% attachment of all 
clusters seeded over the electrode. 
Five circles, 19mm in diameter, were stamped out of sheets of PDMS (that differed in thickness) by-
hand. Four microwell holes, 4mm in diameter, were stamped by-hand out of each circle. A stencil 
was placed underneath during stamping for accurate positioning of microwell holes. The PDMS 
samples were then activated using a plasma treatment and placed over the glass samples. This 
positioning (Table ‎6.5) was also carried out by-hand, resulting in variations in alignment of the circle 
microwells over the electrodes on each sample. Samples 1, 2 and 5 were used in prototype testing at 
the UoN. 
 
Table ‎6.5: The five base substrates that had PDMS samples adhered over the electrode space.  
Sample Number Thickness of PDMS PDMS on the base substrate 
1 150 m 
 
2 240 m 
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3 240 m 
 
4 250 m 
 
5 240 m 
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6.1.4.3 Media wells 
Glass rings, 21mm inner diameter x 24mm outer diameter x 6mm height, were sourced as bespoke 
parts from MDC Vacuum Limited, Sussex, UK, and adhered to samples using transparent epoxy resin 
(Figure ‎6.12). The epoxy resin was replaced by a silicon sealant during testing as the epoxy-glass 
interface resulted in leaks. 
 
Figure ‎6.12: A complete PDMS coated MEA biochip. 
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6.2 Prototype Testing 
The manufactured prototypes were tested by experienced UoN bioscientists using stem cell-derived 
cardiomyocytes as described in case study one (see section ‎4.2). A limited number (20) of beating 
cardiomyocyte clusters were made available for testing by the UoN group due to the time intensive 
and experimental nature of their differentiation. Testing was completed in small batches (2 – 4 
biochips) over a period of several months. Iterative design improvements were implemented as tests 
revealed manufacturing or prototype flaws. The following sections of this chapter describe the 
outcomes of testing using living matter (contracting cardiomyocyte clusters) from the perspective of 
user satisfaction (users can position cardiomyocyte clusters as desired) and functionality (data can 
be collected biochips for analysis). 
6.2.1 Prototype One Testing 
An overview of the entire procedure used to test the first generation of MEA biochip prototypes is 
incorporated in Chapter four, Figure ‎4.4. 
6.2.1.1 User interaction and cluster seeding testing 
The following images (Figure ‎6.13 - Figure ‎6.21) demonstrate the process of cell seeding used. This 
was the first point of interaction between a user and prototype device allowing observations to be 
made and feedback to be captured.  
 
Figure ‎6.13: Sterilisation procedure for the first batch of tests, soaking in industrial methylated spirit (IMS). 
 
The space in which the bioscientist works can also be seen in these figures facilitating better 
understanding of the constraints imposed on design by the environment in which the MEA biochips 
are used. 
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Figure ‎6.14: MEA biochip is left to dry inside the laminar flow culture hood. 
 
 
Figure ‎6.15: MEA biochip is rinsed with phosphate buffered solution (PBS). 
 
Matrigel™ treatment was not used for generation 1 prototype testing as the microwell was intended 
to eradicate the need for surface treatments. 
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Figure ‎6.16: The MEA biochip was filled with Dulbecco’s Modified Eagle Medium (DMEM) and microwells 
were checked for air bubbles. 
 
 
Figure ‎6.17: Dr Anderson locates the stem cell-derived clusters of cardiomyocytes within the embryoid body 
(EB) and confirms cells are contracting. 
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Figure ‎6.18: The contracting cardiomyocyte cluster is identified under the culture hood integrated inverted 
microscope. A stem cell knife is used to carefully dissect the contracting area of cells from the EB.  
 
 
Figure ‎6.19: The dissected area is drawn into the stem cell knife’s tip, held and transferred into the MEA 
biochip. 
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Figure ‎6.20: A cloning ring was used to help move released cardiomyocyte clusters into the microwells. 
 
 
Figure ‎6.21: The lid from a 35mm Petri dish was placed over the MEA biochip to prevent contamination. 
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6.2.1.2 Signal capture testing 
After a period in culture (varied between 3-12 days) the MEA biochips were inserted into a 
commercially available MEA system to test signal detection. The Multi Channels System MEA-60 was 
used for testing of all seeded prototypes (Figure ‎6.22).  
 
Figure ‎6.22: A first generation prototype in the MEA60 system. 
 
A control MEA biochip was used prior to each testing session to ensure the MEA system was 
functional. A commercial MEA biochip seeded with a one cardiomyocyte cluster of the same age, 
and that had been treated and seeded in the same way, was used as the control biochip device.   
Each prototype biochip tested was removed from incubation, visually assessed under a light 
microscope, and if contamination free, was inserted into the pre-heated (37ºC +/-0.5ºC) MEA system 
headstage (Figure ‎2.47). The findings for each individual test conducted are contained in Table ‎6.6. 
During testing stages the lead contact changed from Dr Anderson (DA) to Miss Rajamohan (DR). The 
protocols used to test biochips remained consistent due to adherence to laboratory standard 
operating procedure documents (Appendix D). 
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Table ‎6.6: The tests conducted using the generation one prototypes made using the micro drilling 
manufacturing approach. 
Scientist/ 
Test 
number 
Biochip 
Cells 
monitored 
optically 
Contamination 
free 
Attachment 
to a surface 
Attachment 
in microwell 
Contracting 
before 
insertion 
Signal 
detected 
Contracting 
following 
removal 
DA 
1 
G1 
V1a 
No 
(Figure 6.24) 
Contaminated  Yes No - - - 
DA 
2 
G1 
V1a 
No  
(Figure 6.25) 
Contaminated  Yes Yes - - - 
DA 
3 
G1 
V1b 
No Contaminated  No - - - - 
DA 
4 
G1 
V1b 
No Contaminated  Yes No - - - 
DR 
5 
G1 
V1a 
No Yes Yes No  
(Figure 6.26) 
- - - 
DR 
6 
G1 
V1b 
No Yes Yes Yes  
(Figure 6.27) 
Unknown No Unknown 
DR 
7 
G1 
V2a 
No Yes Yes Yes Unknown No Unknown 
DR 
8 
G1 
V2b 
No Yes Yes No - - - 
DR 
9 
G1 
V2a 
No Yes Yes Yes Unknown No/ No Unknown 
DR 
10 
G1 
V2b 
No Yes Yes Yes Unknown No/ No Unknown 
DA= Dr David Anderson, DR= Miss Divya Rajamohan, G1= Prototype one, V1= opaque media well, V2= 
transparent media well, a,b= prototype identifier. 
Where two results exist the first relates to use in the MEA60 system and the second relates to use in 
the custom-built system. 
Where V1 and V2 are included this represents the media well material change described in 
section ‎6.2.1.  
 
 
6.2.1.3 Discussion of tests 
6.2.1.3.1 Cleaning 
The first sterilisation process used a five minute IMS soak, which was inadequate and led to 
contamination. For all following tests a 20 minute exposure to UV light (Figure ‎6.23) with an IMS 
soak was used. Contamination did not re-occur throughout remaining tests. 
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Figure ‎6.23: A culture hood undergoing UV exposure for sterilisation. 
6.2.1.3.2 Optical monitoring of cells 
Optical assessment of the seeded cardiomyocyte clusters was not possible using the inverted 
microscope systems installed in the UoN laboratory.  The biochip prototypes were assessed to 
establish whether shadowing could be used to identify the cell clusters, electrode tips or tracking. 
Figure ‎6.24 and Figure ‎6.25 demonstrate observations made. Defects that can be seen in these 
figures are damage that occurred to the base substrates underlying surface during manufacturing. 
Tracking, electrodes and cell clusters cannot be identified. 
 
Figure ‎6.24: An image of G1 V1a MEA biochip positioned with electrode tips directly under the microscopes 
field of view. 
 
 
Figure ‎6.25: An image of G1 V2a positioned with an electrode tip directly under the microscopes field of 
view. 
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At the request of the UoN the media well material was changed from white PE (G1 V1) to 
transparent polystyrene (PS) (G1 V2) (see Figure ‎5.67) to improve illumination within the media well. 
This change did not permit users to ascertain if the seeded clusters were beating. The height of the 
media well was also reduced from 10mm to 6mm to improve ease of access while under the 
microscope during cell seeding process. 
 
6.2.1.3.3 Microwell 
End users reported that it was “difficult” and “awkward” to position the cardiomyocyte clusters into 
the microwells respectively. The cardiomyocyte clusters used in testing ranged in size and shape, 
varying between 200 -500 µm in diameter or length.  Ten cell clusters were seeded directly over ten 
microwells throughout G1 tests, eight of which formed attachments to the Melinex surface, and four 
of which attached inside the microwells and were used for signal tests. Figure ‎6.26 demonstrates a 
cardiomyocyte cluster that was initially positioned over the centre of the microwell that, due to its 
contracting nature, formed its attachments with the base substrate away from the microwell and 
electrode. Figure ‎6.27 shows a cardiomyocyte cluster that is attached inside a microwell. 
 
Figure ‎6.26: An example of a cluster of cardiomyocytes attached to the Melinex surface away from the 
microwell. Scale: Target microwell 500µm in diameter. 
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Figure ‎6.27: An example of a cardiomyocyte cluster attached inside a microwell. Scale: Target microwell 
500µm in diameter. 
 
6.2.1.3.4 Signal detection 
Each cardiomyocyte cluster attached inside a microwell over an electrode was tested for signal 
detection. In every case no signal was detected.  
A total of ten cell clusters were seeded over a microwell, four of which attached inside the microwell 
and therefore over an electrode. It was not possible to confirm whether or not these clusters were 
contacting prior to or following tests due to the optical constraints imposed by material choices. The 
importance of being able to confirm visually that the cardiomyocytes were contracting at the start of 
tests was emphasised so it was agreed that a re-design would take place to exploit a transparent 
base substrate that would allow optical assessment.  
Two MEA systems were used for signal detection testing of this prototype. The described MCS 
MEA60 system and an experimental, custom-made system, that is currently under development 
(Appendix F). Neither system detected a signal from any of the prototypes.  
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6.2.2 Prototype Two Testing 
The second concept design (see section ‎5.7.3) was manufactured to provide an alternative prototype 
intended to address problems highlighted in initial tests of the first prototype (see section ‎5.7.1). 
This second generation (G2) of prototype was made using clean room based photolithography (see 
section Error! Reference source not found.) on glass substrates. The results of the testing using 
cardiomyocyte clusters are presented in the following sections. 
 
6.2.2.1 User interaction and cluster seeding testing 
The second generation of prototypes were cleaned, seeded and maintained in culture in the same 
way as the first generation (G1) prototypes (Figure ‎6.28).  
 
Figure ‎6.28: The seeding of second generation prototypes. 
 
Improvements in the testing of this generation of prototype as when compared to testing of the first 
generation were:  
 Suited to cleaning 
 Adequate optical assessment 
 Improved media well height 
 Greater ease of cardiomyocyte cluster positioning in the microwell over the centre of the 
underlying electrode. 
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6.2.2.2 Signal capture testing 
The MCS MEA60 system used (Figure ‎6.29) to test the first generation prototype was also used to 
test all of the generation two prototypes (Table ‎6.7). Three of the G2 prototypes successfully seeded 
with cardiomyocyte clusters over the electrodes were also connected to the custom-made MEA 
system (see Appendix F, Figure ‎6.30).  
No signals were detected from either MEA system from any of the G2 prototypes tested. 
 
 
Figure ‎6.29: A second generation prototype in the MEA 60 system. 
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Figure ‎6.30: A second generation prototype being tested with the custom-made MEA system. 
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Table ‎6.7: The tests conducted using the generation one prototypes made using the micro drilling 
manufacturing approach. 
Scientist/ 
Test 
number 
Biochip 
Cells 
monitored 
optically 
Contamination 
free 
Attachment 
to a surface 
Over 
electrode 
Contracting 
before 
insertion 
Signal 
detected 
Contracting 
following 
removal 
DR 
1 
G2 S 
n/m a 
Yes Yes Yes 
Yes  
(Figure 6.31B) 
Leaked 
Yes No Yes 
DR 
2 
G2 S 
n/m b 
Yes Yes Yes 
Yes 
Leaked 
No - - 
DR 
3 
G2 R 
n/m c 
Yes Yes Yes 
Yes. Lost in 
handling. 
Leaked 
- - - 
DR 
4 
G2 R 
n/m d 
Yes Yes Yes 
Yes  
(Figure 6.31D) 
Leaked 
Yes No Yes 
DR 
5 
G2 S 
n/m 
Yes Yes Yes 
Yes  
(Figure 6.33) 
Yes No Yes 
DR 
6 
G2 S 
w/m 
Yes Yes Yes 
Yes  
(Figure 6.33) 
Yes No Yes 
DR 
7 
G2 S 
w/m 
Yes Yes No 
No  
(Figure 6.34) 
No - - 
DR 
8 
G2 R 
n/m 
Yes Yes Yes 
Yes  
(Figure 6.34) 
Yes /Yes No /No Yes/Yes 
DR 
9 
G2 S 
w/m 
Yes Yes Yes Yes  Yes /Yes No /No Yes /Yes 
DR 
10 
G2 S 
w/m 
 
Yes Yes Yes No  No - - 
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DR 
11 
G2 S 
w/m 
Yes Yes Yes Yes Yes/ Yes No/ No Yes/ Yes 
DR 
12 
G2 S 
w/m 
Yes Yes Yes Yes Yes No Yes 
DR 
13 
G2 S 
w/m 
Yes Yes Yes Yes Yes No Yes 
DR 
14 
G2 S 
w/m 
Yes Yes Yes Yes Yes No Yes 
DR= Miss Divya Rajamohan, G2 = Design concept two, S= spiral shaped electrode design, R= radiator 
electrode design, n/m = no microwell, w/m = with PDMS microwell 
Where two results exist the first relates to use in the MEA60 system and the second relates to use in 
the custom-built system. 
The spiral (S) and radiator (R) electrode designs are described in section ‎5.8.1.1. 
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6.2.2.3 Discussion of tests 
 
Cleaning:  All G2 prototypes were cleaned using a 20 minute UV light exposure and 5 minute IMS 
soak. There were no instances of contamination during generation two tests. 
Optical monitoring of cells: The new design facilitated good optical inspection of cells. It was now 
possible to confirm if cardiomyocyte clusters were contracting prior to and after testing in the two 
MEA systems. 
6.2.2.3.1 Media Well 
The first media wells employed were glass rings (21mm inner diameter x 24 outer diameter x 6mm 
height) adhered using epoxy resin. The G2 prototypes leaked (Figure ‎6.31) and the epoxy showed 
signs of absorption of the culture media (Figure ‎6.32).  
 
Figure ‎6.31: The first batch of tests during which the G2 prototypes leaked. A) Spiral electrode biochip 
prototype. B) The cardiomyocyte cluster attached to the spiral electrode in the biochip demonstrated in A. 
Scale: Electrode tracking width 80µm. C) Radiator electrode biochip prototype. D) The cardiomyocyte cluster 
attached to the radiator electrode in the biochip demonstrated in C. Scale: Electrode tracking width 100µm. 
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For biochips shown on Figure ‎6.31, the attached beating clusters were still contracting and so were 
tested for signals before retrieval and re-seeding. 
In Figure ‎6.31 the prototype shown in image B has not had a Matrigel treatment applied to the 
surface. The cardiomyocyte cluster shows good attachment to the glass/electrode surface. Matrigel 
has been used on the prototype shown in image D, in case cardiomyocyte clusters had failed to 
attach to the glass/electrode so as to ensure a signal test could be conducted. It was also noted that 
if prototypes could function reliably without the need for a Matrigel pre-treatment, further savings 
could be brought to the user, adding an additional competitive advantage to the novel MEA biochip 
over the existing commercial standard.  
 
Figure ‎6.32: Examples of absorption of culture media by the adhesive used to secure the media well. A) A 
spiral electrode prototype. B) A radiator electrode prototype. 
 
The epoxy resin used to secure the media wells was changed to Geocel aquarium grade silicon 
sealant (Geocel Ltd, Plymouth, UK). The Geocel silicon was first tested at Loughborough University 
by securing glass rings and un-patterned glass substrates (Figure ‎6.33). The sealant was tested as it 
would be used during UoN testing prior to incorporation into prototypes: DMEM was left in the 
media wells for 10 days, the samples were then rinsed with deionised water and treated with trypsin 
(used at UoN to remove the cellular matter and to breakdown the Matrigel), followed by an IMS 
soak and 20 minute UV light exposure. The samples were then re-filled with DMEM for 14 days. No 
leaking occurred across any of the samples so the silicon sealant was used for remaining prototypes. 
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The Geocel sealant prevented leaks and did not show signs of culture media absorption following 
use in trials with living matter at the UoN. Cells seeded in prototypes made using this sealant did not 
show any adverse effects after up to three weeks in culture implying that the biocompatibility of the 
sealant is suited to this application. 
 
Figure ‎6.33: An un-patterned glass substrate used to test adhesives. 
 
6.2.2.3.2 Microwell 
PDMS was selected to replace the Melinex™ film for the insulation and microwell material as it was 
believed that PDMS would encourage cell adhesion to the glass/electrode surface as opposed to the 
surrounding areas of the biochip or the microwell walls.  
PDMS possesses a natural tendency that inhibits cell adhesion (De Silva et al, 2004) so it was 
believed that if, due to the contracting nature of the cells the cluster moved to the edge of the 
microwell, then they would preferentially form their attachments with the underlying 
glass/electrode substrate as opposed to the wall of the microwell or the insulating material as 
occurred in first generation prototypes.  
To test attachment to PDMS two cell clusters were seeded per prototype. One cluster was seeded 
the glass/electrode substrate, at the centre of the electrode; and the other at the centre of the 
media well on the PDMS surface. The results of this test are described in Table ‎6.7 and can be seen 
in Figure. The amount of movement that occurred between initial positioning and attachment to the 
underlying surface can also been seen. 
The clusters over the electrodes attached to the underlying substrate surface. The clusters 
positioned over the PDMS demonstrated no attachment. Where Matrigel had been used on some 
samples a lighter attachment was observed between the cell cluster and the PDMS than was 
apparent between the other cell cluster and the glass/electrode substrate in the same prototype at 
the same time. 
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Figure ‎6.34: Second generation prototypes with PDMS microwells, with cardiomyocyte clusters. Beating 
clusters over electrodes were initially positioned at the centre of the corresponding electrode. The beating 
clusters on the PDMS were positioned at the centre of the media well. 
 
6.2.2.3.3 Signal Detection 
Ten beating clusters (differing size diameter ~150 - 500µm) attached directly over the electrodes on 
second generated prototypes that were used to test for signal detection (Figure ‎6.34 and 
Figure  6.35). No signals were detected (Table  6.7). Clusters were seen to be contracting and well-
attached to the base substrate in all cases prior to, and following, insertion into the MEA systems. 
 
 
Figure ‎6.35: Examples of more attached beating clusters over second generation prototype electrodes. Left: 
Spiral electrode. Right: Radiator electrode. 
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6.2.3 Signal detection investigation 
To investigate why both prototypes failed to show signals when tested in two different MEA systems 
the following impedance investigation was conducted to compare the prototype electrodes 
manufactured characteristics to those in the commercial standard. 
 
6.2.3.1 Impedance Measurements  
A Wayne Kerr Principle Component Analyser (PCA) (Figure ‎6.36) was used to measure the 
impedance of electrodes in the prototypes and a commercially available MEA biochip.  
Measurements were taken from each MEA biochip while containing a physiological saline solution 
that was confirmed to have comparable conductivity to the culture media used in this MEA 
application, Dulbecco’s Modified Eagle Medium (DMEM) (Figure ‎6.37). The measured conductivity of 
each solution is contained in Table ‎6.8.  
 
Figure ‎6.36: The Wayne Kerr Principle Component Analyser used for impedance measurements. 
 
 
Figure ‎6.37: The DMEM and saline solutions used during impedance measurements. 
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Table ‎6.8: Conductivity of solutions used in impedance tests. 
Solution mS 
Saline Solution 17.6 
DMEM 17.3-18.07 
 
Table ‎6.9: PCA Impedance Measurement parameters. 
Internal Bias Off 
 150mVac 
Measurement AC 
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6.2.3.1.1 Prototype One 
Ten values were recorded for six frequencies, using the principle component analyser unit shown in 
figure 6.36, for each of the connections indicated in Figure ‎6.38 (A, B and C). The analyser’s 
operational set-up as described in table 6.9. Average impedance values for each frequency are 
displayed in Figure ‎6.38. 
 
 
Figure ‎6.38: Impedance results for the solid 1mm diameter Cu/Au electrodes on an FR4 base substrate in 
prototype generation 1. 
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6.2.3.1.2 Prototype Two 
Ten values were recorded for six frequencies for each of the connections indicated in Figure ‎6.39(A, 
B and C). The analyser was set-up as described in Table ‎6.9. Average impedance values for each 
frequency are displayed in Figure ‎6.39. 
 
 
Figure ‎6.39: Impedance results for the spiral shaped Ti/Au electrodes on the glass base substrate prototype 
generation 2. 
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6.2.3.1.3 Commercial MEA biochip 
Ten values were recorded for six frequencies for each of the connections indicated in Figure ‎6.40 (A 
and B). The analyser was set-up as described in Table ‎6.9. Average impedance values for each 
frequency are displayed in Figure ‎6.40. 
 
 
 
Figure ‎6.40: Impedance results for a commercially available 60 electrode planar MEA biochip. 
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6.2.3.1.4 Discussion 
The hypothesis used during the electrode design throughout this research was: 
 Greater electrode tip surface area results in lower impedance, which would result in 
improved signal detection.  
Impedance measurements were made using two probes, a sensing probe and counter probe (the 
reference), connected to the principle component analyser in Figure ‎6.36. The measurements taken 
demonstrate that the impedance of the electrode change depending on: (1) the frequency of the 
input, and (2) the location of the sensing probes on the MEA biochip. 
The measurement locations that are comparable between the biochips shown in Figure ‎6.38, 
Figure ‎6.39 and Figure ‎6.40 are seen in Table ‎6.10. 
Table ‎6.10: Comparable impedance measurement locations 
Measurement Location 
Description 
Prototype 
One 
Prototype 
Two 
Commercial 
Standard 
Electrode tip – Electrode tip A A 
Not possible with 
probes available 
Electrode tip – interconnect 
contact pad 
B B A 
Interconnect contact pad – 
interconnect contact pad 
C C B 
 
It was not possible to measure the impedance of the electrode tip – electrode tip in the commercial 
standard as the probes used were too large to adequately touch one 30µm diameter tip without 
contacting another adjacent electrode tip. 
The highest impedance values observed from these measurements were from the interconnect 
contact pad – interconnect contact pad locations. This recording location is directly comparable to 
the MEA systems recording interconnections (through spring loaded pins) during the live testing 
conducted.  
Impedance values were also observed to be highest at low frequencies. The recording frequency 
used at the UoN during MEA system employment is 2000Hz. The value used in measurement that 
compares closest to this frequency was 1000Hz. Therefore the impedance values observed at the 
interconnect  contact pad – interconnect contact pad locations while using a frequency of 1000Hz 
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were believed to be closest to the impedance values during the live prototype testing conducted. 
These values were compared and it was confirmed that both of the prototype devices produced 
provided electrodes with significantly lower impedances than the commercial standard. 
A summary of these conclusions is represented in Figure ‎6.41. 
Impedance measurements show...
Impedance measures vary depending upon where the recording probes were placed. The difference in 
values measured that is location dependant (figs. 6.38, 6.39, 6.40) is more significant at low 
frequencies. At higher frequencies the measurements taken at each recording location are comparable.
The location from which measurements were taken that was most representative of the MEA system 
connection with the biochips in testing was: 
Prototype one (G1) = location C
Prototype two (G2) = location C
Commercial standard = location B  
The frequency at which the MEA systems were used in testing was 2000Hz. 
Measurements taken at 1000Hz from location C (G1), C (G2) and B (Commercial) are most 
representative of the testing environment.
Prototype One:  550 Ω 
Prototype Two:  750 Ω 
Commercial standard:  100 kΩ 
Conclusion: The prototype MEA biochips show significantly lower impedances than the commercial 
standard. The hypothesis during electrode design was that greater surface area would provide lower 
impedance, which would result in improved signal capture through MEA biochip devices constructed. 
This hypothesis remains unproven following the research presented in this thesis.
Further work: Further work is required to produce an MEA biochip prototype that meets the user 
specification and provides signals (see Chapter 7). 
 
Figure ‎6.41: Impedance measurements conclusion 
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6.3 Summary 
 
This chapter has demonstrated the results of: (1) the manufacturing approaches implemented 
during this research, (2) testing of prototypes manufactured using live stem cell-derived 
cardiomyocyte clusters, and (3) the work conducted in order to characterise impedance of prototype 
electrodes compared to those of a commercial standard. 
 
Manufacturing 
 Four manufacturing approaches were implemented demonstrating different problems.  
 Two different prototypes resulted from manufacturing approach experimentation. 
 Testing of the first generation of prototype with live cardiomyocyte clusters influenced the 
design and manufacture of the second generation of prototype.   
 
Testing using cardiomyocyte clusters 
 Prototype MEA biochips were tested using the exact protocols used in real application of the 
commercial standard MEA biochip. 
 Problems encountered relating to the first generation prototype were: 
o The initial cleaning procedure employed failed and the seeded cells were lost due to 
contamination. 
o The media well material was opaque limiting illumination of the area to be seeded 
inside the biochip. 
o The media well height made access (for cluster seeding) while under the microscope 
more difficult. 
o The base substrate material and electrode geometry resulted in restricted optical 
monitoring of the cardiomyocyte clusters once seeded inside the MEA biochip.  
o The microwells geometry resulted in difficulty during cluster seeding. It was 
observed that larger microwell geometries may be more suitable due to the differing 
sizes of the cardiomyocyte clusters. 
o No signals were observed from the microwells that had cardiomyocytes successfully 
attached inside. 
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 Improvements implemented in the second generation of prototype: 
o Media well height was reduced so that it was easier to access the area inside more 
easily during cardiomyocyte cluster seeding. 
o The glass base substrate and altered electrode geometry allowed monitoring of the 
clusters after seeding and throughout testing. This allowed confirmation that the 
clusters were contracting prior to and following signal detection tests. 
o The glass/electrode surface exhibited appropriate cardiomyocyte cluster attachment 
over the electrodes. 
o PDMS used as the microwell and insulating material demonstrated poor cell 
attachment making it a more suitable material than the Melinex™ used in the first 
generation of prototype. 
o The large microwells improved ease of cluster positioning during seeding. 
 Problems encountered relating to the second generation prototype were: 
o The media wells leaked and epoxy demonstrated signs of culture media absorption. 
o No signals were observed from the microwells that had cardiomyocytes successfully 
attached inside. 
 First and second generation prototypes were tested in two different MEA systems, one 
commercially available system and one custom-made system. No signals were captured 
from any of the tested prototypes tested in either MEA system. 
 
Impedance comparison 
 Various impedance measurements were made of each prototype and of the commercial 
standard used in testing as the control MEA biochip. 
 Prototype electrodes were shown to have significantly lower impedance as when compared 
to the commercial standard. It was hypothesised that this would result in improved signal 
detection. This hypothesis was disproved through the live testing conducted. 
 It is thought that two factors may have influenced the failed signal detection tests: (1) the 
detection electronics (MEA system configurations) were inappropriately matched to the 
electrode’s properties, or (2) a better understanding is required of the cell-electrode 
interface to ensure electrode properties match the physics of signal transmission. 
Figure ‎6.42 summarises the contents of this chapter. 
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Manufacture and Prototype 
Testing
Four manufacturing 
approaches were 
implemented in pursuit of 
prototype production.
Two generations of 
prototype were 
successfully manufactured 
for testing.
The results of the testing 
conducted of the first 
generation of prototype 
directly influenced the 
design and manufacture of 
the second prototypes.
Protocols used in testing 
were the same as those 
used in the employment of 
a commercial MEA system 
in this application domain 
A number of problems where highlighted during 
testing of the first generation prototypes:
- Opaque media well material was not favoured by 
MEA users. The height of the media well was also too 
high.
-The facility to observe cardiomyocyte clusters 
contracting while in situ is essential in this application 
domain.
-Microwells with a diameter of 500µm are not 
optimally sized for the varying sizes of cardiomyocyte 
clusters produced. A number of clusters seeded failed 
to attach inside the microwells over which they were 
originally positioned. 
- The first prototype failed to show any signals where 
cardiomyocyte clusters were attached over an 
electrode. 
Improvements that were implemented 
in the second generation of prototype 
following testing of generation one 
prototypes:
-Media well material was altered to a 
transparent one and the height 
reduced.
-A glass base substrate was introduced 
and the electrode geometry altered to 
allow optical monitoring of the clusters.
- Microwell goemetry was increased. 
PDMS used as the microwell and 
insulating material demonstrated poor 
cell attachment making it a more 
suitable material than the Melinex™ 
used in the first generation of 
prototype.
Problems highlighted during testing of 
the second generation of prototypes: 
- media wells leaked where epoxy had 
been used to adhere glass to glass.
- This generation of prototype also 
failed to detect signals from the 
contracting cardiomyocyte clusters 
attached over the electrodes.
Two MEA systems were used 
to test for signals from each 
biochip.
1) Multi Channels Systems 
MEA60-Inv-BC-system,
2) Custom-made experimental 
system
Impedance measurements were 
made of each prototype version 
and a commercial standard 
MEA biochip used as the control 
during testing. Impedance of the 
novel prototypes electrode were 
shown to be significantly lower 
than the electrodes in the 
commercial standard. 
Further consideration is required of the 
following points in pursuit of greater 
understanding why signals were not 
detected: 
1) the configuration of the detection 
electronics to complement the 
electrodes,
2) a greater understanding of the 
physics of signal transmission at the 
cell-electrode interface.
Manufacture
Prototypes
Impedance
 
Figure ‎6.42: A summary of the contents of Chapter 6. 
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6.4 Research Questions Answered 
 
1. What has this research done to produce a solution device to meet the requirements 
identified? 
Following user requirement identification (Chapter 4) a design concept was drafted for a 
prototype solution device that would meet the user needs (Chapter 5). In attempts to 
manufacture the design concept a number of manufacturing approaches were implemented 
(Chapter 5).  
The problems that arose during manufacture (section ‎6.1) were strategically targeted until a 
prototype that was suitable for testing was manufactured. The resulting first generation (G1) of 
prototype was tested in a bioscientific laboratory by skilled MEA system users. The testing 
protocol was equivalent to the protocols used in real MEA system application when using stem 
cell-derived cardiomyocyte clusters. The results of testing conducted (section ‎6.2.1) led to a 
concept re-design with the intention to produce a prototype better suited to additional user 
requirements highlighted in G1 tests.   
The new concept design was manufactured using a different manufacturing approach and 
materials combinations resulting in a second generation (G2) of prototypes suitable for testing in 
the cardiomyocyte cluster bioscientific application environment. The results of G2 testing 
(section ‎6.2.2) highlighted further issues with design that must be addressed before arriving at a 
suitable solution MEA biochip device.   
 
2. How were the manufactured prototypes tested, and what were the outcomes of those 
tests? 
Prototypes were tested for user satisfaction and functionality. The ease of cardiomyocyte cluster 
positioning, and optical monitoring were considered as user satisfaction metrics and 
biocompatibility and signal detection were considered as functionality metrics.  
First generation prototypes exhibited poor cardiomyocyte cluster positioning and poor optical 
characteristics. The materials used were demonstrated to be suitably biocompatible but no 
signals were detected through the electrodes. 
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Second generation prototypes exhibited good cardiomyocyte cluster positioning and good 
optical monitoring, satisfying user requirements in terms of these essential metrics. The base 
substrate, electrode, and microwell and insulation materials were demonstrated to be 
appropriately biocompatible. The signal detection function however failed, resulting in overall 
prototype failure.   
 
3. Has a suitable alternative to current the standard commercial biochips used in 
cardiomyocyte cluster application been realised? 
The prototype devices manufactured and tested during this research do not provide a solution 
device that would be equivalent or superior to the commercially available MEA biochips used in 
this MEA system application domain.  
Further work is suggested as required to provide a suitable solution device (see Chapter 7). 
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This Thesis
Chapter 7
Discussion and 
Conclusions
Research Review
Research Achievements
Continuation of Research  
Chapter Seven 
7 Conclusions and Recommendations 
 
 
Early research evaluated the research problem using literature and MEA system user observations so 
that effective design would result in a manufacturable concept that is well suited to testing with 
living tissue. The intention of this research was to realise a new design that would meet the 
identified (Chapters 4 and 5) and prioritised (Chapter 5) requirements.  
Chapters 2, 3 and 4 present the context research that was compiled and used to gain a thorough 
understanding of current MEA system components, applications, developmental trends and user 
requirements.  
Requirements were identified that were separated into global generic requirements, local 
collaborator specific requirements, and application of interest specific requirements, through the 
use of three progressively specific product design specification (PDS) documents (Appendix C).  
A diversity of requirements were identified, that due to limited resources and the time scale of this 
research, could not all be addressed in a single PDS. One user application was focused upon for the 
remainder of the research conducted. The stem cell-derived cardiomyocyte cluster application was 
selected because a PDS containing realistic and achievable design objectives was drafted by MEA 
system users that could be immediately focused upon (PDS 3). 
PDS 3 contained requirements that were analysed and prioritised using an internationally 
standardised quality management system methodology (HoQ Matrix, see section ‎5.2.1.1). This 
methodology led to a prioritised list of design objectives that supported the design and manufacture 
of a device that offers best novelty and competitive advantage. 
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A novel MEA biochip concept was designed that was intended to specifically address issues relating 
to the positioning of the contracting cardiomyocyte clusters over the microelectrodes. The design 
was manufactured and tested (section ‎6.2.1). Feedback gained during testing of this first concept 
(generation one prototypes) led to a revised second novel MEA biochip design (generation two 
prototypes) that sought to meet the original user requirements targeted in PDS 3. 
Prototypes were successfully manufactured that met a number of the PDS design objectives. 
However, the overall functionality of both generations of prototype failed in tests using living 
cardiomyocyte clusters. Contraction field potentials could not be visualised using detection 
hardware available. 
 
In summary research in this thesis was conducted to: 
1. Investigate the feasibility of designing and manufacturing of a novel MEA system 
2. Identify current user and system requirements 
3. Develop solution concepts and manufacture solution prototypes  
4. Test manufactured prototype devices  
 
 
7.1 Research Review 
Numerous research questions arose and were addressed throughout the course of this research. 
Each research question is addressed at the end of each chapter. 
 
Knowledge and understanding of MEA systems has been ascertained through this research in terms 
of: 
1. System components (Chapter 2), 
2. How systems are used (applications) (Chapters 2, 3 and 4),  
3. How system use has changed since their introduction approximately 35 years ago (Chapters 
2, 4 and 6). 
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Experience has been gained of:  
1. Conducting context research and requirement identification, definition and prioritisation 
(Chapter 2),  
2. PDS construction (Chapter 3),  
3. Enterprise modelling (Chapter 4),  
4. Concept design (Chapter 5),  
5. Implementation of manufacturing techniques (Chapter 5),  
6. Testing of prototype devices using stem cell derived cardiomyocyte clusters (Chapter 6).  
 
While seeking to address the throughput issue stated in Chapter 1 the following novelty has been 
presented in this thesis: 
1. A novel electrode layout has been introduced with the specific intention to support >1 
cardiomyocyte cluster in one media well. 
2. A microwell feature has been introduced to limit the mobility of the contraction 
cardiomyocyte clusters immediately after seeding and during the attachment period. 
3. The biochip and microwell features have been manufactured using a manufacturing 
approach that is novel in this domain (e.g. Melinex coupled with excimer laser ablation for 
first generation prototypes, and PDMS over novel electrode geometries for second 
generation prototypes). 
This novelty has been designed to be transferable to future systems that will be humidified 
incubator compatible and also more compact. 
 
 
7.2 Research Achievements 
This research identified MEA system requirements from three perspectives (global, local and 
application specific). This research then developed novel MEA biochip concepts that were 
application specific. The novel design concepts were successfully manufactured as prototypes using 
a combination of approaches not used in this manufacturing domain before. Testing of the 
prototype devices was conducted, validating the manufacturing approaches and the varying material 
combinations exploited.  
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Contributions have been made to academic research through presentations and publications. 
The findings of this research have also emphasised an importance of complimenting MEA biochip 
electrode design and detecting system configuration to facilitate adequately support biochip 
functionality.  
 
7.3 Continuation of Research 
Recommendations for further work in the continuation of this research are as follows: 
1. Implement alterations to the custom-made system currently under development and re-test 
existing prototypes for signal detection. 
2. Reconfigure the electrode and microwell design to provide smaller electrode geometries 
while still providing a microwell that adequately sized to contain cardiomyocyte clusters of 
varying sizes (~200-800µm). 
3. Consider packaging of all components developed such that they are suited to long periods 
within the incubated environments essential during cell culture. 
4. Address the remaining unaddressed requirements cardiac application requirements 
presented in Figure ‎7.1. 
5. Address the remaining unaddressed requirements neural application requirements 
presented in Figure ‎7.1. 
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Case 1:
Stem-cell derived 
cardiomyocytes for 
cardio-active substance 
screening
Case 2:
Dissociated neural cell 
cultures for observation 
and assessment of 
network development 
and synaptic plasticity
Case 3: 
Hippocampal slices for 
known pathway 
plasticity following 
stimulation 
experiments.
Obs. 1.1  Facilitate appropriate handling for cell culture.
Obs. 1.2  Increase the number of contracting cell clusters per media well/per biochip. 
Obs. 1.3  Ensure output  at comparable or better quality than current.
Obs. 1.4  Ensure testing can be comparable, faster and simpler. 
Obs. 1.5  Remove need to sterilise and treat biochip before use.
Obs. 1.6  Provide a way to guarantee attachment of cell cluster over electrodes every 
time.  
Obs. 1.7  Automation of as many processes (or of parts of processes as possible).
Obs. 1.8  Automated extraction of basic parameters.  
Obs. 1.9  Automation of software to be more intuitive and less complex.  
-  Automatic triggering or remove need for triggering.
-  Automatic QT-interval identification and QT-interval value 
   comparisons between different data files (data mining). 
Obs. 2.1  Provide a way to guarantee recordings are obtained.
Obs. 2.2  Reduce or eliminate the need for cell type specific workspace surface 
treatments. 
Obs. 2.3  Facilitate longer or continuous recording.
Obs. 2.4  Correlates new data with previously recorded data automatically and quickly.
Obs. 2.5  Electronic based method of recording MEA biochip use. 
Obs. 2.6  An incubator compatible MEA system.
Obs. 2.7  Remove the need to convert file types.
Obs. 2.8  Statistical outputs in real-time.
Obs. 2.9  Automatic production of plots.
Obs. 2.10  Removal of need to clean MEA biochips or introduction of an automated 
cleaning process.
Obs. 3.1  Biochips for fast and easy hippocampal slice positioning.
Obs. 3.2  Automated data analysis.
Obs. 3.3  One system that can facilitate ≥8 MEA biochips at one time.
Obs. 3.4  A stimulus generator that can deliver protocols to >4 MEA biochips at one 
time.
Obs. 3.5  Analysis features in the recording software delivered in real-time.
Obs. 3.6  Predefined stimulating electrodes facilitated by anatomically precise 
microelectrode positioning.
Obs. 3.7  Automated slice position checking.
Obs. 3.8  Integrated perfusion system. 
Obs. 3.9  Automatic baseline recording feature.
Obs. 3.10  System with lists of stimulation protocols ready for use. 
Addressed in this thesis
To be addressed by future work
 
Figure ‎7.1: Case study observed requirements. Those addressed in this thesis (blue box) and those still to be 
addressed are identified (orange box).
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Research Proposal 
 
Cell Friendly Electrophysiological Characterisation of Cells and Cell Therapies using Novel Modular 
Multi Electrode Array Systems 
Research: 
The objective of this research is to show the feasibility of scalable cell friendly electrophysiological 
characterisation using a novel modular multi electrode array system. 
The work will research a novel physical architecture for each sample well module supporting both 
electrical and optical requirements via vertical electrical interconnect and the integration of novel 
optical waveguide technology to support integrated electrical and optical monitoring capabilities. 
Signal processing, sensor integration and control logic for both stimulation and recording will be 
realised as software web services. Depending on requirements, appropriate encapsulation of the 
module and its rechargeable power units, measurements can proceed without ever needing to 
remove the cells from the cell friendly but electronics harsh environment of the 
incubator/manufacturing system. 
Configuration of the hardware is envisaged to encompass the possibility for end user design of 
electrode: (i) geometry (i.e. 2D, 3D size and shape), (ii) layout and separation, (iii) structure (i.e. 
surface porosity, central through holes to enable possible vacuum attachment to electrodes) and (iv) 
bio-compatible surface coatings. These capabilities will support better cell integration with the 
electrodes ((i), (iii) above), closer mapping recording layout to the physical cell architecture ((ii) 
above) and better longevity of cells ((iv) above).  
 
The aim of this proposal is to support (eventually via a case database of best practice) the end user 
in being able to determine his own appropriate shape, diameter, separation, insulation and coating 
to obtain the best signal to noise ratio for the cells under investigation. If this is unknown best case 
defaults for other successful applications will be available for start-up trials. Configuration of 
software will support the tuning of, for example, system logic, signal processing and signal pattern 
recognition based upon the requirements. Post processing software will include the detailed 
visualisation and analysis of the output of the system based upon the detailed requirements. There 
are significant challenges to the successful outcome of this research, primarily the requirement to 
integrate optical monitoring, integrate control, signal processing and sensors all within a scalable 
wireless package of the size of a well that can operate robustly within the cell culture environment 
and have 2D and 3D electrode geometries of relevance.   
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Key cell organelles 
Nucleus: Every cell contains a nucleus of which the contents are contained by a membrane. The 
nucleus contains the genetic material for the cell (the DNA) which is protected from the constant 
metabolic activity occurring in the cytoplasm.  
 
Endomembrane system: This consists of multiple organelles, the endoplasmic reticulum, vesicles 
and Golgi apparatus. The Golgi bodies and endoplasmic reticulum organelles modify proteins, and 
synthesise lipids as required by the cell for metabolism. The vesicles basically transport, store or 
digest substances. 
 
Mitochondria: Mitochondria are 2-6µm in length and 0.6µm in diameter (Pocock and Richards, 
1999) and are responsible for converting adenosine triphosphate (ATP) into energy. When one of the 
three negatively charged phosphate groups present in ATP is removed by hydrolysis a more stable 
molecule, adenosine diphosphate (ADP) results. The change from a less stable to more stable 
molecule results in the release of energy. This hydrolysis occurs within mitochondria and it is this 
energy that is used for all cell activities (Goldberg, 2010). 
 
Cytoskeleton: The cytoskeleton is made from proteins in the form of filaments (micro and 
intermediate) and microtubules. The cytoskeleton serves to provide support to the cell and gives it 
shape. Cytoskeletal elements interact with the cell membrane (Doherty and McMahon, 2008) and 
aid in movement of cell parts or of the whole cell. 
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Bioscientific Cell Characterisation Techniques 
Optical assessment:  Visual assessment of cell, tissues and their components using light microscopy 
is limited due to various cellular components (e.g. mitochondria) possessing similar optical densities 
(Cormack, 2001). In addition a single culture may contain several thousand cells making it difficult to 
distinguish one cell from another. Skilled cell culture experts rely upon visual methods to assess 
culture viability (e.g. staining) and to quantify cell populations in culture (e.g. to monitor growth 
through calculation of population multiplication/depletion). 
 
Staining:  Difficulties viewing cells and their particular cellular components are over come through 
the use of a range of selectively absorbed dyes or markers. There are dozens of variants of 
histological stains that reveal tissue components by either colouring them selectively or by 
increasing their optical densities to different extents (Cormack, 2001). Stains differ according to the 
sample that is to be observed and what the bioscientist is interested to see. A list of the 50 most 
commonly used stains in cell culture-based research is incorporated in table B1. 
Table B1: Standard histology staining procedures.  [Source: Florida State University College of Medicine, 2012.] 
Acid Fast Stain 
(for 
mycobacteria) 
Acid Fast Stain  
Alcian Blue Stain 
Alcian Blue-PAS 
Stain (PAB) 
Hyaluronidase 
Digestion for 
Alcian Blue 
Alizarin Stain for 
calcium 
Auramine-
Rhodamine Stain 
(fluorescent) 
Bielschowsky 
Stain (for senile 
Colloidal Iron 
Stain 
Congo Red Stain 
Copper Stain 
Elastic van Gieson 
Stain 
Elastic - Weigert's 
resorcin-fuchsin 
method 
Modified Elastic 
van Gieson Stain 
Fontana-Masson 
Stain for melanin 
Melanin Bleach 
Fraser Lendrum 
Stain 
Giemsa (Modified 
Gram (Modified 
Brown-Brenn) 
Stain 
Gridley's Stain for 
ameba 
Grimelius 
Argyrophil Stain 
(Pascual's 
Method) 
Grocott's 
Methenamine 
Silver (GMS) Stain 
Holzer's Glial 
Fiber Stain 
Hortega's Pineal 
Stain 
Iron Stain 
(Prussian blue) 
Methyl Green 
Pyronin (MGP) 
Stain 
Mucicarmine 
Stain 
Nissl Stain 
Oil Red O Stain 
Orcein Stain 
Periodic acid-
Schiff Stain (PAS) 
Periodic acid-
Schiff, digested 
Stain (PAS-D) 
PTAH Stain 
Reticulin Stain 
Spirochete Stain 
(Steiner & Steiner 
Sudan Black B 
Stain (for 
lipochrome) 
Sudan Black B 
Stain (for fat) 
Trichrome Stain - 
Masson's method 
Trichrome Stain - 
microwave 
method 
Thioflavin S Stain 
(for amyloid in 
tissues) 
Modified 
Thioflavin S Stain 
(for senile 
plaques) 
Toluidine Blue 
Stain (for mast 
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plaques) 
Bile Stain 
Bodian's Stain 
 
May-Gruenwald) 
Stain (for 
hematopoietic 
tissues) 
Giemsa Stain (for 
Helicobacter) 
 
Iron Stain 
(Turnbull's blue) 
Jones' Silver Stain 
Luxol Fast Blue 
(LFB) Stain 
 
method) 
 
cells) 
Urate Crystal 
Stain 
VonKossa Stain 
for calcium 
 
Monitoring growth and multiplication/depletion:  Cells can be counted using a tool called a 
haemocytometer (Lund et al, 1958; Wiedemann et al, 2011). This is small tile or specimen slide with 
a microscopic grid etched into the glass. Samples from a culture are prepared to a known 
concentration in a solution with water. A controlled quantity of the mixed solution is dispersed over 
the grid and cells are counted by eye. Calculations are used to estimate the number of cells per ml of 
solution and then corrections are made for dilution to establish populations. This process is time 
consuming and user dependant. There is an advantage to using a haemocytometer, and that is that 
dead cells can be identified by eye and eliminated from the count. 
An electronic alternative such as a Coulter counter can also be utilised which is faster than using a 
haemocytometer, but cannot distinguish between live and dead cells (Strober, 2001).  
Recent technologies intending to offer automated cell counting with the in-built ability to distinguish 
and disregard dead matter include the CASY and xCELLigence systems from Roche (Sussex, United 
Kingdom).  The CASY system is designed for overall cell culture quality control (e.g. cell concentration 
determination, cell viability, cell volume, cell aggregation and cell debris) (Roche Media Release, 
March 2011). The xCELLigence system is “for label-free (e.g. stain free) and real-time monitoring of 
cell viability” (Ke et al 2011). 
 
Biomechanical properties and microforce generation:  It has been shown that there are links 
between the structure, mechanical properties, phenotype behaviour and function of cells in 
microenvironments that are believed to have implications in human health and the biotechnology 
industry (Addae-Mensah and Wikswo, 2008). Scientists seeking to understand forces exerted in cell 
culture environments have created numerous techniques for investigating the mechanical and 
microforce properties of cells in vitro. The deformation of cells in culture has been addressed using 
tools that generate compressive or tensile forces, shear forces, bending forces, twisting forces, or a 
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combination of forces. The following table (table B2) describes methods that have been classified as 
either exerting forces actively or recording forces passively to calculate force generation in cells. 
Table B2: Techniques applied in the study of mechanical and microforce generation of cells in 
vitro, classified as either passive or active.   [Adapted from Addae-Mensah and Wikswo, 2008]. 
Passive Active 
Technique - Principle Example 
publications 
Technique – Principle Example 
publications 
Elastic Substratum Method – 
Wrinkling patterns developed 
in artificial flexible sheets are 
used to infer cell traction 
forces. 
Harris et al, 
1980; 
Danowski, 
1989. 
Atomic force microscopy 
(AFM) - Relative deformation 
of a cantilever tip and 
substrate (cell) is used to 
estimate forces. 
Hoh and 
Schoenenberger, 
1994; 
Radmacher et al, 
1996; 
Mathur et al, 
2001.  
Flexible Sheets with 
Embedded Beads – 
Displacements of beads within 
flexible sheets are used to 
infer cell traction forces.  
Lee et al, 
1994; Dembo 
and Wang, 
1999; 
Munevar et al, 
2001; Butler et 
al, 2002. 
Micropipette Aspiration – 
Gentle suction is applied to a 
micropipette attached to a 
cell. 
Jones et al, 
1999; 
Alexopoulos et 
al, 2003; Chu et 
al, 2004. 
Flexible Sheets with 
Micropatterned Dots or Grids 
– Deformation of grid or dot 
patterns is used to infer cell 
traction forces. 
Balaban et al, 
2001. 
Optical Tweezers – Dielectric 
beads of high refractive 
index are moved using laser 
beams. 
Henon et al, 
1999; Dao et al, 
2005. 
Micromachined Cantilever 
Beam – Horizontal deflection 
of cantilever with attachment 
pad is used to infer traction 
force.  
Galbraith and 
Sheetz, 1997. 
Micromachined Force 
Sensors and Actuators – 
Movable parts are fabricated 
in silicon and various 
methods such as piezo 
actuation are used to move 
them. 
Yang and Saif, 
2005; Serrell et 
al, 2007. 
Array of Vertical 
Microcantilevers – Horizontal 
deflection of individual 
vertical microcantilevers is 
used to infer traction forces.  
Tan et al, 
2003; Addae-
Mensah et al, 
2007; du 
Roure et al , 
2004; du 
Shear Flow Methods – 
Enclosed chambers with inlet 
and outlets for fluid flow are 
used to subject cells to fluid 
shear stress. 
Dong et al, 1999; 
Civelek et al, 
2002; Ainslie et 
al, 2005; Leyton-
Mange et al, 
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Roure et al , 
2005; 
2006. 
  Stretching Devices – The 
flexible membrane is 
attached to structures that 
enable the membrane to be 
stretched. 
Wang et al, 
2000; Zhuang et 
al, 2000. 
  Carbon Fibre- Based Systems 
– Carbon fibres are attached 
to directly to a cell and 
controlled mechanically 
using feedback systems. 
Yasuda et al, 
2001; Nishimura 
et al, 2004; Iribe 
et al, 2007. 
  Magnetic tweezers/magnetic 
twisting cytometry – 
Magnetised ferromagnetic or 
superparamagnetic beads 
are moved by weaker 
directional magnetic 
fields/gradients. 
Bausch et al, 
1999; Chen at al, 
2001; Lele et al, 
2007. 
 
 
Electrical Characterisation:  Cells and tissues can be characterised in terms of electrical activity. The 
details of which are described throughout Chapter 2. 
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Multi Channels System MEA2100-System Headstage 
 
This headstage is available in two configurations to house one or two MEA biochips (B.1). 
 
 
B.1: The two available variants of the MEA2100 headstage. 
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Product Design Specifications 
British standard BS 7373-3:2005 outlines the primary elements of a Product Design Specification 
(PDS); these elements have been considered in the context of this project and given a high, low or 
medium priority according to this work. 
 
PDS1 
The following points can be described as the “gold standard” for this project area. 
Product Design Specification for MEA Systems (in accordance with BS 7373-3:2005).  
1st June 2009 
O.M.Flaherty 
a. Aesthetics. 
Priority: LOW  
Comments: are of relatively low importance to this product. 
 
b. Company constraints. 
Priority: HIGH 
Comments: the development of this novel system is to be completed by three full 
time researchers utilising limited facilities and funding. 
 
c. Competitors.  
Priority: HIGH 
Comments: this is an area of industry that is becoming highly competitive. There is a 
lot of interest globally in how this technology can be developed and adapted (MEA 
Meetings 2008 and 2010). 
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d. Cost of product. 
Priority: HIGH 
Comments: this technology is relatively high-cost in terms of both purchasing and 
setting it up and also in its employment. 
 
e. Customer. 
Priority: HIGH 
Comments: this system is aimed at researchers across a number of biological 
disciplines as well as towards the pharmacology industry. Ability of designs to meet 
their needs will dictate success of this work. 
 
f. Disposal. 
Priority: MEDIUM 
Comments: There are currently no specific regulations governing the disposal of 
MEA systems. The disposal of biochips and systems is likely to require similar 
processing facilities to electrical products regulated by the European Waste 
Electrical and Electronic Equipment directive (WEEE). Reclaimability of materials to 
some degree would be highly desirable. 
 
g. Documentation. 
Priority: MEDIUM 
Comments: the production of appropriate documentation or manuals to for users 
will be required and should be developed alongside the technology at the 
appropriate time. 
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h. Environment. 
Priority: MEDIUM 
Comments: the environment in which the system is to be used will be defined in 
literature. Environmental issues such as power consumption and recycling will be 
considered further into the project once prototyping design in underway. 
 
i. Ergonomics. 
Priority: LOW 
Comments: modular design will be utilised to make the novel system superior to 
present systems from an ergonomic perspective. Current systems are not portable 
and elements that humans interact with are relatively lightweight so this aspect is 
not a pressing priority at this time.  
 
j. Installation. 
Priority: MEDIUM 
Comments: it is not intended that specialist installation will be required as is the 
case for current commercially available systems. 
 
k. Legal.  
Priority: LOW 
Comments: systems used in drug development will need to be robust and 
incorporate appropriate quality control to ensure legal aspects are fully are 
addressed. Regulators will specify details as required. 
 
l. Life (shelf/storage). 
Priority: MEDIUM 
Comments: products will initially be made to order according to demand. 
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m. Life (service). 
Priority: HIGH 
Comments: systems used for chronic studies will be used for months at a time. 
Systems must be robust enough not to fail during use. Biochip parts must be re-
usable at least 10 times, as is the case for commercial equivalents. 
 
n. Life span of product. 
Priority: HIGH 
Comments: System parts must be comparable or better in this element than the 
equivalent part in commercial systems. Biochips = 10 uses, Full system = 5-15 years. 
 
o. Maintenance. 
Priority: HIGH 
Comments: the novel system should require a lesser degree of maintenance than 
present systems. Time savings potentially brought about by design changes must not 
be cancelled out by a need for increased maintenance. 
 
p. Manufacturing facility.  
Priority: HIGH 
Comments: manufacturing capabilities at Loughborough University will be exploited. 
If specialist facilities are required appropriate collaborations will be pursed. 
 
q. Market constraints. 
Priority: LOW 
Comments: this product is intended to compete globally with a number of different 
variants across a number of disciplines. 
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r. Materials. 
Priority: HIGH  
Comments: novel materials may be experimented with. All materials used for 
biochip preparation will be bio inert. 
 
 
s. Packing. 
Priority: LOW 
Comments: will be investigated for each component. Must be able to be sterilised 
and ideally suited to an incubator environment. To be addressed once the initial 
core components have been designed, prototyped and validated. 
 
t. Patents. 
Priority: MEDIUM  
Comments: have been investigated and will be kept up-to-date with regular 
searches throughout the duration of the project so as to ensure Loughborough 
University’s designs do not breach other existing patents. 
 
u. Performance. 
Priority: HIGH 
Comments: all system parts must function robustly. Modes of failure must should be 
considered during design. 
 
v. Politics. 
Priority: LOW 
Comments: are of low importance to this project and product area at this time. 
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w. Processes.  
Priority: HIGH 
Comments: have been identified from the user perspective that must not be 
lengthened but can be shortened.  Manufacturing processes will be addressed in 
more detail in future work according to design decisions. 
 
x. Quality and reliability. 
Priority: HIGH 
Comments: to avoid overall product failure quality and reliability must be proven to 
be equivalent or superior to commercial equivalents at the time of launch. 
 
y. Quantity. 
Priority: MEDIUM 
Comments: will be predicted in future work. 
 
z. Safety.  
Priority: HIGH 
Comments: will be of high importance throughout manufacture and prototype 
testing. The final product must be safe to use and if it fails, it must fail in a safe way. 
Use must pose zero risk to the user.  
 
aa. Shipping.  
Priority: LOW 
Comments: will be considered at the end of the project 
 
 
 
491 
 
__________________________________________________________________________________
Appendices 
 
bb. Size. 
Priority: MEDIUM 
Comments: systems will be designed to be as small and compact as realistically 
possible. 
 
cc. Standards Specifications.  
Priority: MEDIUM  
Comments: shall be investigated in more detail in future work to ensure parts and 
the final system meet any standards identified at the time. 
dd. Testing. 
Priority: HIGH 
Comments: shall be of major importance and will be conducted throughout 
development. 
 
ee. Time scales. 
Priority: HIGH 
Comments: this project is funded for a two years during which time results must be 
generated. 
 
ff. Weight. 
Priority: MEDIUM 
Comments: will not be a major consideration in design. 
 
The following points are in addition to the standard PDS points listed above. The following factors 
are design elements incorporated into the PDS as needs identified of users generically that must be 
addressed by designers in this industry as a whole. 
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MEA technology specific needs identified by users in literature and meetings (broad MEA 
application): 
 
gg. Insulation for cell-to-substrate adhesion. 
Priority: MEDIUM 
Comments: Find a highly hydrophilic insulator that is biocompatible and more 
economical (either in labour or cost) than laminin, Matrigel™, poly-d-lysine, etc. 
 
hh. Opportunity to anchor tissue slices. 
Priority: MEDIUM 
Comments: slices need to be securely but gently secured in place. 
 
ii. Higher density of electrodes. 
Priority: HIGH 
Comments: create opportunity to record from larger areas or to a greater precision 
without compromising the intensity of stimulus that you can pass between the 
electrodes. 
 
jj. One contained system. 
Priority: MEDIUM 
Comments: ideally all testing operations and protocols executed via one interface 
located within full view or as a part of the hardware set-up. 
 
kk. Easy to sterilise. 
Priority: HIGH 
Comments: must withstand current good practice procedures for sterisation. 
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ll. Scalable. 
Priority: HIGH 
Comments: current trends in this industry is for more electrodes and thus data to be 
required. Suggestions that this technology should be used on larger scales would be 
complemented by automation of elements. 
 
mm. Frequency. 
Priority: HIGH 
Comments: maintain or increase current facility to record at rates between 2kHz and 
50kHz. The ability to change frequency of from 0 – a 1000’s Hz is required. It must be 
easy for the user to do this. 
 
nn. Analysis features enhancement. 
Priority: HIGH 
Comments: A new system will be accompanied by an acquisition software that must 
match or be better than current equivalents. Post processing should be designed out 
by writing enhanced capability into a single acquisition and analysis software.  
 
oo. Archiving and data accumulation. 
Priority: MEDIUM 
Comments: ability to automatically analyse hundreds or thousands of trail files 
irrelevant of time of collection quickly is required to make sense of the data being 
captured. 
 
pp. Recording limitations. 
Priority: MEDIUM 
Comments: users do not currently record all of the data but future systems ideally 
should (Kopanitsa et al, 2006). The ability to record from every electrode every time 
without having to be overly concerned about consumption of disk space. 
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qq. Constant evaluation. 
Priority: MEDIUM 
Comments: allow recording and simultaneous analysis 24 hours a day, 7 days a 
week.  
 
rr. Automatic logging. 
Priority: LOW 
Comments: need improved ways to log which exact pieces of equipment have been 
used  in the creation of each file. Incorporating where and when files were recorded 
and by whom.   
 
ss. Non-invasive. 
Priority: HIGH 
Comments: must be non-invasive to cells. 
 
tt. Interface. 
Priority: HIGH 
Comments: user-friendly interface is essential to guarantee scientist acceptance and 
uptake of the system.  Simple “grab and drop” controls are ideal. Interface MUST be 
simple as users do not want to spend much time learning how to use new software. 
Must be quick to learn. Users would like option boxes that they simply check, click 
“go” and it gives requested values. It will be suitable if this feature has to be carried 
out offline as currently it does not exist. 
 
uu. Perfusion. 
Priority: MEDIUM 
Comments: allow integrated control of perfusions systems.  
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vv. Auto-thresholding. 
Priority: HIGH 
Comments: shifting of preset functions in a rack. Many windows in MC_Rack must 
currently be done one by one, by hand. Automatic threshold setting feature where 
the system sets thresholds according the data coming in. 
 
ww. Wave elements. 
Priority: HIGH 
Comments: New systems need to incorporate more functions that will measure 
actual wave elements automatically. Currently much measurement  is done by hand 
after data has been collected. 
 
xx. Simplify employment. 
Priority: HIGH 
Comments: improved methods for seeding of cells. I.e. potentially eradicate the 
need for coating. MEA with incorporated recession to aid in placement of cells. 
 
yy. Data flexibility. 
Priority: MEDIUM 
Comments: The facility to add markers/flags to the data set online and offline. 
 
zz. Quality control 
Priority: HIGH 
Comments: components that reach users must perform consistently. 
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PDS 2 
July 2009 
The following points are additional to the points discussed in PDS1. These requirements have been 
specifically emphasised by users at The Wellcome Trust’s Sanger Institute and Nottingham 
University’s Centre for Biomolecular Sciences during early group meetings.  
 
 System must sample at 10-25kHz. 
 Hardware must be grounded. 
 Hardware biosensor surfaces inside the media well must be made from biocompatible 
material(s). 
 All hardware parts must be contained in a casing that can be sterilised or must 
themselves be suited to sterilisation. 
Comments: If the entire system is to go in an incubator the electronics must be 
sealed in suitable casing for sterilisation as incubators are sterile environments. 
 Input capabilities must be limited in hardware. 
Comments: to protect/prevent damage to cells or tissue. 
 Hardware headstage unit and amplifiers must have appropriate pre-processing and 
amplification to allow for spike identification. 
 System must allow cell environment to be kept constant. 
Comments: I.e. temperature, humidity, etc. 
 System must allow appropriate human access 
Comments: for culture maintenance and perfusions systems. 
 System must incorporate a visual inspection method. 
 New software must allow thresholds to be configured to data at the time of recording. 
 Software must incorporate adjustable and ideally automatic pre-processing. 
 Software must allow for appropriate post-processing facilities if not incorporated in. 
 Software must be simple for users to learn. 
 Software must incorporate a user-friendly graphical user interface. 
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PDS3 
This product design specification lays down exactly what Loughborough University’s team have been 
working on, incorporating specific points from a document developed by Nottingham University 
users (cardiomyocyte applications) with global and local points that are of high importance to 
system success. 
 
Nottingham University users have specified needs for the biochip to be re-designed in accordance 
with their specific application needs. They have also specified the direction in which software 
changes should be made in order to support their analysis requirements more effectively than 
current protocols. It is the needs of Nottingham Users that this project will primarily focus time and 
resource on. 
 
Biosensor PDS: 
 Modify well maintaining commercial interface configuration. 
Comments: that will interface with the current MCS MEA60 System in their lab. 
 Alter well dimensions to be close to those of a 35mm culture dish. 
Comments: internal dimensions 35mm diameter, 10mm height, culture area 8.8cm2, 
media volume 3ml. 
 Incorporate a light-transmissible lid. 
Comments: to prevent evaporation. 
 Interior of well must allow for potential etching or patterning. 
 Re-usable. 
Comments: therefore must withstand sterilisation using UV light and 70% ethanol. 
 16 micro-wells. 
Comments: in any pattern. 
 Microwells as far apart as possible.  
Comments: at least 5mm in from the edge of the dish.  
 Microwells 500µm diameter,  
 with a maximal depth of 250µm,  
 and a slightly curved shape. 
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Comments: beating clusters at time of seeding vary between 200-500µm in 
diameter. 
 Electrode in centre of well flush to the surface. 
 Microwells as large a surface area as possible. 
 Made from biocompatible material(s). 
 
 
 
Software PDS: 
 Intuitive, simple-to-use software. 
 Output results in real-time 
Comments: while maintaining the current feature of optional post-processing if 
desired. 
 Features to allow patch clamp files to be analysed in the same software. 
Comments: WinEDR software format suggested. 
 Facility to average all traces for a given treatment. 
 Facility to compare averaged traces. 
 Increased detail at individual waveform level. 
Comments: QT-period identification and comparison emphasised as most important 
feature for automated extraction. Other waveform elements of interest detailed in 
the MES Specification document by NU below. 
 Adjustable, automatic pre-processing. 
 Automatic thresholding at the time of recording. 
 
System: 
 Sample rates of at least 2-25kHz. 
 Grounded. 
 Parts that can be sterilised  
Comments: If the entire system is to go in an incubator the electronics must be 
sealed in suitable casing for sterilisation as incubators are sterile environments. 
 Input capabilities limited appropriately. 
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Comments: to protect/prevent damage to cells or tissue. 
 Appropriate pre-processing and amplification. 
 Facilitate/support a constant cell environment. 
Comments: I.e. temperature, humidity, etc. 
 Allow easy access 
Comments: for users to perform culture maintenance and run perfusions systems. 
 Support visual inspection of the cells. 
 Simple to learn. 
 User-friendly interfaces. 
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The MEA Specification Document Drafted for LU by Nottingham University Users. 
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Appendix D 
 
 Case Study Timing Data 
 Standard Operating Proceedure Examples 
 QT-interval Analysis Output Example 
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Case study timing data 
In some cases variation of certain user dependant protocols resulted in timing data that is 
represented as a range (i.e. ~1-3mins). Timing information is represented in this manner where 
skilled dependencies exist in MEA system application. An example of such a situation is 
demonstrated in the figure below (D.1). 
 
 
Remove tissue EB 
form incubator
Identify beaters 
and dissect out
Transfer to 
prepared MEA
Incubator
Place lid over petri 
dish and replace 
into incubator
Differentiated EB
Microscope
Dissection tools
Micropipette
Prepared MEA
User
User
User
User
A part of P.3.A.8 that 
has not been modelled 
in detail as is not 
directly relevant to 
system design but is 
useful in understanding 
how a user interacts 
with the MEA biochip.
 
D.1: An example of an activity where timing information was skilled user dependant. 
The above figure accounts for the variable time given by UoN users for P.3.A.8 in Chapter 4, Figure 
4.6. This phase of the protocol differs depending upon the naturally formed geometry of the newly 
differentiated EB, and also depending upon the skill level of the individual scientist that is 
performing the dissecting task. 
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Example University of Nottingham SOP Documents 
 
SOP for Multielectrode array (MEA) use and pharmacological 
testing on hESC cardiomyocytes 
 
Preparing the MEA 
1) Prepare beating EBs by forced aggregation. Use beating EBs of ideally >20 days of 
differentiation. 
a. Use suitable cardiac selected MEFs for BGK-conditioned medium 
b. Use suitable cardiac selected serum for Diff Medium (= 78% DMEM, 20% cardiac 
serum, 1% NEAA, 1% GlutaMax, 10uM -ME 
2) Prepare MEA (all in class II hood) 
a. If MEA is being reused, treat with 0.25% trypsin for at least 16 hrs 
b. Wash with PBS x 2 
c. Place in 70% ethanol for 5 mins 
d. Allow to dry for ~10’ in a fresh Petri dish 
e. UV treat for 30’ 
f. Matrigel treat MEA 
i. use 1ml of Matrigel and allow to polymerise for 45’ in the hood. 
g. Aspirate and add 1ml PBS 
h. Aspirate and add 1ml of Diff Med 
i. Equiliberate in incubator for > 2hrs 
3) Position up to 4 beating areas on the electrodes of the MEA under the stereo scope. Ensure 
they are sufficiently spaced so not touching each other.  
CARE NOT TO DAMAGE ELECTRODES WITH PIPETTE OR STEM CELL KNIFE (MEAs cost ~£300 
each!!!) 
4) Allow to attach for ~2hrs on the heated stage in the hood.  
5) Check attachment and move (very gently) to incubator to fully attach overnight 
6) To pre-equiliberate Diff Med, add sufficient volumes to T75 flask(s) and place in incubator 
overnight (MEA recordings next day) 
N.B. Although not common practice for normal culture, add pen / strep to Diff Med as current 
MEA recording conditions are non-sterile 
 
505 
 
__________________________________________________________________________________
Appendices 
 
MEA setup 
7) Ensure sufficient Diff Med to T75 flask(s) has been pre-equiliberated (see above) 
8) Start computer 
9) Switch on heated stage 
10) Open [MEA select] on desktop 
a. Click [change MEA] 
i. This reduces electrical interference to subsequent recordings 
b. Unclip housing and lift top plate 
c. Insert MEA  
i. reference strip = black strip to right hand side = electrode 15 
d. Replace top plate 
e. Fasten clips 
f. Cover with Petri dish 
g. Unclick [change MEA] 
11) Open [MC_Rack] on desktop 
a. For a previous used recording rack open D:/Profile 
Examples/Example of recording rack. If this rack is used, 
jump to click [play] several steps below 
b. If setting up from scratch, proceed to next step 
12) Establish subfolder system as follows 
a. Recorder 
i. MC_Card 
1. Data display (rename to ‘raw data’) 
13) Set parameters in subfolders and associated tabs as follows  
a. Recorder tabs 
i. Rack – no action 
ii. Channels – tick only Electrode raw data 
iii. Recorder  
1. specify file name for each new recording 
2. Set file size to 3 min and tick auto Stop 
iv. Window – highlight Continuous 
b. MC_Card tabs 
i. Rack – no action 
ii. Hardware 
1. Input voltage range -819 to +819mV 
2. Sampling Freq 10000Hz 
iii. Info – no action 
c. Display (raw data) tabs 
i. Rack – no action 
ii. Layout – open inverted 8x8 file 
iii. Data 
1. check only electrode raw data 
2. Plot type – trace 
iv. Window – highlight continuous 
14) Click [play] to check all working OK. 
a. N.B. some parameter adjustments CANNOT be changed when system is playing or 
recording 
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MEA data capture 
15) With a plastic Pasteur pipette, aspirate medium and discard in to pot containing trigene  
a. take care not to damage beaters or MEA 
16) Add 900 ul pre-equiliberated Diff Med 
17) Allow cells to stabilise for 5 min 
18) Click [recorder] 
a. Click recorder tab 
b. Click [browse] 
c. Assign file name 
19) Add 100ul of 10x stock drug (e.g. isoprenaline) and start recording immediately by clicking 
[record] and then [play].  
a. This will record for 3min and then auto stop. 
20) With one plastic Pasteur pipette, aspirate medium and discard in to pot containing trigene 
21) Using a second plastic Pasteur pipette, wash with ~1ml Diff Med 
a. Using a second pipette only for washing should reduce chance of drug carry over 
between treatments 
22) Add 900 ul pre-equiliberated Diff Med 
23) Go to step highlighted in red above 
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Drug concentrations (Make all drug dilutions on day of use) 
 
Agent   Company  Code  Quantity  Price 
 
Isoprenaline  Tocris    1747  100mg   £35 
(Isoproterenol) 
 
Weight out xxx and dilute into YYY of ZZZ (water??) 
Make 10x stocks at 10-8M 
(10nM) 
10-7M 
(100nM) 
10-6M 
(1000nM) 
10-5M 
(10000nM) 
Using 100ul into 900ul Diff Med gives working conc of 
 
10-9M 
(1nM) 
10-8M 
(10nM) 
10-7M 
(100nM) 
10-6M 
(1000nM) 
 
Propranolol  Sigma   P0884  1g   £12 
 
Weight out xxx and dilute into YYY of ZZZ (water??) 
Make 10x stocks at 10-6M 
(1000nM) 
Using 100ul into 900ul Diff Med gives working conc of 
 
10-7M 
(100nM) 
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Finishing 
24) Ensure locations of different beaters on the MEA are recorded in you lab book in a 
diagrammatic form for future reference 
25) Photograph beaters on MEA  
a. if necessary also take video recordings using digital camera on tripod (see Chris for 
details) 
26) Transfer each beater from MEA to eppendorf tube  
a. Alternative 1, place beater in MatTek dish for immunos 
b. Alternative 2, disaggregate and seed to MatTek dish for immunos 
27) Snap freeze in Liq N.  
28) Store at -80oC 
29) Wash MEA twice with PBS 
30) Add 1ml of 0.25% trypsin and incubate for at least 16hrs at 37oC. This: 
a. releases any cells still attached to the MEA 
b. digests the Matrigel matrix.  
31) MEA can be reused following the instructions in ‘Preparing the MEA’ above 
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Play back and analysis (Off-line analysis) 
32) Open [MC_Rack] on desktop 
a. For a previous used analysis rack open D:/Profile 
Examples/Example of analysis rack. If this rack is used, jump 
to Replay File several steps below 
b. If setting up from scratch, proceed to next step 
33) Establish subfolder system as follows 
a. Replayer 
i. Spike sorter 
1. Analyser (set name to Beat rate) 
a. Parameter Display (set name to beats) 
2. Analyser (set name to Amplitude) 
a. Parameter Display (set name to Amp) 
3. Analyser (set name to Minimum Amp) 
a. Parameter Display (set name to Min Amp) 
34) Set details of each folder as follows 
a. Recorder 
i. This tab does not need to be adjusted 
b. Replayer  
i. Rack – no action 
ii. Replayer  
1. Adjust Replay Speed to ensure spike are being analysed properly in 
the display windows 
2. Each file should be 3 min long. Set the start time to 60s 
3. Use Start / Pause button 
iii. Replay File – use to open file to be analysed 
iv. File info – no action 
v. Buffer info – no action 
c. Spike sorter  
i. Rack – no action 
ii. Settings 
1. Pre trigger = 20ms 
2. Post trigger = 100ms 
3. Dead time = 100ms 
iii. Channels – check Electrode Raw Data 
iv. Detection – Threshold channel 12; -119.9uV negative slope; Std Dev -3 
v. Sorting – no spike sorting 
vi. Layout – Use to define electrode that will appear in the display windows 
d. Beat rate  
i. Rack – no action 
ii. Channels – check only spikes 
iii. Analyser 
1. Window means (No. of windows) = 1 
2. Check only Number 
iv. ROI – continuous 2 min bins 
e. Beats 
i. Rack – no action 
ii. Layout – use to define electrodes to be analysed 
iii. Data 
1. check Parameter 1 and Number 
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2. Highlight Number 
iv. Colour – no action 
v. Ranges 
1. Set X and Y axis to min = 0; max = 100 
f. Amplitude 
i. Rack – no action 
ii. Channels – check only Electrode Raw Data 
iii. Analyser 
1. Window means (No. of windows) = 1 
2. Check only Peak-Peak Ampl. 
iv. ROI – continuous 1 min bins 
g. Amp 
i. Rack – no action 
ii. Layout – use to define electrodes that will appear in the display windows 
iii. Data 
1. check Parameter 2 and Peak-Peak Ampl 
2. Highlight Number 
iv. Colour – no action 
v. Ranges  
1. Set X axis to min = 0; max = 100s 
2. Set Y axis to min = -800; max = 800uV 
h. Minimum Amp 
i. Rack – no action 
ii. Channels – check only Electrode Raw Data 
iii. Analyser 
1. Window means (No. of windows) = 1 
2. Check only Minimum 
iv. ROI – continuous 1 min bins 
i. Min Amp 
i. Rack – no action 
ii. Layout – use to define electrodes that will appear in the display windows 
iii. Data 
1. check Parameter 3 and Minimum 
2. Highlight Number 
iv. Colour – no action 
v. Ranges  
1. Set X axis to min = 0; max = 100s 
2. Set Y axis to min = -800; max = 800uV 
 
35) Open file for play back from replayer > Replay File tab (browse) 
36) Go to Replayer > Replayer tab and set start time at 60s  
37) Click start  
a. Ensure thresholds on spike sorter are detecting spikes correctly 
b. Move thresholds by drag & drop 
38) Record data (Can pause run if time is needed to record data) 
a. One reading / electrode will be produced for beats and represents beats in 120s 
b. Two readings / electrode will be produced for Amp (record both) and represent bin 
1 = 60-120s and bin 2 = 120-180s 
c. Two readings / electrode will be produced for Minimum Amp (record both) and 
represent bin 1 = 60-120s and bin 2 = 120-180s 
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MATRIGEL ALIQUOTS AND COATING 
 
PREPARATION OF MATRIGEL 
Available from BD Biosciences, Growth Factor Reduced (GFR) MatrigelTM Matrix is a solubulized 
basement membrane preparation extracted from Engelbreth-Holm-Swarm (EHS) mouse sarcoma, a 
tumor rich in ECM proteins (Greenlee et al., 2004; see www.bdbeurope.com). Its major component 
is laminin, followed by collagen IV, heparan sulfate proteoglycans, and entactin. Matrigel is frozen at 
-20oC, liquid at 0oC and polymerises at room temperature to produce biologically active matrix 
material. This resembles the mammalian cellular basement membrane and can provide a 
physiologically relevant environment for studies of cell morphology, biochemical function, migration 
or invasion, and gene expression (Greenlee et al., 2004). It is also an effective substrate for the 
culture of hESCs in feeder-free conditions.  
 
MATRIGEL ALIQUOTS 
1. Matrigel will arrive in a 10ml pot frozen on dry ice. Transfer immediately to -80oC until 
ready to make aliquots as described below.  
2. To aliquot, place Matrigel pot in a large beaker of ice overnight in the fridge. The 
beaker must still contain ice by the following morning otherwise the Matrigel will start 
to polymerise. Also place a 5 ml pipette, 20 x 0.5 ml eppendorf tubes and an eppendorf 
tube rack at -20oC  
Note: All plastics must be thoroughly chilled and all procedures must be carried out 
swiftly, otherwise polymerization will occur while aliquotting Matrigel.  
3. Using the chilled pipette and tubes, prepare 0.5ml aliquots of Matrigel and store 
immediately at -80oC  
Note: Matrigel can also be stored at -20oC. However, many 20oC freezers undergo freeze 
/ thaw cycles that could adversely affect Matrigel. Therefore, we store Matrigel aliquots 
at -80oC.  
 
PREPARING MATRIGEL-COATED CULTURE VESSELS 
1. To prepare Matrigel-coated flasks and dishes, place 50 ml cold DMEM base medium 
(direct from fridge) into a tube. Also take a 0.5 ml aliquot from the -80oC freezer.  
2. Using a P1000 pipette, draw up cold medium and use this to defrost the aliquot of 
Matrigel. 
3. Transfer the Matrigel to the 50ml tube and mix well.  
4. Immediately add 0.2ml / cm2 of diluted Matrigel to flasks and dishes (i.e. 5ml diluted 
Matrigel / T25 flask; scale volumes according to culture vessel surface area). 
5. Allow to polymerise for 45 min in the hood or overnight in the fridge  
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Note: There should be no visible changes when the diluted Matrigel polymerises 
because the Matrigel layer will form as a very thin, transparent layer bathed in excess 
diluting DMEM. If blobs of Matrigel are visible, the diluting or coating process was not 
carried out swiftly enough and premature polymerization occurred. 
6. Matrigel-coated vessels can be stored in the fridge for ~ 1 month. Flasks should have 
the caps fully tightened and dishes should be sealed with parafilm to prevent 
evaporation of the bathing DMEM diluent  
Note: The biological properties of Matrigel are only maintained when wet. It is critical 
that evaporation during storage is minimized. We also use a spirit level to ensure the 
shelves of the fridge are level so parts of the Matrigel-coated vessels do not dry out.  
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QT-interval Analysis Output Example 
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Appendix E 
 
 House of Quality Matrix 
 Additional e-beam deposition models 
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House of Quality Matrix 
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Additional drill down models for Process One of the Clean 
Room Based Photolithography Manufacturing Approach 
 
The following interaction models (E.1 – E.4) captured and communicated further detail of the e-
beam deposition used to coat the glass substrates with Ti and Au. 
 
“Dirty”‎Area
P.1.A.1.1
Switch on pump 
isolater, system chiller, 
extraction fan, wet 
bench water and mains.
P.1.A.1.3
Check High Vacuum 
Valve is closed, 
Roughing Valve is 
closed, and Backing 
Valve is open.
P.1.A.1.4
Turn on Rotary Pump 
and check pressure 
( 5 x10
-2 
mbar).
P.1.A.1.2
Check High Vacuum 
Valve is closed, 
Roughing Valve is 
closed, and Backing 
Valve is open.
P.1.A.1.5
Switch on Diffusion 
Pump.
t= 5 mins
LU
LU
LU
LU
LU
P.1.A.1
Enter clean 
room
t= 5 mins
- CIMOSA Domain
- Non-CIMOSA Domain
- External Link
- Activity
- Decision
- Document
- Human Resource
- Physical Resource
- Event
- Information
- Finance
 
E.1: Process One (Electron beam deposition), Activity One (Switch on e-beam depositing system). 
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P.1.A.2.1
Check High Vacuum Valve is 
closed, Roughing Valve is 
closed and Backing Valve is 
open.
P.1.A.2.2
Open Isolation Valve and 
then Vent Valve
Leave to reach 
atmospheric 
pressure 
(~8 mins)
P.1.A.3.1
Winch open chamber. Perform 
a general optical check of the 
inside of the chamber. 
P.1.A.3.2
Position the samples for 
evaporation in crucibles inside 
the crucible carrier. 
P.1.A.3.3
Position the substrates for 
coating in the wafer carrier 
above the crucible area.. 
P.1.A.3.4
Check that the mirror held 
inside the chamber is in a 
position that will allow the 
crucible to be seen from the 
viewing port.
P.1.A3.5
Gently winch down the top 
section of the chamber and 
look into the viewing chamber 
to be assured everything is in 
the correct position. 
LU
LU
LU
LU
LU
LU
LU
t= 10 mins
Crucibles x2 Au Sample (5g) Ti Sample
3 inch glass 
wafers x5
Glass substrates x 5 Adhesive t= 5 mins
P.1.A.2 and A.3
- CIMOSA Domain
- Non-CIMOSA Domain
- External Link
- Activity
- Decision
- Document
- Human Resource
- Physical Resource
- Event
- Information
- Finance
E.2: Process One (Electron beam deposition), Activity Three (Insert substrates and materials for deposition). 
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P.1.A.4.1
Close Vent Valve and 
close Isolation Valve.
P.1.A.4.2
Close Backing Valve and 
open Roughing Valve.
Pressure at Head 
2 should drop to 
~7 x 10
-2
 mbar
P.1.A.4.3
Open Isolation Valve to 
“rough‎out”‎the‎chamber.
Leave for ~30 
mins while 
pressure drops to 
< 1 x 10
-1
 mbar
P.1.A.4.4
Close the Isolation Valve, 
close the Roughing Valve 
and open the Backing 
Valve.
P.1.A.4.5
Open the High Pressure 
Valve. Pressure fluctuation 
may knock off the Diffusion 
Pump but it should recover 
within ~5 mins.
P.1.A.4.6
Switch on the Edwards 
Active Gauge Controller. 
Wait for initialisation to 
complete and turn on 
display.
Leave for ~1.5 – 
2 hours mins 
while pressure 
drops to < 2.2 x 
10
-5
 mbar
LU
LU
LU
LU
LU
LU
t= 40 mins
t= ~90-120 mins
P.1.A.4
Process 
other 
substrates
Process 
other 
substrates
- CIMOSA Domain
- Non-CIMOSA Domain
- External Link
- Activity
- Decision
- Document
- Human Resource
- Physical Resource
- Event
- Information
- Finance
E.3: Process One (Electron beam deposition), Activity Four (Pump down the chamber). 
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“Dirty”‎Area
P.1.A.7.1
Close chamber.
P.1.A.7.2
Close Vent Valve and close 
Isolation Valve.
P.1.V.7.3
Close Backing Valve and 
open the Roughing Valve.
P.1.A.7.4
When pressure at Head 2 is 
~7 x 10
-2  
open Isolation 
Valve to‎“rough‎out”‎the‎
chamber.
P.1.A.7.5
Close Roughing Valve and 
open Backing Valve.
Allow pressure to 
drop
(~20 mins)
P.1.A.7.6
Switch off Diffusion Pump 
and then Rotary Pump.
This‎is‎the‎systems‎“normal‎state”.
P.1.A.7.7
Switch off all power sources 
in cleanroom.
P.1.A.7.8
Switch off pump isolater, 
system chiller, extraction 
fan, wet bench water and 
mains.
LU
LU
LU
LU
LU
LU
LU
LU
t= 25 mins
t= 10 mins
P.1.A.7
Leave clean room - CIMOSA Domain
- Non-CIMOSA Domain
- External Link
- Activity
- Decision
- Document
- Human Resource
- Physical Resource
- Event
- Information
- Finance
 
E.4: Process One (Electron beam deposition), Activity Seven (Close down system). 
530 
 
__________________________________________________________________________________
Appendices 
 
 
 
 
 
 
 
 
 
 
Appendix F 
 
 Custom-made supporting electronics 
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The Supporting Electronics and Software Solution 
 
Additional research overlapping with this work also specified supporting electronics for a new MEA 
system (F.1). Hitex Development Tools, Coventry UK, manufactured the prototype to filter and 
amplify signals with complimenting embedded real-time signal processing capability.  
A signal simulator was incorporated into the unit to test the surrounding electronics that would not 
be required in systems that were to be supplied to an end user.  
 
F.1: The Loughborough University Supporting Electronics Prototype. 
The custom-made supporting electronics was designed to be powered by a +12V continuous power 
supply. 
In order to consider the level of amplification present in the MCS system presently exploited by 
project collaborators an MCS MEA Signal Divider (SD) was purchased (F.2). The MEA-SD is inserted 
into the MEA 60 system between the MEA 1060 amplifier and the MC_Card also using 68-pin SCSI 
cables (see figure below). Comparing values of signals visualised in MC_Rack with those visualised on 
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an oscilloscope connected to the signal divider it is possible to understand the level of amplification 
in the MCS headstage. 
 
 
F.2: An MCS MEA Signal Divider for connection between the MCS 1060 headstage amplifier and the 
MC_Card. The supply voltage inputs are ordinarily not used for this device. A low-noise isolated power 
supply with 21W power and ±7V output voltage (PS20W) can be used for custom setups where the IPS10W 
power supply (usually integrated into the PC) is not connected. Input supply voltage can range from 6V to 
12V in such cases. 
 
The custom-made electronics connects up to 8 channels of signals from a live culture in an MEA 
biochip. The connections for both the live inputs and the simulated inputs, used in pre-test system 
and software validation, are demonstrated in the figure below (F.3). 
 
F.3: The Loughborough University Real-time Inputs and Signal Simulator Connections. 
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The outputted filtered and amplified signals from the custom-made system can be visualised 
through connection of an appropriate device to the inputted channels corresponding BNC connector 
(F.4). 
 
F.4: The Loughborough University Real-time Outputs via BNC connection. 
 
The ARM Cortex-M3 microprocessor was state-of-the-art in January 2009 when hardware 
specifications were drafted. A top of the range microcontroller was selected to facilitate the 
intention to develop improved processing of neural signals in real-time (a long-term objective of the 
project). The contracted company (Hitex, Coventry UK) defined the maximum number of recording 
I/Os as 8 channels per microcontroller. System components designed would be scaled accordingly. 
Therefore 4, 8, 10 and 16 channel layouts were investigated throughout MEA biochip design 
iteration.  
